<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>MDMA</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/MDMA">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/mw.MediaWikiPlayer.loader.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/mw.MediaWikiPlayer.loader.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/mw.PopUpMediaTransform.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/mw.PopUpMediaTransform.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/mw.TMHGalleryHook.js.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/mw.TMHGalleryHook.js.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/mediawiki.page.gallery.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/mediawiki.page.gallery.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.tmh.thumbnail.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.tmh.thumbnail.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">MDMA</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>3,4-Methyl<wbr><span>​</span>enedioxy<wbr><span>​</span>methamphetamine</b> (<b>MDMA</b>),<span class="mw-ref" id="cite_ref-13"><a href="#cite_note-13" style="counter-reset: mw-Ref 1;" data-mw-group="note"><span class="mw-reflink-text">[note 1]</span></a></span> commonly known as <b>ecstasy</b> (<b>E</b>) or <b>molly</b>, is a psychoactive drug primarily used for recreational purposes.<span class="mw-ref" id="cite_ref-Current2013_14-0"><a href="#cite_note-Current2013-14" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> The desired effects include altered sensations, increased energy, empathy, as well as pleasure.<span class="mw-ref" id="cite_ref-Current2013_14-1"><a href="#cite_note-Current2013-14" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span><span class="mw-ref" id="cite_ref-Drugs2014_15-0"><a href="#cite_note-Drugs2014-15" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> When taken by mouth, effects begin in 30 to 45 minutes and last 3 to 6 hours.<span class="mw-ref" id="cite_ref-Freye2009_11-2"><a href="#cite_note-Freye2009-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span><span class="mw-ref" id="cite_ref-NIH2016_16-0"><a href="#cite_note-NIH2016-16" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></p>


<div role="note" class="hatnote navigation-not-searchable">Not to be confused with <a href="3,4-Methylenedioxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/3%2C4-Methylenedioxyamphetamine" title="3,4-Methylenedioxyamphetamine">MDA</a>, EDMA or 2,3-MDMA.</div>
<p></p>

<p></p>
<table class="infobox" style="width:22em;border-spacing:2px;"><caption>MDMA<br><span style="font-size:85%; font-weight:normal;"><abbr>INN</abbr>:</span> Midomafetamine<span class="mw-ref" id="cite_ref-INN_1-0"><a href="#cite_note-INN-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/MDMA_(simple).svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/MDMA_(simple).svg.png" data-file-width="256" data-file-height="113" data-file-type="drawing" height="110" width="250"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/MDMA_molecule_from_xtal_ball.png" tppabs="https://ptable.com/wiki/compounds/I/m/MDMA_molecule_from_xtal_ball.png" data-file-width="3000" data-file-height="2750" data-file-type="bitmap" height="229" width="250"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pronunciation</th><td>methylenedioxy<span>­</span>methamphetamine:<br><span class="rt-commentedText nowrap"><span class="IPA nopopups noexcerpt">/<span style="border-bottom:1px dotted"><span>ˌ</span><span>m</span><span>ɛ</span><span>θ</span><span>ɪ</span><span>l</span><span>iː</span><span>n</span><span>d</span><span>aɪ</span><span>ˈ</span><span>ɒ</span><span>k</span><span>s</span><span>i</span></span>/</span></span><br><span class="rt-commentedText nowrap"><span class="IPA nopopups noexcerpt">/<span style="border-bottom:1px dotted"><span>ˌ</span><span>m</span><span>ɛ</span><span>θ</span><span>æ</span><span>m</span><span>ˈ</span><span>f</span><span>ɛ</span><span>t</span><span>əm</span><span>iː</span><span>n</span></span>/</span></span><span> </span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Other names</th><td><abbr>3,4-MDMA</abbr>; Ecstasy (E, X, XTC); Molly; Mandy<span class="mw-ref" id="cite_ref-nature.com_2-0"><a href="#cite_note-nature.com-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-DrugFacts_3-0"><a href="#cite_note-DrugFacts-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/MDMA.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/MDMA.html'" tppabs="https://www.drugs.com/MDMA.html" class="external text external">MDMA</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Dependence<br>liability</th><td>Physical: not typical<span class="mw-ref" id="cite_ref-palmer_4-0"><a href="#cite_note-palmer-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><br>Psychological: moderate</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Addiction<br>liability</th><td>Low–moderate<span class="mw-ref" id="cite_ref-NHM-MDMA_5-0"><a href="#cite_note-NHM-MDMA-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span><span class="mw-ref" id="cite_ref-Betzler2017_6-0"><a href="#cite_note-Betzler2017-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-Substance_abuse_7-0"><a href="#cite_note-Substance_abuse-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>Common: by mouth<span class="mw-ref" id="cite_ref-EU2015_8-0"><a href="#cite_note-EU2015-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><br> Uncommon: snorting,<span class="mw-ref" id="cite_ref-EU2015_8-1"><a href="#cite_note-EU2015-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> inhalation (vaporization),<span class="mw-ref" id="cite_ref-EU2015_8-2"><a href="#cite_note-EU2015-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> injection,<span class="mw-ref" id="cite_ref-EU2015_8-3"><a href="#cite_note-EU2015-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-9"><a href="#cite_note-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> rectal</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Drug class</th><td>empathogen–entactogen<br> stimulant</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>none</li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>S9 (Prohibited substance)<span> </span></li>
<li><small><abbr class="country-name">BR</abbr>:</small><span> </span>Class F (Prohibited substances)<span> </span></li>
<li><small><abbr class="country-name">CA</abbr></small>:<span> </span>Schedule I<span> </span></li>
<li><small><abbr class="country-name">DE</abbr></small>:<span> </span>Anlage I (Authorized scientific use only)<span> </span></li>
<li><small><abbr class="country-name">NZ</abbr></small>:<span> </span>Class B<span> </span></li>
<li><small><abbr class="country-name">UK</abbr>:</small><span> </span>Class A<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>Schedule I<span> </span></li>
<li><small><abbr class="country-name">UN</abbr>:</small><span> </span>Psychotropic Schedule<span>&nbsp;</span>I<span> </span></li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Liver, CYP450 extensively involved, including CYP2D6</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolites</th><td><a href="3,4-Methylenedioxyamphetamine-2.htm" tppabs="https://ptable.com/wiki/compounds/A/3%2C4-methylenedioxyamphetamine" title="3,4-methylenedioxyamphetamine" class="mw-redirect">MDA</a>, HMMA, <span class="new">HMA</span>, <a href="Alpha-Methyldopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Alpha-Methyldopamine" title="Alpha-Methyldopamine">DHA</a>, MDP2P, MDOH<span class="mw-ref" id="cite_ref-pmid22392347_10-0"><a href="#cite_note-pmid22392347-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Onset of action</th><td>30–45<span>&nbsp;</span>minutes (by mouth)<span class="mw-ref" id="cite_ref-Freye2009_11-0"><a href="#cite_note-Freye2009-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>(<i>R</i>)-MDMA: 5.8<span>&nbsp;</span>±<span>&nbsp;</span>2.2<span>&nbsp;</span>hours (variable)<span class="mw-ref" id="cite_ref-Toxnet_MDMA_12-0"><a href="#cite_note-Toxnet_MDMA-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span><br>(<i>S</i>)-MDMA: 3.6<span>&nbsp;</span>±<span>&nbsp;</span>0.9<span>&nbsp;</span>hours (variable)<span class="mw-ref" id="cite_ref-Toxnet_MDMA_12-1"><a href="#cite_note-Toxnet_MDMA-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Duration of action</th><td>4–6<span>&nbsp;</span>hours<span class="mw-ref" id="cite_ref-Betzler2017_6-1"><a href="#cite_note-Betzler2017-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-Freye2009_11-1"><a href="#cite_note-Freye2009-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Kidney</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">(<i>RS</i>)-1-(1,3-Benzodioxol-5-yl)-<i>N</i>-methylpropan-2-amine</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=42542-10-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=42542-10-9'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=42542-10-9" class="external text external">42542-10-9</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span>[TOXNET]</sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/1615  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/1615'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/1615" class="external text external">1615</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4574  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4574'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4574" class="external text external">4574</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB01454  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB01454'" tppabs="https://www.drugbank.ca/drugs/DB01454" class="external text external">DB01454</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.1556.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.1556.html'" tppabs="http://www.chemspider.com/Chemical-Structure.1556.html" class="external text external">1556</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=KE1SEN21RM  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=KE1SEN21RM'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=KE1SEN21RM" class="external text external">KE1SEN21RM</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D11172  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D11172'" tppabs="https://www.kegg.jp/entry/D11172" class="external text external">D11172</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:1391  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:1391'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:1391" class="external text external">CHEBI:1391</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL43048  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL43048'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL43048" class="external text external">ChEMBL43048</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PDB ligand</th><td><div class="plainlist"><ul><li>B41 (<span><a href="javascript:if(confirm('https://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=B41  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=B41'" tppabs="https://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=B41" class="external text external">PDBe</a></span>, <span><a href="javascript:if(confirm('http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=ChemCompIdQuery&chemCompId=B41&polymericType=Any  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=ChemCompIdQuery&chemCompId=B41&polymericType=Any'" tppabs="http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=ChemCompIdQuery&chemCompId=B41&polymericType=Any" class="external text external">RCSB<span>&nbsp;</span>PDB</a></span>)</li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID90860791  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID90860791'" tppabs="https://comptox.epa.gov/dashboard/DTXSID90860791" class="external text external">DTXSID90860791</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>11</sub><span>H</span><sub>15</sub><span>N</span><span>O</span><sub>2</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">193.246</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=CC%28NC%29CC1%3DCC%3DC%28OCO2%29C2%3DC1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=CC%28NC%29CC1%3DCC%3DC%28OCO2%29C2%3DC1'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=CC%28NC%29CC1%3DCC%3DC%28OCO2%29C2%3DC1" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Chirality</th><td>Racemic mixture</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Boiling point</th><td>105<span>&nbsp;</span>°C (221<span>&nbsp;</span>°F) at 0.4<span>&nbsp;</span>mmHg (experimental)</td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">CC(NC)CC1=CC=C(OCO2)C2=C1</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C11H15NO2/c1-8(12-2)5-9-3-4-10-11(6-9)14-7-13-10/h3-4,6,8,12H,5,7H2,1-2H3<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:SHXWCVYOXRDMCX-UHFFFAOYSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=632164040&page2=MDMA  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=632164040&page2=MDMA'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=632164040&page2=MDMA" class="external text external">(verify)</a></span></span></td></tr></tbody></table>

<p>Adverse effects include addiction, memory problems, paranoia, difficulty sleeping, teeth grinding, blurred vision, sweating and a rapid heartbeat.<span class="mw-ref" id="cite_ref-Drugs2014_15-1"><a href="#cite_note-Drugs2014-15" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> Deaths have been reported due to increased body temperature and dehydration.<span class="mw-ref" id="cite_ref-Drugs2014_15-2"><a href="#cite_note-Drugs2014-15" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> Following use people often feel depressed and tired.<span class="mw-ref" id="cite_ref-Drugs2014_15-3"><a href="#cite_note-Drugs2014-15" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> MDMA acts primarily by increasing the activity of the neurotransmitters <a href="Serotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Serotonin" title="Serotonin">serotonin</a>, <a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">dopamine</a> and noradrenaline in parts of the brain.<span class="mw-ref" id="cite_ref-Drugs2014_15-4"><a href="#cite_note-Drugs2014-15" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span><span class="mw-ref" id="cite_ref-NIH2016_16-1"><a href="#cite_note-NIH2016-16" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> It belongs to the substituted amphetamine classes of drugs and has stimulant and hallucinogenic effects.<span class="mw-ref" id="cite_ref-EU2015_8-4"><a href="#cite_note-EU2015-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-17"><a href="#cite_note-17" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span></p>


<p>MDMA is illegal in most countries<span class="mw-ref" id="cite_ref-Drugs2014_15-5"><a href="#cite_note-Drugs2014-15" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span><span class="mw-ref" id="cite_ref-18"><a href="#cite_note-18" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> and, as of 2018, has no approved medical uses.<span class="mw-ref" id="cite_ref-EU2015_8-5"><a href="#cite_note-EU2015-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-19"><a href="#cite_note-19" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> Limited exceptions are sometimes made for research.<span class="mw-ref" id="cite_ref-NIH2016_16-2"><a href="#cite_note-NIH2016-16" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> Researchers are investigating whether MDMA may assist in treating severe, treatment-resistant posttraumatic stress disorder (PTSD) with phase 3 clinical trials to look at effectiveness and safety expected to begin in 2018.<span class="mw-ref" id="cite_ref-20"><a href="#cite_note-20" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span> In 2017, the FDA granted MDMA a breakthrough therapy designation<span class="mw-ref" id="cite_ref-breakthrough_therapy_24-0"><a href="#cite_note-breakthrough_therapy-24" style="counter-reset: mw-Ref 2;" data-mw-group="note"><span class="mw-reflink-text">[note 2]</span></a></span> for PTSD, meaning that if studies show promise, a review for potential medical use could occur more quickly.<span class="mw-ref" id="cite_ref-25"><a href="#cite_note-25" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span></p>


<p>MDMA was first developed in 1912 by Merck.<span class="mw-ref" id="cite_ref-Merck_26-0"><a href="#cite_note-Merck-26" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span> It was used to enhance psychotherapy beginning in the 1970s and became popular as a street drug in the 1980s.<span class="mw-ref" id="cite_ref-Drugs2014_15-6"><a href="#cite_note-Drugs2014-15" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span><span class="mw-ref" id="cite_ref-NIH2016_16-3"><a href="#cite_note-NIH2016-16" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> MDMA is commonly associated with dance parties, raves, and electronic dance music.<span class="mw-ref" id="cite_ref-WHO2004_27-0"><a href="#cite_note-WHO2004-27" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span> It may be mixed with other substances such as <a href="Ephedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ephedrine" title="Ephedrine">ephedrine</a>, <a href="Amphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphetamine" title="Amphetamine">amphetamine</a>, and <a href="Methamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamphetamine" title="Methamphetamine">methamphetamine</a>.<span class="mw-ref" id="cite_ref-Drugs2014_15-7"><a href="#cite_note-Drugs2014-15" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> In 2016, about 21 million people between the ages of 15 and 64 used ecstasy (0.3% of the world population).<span class="mw-ref" id="cite_ref-UN2018_28-0"><a href="#cite_note-UN2018-28" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span> This was broadly similar to the percentage of people who use <a href="Cocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaine" title="Cocaine">cocaine</a> or amphetamines, but lower than for cannabis or opioids.<span class="mw-ref" id="cite_ref-UN2018_28-1"><a href="#cite_note-UN2018-28" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span> In the United States, as of 2017, about 7% of people have used MDMA at some point in their lives and 0.9% have used it in the last year.<span class="mw-ref" id="cite_ref-29"><a href="#cite_note-29" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span></p>
<style data-mw-deduplicate="TemplateStyles:r886046785">.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}</style><div class="toclimit-3"><meta property="mw:PageProp/toc"></div>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Effects">Effects</h2></summary>
    
<p>In general, MDMA users report feeling the onset of subjective effects within 30 to 60 minutes of oral consumption and reaching peak effect at 75 to 120 minutes, which then plateaus for about 3.5 hours.<span class="mw-ref" id="cite_ref-mcn_30-0"><a href="#cite_note-mcn-30" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span> The desired short-term psychoactive effects of MDMA have been reported to include:</p>
<ul><li>Euphoria – a sense of general well-being and happiness<span class="mw-ref" id="cite_ref-Current2013_14-2"><a href="#cite_note-Current2013-14" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span><span class="mw-ref" id="cite_ref-Acute_amph_toxicity_31-0"><a href="#cite_note-Acute_amph_toxicity-31" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span></li>
<li>Increased self-confidence, sociability, and perception of facilitated communication<span class="mw-ref" id="cite_ref-Betzler2017_6-2"><a href="#cite_note-Betzler2017-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-Current2013_14-3"><a href="#cite_note-Current2013-14" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span><span class="mw-ref" id="cite_ref-Acute_amph_toxicity_31-1"><a href="#cite_note-Acute_amph_toxicity-31" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span></li>
<li>Entactogenic effects—increased empathy or feelings of closeness with others<span class="mw-ref" id="cite_ref-Current2013_14-4"><a href="#cite_note-Current2013-14" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span><span class="mw-ref" id="cite_ref-Acute_amph_toxicity_31-2"><a href="#cite_note-Acute_amph_toxicity-31" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span> and oneself<span class="mw-ref" id="cite_ref-Betzler2017_6-3"><a href="#cite_note-Betzler2017-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></li>
<li>Dilated pupils<span class="mw-ref" id="cite_ref-Betzler2017_6-4"><a href="#cite_note-Betzler2017-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></li>
<li>Relaxation and reduced anxiety<span class="mw-ref" id="cite_ref-Betzler2017_6-5"><a href="#cite_note-Betzler2017-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></li>
<li>Increased emotionality<span class="mw-ref" id="cite_ref-Betzler2017_6-6"><a href="#cite_note-Betzler2017-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></li>
<li>A sense of inner peace<span class="mw-ref" id="cite_ref-Acute_amph_toxicity_31-3"><a href="#cite_note-Acute_amph_toxicity-31" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span></li>
<li>Mild hallucination<span class="mw-ref" id="cite_ref-Acute_amph_toxicity_31-4"><a href="#cite_note-Acute_amph_toxicity-31" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span></li>
<li>Enhanced sensation, perception, or sexuality<span class="mw-ref" id="cite_ref-Betzler2017_6-7"><a href="#cite_note-Betzler2017-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-Current2013_14-5"><a href="#cite_note-Current2013-14" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span><span class="mw-ref" id="cite_ref-Acute_amph_toxicity_31-5"><a href="#cite_note-Acute_amph_toxicity-31" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span></li>
<li>Altered sense of time<span class="mw-ref" id="cite_ref-NIH2016_16-4"><a href="#cite_note-NIH2016-16" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></li></ul>

<p>The experience elicited by MDMA depends on the dose, setting, and user.<span class="mw-ref" id="cite_ref-Betzler2017_6-8"><a href="#cite_note-Betzler2017-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> The variability of the induced altered state is lower compared to other psychedelics. For example, MDMA used at parties is associated with high motor activity, reduced sense of identity, and poor awareness of surroundings. Use of MDMA individually or in small groups in a quiet environment and when concentrating, is associated with increased lucidity, concentration, sensitivity to aesthetic aspects of the environment, enhanced awareness of emotions, and improved capability of communication.<span class="mw-ref" id="cite_ref-pmid22392347_10-1"><a href="#cite_note-pmid22392347-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-Landriscina_32-0"><a href="#cite_note-Landriscina-32" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span> In psychotherapeutic settings, MDMA effects have been characterized by infantile ideas, mood lability, and memories and moods connected with childhood experiences.<span class="mw-ref" id="cite_ref-Landriscina_32-1"><a href="#cite_note-Landriscina-32" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span><span class="mw-ref" id="cite_ref-Baggott_33-0"><a href="#cite_note-Baggott-33" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span></p>

<p>MDMA has been described as an "empathogenic" drug because of its empathy-producing effects.<span class="mw-ref" id="cite_ref-Schmid_34-0"><a href="#cite_note-Schmid-34" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span><span class="mw-ref" id="cite_ref-Wardle_35-0"><a href="#cite_note-Wardle-35" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span> Results of several studies show the effects of increased empathy with others.<span class="mw-ref" id="cite_ref-Schmid_34-1"><a href="#cite_note-Schmid-34" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span> When testing MDMA for medium and high doses, it showed increased hedonic and arousal continuum.<span class="mw-ref" id="cite_ref-Bravo_36-0"><a href="#cite_note-Bravo-36" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span><span class="mw-ref" id="cite_ref-Metzner_37-0"><a href="#cite_note-Metzner-37" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span> The effect of MDMA increasing sociability is consistent, while its effects on empathy have been more mixed.<span class="mw-ref" id="cite_ref-38"><a href="#cite_note-38" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Use">Use</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Recreational">Recreational</h3></summary>
    

<p>MDMA is often considered the drug of choice within the rave culture and is also used at clubs, festivals, and house parties.<span class="mw-ref" id="cite_ref-pmid22392347_10-2"><a href="#cite_note-pmid22392347-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> In the rave environment, the sensory effects of music and lighting are often highly synergistic with the drug. The psychedelic <a href="Amphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphetamine" title="Amphetamine">amphetamine</a> quality of MDMA offers multiple appealing aspects to users in the rave setting. Some users enjoy the feeling of mass communion from the inhibition-reducing effects of the drug, while others use it as party fuel because of the drug's stimulatory effects.<span class="mw-ref" id="cite_ref-39"><a href="#cite_note-39" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span> MDMA is used less often than other stimulants, typically less than once per week.<span class="mw-ref" id="cite_ref-Epstein2013_40-0"><a href="#cite_note-Epstein2013-40" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span></p>

<p>MDMA is sometimes taken in conjunction with other psychoactive drugs such as LSD, psilocybin mushrooms, and <a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">ketamine</a>, an act called "candy-flipping".<span class="mw-ref" id="cite_ref-41"><a href="#cite_note-41" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span></p>  


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Medical">Medical</h3></summary>
    
<div role="note" class="hatnote navigation-not-searchable">See also: <a href="#Research" title="MDMA">MDMA §<span>&nbsp;</span>Research</a></div>
<p><span>As of 2017</span>, MDMA has no accepted medical indications.<span class="mw-ref" id="cite_ref-EU2015_8-6"><a href="#cite_note-EU2015-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-42"><a href="#cite_note-42" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span><span class="mw-ref" id="cite_ref-43"><a href="#cite_note-43" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span> Before it was widely banned, it saw limited use in psychotherapy.<span class="mw-ref" id="cite_ref-Betzler2017_6-9"><a href="#cite_note-Betzler2017-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-EU2015_8-7"><a href="#cite_note-EU2015-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-44"><a href="#cite_note-44" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span> A few psychotherapists continue to use MDMA in therapy despite the drug's legal status.<span class="mw-ref" id="cite_ref-45"><a href="#cite_note-45" style="counter-reset: mw-Ref 43;"><span class="mw-reflink-text">[43]</span></a></span><span class="mw-ref" id="cite_ref-Zarembo_46-0"><a href="#cite_note-Zarembo-46" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Other">Other</h3></summary>
    
<p>Small doses of MDMA are used by some religious practitioners as an entheogen to enhance prayer or meditation.<span class="mw-ref" id="cite_ref-MDMA_and_Religion_47-0"><a href="#cite_note-MDMA_and_Religion-47" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span> MDMA has been used as an adjunct to New Age spiritual practices.<span class="mw-ref" id="cite_ref-Watson_&amp;_Beck_48-0"><a href="#cite_note-Watson_&amp;_Beck-48" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Forms">Forms</h3></summary>
    

<p>MDMA has become widely known as ecstasy (shortened "E", "X", or "XTC"), usually referring to its tablet form, although this term may also include the presence of possible adulterants or diluents. The UK term "mandy" and the US term "molly" colloquially refer to MDMA in a crystalline powder form that is thought to be free of adulterants.<span class="mw-ref" id="cite_ref-nature.com_2-2"><a href="#cite_note-nature.com-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-DrugFacts_3-2"><a href="#cite_note-DrugFacts-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-DEA_2015_assessment_49-0"><a href="#cite_note-DEA_2015_assessment-49" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span> MDMA is also sold in the form of the hydrochloride salt, either as loose crystals or in gelcaps.<span class="mw-ref" id="cite_ref-Molly_S05E07_50-0"><a href="#cite_note-Molly_S05E07-50" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span><span class="mw-ref" id="cite_ref-Molly_S06E05_51-0"><a href="#cite_note-Molly_S06E05-51" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span></p>

<p>Partly due to the global supply shortage of sassafras oil—a problem largely assuaged by use of improved or alternative modern methods of synthesis—the purity of substances sold as molly have been found to vary widely. Some of these substances contain methylone, ethylone, MDPV, mephedrone, or any other of the group of compounds commonly known as bath salts, in addition to, or in place of, MDMA.<span class="mw-ref" id="cite_ref-DrugFacts_3-3"><a href="#cite_note-DrugFacts-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-DEA_2015_assessment_49-1"><a href="#cite_note-DEA_2015_assessment-49" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span><span class="mw-ref" id="cite_ref-Molly_S05E07_50-1"><a href="#cite_note-Molly_S05E07-50" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span><span class="mw-ref" id="cite_ref-Molly_S06E05_51-1"><a href="#cite_note-Molly_S06E05-51" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span> Powdered MDMA ranges from pure MDMA to crushed tablets with 30–40% purity.<span class="mw-ref" id="cite_ref-EU2015_8-8"><a href="#cite_note-EU2015-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> MDMA tablets typically have low purity due to bulking agents that are added to dilute the drug and increase profits (notably lactose) and binding agents.<span class="mw-ref" id="cite_ref-EU2015_8-9"><a href="#cite_note-EU2015-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> Tablets sold as ecstasy sometimes contain <a href="3,4-Methylenedioxyamphetamine-2.htm" tppabs="https://ptable.com/wiki/compounds/A/3%2C4-methylenedioxyamphetamine" title="3,4-methylenedioxyamphetamine" class="mw-redirect">3,4-methylenedioxyamphetamine</a> (MDA), 3,4-methylenedioxyethylamphetamine (MDEA), other amphetamine derivatives, caffeine, opiates, or painkillers.<span class="mw-ref" id="cite_ref-Betzler2017_6-10"><a href="#cite_note-Betzler2017-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> Some tablets contain little or no MDMA.<span class="mw-ref" id="cite_ref-Betzler2017_6-11"><a href="#cite_note-Betzler2017-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-EU2015_8-10"><a href="#cite_note-EU2015-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-Toxnet_MDMA_12-2"><a href="#cite_note-Toxnet_MDMA-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> The proportion of seized ecstasy tablets with MDMA-like impurities has varied annually and by country.<span class="mw-ref" id="cite_ref-EU2015_8-11"><a href="#cite_note-EU2015-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> The average content of MDMA in a preparation is 70 to 120<span>&nbsp;</span>mg with the purity having increased since the 1990s.<span class="mw-ref" id="cite_ref-Betzler2017_6-12"><a href="#cite_note-Betzler2017-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>

<p>MDMA is usually consumed by mouth. It is also sometimes snorted.<span class="mw-ref" id="cite_ref-Drugs2014_15-8"><a href="#cite_note-Drugs2014-15" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span></p>

<style data-mw-deduplicate="TemplateStyles:r923042769/mw-parser-output/.tmulti">.mw-parser-output .tmulti .thumbinner{display:flex;flex-direction:column}.mw-parser-output .tmulti .trow{display:flex;flex-direction:row;clear:left;flex-wrap:wrap;width:100%;box-sizing:border-box}.mw-parser-output .tmulti .tsingle{margin:1px;float:left}.mw-parser-output .tmulti .theader{clear:both;font-weight:bold;text-align:center;align-self:center;background-color:transparent;width:100%}.mw-parser-output .tmulti .thumbcaption{text-align:left;background-color:transparent}.mw-parser-output .tmulti .thumbcaption-center{text-align:center;background-color:transparent}.mw-parser-output .tmulti .text-align-left{text-align:left}.mw-parser-output .tmulti .text-align-right{text-align:right}.mw-parser-output .tmulti .text-align-center{text-align:center}@media all and (max-width:720px){.mw-parser-output .tmulti .thumbinner{width:100%!important;box-sizing:border-box;max-width:none!important;align-items:center}.mw-parser-output .tmulti .trow{justify-content:center}.mw-parser-output .tmulti .tsingle{float:none!important;max-width:100%!important;box-sizing:border-box;text-align:center}.mw-parser-output .tmulti .thumbcaption{text-align:center}}</style><div class="thumb tmulti tnone center"><div class="thumbinner" style="width:593px;max-width:593px"><div class="trow"><div class="tsingle" style="width:163px;max-width:163px"><div class="thumbimage" style="height:157px;overflow:hidden"><figure-inline><img src="../I/m/Ecstasy_monogram.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/Ecstasy_monogram.jpg" data-file-width="434" data-file-height="424" data-file-type="bitmap" height="157" width="161"></figure-inline></div><div class="thumbcaption">Ecstasy tablets which may contain MDMA</div></div><div class="tsingle" style="width:212px;max-width:212px"><div class="thumbimage" style="height:157px;overflow:hidden"><figure-inline><img src="../I/m/Tan_MDMA_Crystals.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/Tan_MDMA_Crystals.jpg" data-file-width="4032" data-file-height="3024" data-file-type="bitmap" height="158" width="210"></figure-inline></div><div class="thumbcaption">A salt of MDMA (typically white) with impurities, resulting in a tan discoloration</div></div><div class="tsingle" style="width:212px;max-width:212px"><div class="thumbimage" style="height:157px;overflow:hidden"><figure-inline><img src="../I/m/Crushed_MDMA_crystals.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/Crushed_MDMA_crystals.jpg" data-file-width="640" data-file-height="478" data-file-type="bitmap" height="157" width="210"></figure-inline></div><div class="thumbcaption">Crushed MDMA (1 gram) crystals</div></div></div></div></div>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Adverse_effects">Adverse effects</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Short-term">Short-term</h3></summary>
    
<p>Acute adverse effects are usually the result of high or multiple doses, although single dose toxicity can occur in susceptible individuals.<span class="mw-ref" id="cite_ref-Current2013_14-6"><a href="#cite_note-Current2013-14" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> The most serious short-term physical health risks of MDMA are hyperthermia and dehydration.<span class="mw-ref" id="cite_ref-Acute_amph_toxicity_31-6"><a href="#cite_note-Acute_amph_toxicity-31" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span><span class="mw-ref" id="cite_ref-Hyponatremia_52-0"><a href="#cite_note-Hyponatremia-52" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span> Cases of life-threatening or fatal hyponatremia (excessively low sodium concentration in the blood) have developed in MDMA users attempting to prevent dehydration by consuming excessive amounts of water without replenishing electrolytes.<span class="mw-ref" id="cite_ref-Acute_amph_toxicity_31-7"><a href="#cite_note-Acute_amph_toxicity-31" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span><span class="mw-ref" id="cite_ref-Hyponatremia_52-1"><a href="#cite_note-Hyponatremia-52" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span><span class="mw-ref" id="cite_ref-hyperpyrexia_53-0"><a href="#cite_note-hyperpyrexia-53" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span></p>

<p>The immediate adverse effects of MDMA use can include:</p>
<div class="div-col columns column-width" style="-moz-column-width: 22em; -webkit-column-width: 22em; column-width: 22em;   ">
<ul><li>Dehydration<span class="mw-ref" id="cite_ref-pmid22392347_10-3"><a href="#cite_note-pmid22392347-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-Acute_amph_toxicity_31-8"><a href="#cite_note-Acute_amph_toxicity-31" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span><span class="mw-ref" id="cite_ref-Hyponatremia_52-2"><a href="#cite_note-Hyponatremia-52" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span></li>
<li>Hyperthermia<span class="mw-ref" id="cite_ref-Betzler2017_6-13"><a href="#cite_note-Betzler2017-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-pmid22392347_10-4"><a href="#cite_note-pmid22392347-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-Hyponatremia_52-3"><a href="#cite_note-Hyponatremia-52" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span></li>
<li>Bruxism (grinding and clenching of the teeth)<span class="mw-ref" id="cite_ref-Betzler2017_6-14"><a href="#cite_note-Betzler2017-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-pmid22392347_10-5"><a href="#cite_note-pmid22392347-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-Current2013_14-7"><a href="#cite_note-Current2013-14" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></li>
<li>Increased wakefulness or insomnia<span class="mw-ref" id="cite_ref-Betzler2017_6-15"><a href="#cite_note-Betzler2017-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-Acute_amph_toxicity_31-9"><a href="#cite_note-Acute_amph_toxicity-31" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span></li>
<li>Increased perspiration and sweating<span class="mw-ref" id="cite_ref-Acute_amph_toxicity_31-10"><a href="#cite_note-Acute_amph_toxicity-31" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span><span class="mw-ref" id="cite_ref-Hyponatremia_52-4"><a href="#cite_note-Hyponatremia-52" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span></li>
<li>Increased heart rate and blood pressure<span class="mw-ref" id="cite_ref-Betzler2017_6-16"><a href="#cite_note-Betzler2017-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-pmid22392347_10-6"><a href="#cite_note-pmid22392347-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-Hyponatremia_52-5"><a href="#cite_note-Hyponatremia-52" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span></li>
<li>Increased psychomotor activity<span class="mw-ref" id="cite_ref-Betzler2017_6-17"><a href="#cite_note-Betzler2017-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></li>
<li>Loss of appetite<span class="mw-ref" id="cite_ref-Betzler2017_6-18"><a href="#cite_note-Betzler2017-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-Toxnet_MDMA_12-3"><a href="#cite_note-Toxnet_MDMA-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></li>
<li>Nausea and vomiting<span class="mw-ref" id="cite_ref-Current2013_14-8"><a href="#cite_note-Current2013-14" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></li>
<li>Diarrhea<span class="mw-ref" id="cite_ref-Acute_amph_toxicity_31-11"><a href="#cite_note-Acute_amph_toxicity-31" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span></li>
<li>Erectile dysfunction<span class="mw-ref" id="cite_ref-Betzler2017_6-19"><a href="#cite_note-Betzler2017-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-54"><a href="#cite_note-54" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span></li>
<li>Visual and auditory hallucinations (rarely)<span class="mw-ref" id="cite_ref-Betzler2017_6-20"><a href="#cite_note-Betzler2017-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></li></ul>
</div>

<p>Other adverse effects that may occur or persist for up to a week following cessation of moderate MDMA use include:<span class="mw-ref" id="cite_ref-Current2013_14-9"><a href="#cite_note-Current2013-14" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span><span class="mw-ref" id="cite_ref-Toxnet_MDMA_after-effects_55-0"><a href="#cite_note-Toxnet_MDMA_after-effects-55" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span></p>

<dl><dt>Physiological</dt></dl>
<div class="div-col columns column-width" style="-moz-column-width: 22em; -webkit-column-width: 22em; column-width: 22em;   ">
<ul><li>Trismus (lockjaw)<span class="mw-ref" id="cite_ref-Current2013_14-10"><a href="#cite_note-Current2013-14" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></li>
<li>Loss of appetite<span class="mw-ref" id="cite_ref-Toxnet_MDMA_after-effects_55-1"><a href="#cite_note-Toxnet_MDMA_after-effects-55" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span></li>
<li>Insomnia<span class="mw-ref" id="cite_ref-Toxnet_MDMA_after-effects_55-2"><a href="#cite_note-Toxnet_MDMA_after-effects-55" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span></li>
<li>Tiredness or lethargy<span class="mw-ref" id="cite_ref-56"><a href="#cite_note-56" style="counter-reset: mw-Ref 54;"><span class="mw-reflink-text">[54]</span></a></span><span class="mw-ref" id="cite_ref-57"><a href="#cite_note-57" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span></li></ul>
</div>
<dl><dt>Psychological</dt></dl>
<div class="div-col columns column-width" style="-moz-column-width: 22em; -webkit-column-width: 22em; column-width: 22em;   ">
<ul><li>Anxiety or paranoia<span class="mw-ref" id="cite_ref-Toxnet_MDMA_after-effects_55-3"><a href="#cite_note-Toxnet_MDMA_after-effects-55" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span></li>
<li>Depression<span class="mw-ref" id="cite_ref-Current2013_14-11"><a href="#cite_note-Current2013-14" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span><span class="mw-ref" id="cite_ref-Toxnet_MDMA_after-effects_55-4"><a href="#cite_note-Toxnet_MDMA_after-effects-55" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span></li>
<li>Irritability<span class="mw-ref" id="cite_ref-Toxnet_MDMA_after-effects_55-5"><a href="#cite_note-Toxnet_MDMA_after-effects-55" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span></li>
<li>Impulsiveness<span class="mw-ref" id="cite_ref-Toxnet_MDMA_after-effects_55-6"><a href="#cite_note-Toxnet_MDMA_after-effects-55" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span></li>
<li>Restlessness<span class="mw-ref" id="cite_ref-Toxnet_MDMA_after-effects_55-7"><a href="#cite_note-Toxnet_MDMA_after-effects-55" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span></li>
<li>Memory impairment<span class="mw-ref" id="cite_ref-Current2013_14-12"><a href="#cite_note-Current2013-14" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></li>
<li>Anhedonia<span class="mw-ref" id="cite_ref-Toxnet_MDMA_after-effects_55-8"><a href="#cite_note-Toxnet_MDMA_after-effects-55" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span></li></ul>
</div>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Long-term">Long-term</h3></summary>
    
<p><span>As of 2015</span>, the long-term effects of MDMA on human brain structure and function have not been fully determined.<span class="mw-ref" id="cite_ref-Abstinent_MDMA_fMRI_review_58-0"><a href="#cite_note-Abstinent_MDMA_fMRI_review-58" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span> However, there is consistent evidence of structural and functional deficits in MDMA users with high lifetime exposure.<span class="mw-ref" id="cite_ref-Abstinent_MDMA_fMRI_review_58-1"><a href="#cite_note-Abstinent_MDMA_fMRI_review-58" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span> There is no evidence of structural or functional changes in MDMA users with only a moderate (&lt;50 doses used and &lt;100 tablets consumed) lifetime exposure. Nonetheless, MDMA in moderate use may still be neurotoxic.<span class="mw-ref" id="cite_ref-mueller2015_59-0"><a href="#cite_note-mueller2015-59" style="counter-reset: mw-Ref 57;"><span class="mw-reflink-text">[57]</span></a></span> Furthermore, it is not clear yet whether "typical" users of MDMA (1 to 2 pills of 75 to 125<span>&nbsp;</span>mg MDMA or analogue every 1 to 4 weeks) will develop neurotoxic brain lesions.<span class="mw-ref" id="cite_ref-60"><a href="#cite_note-60" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span> Long-term exposure to MDMA in humans has been shown to produce marked neurodegeneration in striatal, hippocampal, prefrontal, and occipital serotonergic axon terminals.<span class="mw-ref" id="cite_ref-Abstinent_MDMA_fMRI_review_58-2"><a href="#cite_note-Abstinent_MDMA_fMRI_review-58" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span><span class="mw-ref" id="cite_ref-Meth_MDMA_NTox_61-0"><a href="#cite_note-Meth_MDMA_NTox-61" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span> Neurotoxic damage to serotonergic axon terminals has been shown to persist for more than two years.<span class="mw-ref" id="cite_ref-Meth_MDMA_NTox_61-1"><a href="#cite_note-Meth_MDMA_NTox-61" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span> Elevations in brain temperature from MDMA use are positively correlated with MDMA-induced neurotoxicity.<span class="mw-ref" id="cite_ref-pmid22392347_10-7"><a href="#cite_note-pmid22392347-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-Abstinent_MDMA_fMRI_review_58-3"><a href="#cite_note-Abstinent_MDMA_fMRI_review-58" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span>  However, most studies on MDMA and serotonergic neurotoxicity in humans focus on the heaviest users, those who consume more than seven times the average.  It is therefore possible that no serotonergic neurotoxicity is present in most casual users.<span class="mw-ref" id="cite_ref-62"><a href="#cite_note-62" style="counter-reset: mw-Ref 60;"><span class="mw-reflink-text">[60]</span></a></span> Adverse neuroplastic changes to brain microvasculature and white matter also occur in humans using low doses of MDMA.<span class="mw-ref" id="cite_ref-pmid22392347_10-8"><a href="#cite_note-pmid22392347-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-Abstinent_MDMA_fMRI_review_58-4"><a href="#cite_note-Abstinent_MDMA_fMRI_review-58" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span> Reduced gray matter density in certain brain structures has also been noted in human MDMA users.<span class="mw-ref" id="cite_ref-pmid22392347_10-9"><a href="#cite_note-pmid22392347-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-Abstinent_MDMA_fMRI_review_58-5"><a href="#cite_note-Abstinent_MDMA_fMRI_review-58" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span> Global reductions in gray matter volume, thinning of the parietal and orbitofrontal cortices, and decreased hippocampal activity have been observed in long term users.<span class="mw-ref" id="cite_ref-Betzler2017_6-21"><a href="#cite_note-Betzler2017-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> The effects established so far for recreational use of ecstasy lie in the range of moderate to severe effects for serotonin transporter reduction.<span class="mw-ref" id="cite_ref-63"><a href="#cite_note-63" style="counter-reset: mw-Ref 61;"><span class="mw-reflink-text">[61]</span></a></span></p>

<p>Impairments in multiple aspects of cognition, including attention, learning, memory, visual processing, and sleep have been found in regular MDMA users.<span class="mw-ref" id="cite_ref-Betzler2017_6-22"><a href="#cite_note-Betzler2017-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-Current2013_14-13"><a href="#cite_note-Current2013-14" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span><span class="mw-ref" id="cite_ref-Pharm2014_64-0"><a href="#cite_note-Pharm2014-64" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span><span class="mw-ref" id="cite_ref-Abstinent_MDMA_fMRI_review_58-6"><a href="#cite_note-Abstinent_MDMA_fMRI_review-58" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span> The magnitude of these impairments is correlated with lifetime MDMA usage<span class="mw-ref" id="cite_ref-Current2013_14-14"><a href="#cite_note-Current2013-14" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span><span class="mw-ref" id="cite_ref-Pharm2014_64-1"><a href="#cite_note-Pharm2014-64" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span><span class="mw-ref" id="cite_ref-Abstinent_MDMA_fMRI_review_58-7"><a href="#cite_note-Abstinent_MDMA_fMRI_review-58" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span> and are partially reversible with abstinence.<span class="mw-ref" id="cite_ref-Betzler2017_6-23"><a href="#cite_note-Betzler2017-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> Several forms of memory are impaired by chronic ecstasy use;<span class="mw-ref" id="cite_ref-Current2013_14-15"><a href="#cite_note-Current2013-14" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span><span class="mw-ref" id="cite_ref-Pharm2014_64-2"><a href="#cite_note-Pharm2014-64" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span> however, the effects for memory impairments in ecstasy users are generally small overall.<span class="mw-ref" id="cite_ref-65"><a href="#cite_note-65" style="counter-reset: mw-Ref 63;"><span class="mw-reflink-text">[63]</span></a></span><span class="mw-ref" id="cite_ref-Meta_analysis_-_MDMA_memory_impairment_66-0"><a href="#cite_note-Meta_analysis_-_MDMA_memory_impairment-66" style="counter-reset: mw-Ref 64;"><span class="mw-reflink-text">[64]</span></a></span> MDMA use is also associated with increased impulsivity and depression.<span class="mw-ref" id="cite_ref-Betzler2017_6-24"><a href="#cite_note-Betzler2017-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>

<p>Serotonin depletion following MDMA use can cause depression in subsequent days. In some cases, depressive symptoms persist for longer periods.<span class="mw-ref" id="cite_ref-Betzler2017_6-25"><a href="#cite_note-Betzler2017-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> Some studies indicate repeated recreational use of ecstasy is associated with depression and anxiety, even after quitting the drug.<span class="mw-ref" id="cite_ref-67"><a href="#cite_note-67" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span> Depression is one of the main reasons for cessation of use.<span class="mw-ref" id="cite_ref-Betzler2017_6-26"><a href="#cite_note-Betzler2017-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>

<p>At high doses, MDMA induces a neuroimmune response that, through several mechanisms, increases the permeability of the blood-brain barrier, thereby making the brain more susceptible to environmental toxins and pathogens.<span class="mw-ref" id="cite_ref-MDMA_BBB_68-0"><a href="#cite_note-MDMA_BBB-68" style="counter-reset: mw-Ref 66;"><span class="mw-reflink-text">[66]</span></a></span><span class="mw-ref" id="cite_ref-69"><a href="#cite_note-69" style="counter-reset: mw-Ref 67;"><span class="mw-reflink-text">[67]</span></a></span> In addition, MDMA has immunosuppressive effects in the peripheral nervous system and pro-inflammatory effects in the central nervous system.<span class="mw-ref" id="cite_ref-70"><a href="#cite_note-70" style="counter-reset: mw-Ref 68;"><span class="mw-reflink-text">[68]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="During_pregnancy">During pregnancy</h3></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/Rational_harm_assessment_of_drugs_radar_plot.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Rational_harm_assessment_of_drugs_radar_plot.svg.png" data-file-width="900" data-file-height="900" data-file-type="drawing" height="220" width="220"><div class="thumbcaption" style="text-align: left">Addiction experts in psychiatry, chemistry, pharmacology, forensic science, epidemiology, and the police and legal services engaged in delphic analysis regarding 20 popular recreational drugs. Ecstasy was ranked 18th in dependence, physical harm, and social harm.<span class="mw-ref" id="cite_ref-pmid17382831_71-0"><a href="#cite_note-pmid17382831-71" style="counter-reset: mw-Ref 69;"><span class="mw-reflink-text">[69]</span></a></span></div></div></div>
<p>MDMA is a moderately teratogenic drug (i.e., it is toxic to the fetus).<span class="mw-ref" id="cite_ref-vorhees_72-0"><a href="#cite_note-vorhees-72" style="counter-reset: mw-Ref 70;"><span class="mw-reflink-text">[70]</span></a></span><span class="mw-ref" id="cite_ref-meamar_73-0"><a href="#cite_note-meamar-73" style="counter-reset: mw-Ref 71;"><span class="mw-reflink-text">[71]</span></a></span> In utero exposure to MDMA is associated with a neuro- and cardiotoxicity<span class="mw-ref" id="cite_ref-meamar_73-1"><a href="#cite_note-meamar-73" style="counter-reset: mw-Ref 71;"><span class="mw-reflink-text">[71]</span></a></span> and impaired motor functioning. Motor delays may be temporary during infancy or long-term. The severity of these developmental delays increases with heavier MDMA use.<span class="mw-ref" id="cite_ref-Pharm2014_64-3"><a href="#cite_note-Pharm2014-64" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span><span class="mw-ref" id="cite_ref-singer_74-0"><a href="#cite_note-singer-74" style="counter-reset: mw-Ref 72;"><span class="mw-reflink-text">[72]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Reinforcement_disorders">Reinforcement disorders</h3></summary>
    

<p>Approximately 60% of MDMA users experience withdrawal symptoms when they stop taking MDMA.<span class="mw-ref" id="cite_ref-Toxnet_MDMA_12-4"><a href="#cite_note-Toxnet_MDMA-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> Some of these symptoms include fatigue, loss of appetite, depression, and trouble concentrating.<span class="mw-ref" id="cite_ref-Toxnet_MDMA_12-5"><a href="#cite_note-Toxnet_MDMA-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> Tolerance to some of the desired and adverse effects of MDMA is expected to occur with consistent MDMA use.<span class="mw-ref" id="cite_ref-Toxnet_MDMA_12-6"><a href="#cite_note-Toxnet_MDMA-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> A 2007 analysis estimated MDMA to have a psychological dependence and physical dependence potential roughly three-fourths to four-fifths that of cannabis.<span class="mw-ref" id="cite_ref-pmid17382831_71-1"><a href="#cite_note-pmid17382831-71" style="counter-reset: mw-Ref 69;"><span class="mw-reflink-text">[69]</span></a></span></p>


<p>MDMA has been shown to induce ΔFosB in the nucleus accumbens.<span class="mw-ref" id="cite_ref-MDMA_ΔFosB_75-0"><a href="#cite_note-MDMA_ΔFosB-75" style="counter-reset: mw-Ref 73;"><span class="mw-reflink-text">[73]</span></a></span> Because MDMA releases dopamine in the striatum, the mechanisms by which it induces ΔFosB in the nucleus accumbens are analogous to other dopaminergic psychostimulants.<span class="mw-ref" id="cite_ref-MDMA_ΔFosB_75-1"><a href="#cite_note-MDMA_ΔFosB-75" style="counter-reset: mw-Ref 73;"><span class="mw-reflink-text">[73]</span></a></span><span class="mw-ref" id="cite_ref-Nestler_76-0"><a href="#cite_note-Nestler-76" style="counter-reset: mw-Ref 74;"><span class="mw-reflink-text">[74]</span></a></span>  Therefore, chronic use of MDMA at high doses can result in altered brain structure and drug addiction that occur as a consequence of ΔFosB overexpression in the nucleus accumbens.<span class="mw-ref" id="cite_ref-Nestler_76-1"><a href="#cite_note-Nestler-76" style="counter-reset: mw-Ref 74;"><span class="mw-reflink-text">[74]</span></a></span> MDMA is less addictive than other stimulants such as methamphetamine and cocaine.<span class="mw-ref" id="cite_ref-77"><a href="#cite_note-77" style="counter-reset: mw-Ref 75;"><span class="mw-reflink-text">[75]</span></a></span><span class="mw-ref" id="cite_ref-78"><a href="#cite_note-78" style="counter-reset: mw-Ref 76;"><span class="mw-reflink-text">[76]</span></a></span> Compared with amphetamine, MDMA and its metabolite MDA are less reinforcing.<span class="mw-ref" id="cite_ref-79"><a href="#cite_note-79" style="counter-reset: mw-Ref 77;"><span class="mw-reflink-text">[77]</span></a></span></p>


<p>One study found approximately 15% of chronic MDMA users met the DSM-IV diagnostic criteria for substance dependence.<span class="mw-ref" id="cite_ref-Steinkellner2011_80-0"><a href="#cite_note-Steinkellner2011-80" style="counter-reset: mw-Ref 78;"><span class="mw-reflink-text">[78]</span></a></span> However, there is little evidence for a specific diagnosable MDMA dependence syndrome because MDMA is typically used relatively infrequently.<span class="mw-ref" id="cite_ref-Epstein2013_40-1"><a href="#cite_note-Epstein2013-40" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span></p>


<p>There are currently no medications to treat MDMA addiction.<span class="mw-ref" id="cite_ref-81"><a href="#cite_note-81" style="counter-reset: mw-Ref 79;"><span class="mw-reflink-text">[79]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Harm_assessment">Harm assessment</h3></summary>
    
<p>A 2007 UK study ranked MDMA 18th in harmfulness out of 20 recreational drugs. Rankings for each drug were based on the risk for acute physical harm, the propensity for physical and psychological dependency on the drug, and the negative familial and societal impacts of the drug. The authors did not evaluate or rate the negative impact of ecstasy on the cognitive health of ecstasy users (e.g. impaired memory and concentration).<span class="mw-ref" id="cite_ref-pmid17382831_71-2"><a href="#cite_note-pmid17382831-71" style="counter-reset: mw-Ref 69;"><span class="mw-reflink-text">[69]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Overdose">Overdose</h2></summary>
    
<p>MDMA overdose symptoms vary widely due to the involvement of multiple organ systems. Some of the more overt overdose symptoms are listed in the table below. The number of instances of fatal MDMA intoxication is low relative to its usage rates. In most fatalities, MDMA was not the only drug involved. Acute toxicity is mainly caused by serotonin syndrome and sympathomimetic effects.<span class="mw-ref" id="cite_ref-Steinkellner2011_80-1"><a href="#cite_note-Steinkellner2011-80" style="counter-reset: mw-Ref 78;"><span class="mw-reflink-text">[78]</span></a></span>  MDMA's toxicity in overdose may be exacerbated by caffeine, with which it is frequently cut in order to increase volume.<span class="mw-ref" id="cite_ref-82"><a href="#cite_note-82" style="counter-reset: mw-Ref 80;"><span class="mw-reflink-text">[80]</span></a></span> A scheme for management of acute MDMA toxicity has been published focusing on treatment of hyperthermia, hyponatraemia, serotonin syndrome, and multiple organ failure.<span class="mw-ref" id="cite_ref-83"><a href="#cite_note-83" style="counter-reset: mw-Ref 81;"><span class="mw-reflink-text">[81]</span></a></span></p>

<center>
<table class="wikitable unsortable">
<caption>Symptoms of overdose</caption>
<tbody><tr><th scope="col" style="text-align:center">System</th>
<th scope="col">Minor or moderate overdose<span class="mw-ref" id="cite_ref-pmid15228154_84-0"><a href="#cite_note-pmid15228154-84" style="counter-reset: mw-Ref 82;"><span class="mw-reflink-text">[82]</span></a></span></th><th>Severe overdose<span class="mw-ref" id="cite_ref-pmid15228154_84-1"><a href="#cite_note-pmid15228154-84" style="counter-reset: mw-Ref 82;"><span class="mw-reflink-text">[82]</span></a></span></th></tr>
<tr>
<th scope="row">Cardiovascular</th>
<td></td>
<td>
<ul><li>Disseminated intravascular coagulation<span class="mw-ref" id="cite_ref-Acute_amph_toxicity_31-12"><a href="#cite_note-Acute_amph_toxicity-31" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span></li>
<li>Intracranial hemorrhage<span class="mw-ref" id="cite_ref-Acute_amph_toxicity_31-13"><a href="#cite_note-Acute_amph_toxicity-31" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span></li>
<li>Severe hypertension<span class="mw-ref" id="cite_ref-Acute_amph_toxicity_31-14"><a href="#cite_note-Acute_amph_toxicity-31" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span><span class="mw-ref" id="cite_ref-oxford_85-0"><a href="#cite_note-oxford-85" style="counter-reset: mw-Ref 83;"><span class="mw-reflink-text">[83]</span></a></span> or hypotension<span class="mw-ref" id="cite_ref-Acute_amph_toxicity_31-15"><a href="#cite_note-Acute_amph_toxicity-31" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span></li>
<li>Hypotensive bleeding<span class="mw-ref" id="cite_ref-Betzler2017_6-27"><a href="#cite_note-Betzler2017-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></li></ul></td></tr>
<tr>
<th scope="row">Central nervous<br>system</th>
<td>
<ul><li>Hyperreflexia<span class="mw-ref" id="cite_ref-86"><a href="#cite_note-86" style="counter-reset: mw-Ref 84;"><span class="mw-reflink-text">[84]</span></a></span></li>
<li>Agitation<span class="mw-ref" id="cite_ref-Acute_amph_toxicity_31-16"><a href="#cite_note-Acute_amph_toxicity-31" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span><span class="mw-ref" id="cite_ref-oxford_85-1"><a href="#cite_note-oxford-85" style="counter-reset: mw-Ref 83;"><span class="mw-reflink-text">[83]</span></a></span></li>
<li>Mental confusion<span class="mw-ref" id="cite_ref-Acute_amph_toxicity_31-17"><a href="#cite_note-Acute_amph_toxicity-31" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span></li>
<li>Paranoia<span class="mw-ref" id="cite_ref-Acute_amph_toxicity_31-18"><a href="#cite_note-Acute_amph_toxicity-31" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span><span class="mw-ref" id="cite_ref-oxford_85-2"><a href="#cite_note-oxford-85" style="counter-reset: mw-Ref 83;"><span class="mw-reflink-text">[83]</span></a></span></li>
<li>Stimulant psychosis<span class="mw-ref" id="cite_ref-Betzler2017_6-28"><a href="#cite_note-Betzler2017-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-pmid22392347_10-10"><a href="#cite_note-pmid22392347-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></li></ul></td>
<td>
<ul><li>Cognitive and memory impairment<span class="mw-ref" id="cite_ref-Acute_amph_toxicity_31-19"><a href="#cite_note-Acute_amph_toxicity-31" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span> potentially to the point of retrograde or anterograde amnesia<span class="mw-ref" id="cite_ref-87"><a href="#cite_note-87" style="counter-reset: mw-Ref 85;"><span class="mw-reflink-text">[85]</span></a></span></li>
<li>Coma<span class="mw-ref" id="cite_ref-pmid22392347_10-11"><a href="#cite_note-pmid22392347-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-oxford_85-3"><a href="#cite_note-oxford-85" style="counter-reset: mw-Ref 83;"><span class="mw-reflink-text">[83]</span></a></span></li>
<li>Convulsions<span class="mw-ref" id="cite_ref-Acute_amph_toxicity_31-20"><a href="#cite_note-Acute_amph_toxicity-31" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span><span class="mw-ref" id="cite_ref-oxford_85-4"><a href="#cite_note-oxford-85" style="counter-reset: mw-Ref 83;"><span class="mw-reflink-text">[83]</span></a></span></li>
<li>Hallucinations<span class="mw-ref" id="cite_ref-Acute_amph_toxicity_31-21"><a href="#cite_note-Acute_amph_toxicity-31" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span><span class="mw-ref" id="cite_ref-oxford_85-5"><a href="#cite_note-oxford-85" style="counter-reset: mw-Ref 83;"><span class="mw-reflink-text">[83]</span></a></span></li>
<li>Loss of consciousness<span class="mw-ref" id="cite_ref-pmid22392347_10-12"><a href="#cite_note-pmid22392347-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></li>
<li>Serotonin syndrome<span class="mw-ref" id="cite_ref-pmid22392347_10-13"><a href="#cite_note-pmid22392347-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-Acute_amph_toxicity_31-22"><a href="#cite_note-Acute_amph_toxicity-31" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span><span class="mw-ref" id="cite_ref-hyperpyrexia_53-1"><a href="#cite_note-hyperpyrexia-53" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span></li></ul></td></tr>
<tr>
<th scope="row">Musculoskeletal</th>
<td></td>
<td>
<ul><li>Muscle rigidity<span class="mw-ref" id="cite_ref-Acute_amph_toxicity_31-23"><a href="#cite_note-Acute_amph_toxicity-31" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span></li>
<li>Rhabdomyolysis (i.e., rapid muscle breakdown)<span class="mw-ref" id="cite_ref-Acute_amph_toxicity_31-24"><a href="#cite_note-Acute_amph_toxicity-31" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span><span class="mw-ref" id="cite_ref-hyperpyrexia_53-2"><a href="#cite_note-hyperpyrexia-53" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span></li></ul></td></tr>
<tr>
<th scope="row">Respiratory</th>
<td></td>
<td>
<ul><li>Acute respiratory distress syndrome<span class="mw-ref" id="cite_ref-Acute_amph_toxicity_31-25"><a href="#cite_note-Acute_amph_toxicity-31" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span></li></ul></td></tr>
<tr>
<th scope="row">Urinary</th>
<td></td>
<td>
<ul><li>Acute kidney injury<span class="mw-ref" id="cite_ref-Acute_amph_toxicity_31-26"><a href="#cite_note-Acute_amph_toxicity-31" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span><span class="mw-ref" id="cite_ref-88"><a href="#cite_note-88" style="counter-reset: mw-Ref 86;"><span class="mw-reflink-text">[86]</span></a></span></li></ul></td></tr>
<tr>
<th scope="row">Other</th>
<td></td>
<td>
<ul><li>Cerebral edema<span class="mw-ref" id="cite_ref-pmid22392347_10-14"><a href="#cite_note-pmid22392347-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></li>
<li>Hepatitis<span class="mw-ref" id="cite_ref-Acute_amph_toxicity_31-27"><a href="#cite_note-Acute_amph_toxicity-31" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span><span class="mw-ref" id="cite_ref-hyperpyrexia_53-3"><a href="#cite_note-hyperpyrexia-53" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span></li>
<li>Hyperpyrexia (a life-threatening elevation of body temperature greater than or equal to <span>40.0 or 41.5</span><span>&nbsp;</span><span>°C (104.0 or 106.7</span><span>&nbsp;</span><span>°F)</span>)<span class="mw-ref" id="cite_ref-Acute_amph_toxicity_31-28"><a href="#cite_note-Acute_amph_toxicity-31" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span><span class="mw-ref" id="cite_ref-hyperpyrexia_53-4"><a href="#cite_note-hyperpyrexia-53" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span></li>
<li>Hyponatremia (Syndrome of inappropriate antidiuretic hormone)<span class="mw-ref" id="cite_ref-Acute_amph_toxicity_31-29"><a href="#cite_note-Acute_amph_toxicity-31" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span><span class="mw-ref" id="cite_ref-Hyponatremia_52-6"><a href="#cite_note-Hyponatremia-52" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span><span class="mw-ref" id="cite_ref-hyperpyrexia_53-5"><a href="#cite_note-hyperpyrexia-53" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span></li></ul></td></tr>
</tbody></table>
</center>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Interactions">Interactions</h2></summary>
    

<p>A number of drug interactions can occur between MDMA and other drugs, including serotonergic drugs.<span class="mw-ref" id="cite_ref-Toxnet_MDMA_12-7"><a href="#cite_note-Toxnet_MDMA-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span><span class="mw-ref" id="cite_ref-89"><a href="#cite_note-89" style="counter-reset: mw-Ref 87;"><span class="mw-reflink-text">[87]</span></a></span> MDMA also interacts with drugs which inhibit CYP450 enzymes, like <a href="Ritonavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Ritonavir" title="Ritonavir">ritonavir</a> (Norvir), particularly CYP2D6 inhibitors.<span class="mw-ref" id="cite_ref-Toxnet_MDMA_12-8"><a href="#cite_note-Toxnet_MDMA-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> Concurrent use of MDMA high dosages with another serotonergic drug can result in a life-threatening condition called serotonin syndrome.<span class="mw-ref" id="cite_ref-Betzler2017_6-29"><a href="#cite_note-Betzler2017-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-Toxnet_MDMA_12-9"><a href="#cite_note-Toxnet_MDMA-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> Severe overdose resulting in death has also been reported in people who took MDMA in combination with certain monoamine oxidase inhibitors,<span class="mw-ref" id="cite_ref-Betzler2017_6-30"><a href="#cite_note-Betzler2017-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-Toxnet_MDMA_12-10"><a href="#cite_note-Toxnet_MDMA-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> such as <a href="Phenelzine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenelzine" title="Phenelzine">phenelzine</a> (Nardil), <a href="Tranylcypromine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tranylcypromine" title="Tranylcypromine">tranylcypromine</a> (Parnate), or <a href="Moclobemide.htm" tppabs="https://ptable.com/wiki/compounds/A/Moclobemide" title="Moclobemide">moclobemide</a> (Aurorix, Manerix).<span class="mw-ref" id="cite_ref-90"><a href="#cite_note-90" style="counter-reset: mw-Ref 88;"><span class="mw-reflink-text">[88]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacology">Pharmacology</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacodynamics">Pharmacodynamics</h3></summary>
    
<p>MDMA acts primarily as a presynaptic releasing agent of <a href="Serotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Serotonin" title="Serotonin">serotonin</a>, norepinephrine, and <a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">dopamine</a>, which arises from its activity at trace amine-associated receptor 1 (TAAR1) and vesicular monoamine transporter 2 (VMAT2).<span class="mw-ref" id="cite_ref-Toxnet_MDMA_12-11"><a href="#cite_note-Toxnet_MDMA-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span><span class="mw-ref" id="cite_ref-Miller_91-0"><a href="#cite_note-Miller-91" style="counter-reset: mw-Ref 89;"><span class="mw-reflink-text">[89]</span></a></span><span class="mw-ref" id="cite_ref-Drugbank_MDMA_92-0"><a href="#cite_note-Drugbank_MDMA-92" style="counter-reset: mw-Ref 90;"><span class="mw-reflink-text">[90]</span></a></span><span class="mw-ref" id="cite_ref-Berry_hTAAR_pharmacology_December_2017_review_93-0"><a href="#cite_note-Berry_hTAAR_pharmacology_December_2017_review-93" style="counter-reset: mw-Ref 91;"><span class="mw-reflink-text">[91]</span></a></span> MDMA is also a monoamine transporter substrate (i.e., a substrate for DAT, NET, and SERT), so it enters monoamine neurons via these neuronal membrane transport proteins;<span class="mw-ref" id="cite_ref-Miller_91-1"><a href="#cite_note-Miller-91" style="counter-reset: mw-Ref 89;"><span class="mw-reflink-text">[89]</span></a></span> by acting as a monoamine transporter substrate, MDMA produces competitive reuptake inhibition at the neuronal membrane transporters (i.e., it competes with endogenous monoamines for reuptake).<span class="mw-ref" id="cite_ref-Miller_91-2"><a href="#cite_note-Miller-91" style="counter-reset: mw-Ref 89;"><span class="mw-reflink-text">[89]</span></a></span><span class="mw-ref" id="cite_ref-pmid1982265_94-0"><a href="#cite_note-pmid1982265-94" style="counter-reset: mw-Ref 92;"><span class="mw-reflink-text">[92]</span></a></span> MDMA inhibits both vesicular monoamine transporters (VMATs), the second of which (VMAT2) is highly expressed within monoamine neurons at vesicular membranes.<span class="mw-ref" id="cite_ref-Drugbank_MDMA_92-1"><a href="#cite_note-Drugbank_MDMA-92" style="counter-reset: mw-Ref 90;"><span class="mw-reflink-text">[90]</span></a></span> Once inside a monoamine neuron, MDMA acts as a VMAT2 inhibitor and a TAAR1 agonist.<span class="mw-ref" id="cite_ref-Drugbank_MDMA_92-2"><a href="#cite_note-Drugbank_MDMA-92" style="counter-reset: mw-Ref 90;"><span class="mw-reflink-text">[90]</span></a></span><span class="mw-ref" id="cite_ref-Berry_hTAAR_pharmacology_December_2017_review_93-1"><a href="#cite_note-Berry_hTAAR_pharmacology_December_2017_review-93" style="counter-reset: mw-Ref 91;"><span class="mw-reflink-text">[91]</span></a></span></p>

<p>Inhibition of VMAT2 by MDMA results in increased concentrations of the associated neurotransmitter (serotonin, norepinephrine, or dopamine) in the cytosol of a monoamine neuron.<span class="mw-ref" id="cite_ref-Drugbank_MDMA_92-3"><a href="#cite_note-Drugbank_MDMA-92" style="counter-reset: mw-Ref 90;"><span class="mw-reflink-text">[90]</span></a></span><span class="mw-ref" id="cite_ref-pmid12742084_95-0"><a href="#cite_note-pmid12742084-95" style="counter-reset: mw-Ref 93;"><span class="mw-reflink-text">[93]</span></a></span> Activation of TAAR1 by MDMA triggers protein kinase A and protein kinase C signaling events which then phosphorylates the associated monoamine transporters – DAT, NET, or SERT – of the neuron.<span class="mw-ref" id="cite_ref-Miller_91-3"><a href="#cite_note-Miller-91" style="counter-reset: mw-Ref 89;"><span class="mw-reflink-text">[89]</span></a></span><span class="mw-ref" id="cite_ref-Berry_hTAAR_pharmacology_December_2017_review_93-2"><a href="#cite_note-Berry_hTAAR_pharmacology_December_2017_review-93" style="counter-reset: mw-Ref 91;"><span class="mw-reflink-text">[91]</span></a></span> In turn, these phosphorylated monoamine transporters either reverse transport direction – i.e., move neurotransmitters from the cytosol to the synaptic cleft – or withdraw into the neuron, respectively producing neurotransmitter efflux and noncompetitive reuptake inhibition at the neuronal membrane transporters.<span class="mw-ref" id="cite_ref-Miller_91-4"><a href="#cite_note-Miller-91" style="counter-reset: mw-Ref 89;"><span class="mw-reflink-text">[89]</span></a></span><span class="mw-ref" id="cite_ref-Drugbank_MDMA_92-4"><a href="#cite_note-Drugbank_MDMA-92" style="counter-reset: mw-Ref 90;"><span class="mw-reflink-text">[90]</span></a></span> The actions increase the synaptic concentrations of monoamine neurotransmitters.<span class="mw-ref" id="cite_ref-96"><a href="#cite_note-96" style="counter-reset: mw-Ref 94;"><span class="mw-reflink-text">[94]</span></a></span> MDMA has ten times more affinity for uptake at serotonin transporters compared to dopamine and norepinephrine transporters and consequently has mainly serotonergic effects.<span class="mw-ref" id="cite_ref-Goldfrank_2011_97-0"><a href="#cite_note-Goldfrank_2011-97" style="counter-reset: mw-Ref 95;"><span class="mw-reflink-text">[95]</span></a></span><sup class="reference" style="white-space:nowrap;">:<span>1080</span></sup></p>

<p>In summary, MDMA enters monoamine neurons by acting as a monoamine transporter substrate.<span class="mw-ref" id="cite_ref-Miller_91-5"><a href="#cite_note-Miller-91" style="counter-reset: mw-Ref 89;"><span class="mw-reflink-text">[89]</span></a></span> MDMA activity at VMAT2 moves neurotransmitters out from synaptic vesicles and into the cytosol;<span class="mw-ref" id="cite_ref-Drugbank_MDMA_92-5"><a href="#cite_note-Drugbank_MDMA-92" style="counter-reset: mw-Ref 90;"><span class="mw-reflink-text">[90]</span></a></span> MDMA activity at TAAR1 moves neurotransmitters out of the cytosol and into the synaptic cleft.<span class="mw-ref" id="cite_ref-Miller_91-6"><a href="#cite_note-Miller-91" style="counter-reset: mw-Ref 89;"><span class="mw-reflink-text">[89]</span></a></span><span class="mw-ref" id="cite_ref-Drugbank_MDMA_92-6"><a href="#cite_note-Drugbank_MDMA-92" style="counter-reset: mw-Ref 90;"><span class="mw-reflink-text">[90]</span></a></span><span class="mw-ref" id="cite_ref-Berry_hTAAR_pharmacology_December_2017_review_93-3"><a href="#cite_note-Berry_hTAAR_pharmacology_December_2017_review-93" style="counter-reset: mw-Ref 91;"><span class="mw-reflink-text">[91]</span></a></span></p>

<p>MDMA also has weak agonist activity at postsynaptic serotonin receptors 5-HT<sub>1</sub> and 5-HT<sub>2</sub> receptors, and its more efficacious metabolite <a href="3,4-Methylenedioxyamphetamine-2.htm" tppabs="https://ptable.com/wiki/compounds/A/3%2C4-methylenedioxyamphetamine" title="3,4-methylenedioxyamphetamine" class="mw-redirect">MDA</a> likely augments this action.<span class="mw-ref" id="cite_ref-pmid2899513_98-0"><a href="#cite_note-pmid2899513-98" style="counter-reset: mw-Ref 96;"><span class="mw-reflink-text">[96]</span></a></span><span class="mw-ref" id="cite_ref-pmid2871581_99-0"><a href="#cite_note-pmid2871581-99" style="counter-reset: mw-Ref 97;"><span class="mw-reflink-text">[97]</span></a></span><span class="mw-ref" id="cite_ref-pmid7824160_100-0"><a href="#cite_note-pmid7824160-100" style="counter-reset: mw-Ref 98;"><span class="mw-reflink-text">[98]</span></a></span><span class="mw-ref" id="cite_ref-pmid12761331_101-0"><a href="#cite_note-pmid12761331-101" style="counter-reset: mw-Ref 99;"><span class="mw-reflink-text">[99]</span></a></span> Cortisol, prolactin, and oxytocin quantities in serum are increased by MDMA.<span class="mw-ref" id="cite_ref-Betzler2017_6-31"><a href="#cite_note-Betzler2017-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>

<p>MDMA is a ligand at both sigma receptor subtypes, though its efficacies at the receptors have not yet been elucidated.<span class="mw-ref" id="cite_ref-Sigma_102-0"><a href="#cite_note-Sigma-102" style="counter-reset: mw-Ref 100;"><span class="mw-reflink-text">[100]</span></a></span></p>
<ul class="gallery mw-gallery-traditional">
<li class="gallerybox" style="width: 155px;"><div class="thumb" style="width: 150px; height: 150px;"><figure-inline><img src="../I/m/The_Serotonin_Neuron.gif" tppabs="https://ptable.com/wiki/compounds/I/m/The_Serotonin_Neuron.gif" data-file-width="720" data-file-height="540" data-file-type="bitmap" height="90" width="120"></figure-inline></div><div class="gallerytext">Serotonin binds to receptors on neurons.</div></li>
<li class="gallerybox" style="width: 155px;"><div class="thumb" style="width: 150px; height: 150px;"><figure-inline><img src="../I/m/The_Serotonin_Neuron_with_Transporter.gif" tppabs="https://ptable.com/wiki/compounds/I/m/The_Serotonin_Neuron_with_Transporter.gif" data-file-width="720" data-file-height="540" data-file-type="bitmap" height="90" width="120"></figure-inline></div><div class="gallerytext">A serotonin transporter moves a serotonin molecule.</div></li>
<li class="gallerybox" style="width: 155px;"><div class="thumb" style="width: 150px; height: 150px;"><figure-inline><img src="../I/m/The_Neurobiology_of_Ecstasy_(MDMA).gif" tppabs="https://ptable.com/wiki/compounds/I/m/The_Neurobiology_of_Ecstasy_(MDMA).gif" data-file-width="720" data-file-height="540" data-file-type="bitmap" height="90" width="120"></figure-inline></div><div class="gallerytext">MDMA binds to serotonin transporters.</div></li>
</ul>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacokinetics">Pharmacokinetics</h3></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/page1-220px-MDMA_en.pdf.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/page1-220px-MDMA_en.pdf.jpg" data-file-width="1097" data-file-height="1075" data-file-type="office" height="216" width="220"><div class="thumbcaption" style="text-align: left">Diagram showing the sequence of MDMA metabolization</div></div></div>
<p>The MDMA concentration in the blood stream starts to rise after about 30 minutes,<span class="mw-ref" id="cite_ref-103"><a href="#cite_note-103" style="counter-reset: mw-Ref 101;"><span class="mw-reflink-text">[101]</span></a></span> and reaches its maximal concentration in the blood stream between 1.5 and 3 hours after ingestion.<span class="mw-ref" id="cite_ref-TORRE1_104-0"><a href="#cite_note-TORRE1-104" style="counter-reset: mw-Ref 102;"><span class="mw-reflink-text">[102]</span></a></span> It is then slowly metabolized and excreted, with levels of MDMA and its metabolites decreasing to half their peak concentration over the next several hours.<span class="mw-ref" id="cite_ref-TORRE2_105-0"><a href="#cite_note-TORRE2-105" style="counter-reset: mw-Ref 103;"><span class="mw-reflink-text">[103]</span></a></span> The duration of action of MDMA is usually four to six hours, after which serotonin levels in the brain are depleted.<span class="mw-ref" id="cite_ref-Betzler2017_6-32"><a href="#cite_note-Betzler2017-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> Serotonin levels typically return to normal within 24–48 hours.<span class="mw-ref" id="cite_ref-Betzler2017_6-33"><a href="#cite_note-Betzler2017-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>

<p>Metabolites of MDMA that have been identified in humans include <a href="3,4-Methylenedioxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/3%2C4-Methylenedioxyamphetamine" title="3,4-Methylenedioxyamphetamine">3,4-methylenedioxyamphetamine</a> (MDA), 4-hydroxy-3-methoxymethamphetamine (HMMA), <span class="new">4-hydroxy-3-methoxyamphetamine</span> (HMA), <a href="Alpha-Methyldopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Alpha-Methyldopamine" title="Alpha-Methyldopamine">3,4-dihydroxyamphetamine</a> (DHA) (also called alpha-methyldopamine (α-Me-DA)), 3,4-methylenedioxyphenylacetone (MDP2P), and 3,4-Methylenedioxy-N-hydroxyamphetamine (MDOH). The contributions of these metabolites to the psychoactive and toxic effects of MDMA are an area of active research. 80% of MDMA is metabolised in the liver, and about 20% is excreted unchanged in the urine.<span class="mw-ref" id="cite_ref-pmid22392347_10-15"><a href="#cite_note-pmid22392347-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></p>

<p>MDMA is known to be metabolized by two main metabolic pathways: (1) <i>O</i>-demethylenation followed by catechol-<i>O</i>-methyltransferase (COMT)-catalyzed methylation and/or glucuronide/sulfate conjugation; and (2) <i>N</i>-dealkylation, deamination, and oxidation to the corresponding <a href="Benzoic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzoic_acid" title="Benzoic acid">benzoic acid</a> derivatives conjugated with <a href="Glycine.htm" tppabs="https://ptable.com/wiki/compounds/A/Glycine" title="Glycine">glycine</a>.<span class="mw-ref" id="cite_ref-pmid15228154_84-2"><a href="#cite_note-pmid15228154-84" style="counter-reset: mw-Ref 82;"><span class="mw-reflink-text">[82]</span></a></span> The metabolism may be primarily by cytochrome P450 (CYP450) enzymes CYP2D6 and CYP3A4 and COMT. Complex, nonlinear pharmacokinetics arise via autoinhibition of CYP2D6 and CYP2D8, resulting in zeroth order kinetics at higher doses. It is thought that this can result in sustained and higher concentrations of MDMA if the user takes consecutive doses of the drug.<span class="mw-ref" id="cite_ref-106"><a href="#cite_note-106" style="counter-reset: mw-Ref 104;"><span class="mw-reflink-text">[104]</span></a></span></p>

<p>MDMA and metabolites are primarily excreted as conjugates, such as sulfates and glucuronides.<span class="mw-ref" id="cite_ref-pmid17643356_107-0"><a href="#cite_note-pmid17643356-107" style="counter-reset: mw-Ref 105;"><span class="mw-reflink-text">[105]</span></a></span> MDMA is a chiral compound and has been almost exclusively administered as a racemate. However, the two enantiomers have been shown to exhibit different kinetics. The disposition of MDMA may also be stereoselective, with the S-enantiomer having a shorter elimination half-life and greater excretion than the R-enantiomer. Evidence suggests<span class="mw-ref" id="cite_ref-fallon_108-0"><a href="#cite_note-fallon-108" style="counter-reset: mw-Ref 106;"><span class="mw-reflink-text">[106]</span></a></span> that the area under the blood plasma concentration versus time curve (AUC) was two to four times higher for the (<i>R</i>)-enantiomer than the (<i>S</i>)-enantiomer after a 40<span>&nbsp;</span>mg oral dose in human volunteers. Likewise, the plasma half-life of (<i>R</i>)-MDMA was significantly longer than that of the (<i>S</i>)-enantiomer (5.8<span>&nbsp;</span>±<span>&nbsp;</span>2.2 hours vs 3.6<span>&nbsp;</span>±<span>&nbsp;</span>0.9 hours).<span class="mw-ref" id="cite_ref-Toxnet_MDMA_12-12"><a href="#cite_note-Toxnet_MDMA-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> However, because MDMA excretion and metabolism have nonlinear kinetics,<span class="mw-ref" id="cite_ref-mueller_109-0"><a href="#cite_note-mueller-109" style="counter-reset: mw-Ref 107;"><span class="mw-reflink-text">[107]</span></a></span> the half-lives would be higher at more typical doses (100<span>&nbsp;</span>mg is sometimes considered a typical dose<span class="mw-ref" id="cite_ref-TORRE1_104-1"><a href="#cite_note-TORRE1-104" style="counter-reset: mw-Ref 102;"><span class="mw-reflink-text">[102]</span></a></span>).</p>
<div style="clear:both;"></div>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Chemistry">Chemistry</h2></summary>
    
<table style="float:right">
<tbody><tr><td><span>
</span><table role="presentation" cellpadding="0" style="border-spacing:0; clear:right; float:right;">
<tbody><tr>
<td><div class="thumb tright">
<div class="thumbinner" style="width:202px; ">

<div style="position:relative; width:200px; height:195px; overflow:hidden; border:solid #ccc 1px; background-color:white;">
<div style="left:0px; top:0px; width:200px; position:absolute"> <figure-inline><img src="../I/m/(±)-MDMA-Formel_Structural_Formulae.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/(%C2%B1)-MDMA-Formel_Structural_Formulae.svg.png" data-file-width="430" data-file-height="391" data-file-type="drawing" height="182" width="200"></figure-inline>
</div> 
<div style="text-align:center; font-size:16px; line-height:110%;">
<div style="background-color:transparent; color:black"><div id="annotation_60x70" style="position:absolute; left:60px; top:70px;      line-height:110% "><span style="background-color:transparent; ">(<i>R</i>)-MDMA</span></div>
<div id="annotation_60x175" style="position:absolute; left:60px; top:175px;      line-height:110% "><span style="background-color:transparent; ">(<i>S</i>)-MDMA</span></div></div>
</div>
</div>
<div class="thumbcaption" style="clear:left">MDMA is a racemic mixture and exists as two enantiomers: (<i>R</i>)- and (<i>S</i>)-MDMA.</div>
</div>
</div></td></tr>
</tbody></table></td></tr>
<tr>
<td><div class="thumb tmulti tright"><div class="thumbinner" style="width:204px;max-width:204px"><div class="trow"><div class="tsingle" style="width:202px;max-width:202px"><div class="thumbimage"><figure-inline><img src="../I/m/White_MDMA_salt_in_a_bag.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/White_MDMA_salt_in_a_bag.jpg" data-file-width="2264" data-file-height="1920" data-file-type="bitmap" height="170" width="200"></figure-inline></div><div class="thumbcaption">A powdered salt of MDMA</div></div></div><div class="trow"><div class="tsingle" style="width:202px;max-width:202px"><div class="thumbimage"><figure-inline><img src="../I/m/MDMAjakarta.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/MDMAjakarta.jpg" data-file-width="250" data-file-height="224" data-file-type="bitmap" height="179" width="200"></figure-inline></div><div class="thumbcaption">Reactors used to synthesize MDMA on an industrial scale in a clandestine chemical factory in Cikande, Indonesia</div></div></div></div></div></td></tr>
</tbody></table>
<p>MDMA is in the substituted methylenedioxyphenethylamine and substituted amphetamine classes of chemicals. As a free base, MDMA is a colorless oil insoluble in water.<span class="mw-ref" id="cite_ref-EU2015_8-12"><a href="#cite_note-EU2015-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> The most common salt of MDMA is the hydrochloride salt;<span class="mw-ref" id="cite_ref-EU2015_8-13"><a href="#cite_note-EU2015-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span>  pure MDMA hydrochloride is water-soluble and appears as a white or off-white powder or crystal.<span class="mw-ref" id="cite_ref-EU2015_8-14"><a href="#cite_note-EU2015-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Synthesis">Synthesis</h3></summary>
    
<p>There are numerous methods available to synthesize MDMA via different intermediates.<span class="mw-ref" id="cite_ref-110"><a href="#cite_note-110" style="counter-reset: mw-Ref 108;"><span class="mw-reflink-text">[108]</span></a></span><span class="mw-ref" id="cite_ref-111"><a href="#cite_note-111" style="counter-reset: mw-Ref 109;"><span class="mw-reflink-text">[109]</span></a></span><span class="mw-ref" id="cite_ref-112"><a href="#cite_note-112" style="counter-reset: mw-Ref 110;"><span class="mw-reflink-text">[110]</span></a></span><span class="mw-ref" id="cite_ref-113"><a href="#cite_note-113" style="counter-reset: mw-Ref 111;"><span class="mw-reflink-text">[111]</span></a></span> The original MDMA synthesis described in Merck's patent involves brominating <a href="Safrole.htm" tppabs="https://ptable.com/wiki/compounds/A/Safrole" title="Safrole">safrole</a> to 1-(3,4-methylenedioxyphenyl)-2-bromopropane and then reacting this adduct with methylamine.<span class="mw-ref" id="cite_ref-114"><a href="#cite_note-114" style="counter-reset: mw-Ref 112;"><span class="mw-reflink-text">[112]</span></a></span><span class="mw-ref" id="cite_ref-115"><a href="#cite_note-115" style="counter-reset: mw-Ref 113;"><span class="mw-reflink-text">[113]</span></a></span> Most illicit MDMA is synthesized using MDP2P (3,4-methylenedioxyphenyl-2-propanone) as a precursor. MDP2P in turn is generally synthesized from <a href="Piperonal.htm" tppabs="https://ptable.com/wiki/compounds/A/Piperonal" title="Piperonal">piperonal</a>, <a href="Safrole.htm" tppabs="https://ptable.com/wiki/compounds/A/Safrole" title="Safrole">safrole</a> or <a href="Isosafrole.htm" tppabs="https://ptable.com/wiki/compounds/A/Isosafrole" title="Isosafrole">isosafrole</a>.<span class="mw-ref" id="cite_ref-World_Drug_Report_2014_116-0"><a href="#cite_note-World_Drug_Report_2014-116" style="counter-reset: mw-Ref 114;"><span class="mw-reflink-text">[114]</span></a></span>  One method is to isomerize safrole to isosafrole in the presence of a strong base, and then oxidize <a href="Isosafrole.htm" tppabs="https://ptable.com/wiki/compounds/A/Isosafrole" title="Isosafrole">isosafrole</a> to MDP2P. Another method uses the Wacker process to oxidize safrole directly to the MDP2P intermediate with a <a href="Palladium.htm" tppabs="https://ptable.com/wiki/compounds/A/Palladium" title="Palladium">palladium</a> catalyst. Once the MDP2P intermediate has been prepared, a reductive amination leads to racemic MDMA (an equal parts mixture of (<i>R</i>)-MDMA and (<i>S</i>)-MDMA). Relatively small quantities of essential oil are required to make large amounts of MDMA. The essential oil of <i>Ocotea cymbarum</i>, for example, typically contains between 80 and 94% safrole. This allows 500<span>&nbsp;</span>ml of the oil to produce between 150 and 340 grams of MDMA.<span class="mw-ref" id="cite_ref-117"><a href="#cite_note-117" style="counter-reset: mw-Ref 115;"><span class="mw-reflink-text">[115]</span></a></span></p>
<div class="thumb tmulti tleft"><div class="thumbinner" style="width:604px;max-width:604px"><div class="trow"><div class="tsingle" style="width:602px;max-width:602px"><div class="thumbimage"><figure-inline><img src="../I/m/MDMA_Synthesis_1.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/MDMA_Synthesis_1.svg.png" data-file-width="1559" data-file-height="146" data-file-type="drawing" height="56" width="600"></figure-inline></div></div></div><div class="trow"><div class="tsingle" style="width:402px;max-width:402px"><div class="thumbimage"><figure-inline><img src="../I/m/MDMA_Synthese_2.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/MDMA_Synthese_2.svg.png" data-file-width="1026" data-file-height="102" data-file-type="drawing" height="40" width="400"></figure-inline></div><div class="thumbcaption">Synthesis of MDMA from piperonal</div></div></div><div class="trow"><div class="tsingle" style="width:402px;max-width:402px"><div class="thumbimage"><figure-inline><img src="../I/m/MDA_from_safrole_en.png" tppabs="https://ptable.com/wiki/compounds/I/m/MDA_from_safrole_en.png" data-file-width="1000" data-file-height="127" data-file-type="bitmap" height="51" width="400"></figure-inline></div><div class="thumbcaption">Synthesis of MDMA and related analogs from safrole</div></div></div></div></div>
<div style="clear:left;"></div>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Detection_in_body_fluids">Detection in body fluids</h3></summary>
    
<p>MDMA and MDA may be quantitated in blood, plasma or urine to monitor for use, confirm a diagnosis of poisoning or assist in the forensic investigation of a traffic or other criminal violation or a sudden death. Some drug abuse screening programs rely on hair, saliva, or sweat as specimens. Most commercial amphetamine immunoassay screening tests cross-react significantly with MDMA or its major metabolites, but chromatographic techniques can easily distinguish and separately measure each of these substances. The concentrations of MDA in the blood or urine of a person who has taken only MDMA are, in general, less than 10% those of the parent drug.<span class="mw-ref" id="cite_ref-118"><a href="#cite_note-118" style="counter-reset: mw-Ref 116;"><span class="mw-reflink-text">[116]</span></a></span><span class="mw-ref" id="cite_ref-119"><a href="#cite_note-119" style="counter-reset: mw-Ref 117;"><span class="mw-reflink-text">[117]</span></a></span><span class="mw-ref" id="cite_ref-120"><a href="#cite_note-120" style="counter-reset: mw-Ref 118;"><span class="mw-reflink-text">[118]</span></a></span></p>
<div style="clear:both;"></div>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Early_research_and_use">Early research and use</h3></summary>
    
<div class="thumb tmulti tright"><div class="thumbinner" style="width:338px;max-width:338px"><div class="trow"><div class="tsingle" style="width:167px;max-width:167px"><div class="thumbimage"><figure-inline><img src="../I/m/page1-165px-Merck_MDMA_Synthesis_Patent.pdf.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/page1-165px-Merck_MDMA_Synthesis_Patent.pdf.jpg" data-file-width="1239" data-file-height="1754" data-file-type="office" height="234" width="165"></figure-inline></div></div><div class="tsingle" style="width:167px;max-width:167px"><div class="thumbimage"><figure-inline><img src="../I/m/page1-165px-Merck_patent_for_synthesizing_methylhydrastinine_from_MDMA.pdf.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/page1-165px-Merck_patent_for_synthesizing_methylhydrastinine_from_MDMA.pdf.jpg" data-file-width="1239" data-file-height="1754" data-file-type="office" height="234" width="165"></figure-inline></div></div></div><div class="trow" style="display:flex"><div class="thumbcaption" style="background-color:transparent">German patents for MDMA synthesis and the subsequent methylhydrastinine synthesis filed by Merck on 24 December 1912 and issued in 1914</div></div></div></div>
<p>MDMA was first synthesized in 1912 by Merck chemist Anton Köllisch. At the time, Merck was interested in developing substances that stopped abnormal bleeding. Merck wanted to avoid an existing patent held by Bayer for one such compound: hydrastinine. Köllisch developed a preparation of a hydrastinine analogue, methylhydrastinine, at the request of fellow lab members, Walther Beckh and Otto Wolfes. MDMA (called methylsafrylamin, safrylmethylamin or N-Methyl-a-Methylhomopiperonylamin in Merck laboratory reports) was an intermediate compound in the synthesis of methylhydrastinine. Merck was not interested in MDMA itself at the time.<span class="mw-ref" id="cite_ref-pmid17152992_121-0"><a href="#cite_note-pmid17152992-121" style="counter-reset: mw-Ref 119;"><span class="mw-reflink-text">[119]</span></a></span> On 24 December 1912, Merck filed two patent applications that described the synthesis and some chemical properties of MDMA<span class="mw-ref" id="cite_ref-DE274350_122-0"><a href="#cite_note-DE274350-122" style="counter-reset: mw-Ref 120;"><span class="mw-reflink-text">[120]</span></a></span> and its subsequent conversion to methylhydrastinine.<span class="mw-ref" id="cite_ref-DE279194_123-0"><a href="#cite_note-DE279194-123" style="counter-reset: mw-Ref 121;"><span class="mw-reflink-text">[121]</span></a></span></p>

<p>Merck records indicate its researchers returned to the compound sporadically. A 1920 Merck patent describes a chemical modification to MDMA.<span class="mw-ref" id="cite_ref-124"><a href="#cite_note-124" style="counter-reset: mw-Ref 122;"><span class="mw-reflink-text">[122]</span></a></span> In 1927, Max Oberlin studied the pharmacology of MDMA while searching for substances with effects similar to adrenaline or <a href="Ephedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ephedrine" title="Ephedrine">ephedrine</a>, the latter being structurally similar to MDMA. Compared to ephedrine, Oberlin observed that it had similar effects on vascular smooth muscle tissue, stronger effects at the uterus, and no "local effect at the eye". MDMA was also found to have effects on blood sugar levels comparable to high doses of ephedrine. Oberlin concluded that the effects of MDMA were not limited to the sympathetic nervous system. Research was stopped "particularly due to a strong price increase of safrylmethylamine", which was still used as an intermediate in methylhydrastinine synthesis. Albert van Schoor performed simple toxicological tests with the drug in 1952, most likely while researching new stimulants or circulatory medications. After pharmacological studies, research on MDMA was not continued. In 1959, Wolfgang Fruhstorfer synthesized MDMA for pharmacological testing while researching stimulants. It is unclear if Fruhstorfer investigated the effects of MDMA in humans.<span class="mw-ref" id="cite_ref-pmid17152992_121-1"><a href="#cite_note-pmid17152992-121" style="counter-reset: mw-Ref 119;"><span class="mw-reflink-text">[119]</span></a></span></p>

<p>Outside of Merck, other researchers began to investigate MDMA. In 1953 and 1954, the United States Army commissioned a study of toxicity and behavioral effects in animals injected with mescaline and several analogues, including MDMA. Conducted at the University of Michigan in Ann Arbor, these investigations were declassified in October 1969 and published in 1973.<span class="mw-ref" id="cite_ref-pmid4197635_125-0"><a href="#cite_note-pmid4197635-125" style="counter-reset: mw-Ref 123;"><span class="mw-reflink-text">[123]</span></a></span><span class="mw-ref" id="cite_ref-Shulgin_126-0"><a href="#cite_note-Shulgin-126" style="counter-reset: mw-Ref 124;"><span class="mw-reflink-text">[124]</span></a></span> A 1960 Polish paper by Biniecki and Krajewski describing the synthesis of MDMA as an intermediate was the first published scientific paper on the substance.<span class="mw-ref" id="cite_ref-pmid17152992_121-2"><a href="#cite_note-pmid17152992-121" style="counter-reset: mw-Ref 119;"><span class="mw-reflink-text">[119]</span></a></span><span class="mw-ref" id="cite_ref-Shulgin_126-1"><a href="#cite_note-Shulgin-126" style="counter-reset: mw-Ref 124;"><span class="mw-reflink-text">[124]</span></a></span><span class="mw-ref" id="cite_ref-127"><a href="#cite_note-127" style="counter-reset: mw-Ref 125;"><span class="mw-reflink-text">[125]</span></a></span></p>

<p>MDMA may have been in non-medical use in the western United States in 1968.<span class="mw-ref" id="cite_ref-Siegel_1986_128-0"><a href="#cite_note-Siegel_1986-128" style="counter-reset: mw-Ref 126;"><span class="mw-reflink-text">[126]</span></a></span> An August 1970 report at a meeting of crime laboratory chemists indicates MDMA was being used recreationally in the Chicago area by 1970.<span class="mw-ref" id="cite_ref-Shulgin_126-2"><a href="#cite_note-Shulgin-126" style="counter-reset: mw-Ref 124;"><span class="mw-reflink-text">[124]</span></a></span><span class="mw-ref" id="cite_ref-129"><a href="#cite_note-129" style="counter-reset: mw-Ref 127;"><span class="mw-reflink-text">[127]</span></a></span> MDMA likely emerged as a substitute for its analog methylenedioxyamphetamine (MDA),<span class="mw-ref" id="cite_ref-Foderaro_1988_130-0"><a href="#cite_note-Foderaro_1988-130" style="counter-reset: mw-Ref 128;"><span class="mw-reflink-text">[128]</span></a></span> a drug at the time popular among users of psychedelics<span class="mw-ref" id="cite_ref-Professor_X_131-0"><a href="#cite_note-Professor_X-131" style="counter-reset: mw-Ref 129;"><span class="mw-reflink-text">[129]</span></a></span> which was made a Schedule 1 substance in the United States in 1970.<span class="mw-ref" id="cite_ref-Beck_1987_132-0"><a href="#cite_note-Beck_1987-132" style="counter-reset: mw-Ref 130;"><span class="mw-reflink-text">[130]</span></a></span><span class="mw-ref" id="cite_ref-exploration_133-0"><a href="#cite_note-exploration-133" style="counter-reset: mw-Ref 131;"><span class="mw-reflink-text">[131]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Shulgin's_research">Shulgin's research</h3></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/Shulgin_sasha_2011_hanna_jon.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/Shulgin_sasha_2011_hanna_jon.jpg" data-file-width="3714" data-file-height="3714" data-file-type="bitmap" height="220" width="220"><div class="thumbcaption" style="text-align: left">Alexander and Ann Shulgin in December 2011</div></div></div>

<p>American chemist and psychopharmacologist Alexander Shulgin reported he synthesized MDMA in 1965 while researching methylenedioxy compounds at Dow Chemical Company, but did not test the psychoactivity of the compound at this time. Around 1970, Shulgin sent instructions for N-methylated MDA (MDMA) synthesis to the founder of a Los Angeles chemical company who had requested them. This individual later provided these instructions to a client in the Midwest. Shulgin may have suspected he played a role in the emergence of MDMA in Chicago.<span class="mw-ref" id="cite_ref-Shulgin_126-3"><a href="#cite_note-Shulgin-126" style="counter-reset: mw-Ref 124;"><span class="mw-reflink-text">[124]</span></a></span></p>

<p>Shulgin first heard of the psychoactive effects of N-methylated MDA around 1975 from a young student who reported "amphetamine-like content".<span class="mw-ref" id="cite_ref-Shulgin_126-4"><a href="#cite_note-Shulgin-126" style="counter-reset: mw-Ref 124;"><span class="mw-reflink-text">[124]</span></a></span> Around 30 May 1976, Shulgin again heard about the effects of N-methylated MDA,<span class="mw-ref" id="cite_ref-Shulgin_126-5"><a href="#cite_note-Shulgin-126" style="counter-reset: mw-Ref 124;"><span class="mw-reflink-text">[124]</span></a></span> this time from a graduate student in a medicinal chemistry group he advised at San Francisco State University<span class="mw-ref" id="cite_ref-Professor_X_131-1"><a href="#cite_note-Professor_X-131" style="counter-reset: mw-Ref 129;"><span class="mw-reflink-text">[129]</span></a></span><span class="mw-ref" id="cite_ref-134"><a href="#cite_note-134" style="counter-reset: mw-Ref 132;"><span class="mw-reflink-text">[132]</span></a></span> who directed him to the University of Michigan study.<span class="mw-ref" id="cite_ref-PiHKAL_135-0"><a href="#cite_note-PiHKAL-135" style="counter-reset: mw-Ref 133;"><span class="mw-reflink-text">[133]</span></a></span> She and two close friends had consumed 100<span>&nbsp;</span>mg of MDMA and reported positive emotional experiences.<span class="mw-ref" id="cite_ref-Shulgin_126-6"><a href="#cite_note-Shulgin-126" style="counter-reset: mw-Ref 124;"><span class="mw-reflink-text">[124]</span></a></span> Following the self-trials of a colleague at the University of San Francisco, Shulgin synthesized MDMA and tried it himself in September and October 1976.<span class="mw-ref" id="cite_ref-Shulgin_126-7"><a href="#cite_note-Shulgin-126" style="counter-reset: mw-Ref 124;"><span class="mw-reflink-text">[124]</span></a></span><span class="mw-ref" id="cite_ref-Professor_X_131-2"><a href="#cite_note-Professor_X-131" style="counter-reset: mw-Ref 129;"><span class="mw-reflink-text">[129]</span></a></span> Shulgin first reported on MDMA in a presentation at a conference in Bethesda, Maryland in December 1976.<span class="mw-ref" id="cite_ref-Shulgin_126-8"><a href="#cite_note-Shulgin-126" style="counter-reset: mw-Ref 124;"><span class="mw-reflink-text">[124]</span></a></span> In 1978, he and David E. Nichols published a report on the drug's psychoactive effect in humans. They described MDMA as inducing "an easily controlled altered state of consciousness with emotional and sensual overtones" comparable "to marijuana, to psilocybin devoid of the hallucinatory component, or to low levels of MDA".<span class="mw-ref" id="cite_ref-isbn0-08-021938-1_136-0"><a href="#cite_note-isbn0-08-021938-1-136" style="counter-reset: mw-Ref 134;"><span class="mw-reflink-text">[134]</span></a></span></p>

<p>While not finding his own experiences with MDMA particularly powerful,<span class="mw-ref" id="cite_ref-PiHKAL_135-1"><a href="#cite_note-PiHKAL-135" style="counter-reset: mw-Ref 133;"><span class="mw-reflink-text">[133]</span></a></span><span class="mw-ref" id="cite_ref-Dr._Ecstasy_137-0"><a href="#cite_note-Dr._Ecstasy-137" style="counter-reset: mw-Ref 135;"><span class="mw-reflink-text">[135]</span></a></span> Shulgin was impressed with the drug's disinhibiting effects and thought it could be useful in therapy.<span class="mw-ref" id="cite_ref-Dr._Ecstasy_137-1"><a href="#cite_note-Dr._Ecstasy-137" style="counter-reset: mw-Ref 135;"><span class="mw-reflink-text">[135]</span></a></span> Believing MDMA allowed users to strip away habits and perceive the world clearly, Shulgin called the drug "window".<span class="mw-ref" id="cite_ref-PiHKAL_135-2"><a href="#cite_note-PiHKAL-135" style="counter-reset: mw-Ref 133;"><span class="mw-reflink-text">[133]</span></a></span><span class="mw-ref" id="cite_ref-rising_138-0"><a href="#cite_note-rising-138" style="counter-reset: mw-Ref 136;"><span class="mw-reflink-text">[136]</span></a></span> Shulgin occasionally used MDMA for relaxation, referring to it as "my low-calorie martini", and gave the drug to friends, researchers, and others who he thought could benefit from it.<span class="mw-ref" id="cite_ref-PiHKAL_135-3"><a href="#cite_note-PiHKAL-135" style="counter-reset: mw-Ref 133;"><span class="mw-reflink-text">[133]</span></a></span> One such person was Leo Zeff, a psychotherapist who had been known to use psychedelic substances in his practice. When he tried the drug in 1977, Zeff was impressed with the effects of MDMA and came out of his semi-retirement to promote its use in therapy. Over the following years, Zeff traveled around the United States and occasionally to Europe, eventually training an estimated four thousand psychotherapists in the therapeutic use of MDMA.<span class="mw-ref" id="cite_ref-Dr._Ecstasy_137-2"><a href="#cite_note-Dr._Ecstasy-137" style="counter-reset: mw-Ref 135;"><span class="mw-reflink-text">[135]</span></a></span><span class="mw-ref" id="cite_ref-139"><a href="#cite_note-139" style="counter-reset: mw-Ref 137;"><span class="mw-reflink-text">[137]</span></a></span> Zeff named the drug "<b>Adam</b>", believing it put users in a state of primordial innocence.<span class="mw-ref" id="cite_ref-Professor_X_131-3"><a href="#cite_note-Professor_X-131" style="counter-reset: mw-Ref 129;"><span class="mw-reflink-text">[129]</span></a></span></p>

<p>Psychotherapists who used MDMA believed the drug eliminated the typical fear response and increased communication. Sessions were usually held in the home of the patient or the therapist. The role of the therapist was minimized in favor of patient self-discovery accompanied by MDMA induced feelings of empathy. Depression, substance abuse, relationship problems, premenstrual syndrome, and autism were among several psychiatric disorders MDMA assisted therapy was reported to treat.<span class="mw-ref" id="cite_ref-exploration_133-1"><a href="#cite_note-exploration-133" style="counter-reset: mw-Ref 131;"><span class="mw-reflink-text">[131]</span></a></span> According to psychiatrist George Greer, therapists who used MDMA in their practice were impressed by the results. Anecdotally, MDMA was said to greatly accelerate therapy.<span class="mw-ref" id="cite_ref-Dr._Ecstasy_137-3"><a href="#cite_note-Dr._Ecstasy-137" style="counter-reset: mw-Ref 135;"><span class="mw-reflink-text">[135]</span></a></span> According to David Nutt, MDMA was widely used in the western US in couples counseling, and was called "empathy". Only later was the term "ecstasy" used for it, coinciding with rising opposition to its use.<span class="mw-ref" id="cite_ref-Nutt_140-0"><a href="#cite_note-Nutt-140" style="counter-reset: mw-Ref 138;"><span class="mw-reflink-text">[138]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Rising_recreational_use">Rising recreational use</h3></summary>
    

<p>In the late 1970s and early 1980s, "Adam" spread through personal networks of psychotherapists, psychiatrists, users of psychedelics, and yuppies. Hoping MDMA could avoid criminalization like LSD and mescaline, psychotherapists and experimenters attempted to limit the spread of MDMA and information about it while conducting informal research.<span class="mw-ref" id="cite_ref-exploration_133-2"><a href="#cite_note-exploration-133" style="counter-reset: mw-Ref 131;"><span class="mw-reflink-text">[131]</span></a></span><span class="mw-ref" id="cite_ref-Eisner_141-0"><a href="#cite_note-Eisner-141" style="counter-reset: mw-Ref 139;"><span class="mw-reflink-text">[139]</span></a></span> Early MDMA distributors were deterred from large scale operations by the threat of possible legislation.<span class="mw-ref" id="cite_ref-Beck_&amp;_Rosenbaum_142-0"><a href="#cite_note-Beck_&amp;_Rosenbaum-142" style="counter-reset: mw-Ref 140;"><span class="mw-reflink-text">[140]</span></a></span> Between the 1970s and the mid-1980s, this network of MDMA users consumed an estimated 500,000 doses.<span class="mw-ref" id="cite_ref-Current2013_14-16"><a href="#cite_note-Current2013-14" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span><span class="mw-ref" id="cite_ref-isbn0803936788_143-0"><a href="#cite_note-isbn0803936788-143" style="counter-reset: mw-Ref 141;"><span class="mw-reflink-text">[141]</span></a></span></p>

<p>A small recreational market for MDMA developed by the late 1970s,<span class="mw-ref" id="cite_ref-isbn9781847656414_144-0"><a href="#cite_note-isbn9781847656414-144" style="counter-reset: mw-Ref 142;"><span class="mw-reflink-text">[142]</span></a></span> consuming perhaps 10,000 doses in 1976.<span class="mw-ref" id="cite_ref-Beck_1987_132-1"><a href="#cite_note-Beck_1987-132" style="counter-reset: mw-Ref 130;"><span class="mw-reflink-text">[130]</span></a></span> By the early 1980s MDMA was being used in Boston and New York City nightclubs such as Studio 54 and Paradise Garage.<span class="mw-ref" id="cite_ref-145"><a href="#cite_note-145" style="counter-reset: mw-Ref 143;"><span class="mw-reflink-text">[143]</span></a></span><span class="mw-ref" id="cite_ref-146"><a href="#cite_note-146" style="counter-reset: mw-Ref 144;"><span class="mw-reflink-text">[144]</span></a></span> Into the early 1980s, as the recreational market slowly expanded, production of MDMA was dominated by a small group of therapeutically minded Boston chemists. Having commenced production in 1976, this "Boston Group" did not keep up with growing demand and shortages frequently occurred.<span class="mw-ref" id="cite_ref-Beck_&amp;_Rosenbaum_142-1"><a href="#cite_note-Beck_&amp;_Rosenbaum-142" style="counter-reset: mw-Ref 140;"><span class="mw-reflink-text">[140]</span></a></span></p>

<p>Perceiving a business opportunity, Michael Clegg, the Southwest distributor for the Boston Group, started his own "Texas Group" backed financially by Texas friends.<span class="mw-ref" id="cite_ref-Beck_&amp;_Rosenbaum_142-2"><a href="#cite_note-Beck_&amp;_Rosenbaum-142" style="counter-reset: mw-Ref 140;"><span class="mw-reflink-text">[140]</span></a></span><span class="mw-ref" id="cite_ref-147"><a href="#cite_note-147" style="counter-reset: mw-Ref 145;"><span class="mw-reflink-text">[145]</span></a></span> In 1981,<span class="mw-ref" id="cite_ref-Beck_&amp;_Rosenbaum_142-3"><a href="#cite_note-Beck_&amp;_Rosenbaum-142" style="counter-reset: mw-Ref 140;"><span class="mw-reflink-text">[140]</span></a></span> Clegg had coined "Ecstasy" as a slang term for MDMA to increase its marketability.<span class="mw-ref" id="cite_ref-rising_138-1"><a href="#cite_note-rising-138" style="counter-reset: mw-Ref 136;"><span class="mw-reflink-text">[136]</span></a></span><span class="mw-ref" id="cite_ref-Eisner_141-1"><a href="#cite_note-Eisner-141" style="counter-reset: mw-Ref 139;"><span class="mw-reflink-text">[139]</span></a></span> Starting in 1983,<span class="mw-ref" id="cite_ref-Beck_&amp;_Rosenbaum_142-4"><a href="#cite_note-Beck_&amp;_Rosenbaum-142" style="counter-reset: mw-Ref 140;"><span class="mw-reflink-text">[140]</span></a></span> the Texas Group mass-produced MDMA in a Texas lab<span class="mw-ref" id="cite_ref-Eisner_141-2"><a href="#cite_note-Eisner-141" style="counter-reset: mw-Ref 139;"><span class="mw-reflink-text">[139]</span></a></span> or imported it from California<span class="mw-ref" id="cite_ref-rising_138-2"><a href="#cite_note-rising-138" style="counter-reset: mw-Ref 136;"><span class="mw-reflink-text">[136]</span></a></span> and marketed tablets using pyramid sales structures and toll-free numbers.<span class="mw-ref" id="cite_ref-isbn0803936788_143-1"><a href="#cite_note-isbn0803936788-143" style="counter-reset: mw-Ref 141;"><span class="mw-reflink-text">[141]</span></a></span> MDMA could be purchased via credit card and taxes were paid on sales.<span class="mw-ref" id="cite_ref-Beck_&amp;_Rosenbaum_142-5"><a href="#cite_note-Beck_&amp;_Rosenbaum-142" style="counter-reset: mw-Ref 140;"><span class="mw-reflink-text">[140]</span></a></span> Under the brand name "Sassyfras", MDMA tablets were sold in brown bottles.<span class="mw-ref" id="cite_ref-Eisner_141-3"><a href="#cite_note-Eisner-141" style="counter-reset: mw-Ref 139;"><span class="mw-reflink-text">[139]</span></a></span> The Texas Group advertised "Ecstasy parties" at bars and discos, describing MDMA as a "fun drug" and "good to dance to".<span class="mw-ref" id="cite_ref-Beck_&amp;_Rosenbaum_142-6"><a href="#cite_note-Beck_&amp;_Rosenbaum-142" style="counter-reset: mw-Ref 140;"><span class="mw-reflink-text">[140]</span></a></span> MDMA was openly distributed in Austin and Dallas–Fort Worth area bars and nightclubs, becoming popular with yuppies, college students, and gays.<span class="mw-ref" id="cite_ref-Foderaro_1988_130-1"><a href="#cite_note-Foderaro_1988-130" style="counter-reset: mw-Ref 128;"><span class="mw-reflink-text">[128]</span></a></span><span class="mw-ref" id="cite_ref-Beck_&amp;_Rosenbaum_142-7"><a href="#cite_note-Beck_&amp;_Rosenbaum-142" style="counter-reset: mw-Ref 140;"><span class="mw-reflink-text">[140]</span></a></span><span class="mw-ref" id="cite_ref-isbn0803936788_143-2"><a href="#cite_note-isbn0803936788-143" style="counter-reset: mw-Ref 141;"><span class="mw-reflink-text">[141]</span></a></span></p>

<p>Recreational use also increased after several cocaine dealers switched to distributing MDMA following experiences with the drug.<span class="mw-ref" id="cite_ref-isbn0803936788_143-3"><a href="#cite_note-isbn0803936788-143" style="counter-reset: mw-Ref 141;"><span class="mw-reflink-text">[141]</span></a></span>  A California laboratory that analyzed confidentially submitted drug samples first detected MDMA in 1975. Over the following years the number of MDMA samples increased, eventually exceeding the number of MDA samples in the early 1980s.<span class="mw-ref" id="cite_ref-148"><a href="#cite_note-148" style="counter-reset: mw-Ref 146;"><span class="mw-reflink-text">[146]</span></a></span><span class="mw-ref" id="cite_ref-149"><a href="#cite_note-149" style="counter-reset: mw-Ref 147;"><span class="mw-reflink-text">[147]</span></a></span> By the mid-1980s, MDMA use had spread to colleges around the United States.<span class="mw-ref" id="cite_ref-Beck_&amp;_Rosenbaum_142-8"><a href="#cite_note-Beck_&amp;_Rosenbaum-142" style="counter-reset: mw-Ref 140;"><span class="mw-reflink-text">[140]</span></a></span><sup class="reference" style="white-space:nowrap;">:<span>33</span></sup></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Media_attention_and_scheduling">Media attention and scheduling</h3></summary>
    


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="United_States">United States</h4></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:172px"><img src="../I/m/page1-170px-Federal_Register_notice_of_planned_MDMA_scheduling.pdf.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/page1-170px-Federal_Register_notice_of_planned_MDMA_scheduling.pdf.jpg" data-file-width="1275" data-file-height="1650" data-file-type="office" height="220" width="170"><div class="thumbcaption" style="text-align: left">27 July 1984 Federal Register notice of the proposed MDMA scheduling</div></div></div>

<p>In an early media report on MDMA published in 1982, a <a href="Drug_Enforcement_Administration.htm" tppabs="https://ptable.com/wiki/compounds/A/Drug_Enforcement_Administration" title="Drug Enforcement Administration">Drug Enforcement Administration</a> (DEA) spokesman stated the agency would ban the drug if enough evidence for abuse could be found.<span class="mw-ref" id="cite_ref-Beck_&amp;_Rosenbaum_142-9"><a href="#cite_note-Beck_&amp;_Rosenbaum-142" style="counter-reset: mw-Ref 140;"><span class="mw-reflink-text">[140]</span></a></span> By mid-1984, MDMA use was becoming more noticed. Bill Mandel reported on "Adam" in a 10 June San Francisco Chronicle article, but misidentified the drug as methyloxymethylenedioxyamphetamine (MMDA). In the next month, the World Health Organization identified MDMA as the only substance out of twenty phenethylamines to be seized a significant number of times.<span class="mw-ref" id="cite_ref-Eisner_141-4"><a href="#cite_note-Eisner-141" style="counter-reset: mw-Ref 139;"><span class="mw-reflink-text">[139]</span></a></span></p>

<p>After a year of planning and data collection, MDMA was proposed for scheduling by the DEA on 27 July 1984 with a request for comments and objections.<span class="mw-ref" id="cite_ref-Eisner_141-5"><a href="#cite_note-Eisner-141" style="counter-reset: mw-Ref 139;"><span class="mw-reflink-text">[139]</span></a></span><span class="mw-ref" id="cite_ref-150"><a href="#cite_note-150" style="counter-reset: mw-Ref 148;"><span class="mw-reflink-text">[148]</span></a></span> The DEA was surprised when a number of psychiatrists, psychotherapists, and researchers objected to the proposed scheduling and requested a hearing.<span class="mw-ref" id="cite_ref-exploration_133-3"><a href="#cite_note-exploration-133" style="counter-reset: mw-Ref 131;"><span class="mw-reflink-text">[131]</span></a></span> In a Newsweek article published the next year, a DEA pharmacologist stated that the agency had been unaware of its use among psychiatrists.<span class="mw-ref" id="cite_ref-151"><a href="#cite_note-151" style="counter-reset: mw-Ref 149;"><span class="mw-reflink-text">[149]</span></a></span> An initial hearing was held on 1 February 1985 at the DEA offices in Washington, D.C. with administrative law judge Francis L. Young presiding.<span class="mw-ref" id="cite_ref-Eisner_141-6"><a href="#cite_note-Eisner-141" style="counter-reset: mw-Ref 139;"><span class="mw-reflink-text">[139]</span></a></span> It was decided there to hold three more hearings that year: Los Angeles on 10 June, Kansas City, Missouri on 10–11 July, and Washington, D.C. on 8–11 October.<span class="mw-ref" id="cite_ref-exploration_133-4"><a href="#cite_note-exploration-133" style="counter-reset: mw-Ref 131;"><span class="mw-reflink-text">[131]</span></a></span><span class="mw-ref" id="cite_ref-Eisner_141-7"><a href="#cite_note-Eisner-141" style="counter-reset: mw-Ref 139;"><span class="mw-reflink-text">[139]</span></a></span></p>

<p>Sensational media attention was given to the proposed criminalization and the reaction of MDMA proponents, effectively advertising the drug.<span class="mw-ref" id="cite_ref-exploration_133-5"><a href="#cite_note-exploration-133" style="counter-reset: mw-Ref 131;"><span class="mw-reflink-text">[131]</span></a></span> In response to the proposed scheduling, the Texas Group increased production from 1985 estimates of 30,000 tablets a month to as many as 8,000 per day, potentially making two million ecstasy tablets in the months before MDMA was made illegal.<span class="mw-ref" id="cite_ref-comprehensive_152-0"><a href="#cite_note-comprehensive-152" style="counter-reset: mw-Ref 150;"><span class="mw-reflink-text">[150]</span></a></span> By some estimates the Texas Group distributed 500,000 tablets per month in Dallas alone.<span class="mw-ref" id="cite_ref-rising_138-3"><a href="#cite_note-rising-138" style="counter-reset: mw-Ref 136;"><span class="mw-reflink-text">[136]</span></a></span> According to one participant in an ethnographic study, the Texas Group produced more MDMA in eighteen months than all other distribution networks combined across their entire histories.<span class="mw-ref" id="cite_ref-Beck_&amp;_Rosenbaum_142-10"><a href="#cite_note-Beck_&amp;_Rosenbaum-142" style="counter-reset: mw-Ref 140;"><span class="mw-reflink-text">[140]</span></a></span> By May 1985, MDMA use was widespread in California, Texas, southern Florida, and the northeastern United States.<span class="mw-ref" id="cite_ref-Siegel_1986_128-1"><a href="#cite_note-Siegel_1986-128" style="counter-reset: mw-Ref 126;"><span class="mw-reflink-text">[126]</span></a></span><span class="mw-ref" id="cite_ref-New_York_Times_153-0"><a href="#cite_note-New_York_Times-153" style="counter-reset: mw-Ref 151;"><span class="mw-reflink-text">[151]</span></a></span> According to the DEA there was evidence of use in twenty-eight states<span class="mw-ref" id="cite_ref-154"><a href="#cite_note-154" style="counter-reset: mw-Ref 152;"><span class="mw-reflink-text">[152]</span></a></span> and Canada.<span class="mw-ref" id="cite_ref-Siegel_1986_128-2"><a href="#cite_note-Siegel_1986-128" style="counter-reset: mw-Ref 126;"><span class="mw-reflink-text">[126]</span></a></span> Urged by Senator Lloyd Bentsen, the DEA announced an emergency Schedule I classification of MDMA on 31 May 1985. The agency cited increased distribution in Texas, escalating street use, and new evidence of MDA (an analog of MDMA) neurotoxicity as reasons for the emergency measure.<span class="mw-ref" id="cite_ref-New_York_Times_153-1"><a href="#cite_note-New_York_Times-153" style="counter-reset: mw-Ref 151;"><span class="mw-reflink-text">[151]</span></a></span><span class="mw-ref" id="cite_ref-155"><a href="#cite_note-155" style="counter-reset: mw-Ref 153;"><span class="mw-reflink-text">[153]</span></a></span><span class="mw-ref" id="cite_ref-156"><a href="#cite_note-156" style="counter-reset: mw-Ref 154;"><span class="mw-reflink-text">[154]</span></a></span> The ban took effect one month later on 1 July 1985<span class="mw-ref" id="cite_ref-comprehensive_152-1"><a href="#cite_note-comprehensive-152" style="counter-reset: mw-Ref 150;"><span class="mw-reflink-text">[150]</span></a></span> in the midst of Nancy Reagan's "Just Say No" campaign.<span class="mw-ref" id="cite_ref-157"><a href="#cite_note-157" style="counter-reset: mw-Ref 155;"><span class="mw-reflink-text">[155]</span></a></span><span class="mw-ref" id="cite_ref-158"><a href="#cite_note-158" style="counter-reset: mw-Ref 156;"><span class="mw-reflink-text">[156]</span></a></span></p>

<p>As a result of several expert witnesses testifying that MDMA had an accepted medical usage, the administrative law judge presiding over the hearings recommended that MDMA be classified as a Schedule III substance. Despite this, DEA administrator John C. Lawn overruled and classified the drug as Schedule I.<span class="mw-ref" id="cite_ref-exploration_133-6"><a href="#cite_note-exploration-133" style="counter-reset: mw-Ref 131;"><span class="mw-reflink-text">[131]</span></a></span><span class="mw-ref" id="cite_ref-Harpers_159-0"><a href="#cite_note-Harpers-159" style="counter-reset: mw-Ref 157;"><span class="mw-reflink-text">[157]</span></a></span> Later Harvard psychiatrist Lester Grinspoon sued the DEA, claiming that the DEA had ignored the medical uses of MDMA, and the federal court sided with Grinspoon, calling Lawn's argument "strained" and "unpersuasive", and vacated MDMA's Schedule I status. Despite this, less than a month later Lawn reviewed the evidence and reclassified MDMA as Schedule I again, claiming that the expert testimony of several psychiatrists claiming over 200 cases where MDMA had been used in a therapeutic context with positive results could be dismissed because they weren't published in medical journals.<span class="mw-ref" id="cite_ref-exploration_133-7"><a href="#cite_note-exploration-133" style="counter-reset: mw-Ref 131;"><span class="mw-reflink-text">[131]</span></a></span> No double blind studies had yet been conducted as to the efficacy of MDMA for therapy. In 2017 the FDA <a href="#Research" title="MDMA">granted</a> breakthrough therapy designation for its use with psychotherapy for PTSD.</p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="United_Nations">United Nations</h4></summary>
    
<p>While engaged in scheduling debates in the United States, the DEA also pushed for international scheduling.<span class="mw-ref" id="cite_ref-comprehensive_152-2"><a href="#cite_note-comprehensive-152" style="counter-reset: mw-Ref 150;"><span class="mw-reflink-text">[150]</span></a></span> In 1985 the World Health Organization's Expert Committee on Drug Dependence recommended that MDMA be placed in Schedule I of the 1971 United Nations Convention on Psychotropic Substances. The committee made this recommendation on the basis of the pharmacological similarity of MDMA to previously scheduled drugs, reports of illicit trafficking in Canada, drug seizures in the United States, and lack of well-defined therapeutic use. While intrigued by reports of psychotherapeutic uses for the drug, the committee viewed the studies as lacking appropriate methodological design and encouraged further research. Committee chairman Paul Grof dissented, believing international control was not warranted at the time and a recommendation should await further therapeutic data.<span class="mw-ref" id="cite_ref-160"><a href="#cite_note-160" style="counter-reset: mw-Ref 158;"><span class="mw-reflink-text">[158]</span></a></span> The Commission on Narcotic Drugs added MDMA to Schedule I of the convention on 11 February 1986.<span class="mw-ref" id="cite_ref-161"><a href="#cite_note-161" style="counter-reset: mw-Ref 159;"><span class="mw-reflink-text">[159]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Post-scheduling">Post-scheduling</h3></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/1995-04-08_Vibe_Tribe_09_(10937582).jpg" tppabs="https://ptable.com/wiki/compounds/I/m/1995-04-08_Vibe_Tribe_09_(10937582).jpg" data-file-width="1761" data-file-height="1109" data-file-type="bitmap" height="139" width="220"><div class="thumbcaption" style="text-align: left">A 1995 Vibe Tribe rave in Erskineville, New South Wales, Australia being broken up by police. MDMA use spread globally along with rave culture.</div></div></div> 
<div class="thumb tright"><div class="thumbinner" style="width:222px"><video poster="../I/m/-Ecstasy_-_Is_it_Really_the_Dream_Drug.ogv.jpg" preload="none" height="165" width="220" controls="40"><source src="../I/m/Ecstasy_-_Is_it_Really_the_Dream_Drug.ogv.120p.vp9.webm" tppabs="https://ptable.com/wiki/compounds/I/m/Ecstasy_-_Is_it_Really_the_Dream_Drug.ogv.120p.vp9.webm" type="video/webm; codecs=&quot;vp9, opus&quot;" data-width="160" data-height="120" data-title="Lowest bandwidth VP9 (120P)" data-shorttitle="VP9 120P"></video><div class="thumbcaption" style="text-align: left">A 2000 United States Air Force video dramatizing the dangers of MDMA abuse</div></div></div>
<p>The use of MDMA in Texas clubs declined rapidly after criminalization, although by 1991 the drug remained popular among young middle-class whites and in nightclubs.<span class="mw-ref" id="cite_ref-Beck_&amp;_Rosenbaum_142-11"><a href="#cite_note-Beck_&amp;_Rosenbaum-142" style="counter-reset: mw-Ref 140;"><span class="mw-reflink-text">[140]</span></a></span><sup class="reference" style="white-space:nowrap;">:<span>46</span></sup> In 1985, MDMA use became associated with Acid House on the Spanish island of Ibiza.<span class="mw-ref" id="cite_ref-Beck_&amp;_Rosenbaum_142-12"><a href="#cite_note-Beck_&amp;_Rosenbaum-142" style="counter-reset: mw-Ref 140;"><span class="mw-reflink-text">[140]</span></a></span><sup class="reference" style="white-space:nowrap;">:<span>50</span></sup><span class="mw-ref" id="cite_ref-162"><a href="#cite_note-162" style="counter-reset: mw-Ref 160;"><span class="mw-reflink-text">[160]</span></a></span> Thereafter in the late 1980s, the drug spread alongside rave culture to the UK and then to other European and American cities.<span class="mw-ref" id="cite_ref-Beck_&amp;_Rosenbaum_142-13"><a href="#cite_note-Beck_&amp;_Rosenbaum-142" style="counter-reset: mw-Ref 140;"><span class="mw-reflink-text">[140]</span></a></span><sup class="reference" style="white-space:nowrap;">:<span>50</span></sup> Illicit MDMA use became increasingly widespread among young adults in universities and later, in high schools. Since the mid-1990s, MDMA has become the most widely used amphetamine-type drug by college students and teenagers.<span class="mw-ref" id="cite_ref-Goldfrank_2011_97-1"><a href="#cite_note-Goldfrank_2011-97" style="counter-reset: mw-Ref 95;"><span class="mw-reflink-text">[95]</span></a></span><sup class="reference" style="white-space:nowrap;">:<span>1080</span></sup> MDMA became one of the four most widely used illicit drugs in the US, along with <a href="Cocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaine" title="Cocaine">cocaine</a>, <a href="Heroin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heroin" title="Heroin">heroin</a>, and cannabis.<span class="mw-ref" id="cite_ref-rising_138-4"><a href="#cite_note-rising-138" style="counter-reset: mw-Ref 136;"><span class="mw-reflink-text">[136]</span></a></span>
According to some estimates as of 2004, only marijuana attracts more first time users in the US.<span class="mw-ref" id="cite_ref-rising_138-5"><a href="#cite_note-rising-138" style="counter-reset: mw-Ref 136;"><span class="mw-reflink-text">[136]</span></a></span></p>

<p>After MDMA was criminalized, most medical use stopped, although some therapists continued to prescribe the drug illegally. Later, Charles Grob initiated an ascending-dose safety study in healthy volunteers. Subsequent legally-approved MDMA studies in humans have taken place in the US. in Detroit (Wayne State University), Chicago (University of Chicago), San Francisco (UCSF and California Pacific Medical Center), Baltimore (NIDA–NIH Intramural Program), and South Carolina, as well as in Switzerland (University Hospital of Psychiatry, Zürich), the Netherlands (Maastricht University), and Spain (Universitat Autònoma de Barcelona).<span class="mw-ref" id="cite_ref-163"><a href="#cite_note-163" style="counter-reset: mw-Ref 161;"><span class="mw-reflink-text">[161]</span></a></span></p>

<p>"Molly", short for 'molecule', was recognized as a slang term for crystalline or powder MDMA in the 2000s.<span class="mw-ref" id="cite_ref-164"><a href="#cite_note-164" style="counter-reset: mw-Ref 162;"><span class="mw-reflink-text">[162]</span></a></span><span class="mw-ref" id="cite_ref-165"><a href="#cite_note-165" style="counter-reset: mw-Ref 163;"><span class="mw-reflink-text">[163]</span></a></span></p>

<p>In 2010, the BBC reported that use of MDMA had decreased in the UK in previous years. This may be due to increased seizures during use and decreased production of the precursor chemicals used to manufacture MDMA. Unwitting substitution with other drugs, such as mephedrone and <a href="Methamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamphetamine" title="Methamphetamine">methamphetamine</a>,<span class="mw-ref" id="cite_ref-166"><a href="#cite_note-166" style="counter-reset: mw-Ref 164;"><span class="mw-reflink-text">[164]</span></a></span> as well as legal alternatives to MDMA, such as <a href="Benzylpiperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzylpiperazine" title="Benzylpiperazine">BZP</a>, MDPV, and methylone, are also thought to have contributed to its decrease in popularity.<span class="mw-ref" id="cite_ref-167"><a href="#cite_note-167" style="counter-reset: mw-Ref 165;"><span class="mw-reflink-text">[165]</span></a></span></p>

<p>In 2017 it was found that some pills being sold as MDMA contained pentylone, which can cause very unpleasant agitation and paranoia.<span class="mw-ref" id="cite_ref-168"><a href="#cite_note-168" style="counter-reset: mw-Ref 166;"><span class="mw-reflink-text">[166]</span></a></span></p>

<p>According to David Nutt, when <a href="Safrole.htm" tppabs="https://ptable.com/wiki/compounds/A/Safrole" title="Safrole">safrole</a> was restricted by the United Nations in order to reduce the supply of MDMA, producers in China began using <a href="Anethole.htm" tppabs="https://ptable.com/wiki/compounds/A/Anethole" title="Anethole">anethole</a> instead, but this gives <a href="Para-Methoxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Para-methoxyamphetamine" title="Para-methoxyamphetamine" class="mw-redirect">para-methoxyamphetamine</a> (PMA, also known as "Dr Death"), which is much more toxic than MDMA and can cause overheating, muscle spasms, seizures, unconsciousness, and death. People wanting MDMA are sometimes sold PMA instead.<span class="mw-ref" id="cite_ref-Nutt_140-1"><a href="#cite_note-Nutt-140" style="counter-reset: mw-Ref 138;"><span class="mw-reflink-text">[138]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Society_and_culture">Society and culture</h2></summary>
    
<span>
</span><table class="wikitable sortable" style="text-align:center; margin-left:8px; float:right">
<caption>Global estimates of drug users in 2016<br>(in millions of users)<span class="mw-ref" id="cite_ref-169"><a href="#cite_note-169" style="counter-reset: mw-Ref 167;"><span class="mw-reflink-text">[167]</span></a></span></caption>
<tbody><tr><th>Substance</th><th>Best<br>estimate</th><th>Low<br>estimate</th><th>High<br>estimate</th></tr>
<tr>
<td>Amphetamine-<br>type stimulants</td><td>34.16</td><td>13.42</td><td>55.24</td></tr>
<tr>
<td>Cannabis</td><td>192.15</td><td>165.76</td><td>234.06</td></tr>
<tr>
<td><a href="Cocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaine" title="Cocaine">Cocaine</a></td><td>18.20</td><td>13.87</td><td>22.85</td></tr>
<tr>
<td><a href="MDMA.htm" tppabs="https://ptable.com/wiki/compounds/A/MDMA" title="MDMA">Ecstasy</a></td><td>20.57</td><td>8.99</td><td>32.34</td></tr>
<tr>
<td>Opiates</td><td>19.38</td><td>13.80</td><td>26.15</td></tr>
<tr>
<td>Opioids</td><td>34.26</td><td>27.01</td><td>44.54</td></tr>

</tbody></table>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Legal_status">Legal status</h3></summary>
    
<p>MDMA is legally controlled in most of the world under the UN Convention on Psychotropic Substances and other international agreements, although exceptions exist for research and limited medical use. In general, the unlicensed use, sale or manufacture of MDMA are all criminal offences.</p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Australia">Australia</h4></summary>
    
<p>In Australia, MDMA was declared an illegal substance in 1986 because of its harmful effects and potential for abuse. It is classed as a Schedule 9 Prohibited Substance in the country, meaning it is available for scientific research purposes only. Any other type of sale, use or manufacture is strictly prohibited by law. Permits for research uses on humans must be approved by a recognized ethics committee on human research.</p>

<p>In Western Australia under the <span class="new">Misuse of Drugs Act 1981</span> 4.0g of MDMA is the amount required determining a court of trial, 2.0g is considered a presumption with intent to sell or supply and 28.0g is considered trafficking under Australian law.<span class="mw-ref" id="cite_ref-170"><a href="#cite_note-170" style="counter-reset: mw-Ref 168;"><span class="mw-reflink-text">[168]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="United_Kingdom">United Kingdom</h4></summary>
    
<p>In the United Kingdom, MDMA was made illegal in 1977 by a modification order to the existing Misuse of Drugs Act 1971. Although MDMA was not named explicitly in this legislation, the order extended the definition of Class A drugs to include various ring-substituted phenethylamines.<span class="mw-ref" id="cite_ref-Drugs_2.0_171-0"><a href="#cite_note-Drugs_2.0-171" style="counter-reset: mw-Ref 169;"><span class="mw-reflink-text">[169]</span></a></span><span class="mw-ref" id="cite_ref-UK_legality_172-0"><a href="#cite_note-UK_legality-172" style="counter-reset: mw-Ref 170;"><span class="mw-reflink-text">[170]</span></a></span> The drug is therefore illegal to sell, buy, or possess without a licence in the UK. Penalties include a maximum of seven years and/or unlimited fine for possession; life and/or unlimited fine for production or trafficking.</p>

<p>Some researchers such as David Nutt have criticized the current scheduling of MDMA, which he determines to be a relatively harmless drug.<span class="mw-ref" id="cite_ref-173"><a href="#cite_note-173" style="counter-reset: mw-Ref 171;"><span class="mw-reflink-text">[171]</span></a></span><span class="mw-ref" id="cite_ref-174"><a href="#cite_note-174" style="counter-reset: mw-Ref 172;"><span class="mw-reflink-text">[172]</span></a></span>  An editorial he wrote in the Journal of Psychopharmacology, where he compared the risk of harm for horse riding (1 adverse event in 350) to that of ecstasy (1 in 10,000) resulted in his dismissal as well as the resignation of his colleagues from the ACMD.<span class="mw-ref" id="cite_ref-johnson_175-0"><a href="#cite_note-johnson-175" style="counter-reset: mw-Ref 173;"><span class="mw-reflink-text">[173]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="United_States_2">United States</h4></summary>
    
<p>In the United States, MDMA is currently placed in Schedule I of the Controlled Substances Act.<span class="mw-ref" id="cite_ref-176"><a href="#cite_note-176" style="counter-reset: mw-Ref 174;"><span class="mw-reflink-text">[174]</span></a></span> In a 2011 federal court hearing, the American Civil Liberties Union successfully argued that the sentencing guideline for MDMA/ecstasy is based on outdated science, leading to excessive prison sentences.<span class="mw-ref" id="cite_ref-177"><a href="#cite_note-177" style="counter-reset: mw-Ref 175;"><span class="mw-reflink-text">[175]</span></a></span>  Other courts have upheld the sentencing guidelines.  The United States District Court for the Eastern District of Tennessee explained its ruling by noting that "an individual federal district court judge simply cannot marshal resources akin to those available to the Commission for tackling the manifold issues involved with determining a proper drug equivalency."<span class="mw-ref" id="cite_ref-papers.ssrn.com_178-0"><a href="#cite_note-papers.ssrn.com-178" style="counter-reset: mw-Ref 176;"><span class="mw-reflink-text">[176]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Netherlands">Netherlands</h4></summary>
    
<p>In the Netherlands, the Expert Committee on the List (Expertcommissie Lijstensystematiek Opiumwet) issued a report in June 2011 which discussed the evidence for harm and the legal status of MDMA, arguing in favor of maintaining it on List I.<span class="mw-ref" id="cite_ref-papers.ssrn.com_178-1"><a href="#cite_note-papers.ssrn.com-178" style="counter-reset: mw-Ref 176;"><span class="mw-reflink-text">[176]</span></a></span><span class="mw-ref" id="cite_ref-179"><a href="#cite_note-179" style="counter-reset: mw-Ref 177;"><span class="mw-reflink-text">[177]</span></a></span><span class="mw-ref" id="cite_ref-180"><a href="#cite_note-180" style="counter-reset: mw-Ref 178;"><span class="mw-reflink-text">[178]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Canada">Canada</h4></summary>
    
<p>In Canada, MDMA is listed as a Schedule 1<span class="mw-ref" id="cite_ref-CDSA_Schedule_I:_Amphetamines_181-0"><a href="#cite_note-CDSA_Schedule_I:_Amphetamines-181" style="counter-reset: mw-Ref 179;"><span class="mw-reflink-text">[179]</span></a></span> as it is an analogue of amphetamine.<span class="mw-ref" id="cite_ref-Definitions_and_Interpretations_182-0"><a href="#cite_note-Definitions_and_Interpretations-182" style="counter-reset: mw-Ref 180;"><span class="mw-reflink-text">[180]</span></a></span> The CDSA was updated as a result of the Safe Streets and Communities Act changing amphetamines from Schedule III to Schedule I in March 2012.</p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Demographics">Demographics</h3></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:332px"><img src="../I/m/UNODC_2016_World_Drug_Report_use_of_ecstasy_in_2014_(page_1_crop).jpg" tppabs="https://ptable.com/wiki/compounds/I/m/UNODC_2016_World_Drug_Report_use_of_ecstasy_in_2014_(page_1_crop).jpg" data-file-width="3375" data-file-height="1964" data-file-type="bitmap" height="192" width="330"><div class="thumbcaption" style="text-align: left">UNODC map showing the use of ecstasy by country in 2014 for the global population aged 15–64</div></div></div>
<p>In 2014, 3.5% of 18 to 25 year-olds had used MDMA in the United States.<span class="mw-ref" id="cite_ref-Betzler2017_6-34"><a href="#cite_note-Betzler2017-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> In the European Union as of 2018, 4.1% of adults (15–64 years old) have used MDMA at least once in their life, and 0.8% had used it in the last year.<span class="mw-ref" id="cite_ref-:0_183-0"><a href="#cite_note-:0-183" style="counter-reset: mw-Ref 181;"><span class="mw-reflink-text">[181]</span></a></span> Among young adults, 1.8% had used MDMA in the last 1.8% year.<span class="mw-ref" id="cite_ref-:0_183-1"><a href="#cite_note-:0-183" style="counter-reset: mw-Ref 181;"><span class="mw-reflink-text">[181]</span></a></span></p>

<p>In Europe, an estimated 37% of regular club-goers aged 14 to 35 used MDMA in the past year according to the 2015 European Drug report.<span class="mw-ref" id="cite_ref-Betzler2017_6-35"><a href="#cite_note-Betzler2017-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> The highest one-year prevalence of MDMA use in Germany in 2012 was 1.7% among people aged 25 to 29 compared with a population average of 0.4%.<span class="mw-ref" id="cite_ref-Betzler2017_6-36"><a href="#cite_note-Betzler2017-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> Among adolescent users in the United States between 1999 and 2008, girls were more likely to use MDMA than boys.<span class="mw-ref" id="cite_ref-184"><a href="#cite_note-184" style="counter-reset: mw-Ref 182;"><span class="mw-reflink-text">[182]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Economics">Economics</h3></summary>
    


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Europe">Europe</h4></summary>
    
<p>In 2008 the European Monitoring Centre for Drugs and Drug Addiction noted that although there were some reports of tablets being sold for as little as €1, most countries in Europe then reported typical retail prices in the range of €3 to €9 per tablet, typically containing 25–65<span>&nbsp;</span>mg of MDMA.<span class="mw-ref" id="cite_ref-185"><a href="#cite_note-185" style="counter-reset: mw-Ref 183;"><span class="mw-reflink-text">[183]</span></a></span> By 2014 the EMCDDA reported that the range was more usually between €5 and €10 per tablet, typically containing 57–102<span>&nbsp;</span>mg of MDMA, although MDMA in powder form was becoming more common.<span class="mw-ref" id="cite_ref-186"><a href="#cite_note-186" style="counter-reset: mw-Ref 184;"><span class="mw-reflink-text">[184]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="North_America">North America</h4></summary>
    
<p>The United Nations Office on Drugs and Crime stated in its 2014 World Drug Report that US ecstasy retail prices range from US$1 to $70 per pill, or from $15,000 to $32,000 per kilogram.<span class="mw-ref" id="cite_ref-187"><a href="#cite_note-187" style="counter-reset: mw-Ref 185;"><span class="mw-reflink-text">[185]</span></a></span> A new research area named Drug Intelligence aims to automatically monitor distribution networks based on image processing and machine learning techniques, in which an Ecstasy pill picture is analyzed to detect correlations among different production batches.<span class="mw-ref" id="cite_ref-188"><a href="#cite_note-188" style="counter-reset: mw-Ref 186;"><span class="mw-reflink-text">[186]</span></a></span> These novel techniques allow police scientists to facilitate the monitoring of illicit distribution networks.</p>

<p><span>As of October 2015</span>, most of the MDMA in the United States is produced in British Columbia, Canada and imported by Canada-based Asian transnational criminal organizations.<span class="mw-ref" id="cite_ref-DEA_2015_assessment_49-2"><a href="#cite_note-DEA_2015_assessment-49" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span> The market for MDMA in the United States is relatively small compared to <a href="Methamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamphetamine" title="Methamphetamine">methamphetamine</a>, <a href="Cocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaine" title="Cocaine">cocaine</a>, and <a href="Heroin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heroin" title="Heroin">heroin</a>.<span class="mw-ref" id="cite_ref-DEA_2015_assessment_49-3"><a href="#cite_note-DEA_2015_assessment-49" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span> In the United States, about 0.9 million people used ecstasy in 2010.<span class="mw-ref" id="cite_ref-Drugs2014_15-9"><a href="#cite_note-Drugs2014-15" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Australia_2">Australia</h4></summary>
    
<p>MDMA is particularly expensive in Australia, costing A$15–A$30 per tablet. In terms of purity data for Australian MDMA, the average is around 34%, ranging from less than 1% to about 85%. The majority of tablets contain 70–85<span>&nbsp;</span>mg of MDMA. Most MDMA enters Australia from the Netherlands, the UK, Asia, and the US.<span class="mw-ref" id="cite_ref-189"><a href="#cite_note-189" style="counter-reset: mw-Ref 187;"><span class="mw-reflink-text">[187]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Corporate_logos_on_pills">Corporate logos on pills</h4></summary>
    

<p>A number of ecstasy manufacturers brand their pills with a logo, often being the logo of an unrelated corporation.<span class="mw-ref" id="cite_ref-190"><a href="#cite_note-190" style="counter-reset: mw-Ref 188;"><span class="mw-reflink-text">[188]</span></a></span> Some pills depict logos of products or shows popular with children, such as Shaun the Sheep.<span class="mw-ref" id="cite_ref-191"><a href="#cite_note-191" style="counter-reset: mw-Ref 189;"><span class="mw-reflink-text">[189]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Research">Research</h2></summary>
    


<p>The Multidisciplinary Association for Psychedelic Studies (MAPS) is funding pilot studies and clinical trials investigating the use of MDMA in psychotherapy to treat posttraumatic stress disorder (PTSD),<span class="mw-ref" id="cite_ref-Zarembo_46-1"><a href="#cite_note-Zarembo-46" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span> social anxiety in autistic adults,<span class="mw-ref" id="cite_ref-Betzler2017_6-37"><a href="#cite_note-Betzler2017-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-192"><a href="#cite_note-192" style="counter-reset: mw-Ref 190;"><span class="mw-reflink-text">[190]</span></a></span><span class="mw-ref" id="cite_ref-193"><a href="#cite_note-193" style="counter-reset: mw-Ref 191;"><span class="mw-reflink-text">[191]</span></a></span><span class="mw-ref" id="cite_ref-194"><a href="#cite_note-194" style="counter-reset: mw-Ref 192;"><span class="mw-reflink-text">[192]</span></a></span><span class="mw-ref" id="cite_ref-195"><a href="#cite_note-195" style="counter-reset: mw-Ref 193;"><span class="mw-reflink-text">[193]</span></a></span> and anxiety in terminal illness.<span class="mw-ref" id="cite_ref-196"><a href="#cite_note-196" style="counter-reset: mw-Ref 194;"><span class="mw-reflink-text">[194]</span></a></span><span class="mw-ref" id="cite_ref-Mithoefer_2016_197-0"><a href="#cite_note-Mithoefer_2016-197" style="counter-reset: mw-Ref 195;"><span class="mw-reflink-text">[195]</span></a></span> In November 2016, the United States Food and Drug Administration (FDA) approved large-scale phase 3 clinical trials involving the use of MDMA for the treatment of PTSD in individuals who do not respond to traditional prescription drugs or psychotherapy.<span class="mw-ref" id="cite_ref-The_New_York_Times_Company_198-0"><a href="#cite_note-The_New_York_Times_Company-198" style="counter-reset: mw-Ref 196;"><span class="mw-reflink-text">[196]</span></a></span> MDMA has also been proposed as an adjunct to substance abuse treatment.<span class="mw-ref" id="cite_ref-Substance_abuse_7-1"><a href="#cite_note-Substance_abuse-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> In 2017, doctors in the UK began the first clinical study of MDMA in alcohol addiction.<span class="mw-ref" id="cite_ref-199"><a href="#cite_note-199" style="counter-reset: mw-Ref 197;"><span class="mw-reflink-text">[197]</span></a></span></p><p>

The potential for MDMA to be used as a rapid-acting antidepressant has been studied in clinical trials, but as of 2017 the evidence on efficacy and safety were insufficient to reach a conclusion.<span class="mw-ref" id="cite_ref-200"><a href="#cite_note-200" style="counter-reset: mw-Ref 198;"><span class="mw-reflink-text">[198]</span></a></span> A 2014 review of the safety and efficacy of MDMA as a treatment for various disorders, particularly PTSD, indicated that MDMA has therapeutic efficacy in some patients;<span class="mw-ref" id="cite_ref-Pharm2014_64-4"><a href="#cite_note-Pharm2014-64" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span> however, it emphasized that issues regarding the controlability of MDMA-induced experiences and neurochemical recovery must be addressed.<span class="mw-ref" id="cite_ref-Pharm2014_64-5"><a href="#cite_note-Pharm2014-64" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span> The author noted that <a href="Oxytocin.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxytocin" title="Oxytocin">oxytocin</a> and <a href="Cycloserine.htm" tppabs="https://ptable.com/wiki/compounds/A/D-cycloserine" title="D-cycloserine" class="mw-redirect"><span class="smallcaps"><span style="font-variant: small-caps; text-transform: lowercase;">D</span></span>-cycloserine</a> are potentially safer co-drugs in PTSD treatment, albeit with limited evidence of efficacy.<span class="mw-ref" id="cite_ref-Pharm2014_64-6"><a href="#cite_note-Pharm2014-64" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span> This review and a second corroborating review by a different author both concluded that, because of MDMA's demonstrated potential to cause lasting harm in humans (e.g., serotonergic neurotoxicity and persistent memory impairment), "considerably more research must be performed" on its efficacy in PTSD treatment to determine if the potential treatment benefits outweigh its potential to harm to a patient.<span class="mw-ref" id="cite_ref-Current2013_14-17"><a href="#cite_note-Current2013-14" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span><span class="mw-ref" id="cite_ref-Pharm2014_64-7"><a href="#cite_note-Pharm2014-64" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span></p><div style="clear:both;"></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Notes">Notes</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap"><ol class="mw-references references" data-mw-group="note"><li id="cite_note-13"> <span id="mw-reference-text-cite_note-13" class="mw-reference-text">The term <i>MDMA</i> is a contraction of <span class="nowrap">3,4-<u>m</u>ethylene<u>d</u>ioxy-<a href="Methamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamphetamine" title="Methamphetamine"><u>m</u>ethamphet<u>a</u>mine</a></span>; it is also known as ecstasy (shortened to "E", "X", or "XTC"), mandy, and molly.<span class="mw-ref" id="cite_ref-nature.com_2-1"><a href="#cite_note-nature.com-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-DrugFacts_3-1"><a href="#cite_note-DrugFacts-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></span></li><li id="cite_note-breakthrough_therapy-24"> <span id="mw-reference-text-cite_note-breakthrough_therapy-24" class="mw-reference-text">The FDA's "breakthrough therapy" designation is not intended to imply that a drug is actually a "breakthrough" or that there is high-quality evidence of treatment efficacy for a particular condition;<span class="mw-ref" id="cite_ref-healthnews_21-0"><a href="#cite_note-healthnews-21" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span><span class="mw-ref" id="cite_ref-pmid25713472_22-0"><a href="#cite_note-pmid25713472-22" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span> rather, it allows the FDA to grant priority review to drug candidates if preliminary clinical trials indicate that the therapy may offer substantial treatment advantages over existing options for patients with serious or life-threatening diseases.<span class="mw-ref" id="cite_ref-pmid25713472_22-1"><a href="#cite_note-pmid25713472-22" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span><span class="mw-ref" id="cite_ref-FDA_2012_23-0"><a href="#cite_note-FDA_2012-23" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-INN-1"> <span id="mw-reference-text-cite_note-INN-1" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/unii/KE1SEN21RM  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/unii/KE1SEN21RM'" tppabs="https://fdasis.nlm.nih.gov/srs/unii/KE1SEN21RM" class="external text external">"FDA Substance Registration System"</a>. United States National Library of Medicine<span class="reference-accessdate">. Retrieved <span class="nowrap">31 August</span> 2017</span>.</cite></span></li><li id="cite_note-nature.com-2"> <span id="mw-reference-text-cite_note-nature.com-2" class="mw-reference-text"><cite id="CITEREFLucianoPerazella2014" class="citation journal cs1">Luciano RL, Perazella MA (June 2014). "Nephrotoxic effects of designer drugs: synthetic is not better!". <i>Nature Reviews. Nephrology</i>. <b>10</b> (6): 314–24. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2Fnrneph.2014.44  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fnrneph.2014.44'" tppabs="https://doi.org/10.1038%2Fnrneph.2014.44" class="external text external">10.1038/nrneph.2014.44</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24662435  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24662435'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24662435" class="external text external">24662435</a>.</cite></span></li><li id="cite_note-DrugFacts-3"> <span id="mw-reference-text-cite_note-DrugFacts-3" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.drugabuse.gov/publications/drugfacts/mdma-ecstasy-or-molly  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.drugabuse.gov/publications/drugfacts/mdma-ecstasy-or-molly'" tppabs="http://www.drugabuse.gov/publications/drugfacts/mdma-ecstasy-or-molly" class="external text external">"DrugFacts: MDMA (Ecstasy or Molly)"</a>. National Institute on Drug Abuse. <a href="javascript:if(confirm('https://web.archive.org/web/20141203115531/http://www.drugabuse.gov/publications/drugfacts/mdma-ecstasy-or-molly  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20141203115531/http://www.drugabuse.gov/publications/drugfacts/mdma-ecstasy-or-molly'" tppabs="https://web.archive.org/web/20141203115531/http://www.drugabuse.gov/publications/drugfacts/mdma-ecstasy-or-molly" class="external text external">Archived</a> from the original on 3 December 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">2 December</span> 2014</span>.</cite></span></li><li id="cite_note-palmer-4"> <span id="mw-reference-text-cite_note-palmer-4" class="mw-reference-text"><cite id="CITEREFPalmer2012" class="citation book cs1">Palmer RB (2012). <a href="javascript:if(confirm('https://books.google.com/books?id=OWFiVaDZnkQC&pg=PA139  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=OWFiVaDZnkQC&pg=PA139'" tppabs="https://books.google.com/books?id=OWFiVaDZnkQC&pg=PA139" class="external text external"><i>Medical toxicology of drug abuse<span>&nbsp;</span>: synthesized chemicals and psychoactive plants</i></a>. Hoboken, N.J.: John Wiley &amp; Sons. p.<span>&nbsp;</span>139. ISBN<span>&nbsp;</span><bdi>978-0-471-72760-6</bdi>.</cite></span></li><li id="cite_note-NHM-MDMA-5"> <span id="mw-reference-text-cite_note-NHM-MDMA-5" class="mw-reference-text"><cite id="CITEREFMalenkaNestlerHyman2009" class="citation book cs1">Malenka RC, Nestler EJ, Hyman SE (2009). "Chapter 15: Reinforcement and Addictive Disorders".  In Sydor A, Brown RY (eds.). <i>Molecular Neuropharmacology: A Foundation for Clinical Neuroscience</i> (2nd ed.). New York: McGraw-Hill Medical. p.<span>&nbsp;</span>375. ISBN<span>&nbsp;</span><bdi>978-0-07-148127-4</bdi>.</cite></span></li><li id="cite_note-Betzler2017-6"> <span id="mw-reference-text-cite_note-Betzler2017-6" class="mw-reference-text"><cite id="CITEREFBetzlerViohlRomanczuk-Seiferth2017" class="citation journal cs1">Betzler F, Viohl L, Romanczuk-Seiferth N (January 2017). "Decision-making in chronic ecstasy users: a systematic review". <i>The European Journal of Neuroscience</i>. <b>45</b> (1): 34–44. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fejn.13480  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fejn.13480'" tppabs="https://doi.org/10.1111%2Fejn.13480" class="external text external">10.1111/ejn.13480</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27859780  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27859780'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27859780" class="external text external">27859780</a>. <q>...the addictive potential of MDMA itself is relatively small.</q></cite></span></li><li id="cite_note-Substance_abuse-7"> <span id="mw-reference-text-cite_note-Substance_abuse-7" class="mw-reference-text"><cite id="CITEREFJeromeSchusterYazar-Klosinski2013" class="citation journal cs1">Jerome L, Schuster S, Yazar-Klosinski BB (March 2013). <a href="javascript:if(confirm('http://pdfs.semanticscholar.org/33fd/4f5decd405dee8d4f280a9158bfb16ae6e27.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://pdfs.semanticscholar.org/33fd/4f5decd405dee8d4f280a9158bfb16ae6e27.pdf'" tppabs="http://pdfs.semanticscholar.org/33fd/4f5decd405dee8d4f280a9158bfb16ae6e27.pdf" class="external text external">"Can MDMA play a role in the treatment of substance abuse?"</a> <span class="cs1-format">(PDF)</span>. <i>Current Drug Abuse Reviews</i>. <b>6</b> (1): 54–62. doi:<a href="javascript:if(confirm('https://doi.org/10.2174%2F18744737112059990005  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2174%2F18744737112059990005'" tppabs="https://doi.org/10.2174%2F18744737112059990005" class="external text external">10.2174/18744737112059990005</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23627786  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23627786'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23627786" class="external text external">23627786</a>. <q>Animal and human studies demonstrate moderate abuse liability for MDMA, and this effect may be of most concern to those treating substance abuse disorders.</q></cite></span></li><li id="cite_note-EU2015-8"> <span id="mw-reference-text-cite_note-EU2015-8" class="mw-reference-text"><cite id="EMCDDA" class="citation web cs1"><a href="javascript:if(confirm('http://www.emcdda.europa.eu/publications/drug-profiles/mdma  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.emcdda.europa.eu/publications/drug-profiles/mdma'" tppabs="http://www.emcdda.europa.eu/publications/drug-profiles/mdma" class="external text external">"Methylenedioxymethamphetamine (MDMA or 'Ecstasy')"</a>. <i>EMCDDA</i>. European Monitoring Centre for Drugs and Drug Addiction<span class="reference-accessdate">. Retrieved <span class="nowrap">17 October</span> 2014</span>.</cite></span></li><li id="cite_note-9"> <span id="mw-reference-text-cite_note-9" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20120503102427/http://www.nhtsa.gov/people/injury/research/job185drugs/methylenedioxymethamphetamine.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20120503102427/http://www.nhtsa.gov/people/injury/research/job185drugs/methylenedioxymethamphetamine.htm'" tppabs="https://web.archive.org/web/20120503102427/http://www.nhtsa.gov/people/injury/research/job185drugs/methylenedioxymethamphetamine.htm" class="external text external">"Methylenedioxymethamphetamine (MDMA, ecstasy)"</a>. <i>Drugs and Human Performance Fact Sheets</i>. National Highway Traffic Safety Administration. Archived from <a href="javascript:if(confirm('http://www.nhtsa.dot.gov/people/injury/research/job185drugs/methylenedioxymethamphetamine.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.nhtsa.dot.gov/people/injury/research/job185drugs/methylenedioxymethamphetamine.htm'" tppabs="http://www.nhtsa.dot.gov/people/injury/research/job185drugs/methylenedioxymethamphetamine.htm" class="external text external">the original</a> on 3 May 2012.</cite></span></li><li id="cite_note-pmid22392347-10"> <span id="mw-reference-text-cite_note-pmid22392347-10" class="mw-reference-text"><cite id="CITEREFCarvalhoCarmoCostaCapela2012" class="citation journal cs1">Carvalho M, Carmo H, Costa VM, Capela JP, Pontes H, Remião F, Carvalho F, Bastos M (August 2012). "Toxicity of amphetamines: an update". <i>Archives of Toxicology</i>. <b>86</b> (8): 1167–231. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs00204-012-0815-5  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs00204-012-0815-5'" tppabs="https://doi.org/10.1007%2Fs00204-012-0815-5" class="external text external">10.1007/s00204-012-0815-5</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22392347  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22392347'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22392347" class="external text external">22392347</a>.</cite></span></li><li id="cite_note-Freye2009-11"> <span id="mw-reference-text-cite_note-Freye2009-11" class="mw-reference-text"><cite id="CITEREFFreye2009" class="citation book cs1">Freye E (28 July 2009). "Pharmacological Effects of MDMA in Man". <i>Pharmacology and Abuse of Cocaine, Amphetamines, Ecstasy and Related Designer Drugs</i>. Springer Netherlands. pp.<span>&nbsp;</span>151–160. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2F978-90-481-2448-0_24  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2F978-90-481-2448-0_24'" tppabs="https://doi.org/10.1007%2F978-90-481-2448-0_24" class="external text external">10.1007/978-90-481-2448-0_24</a>. ISBN<span>&nbsp;</span><bdi>978-90-481-2448-0</bdi>.</cite></span></li><li id="cite_note-Toxnet_MDMA-12"> <span id="mw-reference-text-cite_note-Toxnet_MDMA-12" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+hsdb:@term+@rn+@rel+42542-10-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+hsdb:@term+@rn+@rel+42542-10-9'" tppabs="http://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+hsdb:@term+@rn+@rel+42542-10-9" class="external text external">"3,4-Methylenedioxymethamphetamine"</a>. <i>Hazardous Substances Data Bank</i>. National Library of Medicine. 28 August 2008<span class="reference-accessdate">. Retrieved <span class="nowrap">22 August</span> 2014</span>.</cite></span></li><li id="cite_note-Current2013-14"> <span id="mw-reference-text-cite_note-Current2013-14" class="mw-reference-text"><cite id="CITEREFMeyer2013" class="citation journal cs1">Meyer JS (2013). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931692  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931692'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931692" class="external text external">"3,4-methylenedioxymethamphetamine (MDMA): current perspectives"</a>. <i>Substance Abuse and Rehabilitation</i>. <b>4</b>: 83–99. doi:<a href="javascript:if(confirm('https://doi.org/10.2147%2FSAR.S37258  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2147%2FSAR.S37258'" tppabs="https://doi.org/10.2147%2FSAR.S37258" class="external text external">10.2147/SAR.S37258</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931692  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931692'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931692" class="external text external">3931692</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24648791  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24648791'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24648791" class="external text external">24648791</a>.</cite></span></li><li id="cite_note-Drugs2014-15"> <span id="mw-reference-text-cite_note-Drugs2014-15" class="mw-reference-text"><cite id="CITEREFAnderson2014" class="citation web cs1">Anderson L, ed. (18 May 2014). <a href="javascript:if(confirm('https://www.drugs.com/illicit/mdma.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/illicit/mdma.html'" tppabs="https://www.drugs.com/illicit/mdma.html" class="external text external">"MDMA"</a>. <i>Drugs.com</i>. Drugsite Trust. <a href="javascript:if(confirm('https://web.archive.org/web/20160323161153/http://www.drugs.com/illicit/mdma.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20160323161153/http://www.drugs.com/illicit/mdma.html'" tppabs="https://web.archive.org/web/20160323161153/http://www.drugs.com/illicit/mdma.html" class="external text external">Archived</a> from the original on 23 March 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">30 March</span> 2016</span>.</cite></span></li><li id="cite_note-NIH2016-16"> <span id="mw-reference-text-cite_note-NIH2016-16" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugabuse.gov/publications/drugfacts/mdma-ecstasymolly  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugabuse.gov/publications/drugfacts/mdma-ecstasymolly'" tppabs="https://www.drugabuse.gov/publications/drugfacts/mdma-ecstasymolly" class="external text external">"DrugFacts: MDMA (Ecstasy/Molly)"</a>. <i>National Institute on Drug Abuse</i>. February 2016. <a href="javascript:if(confirm('https://web.archive.org/web/20160323164024/https://www.drugabuse.gov/publications/drugfacts/mdma-ecstasymolly  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20160323164024/https://www.drugabuse.gov/publications/drugfacts/mdma-ecstasymolly'" tppabs="https://web.archive.org/web/20160323164024/https://www.drugabuse.gov/publications/drugfacts/mdma-ecstasymolly" class="external text external">Archived</a> from the original on 23 March 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">30 March</span> 2016</span>.</cite></span></li><li id="cite_note-17"> <span id="mw-reference-text-cite_note-17" class="mw-reference-text"><cite class="citation book cs1">Freye E (2009). <a href="javascript:if(confirm('https://books.google.com/books?id=OTAlolM3XlwC&pg=PA147  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=OTAlolM3XlwC&pg=PA147'" tppabs="https://books.google.com/books?id=OTAlolM3XlwC&pg=PA147" class="external text external"><i>Pharmacology and Abuse of Cocaine, Amphetamines, Ecstasy and Related Designer Drugs: A comprehensive review on their mode of action, treatment of abuse and intoxication</i></a>. Springer Science &amp; Business Media. p.<span>&nbsp;</span>147. ISBN<span>&nbsp;</span><bdi>978-90-481-2448-0</bdi>.</cite></span></li><li id="cite_note-18"> <span id="mw-reference-text-cite_note-18" class="mw-reference-text"><cite id="CITEREFPatel2010" class="citation book cs1">Patel V (2010). <a href="javascript:if(confirm('https://books.google.com/books?id=8fihf3VWbcIC&pg=PA57  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=8fihf3VWbcIC&pg=PA57'" tppabs="https://books.google.com/books?id=8fihf3VWbcIC&pg=PA57" class="external text external"><i>Mental and neurological public health a global perspective</i></a> (1st ed.). San Diego, CA: Academic Press/Elsevier. p.<span>&nbsp;</span>57. ISBN<span>&nbsp;</span><bdi>978-0-12-381527-9</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20170910234523/https://books.google.com/books?id=8fihf3VWbcIC&pg=PA57  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170910234523/https://books.google.com/books?id=8fihf3VWbcIC&pg=PA57'" tppabs="https://web.archive.org/web/20170910234523/https://books.google.com/books?id=8fihf3VWbcIC&pg=PA57" class="external text external">Archived</a> from the original on 10 September 2017.</cite></span></li><li id="cite_note-19"> <span id="mw-reference-text-cite_note-19" class="mw-reference-text"><cite id="CITEREFPhilipps2018" class="citation news cs1">Philipps D (1 May 2018). <a href="javascript:if(confirm('https://www.nytimes.com/2018/05/01/us/ecstasy-molly-ptsd-mdma.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nytimes.com/2018/05/01/us/ecstasy-molly-ptsd-mdma.html'" tppabs="https://www.nytimes.com/2018/05/01/us/ecstasy-molly-ptsd-mdma.html" class="external text external">"Ecstasy as a Remedy for PTSD? You Probably Have Some Questions"</a>. <i>The New York Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">14 July</span> 2018</span>.</cite></span></li><li id="cite_note-20"> <span id="mw-reference-text-cite_note-20" class="mw-reference-text"><cite id="CITEREFFeducciaHollandMithoefer2018" class="citation journal cs1">Feduccia AA, Holland J, Mithoefer MC (February 2018). "Progress and promise for the MDMA drug development program". <i>Psychopharmacology</i>. <b>235</b> (2): 561–571. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs00213-017-4779-2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs00213-017-4779-2'" tppabs="https://doi.org/10.1007%2Fs00213-017-4779-2" class="external text external">10.1007/s00213-017-4779-2</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29152674  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29152674'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29152674" class="external text external">29152674</a>.</cite></span></li><li id="cite_note-healthnews-21"> <span id="mw-reference-text-cite_note-healthnews-21" class="mw-reference-text"><cite id="CITEREFSchwitzer2016" class="citation news cs1">Schwitzer G (13 May 2016). <a href="javascript:if(confirm('http://www.healthnewsreview.org/2016/05/cbs-proclaims-cancer-breakthrough-doesnt-explain-what-fda-means-by-that-term/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.healthnewsreview.org/2016/05/cbs-proclaims-cancer-breakthrough-doesnt-explain-what-fda-means-by-that-term/'" tppabs="http://www.healthnewsreview.org/2016/05/cbs-proclaims-cancer-breakthrough-doesnt-explain-what-fda-means-by-that-term/" class="external text external">"CBS proclaims 'cancer breakthrough' – doesn't explain what FDA means by that term"</a>. <i>Health News Review</i><span class="reference-accessdate">. Retrieved <span class="nowrap">9 October</span> 2017</span>.</cite></span></li><li id="cite_note-pmid25713472-22"> <span id="mw-reference-text-cite_note-pmid25713472-22" class="mw-reference-text"><cite id="CITEREFKepplinger2015" class="citation journal cs1">Kepplinger EE (February 2015). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326266  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326266'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326266" class="external text external">"FDA's Expedited Approval Mechanisms for New Drug Products"</a>. <i>Biotechnology Law Report</i>. <b>34</b> (1): 15–37. doi:<a href="javascript:if(confirm('https://doi.org/10.1089%2Fblr.2015.9999  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1089%2Fblr.2015.9999'" tppabs="https://doi.org/10.1089%2Fblr.2015.9999" class="external text external">10.1089/blr.2015.9999</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326266  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326266'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326266" class="external text external">4326266</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25713472  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25713472'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25713472" class="external text external">25713472</a>.</cite></span></li><li id="cite_note-FDA_2012-23"> <span id="mw-reference-text-cite_note-FDA_2012-23" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.fda.gov/RegulatoryInformation/LawsEnforcedbyFDA/SignificantAmendmentstotheFDCAct/FDASIA/ucm329491.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/RegulatoryInformation/LawsEnforcedbyFDA/SignificantAmendmentstotheFDCAct/FDASIA/ucm329491.htm'" tppabs="https://www.fda.gov/RegulatoryInformation/LawsEnforcedbyFDA/SignificantAmendmentstotheFDCAct/FDASIA/ucm329491.htm" class="external text external">"Fact Sheet: Breakthrough Therapies"</a>. United States Food and Drug Administration. 10 December 2014. <a href="javascript:if(confirm('https://web.archive.org/web/20171009081511/https://www.fda.gov/RegulatoryInformation/LawsEnforcedbyFDA/SignificantAmendmentstotheFDCAct/FDASIA/ucm329491.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20171009081511/https://www.fda.gov/RegulatoryInformation/LawsEnforcedbyFDA/SignificantAmendmentstotheFDCAct/FDASIA/ucm329491.htm'" tppabs="https://web.archive.org/web/20171009081511/https://www.fda.gov/RegulatoryInformation/LawsEnforcedbyFDA/SignificantAmendmentstotheFDCAct/FDASIA/ucm329491.htm" class="external text external">Archived</a> from the original on 9 October 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">9 October</span> 2017</span>. <q>A breakthrough therapy is a drug:<br><span>&nbsp;</span><span>•</span><span> </span>intended alone or in combination with one or more other drugs to treat a serious or life-threatening disease or condition and<br><span>&nbsp;</span><span>•</span><span> </span>preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development.</q></cite></span></li><li id="cite_note-25"> <span id="mw-reference-text-cite_note-25" class="mw-reference-text"><cite id="CITEREFWan2017" class="citation news cs1">Wan W (26 August 2017). <a href="javascript:if(confirm('https://www.washingtonpost.com/national/health-science/ecstasy-could-be-breakthrough-therapy-for-soldiers-others-suffering-from-ptsd/2017/08/26/009314ca-842f-11e7-b359-15a3617c767b_story.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.washingtonpost.com/national/health-science/ecstasy-could-be-breakthrough-therapy-for-soldiers-others-suffering-from-ptsd/2017/08/26/009314ca-842f-11e7-b359-15a3617c767b_story.html'" tppabs="https://www.washingtonpost.com/national/health-science/ecstasy-could-be-breakthrough-therapy-for-soldiers-others-suffering-from-ptsd/2017/08/26/009314ca-842f-11e7-b359-15a3617c767b_story.html" class="external text external">"Ecstasy could be 'breakthrough' therapy for soldiers, others suffering from PTSD"</a>. <i>Washington Post</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20170829081013/https://www.washingtonpost.com/national/health-science/ecstasy-could-be-breakthrough-therapy-for-soldiers-others-suffering-from-ptsd/2017/08/26/009314ca-842f-11e7-b359-15a3617c767b_story.html?utm_term=.e5b3c1c4854a  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170829081013/https://www.washingtonpost.com/national/health-science/ecstasy-could-be-breakthrough-therapy-for-soldiers-others-suffering-from-ptsd/2017/08/26/009314ca-842f-11e7-b359-15a3617c767b_story.html?utm_term=.e5b3c1c4854a'" tppabs="https://web.archive.org/web/20170829081013/https://www.washingtonpost.com/national/health-science/ecstasy-could-be-breakthrough-therapy-for-soldiers-others-suffering-from-ptsd/2017/08/26/009314ca-842f-11e7-b359-15a3617c767b_story.html?utm_term=.e5b3c1c4854a" class="external text external">Archived</a> from the original on 29 August 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">29 August</span> 2017</span>.</cite></span></li><li id="cite_note-Merck-26"> <span id="mw-reference-text-cite_note-Merck-26" class="mw-reference-text"><cite id="CITEREFFreudenmannÖxlerBernschneider-Reif2006" class="citation journal cs1">Freudenmann RW, Öxler F, Bernschneider-Reif S (August 2006). <a href="javascript:if(confirm('http://www.thedea.org/docs/2006_Freudenmann_22846_1.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.thedea.org/docs/2006_Freudenmann_22846_1.pdf'" tppabs="http://www.thedea.org/docs/2006_Freudenmann_22846_1.pdf" class="external text external">"The origin of MDMA (ecstasy) revisited: the true story reconstructed from the original documents"</a> <span class="cs1-format">(PDF)</span>. <i>Addiction</i>. <b>101</b> (9): 1241–1245. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1360-0443.2006.01511.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1360-0443.2006.01511.x'" tppabs="https://doi.org/10.1111%2Fj.1360-0443.2006.01511.x" class="external text external">10.1111/j.1360-0443.2006.01511.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16911722  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16911722'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16911722" class="external text external">16911722</a>. <q>Although MDMA was, in fact, first synthesized at Merck in 1912, it was not tested pharmacologically because it was only an unimportant precursor in a new synthesis for haemostatic substances.</q></cite></span></li><li id="cite_note-WHO2004-27"> <span id="mw-reference-text-cite_note-WHO2004-27" class="mw-reference-text"><cite id="CITEREFWorld_Health_Organization2004" class="citation book cs1">World Health Organization (2004). <a href="javascript:if(confirm('https://books.google.com/books?id=G9OhG-dZdAwC&pg=PA97  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=G9OhG-dZdAwC&pg=PA97'" tppabs="https://books.google.com/books?id=G9OhG-dZdAwC&pg=PA97" class="external text external"><i>Neuroscience of Psychoactive Substance Use and Dependence</i></a>. World Health Organization. pp.<span>&nbsp;</span>97–. ISBN<span>&nbsp;</span><bdi>978-92-4-156235-5</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20160428231233/https://books.google.com/books?id=G9OhG-dZdAwC&pg=PA97  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20160428231233/https://books.google.com/books?id=G9OhG-dZdAwC&pg=PA97'" tppabs="https://web.archive.org/web/20160428231233/https://books.google.com/books?id=G9OhG-dZdAwC&pg=PA97" class="external text external">Archived</a> from the original on 28 April 2016.</cite></span></li><li id="cite_note-UN2018-28"> <span id="mw-reference-text-cite_note-UN2018-28" class="mw-reference-text"><cite class="citation book cs1"><a href="javascript:if(confirm('https://www.unodc.org/wdr2018/prelaunch/WDR18_Booklet_1_EXSUM.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.unodc.org/wdr2018/prelaunch/WDR18_Booklet_1_EXSUM.pdf'" tppabs="https://www.unodc.org/wdr2018/prelaunch/WDR18_Booklet_1_EXSUM.pdf" class="external text external"><i>World Drug Report 2018</i></a> <span class="cs1-format">(PDF)</span>. United Nations. June 2018. p.<span>&nbsp;</span>7. ISBN<span>&nbsp;</span><bdi>978-92-1-148304-8</bdi><span class="reference-accessdate">. Retrieved <span class="nowrap">14 July</span> 2018</span>.</cite></span></li><li id="cite_note-29"> <span id="mw-reference-text-cite_note-29" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugabuse.gov/drugs-abuse/mdma-ecstasymolly  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugabuse.gov/drugs-abuse/mdma-ecstasymolly'" tppabs="https://www.drugabuse.gov/drugs-abuse/mdma-ecstasymolly" class="external text external">"MDMA (Ecstasy/Molly)"</a>. <i>National Institute on Drug Abuse</i><span class="reference-accessdate">. Retrieved <span class="nowrap">14 July</span> 2018</span>.</cite></span></li><li id="cite_note-mcn-30"> <span id="mw-reference-text-cite_note-mcn-30" class="mw-reference-text"><cite id="CITEREFLiechtiGammaVollenweider2001" class="citation journal cs1">Liechti ME, Gamma A, Vollenweider FX (March 2001). "Gender differences in the subjective effects of MDMA". <i>Psychopharmacology</i>. <b>154</b> (2): 161–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs002130000648  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs002130000648'" tppabs="https://doi.org/10.1007%2Fs002130000648" class="external text external">10.1007/s002130000648</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11314678  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11314678'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11314678" class="external text external">11314678</a>.</cite></span></li><li id="cite_note-Acute_amph_toxicity-31"> <span id="mw-reference-text-cite_note-Acute_amph_toxicity-31" class="mw-reference-text"><cite id="CITEREFGreeneKerrBraitberg2008" class="citation journal cs1">Greene SL, Kerr F, Braitberg G (October 2008). "Review article: amphetamines and related drugs of abuse". <i>Emergency Medicine Australasia</i>. <b>20</b> (5): 391–402. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1742-6723.2008.01114.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1742-6723.2008.01114.x'" tppabs="https://doi.org/10.1111%2Fj.1742-6723.2008.01114.x" class="external text external">10.1111/j.1742-6723.2008.01114.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18973636  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18973636'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18973636" class="external text external">18973636</a>.</cite></span></li><li id="cite_note-Landriscina-32"> <span id="mw-reference-text-cite_note-Landriscina-32" class="mw-reference-text"><cite id="CITEREFLandriscina1995" class="citation journal cs1">Landriscina F (1995). "MDMA and the states of Consciousness". <i>Eleusis</i>. <b>2</b>: 3–9.</cite></span></li><li id="cite_note-Baggott-33"> <span id="mw-reference-text-cite_note-Baggott-33" class="mw-reference-text"><cite id="CITEREFBaggottKirkpatrickBedide_Wit2015" class="citation journal cs1">Baggott MJ, Kirkpatrick MG, Bedi G, de Wit H (June 2015). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698152  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698152'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698152" class="external text external">"Intimate insight: MDMA changes how people talk about significant others"</a>. <i>Journal of Psychopharmacology</i>. <b>29</b> (6): 669–77. doi:<a href="javascript:if(confirm('https://doi.org/10.1177%2F0269881115581962  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1177%2F0269881115581962'" tppabs="https://doi.org/10.1177%2F0269881115581962" class="external text external">10.1177/0269881115581962</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698152  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698152'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698152" class="external text external">4698152</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25922420  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25922420'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25922420" class="external text external">25922420</a>.</cite></span></li><li id="cite_note-Schmid-34"> <span id="mw-reference-text-cite_note-Schmid-34" class="mw-reference-text"><cite id="CITEREFSchmidHysekSimmlerCrockett2014" class="citation journal cs1">Schmid Y, Hysek CM, Simmler LD, Crockett MJ, Quednow BB, Liechti ME (September 2014). <a href="javascript:if(confirm('http://edoc.unibas.ch/42235/1/20160316152928_56e96dc8bdaad.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://edoc.unibas.ch/42235/1/20160316152928_56e96dc8bdaad.pdf'" tppabs="http://edoc.unibas.ch/42235/1/20160316152928_56e96dc8bdaad.pdf" class="external text external">"Differential effects of MDMA and methylphenidate on social cognition"</a> <span class="cs1-format">(PDF)</span>. <i>Journal of Psychopharmacology</i>. <b>28</b> (9): 847–56. doi:<a href="javascript:if(confirm('https://doi.org/10.1177%2F0269881114542454  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1177%2F0269881114542454'" tppabs="https://doi.org/10.1177%2F0269881114542454" class="external text external">10.1177/0269881114542454</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25052243  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25052243'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25052243" class="external text external">25052243</a>.</cite></span></li><li id="cite_note-Wardle-35"> <span id="mw-reference-text-cite_note-Wardle-35" class="mw-reference-text"><cite id="CITEREFWardlede_Wit2014" class="citation journal cs1">Wardle MC, de Wit H (October 2014). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194242  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194242'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194242" class="external text external">"MDMA alters emotional processing and facilitates positive social interaction"</a>. <i>Psychopharmacology</i>. <b>231</b> (21): 4219–29. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs00213-014-3570-x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs00213-014-3570-x'" tppabs="https://doi.org/10.1007%2Fs00213-014-3570-x" class="external text external">10.1007/s00213-014-3570-x</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194242  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194242'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194242" class="external text external">4194242</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24728603  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24728603'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24728603" class="external text external">24728603</a>.</cite></span></li><li id="cite_note-Bravo-36"> <span id="mw-reference-text-cite_note-Bravo-36" class="mw-reference-text"><cite id="CITEREFBravo2001" class="citation book cs1">Bravo GL (2001). "What does MDMA feel like?".  In Holland J (ed.). <i>Ecstasy: The complete guide. A comprehensive look at the risks and benefits of MDMA</i>. Rochester: Park Street Press.</cite></span></li><li id="cite_note-Metzner-37"> <span id="mw-reference-text-cite_note-Metzner-37" class="mw-reference-text"><cite id="CITEREFMetzner2005" class="citation book cs1">Metzner R (2005). <a href="javascript:if(confirm('http://www.greenearthfound.org/write/psychedelic.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.greenearthfound.org/write/psychedelic.html'" tppabs="http://www.greenearthfound.org/write/psychedelic.html" class="external text external">"Psychedelic, Psychoactive, and Addictive Drugs and States of Consciousness"</a>.  In Earleywine M (ed.). <i>Mind-Altering Drugs: The Science of Subjective Experience</i>. New York: Oxford University.</cite></span></li><li id="cite_note-38"> <span id="mw-reference-text-cite_note-38" class="mw-reference-text"><cite id="CITEREFKamilar-BrittBedi2015" class="citation journal cs1">Kamilar-Britt P, Bedi G (October 2015). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678620  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678620'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678620" class="external text external">"The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals"</a>. <i>Neuroscience and Biobehavioral Reviews</i>. <b>57</b>: 433–46. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.neubiorev.2015.08.016  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.neubiorev.2015.08.016'" tppabs="https://doi.org/10.1016%2Fj.neubiorev.2015.08.016" class="external text external">10.1016/j.neubiorev.2015.08.016</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678620  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678620'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678620" class="external text external">4678620</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26408071  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26408071'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26408071" class="external text external">26408071</a>.</cite></span></li><li id="cite_note-39"> <span id="mw-reference-text-cite_note-39" class="mw-reference-text"><cite id="CITEREFReynolds1999" class="citation book cs1">Reynolds S (1999). <a href="javascript:if(confirm('https://books.google.com/books?id=tGaRJiXe74UC&pg=PA81&dq=Generation+Ecstasy+MDMA  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=tGaRJiXe74UC&pg=PA81&dq=Generation+Ecstasy+MDMA#v=onepage'" tppabs="https://books.google.com/books?id=tGaRJiXe74UC&pg=PA81&dq=Generation+Ecstasy+MDMA#v=onepage" class="external text external"><i>Generation Ecstasy: Into the World of Techno and Rave Culture</i></a>. Routledge. p.<span>&nbsp;</span>81. ISBN<span>&nbsp;</span><bdi>978-0-415-92373-6</bdi>.</cite></span></li><li id="cite_note-Epstein2013-40"> <span id="mw-reference-text-cite_note-Epstein2013-40" class="mw-reference-text"><cite id="CITEREFMcCradyEpstein2013" class="citation book cs1">McCrady BS, Epstein EE, eds. (2013). <a href="javascript:if(confirm('https://books.google.com/books?id=MUYfAQAAQBAJ&pg=PA299  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=MUYfAQAAQBAJ&pg=PA299'" tppabs="https://books.google.com/books?id=MUYfAQAAQBAJ&pg=PA299" class="external text external"><i>Addictions: a comprehensive guidebook</i></a> (Second ed.). Oxford: Oxford University Press. p.<span>&nbsp;</span>299. ISBN<span>&nbsp;</span><bdi>978-0-19-975366-6</bdi>.</cite></span></li><li id="cite_note-41"> <span id="mw-reference-text-cite_note-41" class="mw-reference-text"><cite id="CITEREFCapuzziGross2014" class="citation book cs1">Capuzzi D, Gross DR, eds. (21 November 2014). <a href="javascript:if(confirm('https://books.google.com/books?id=s7iTBQAAQBAJ&pg=PA367&dq=mdma+flipping  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=s7iTBQAAQBAJ&pg=PA367&dq=mdma+flipping#v=onepage'" tppabs="https://books.google.com/books?id=s7iTBQAAQBAJ&pg=PA367&dq=mdma+flipping#v=onepage" class="external text external"><i>Youth at Risk: A Prevention Resource for Counselors, Teachers, and Parents</i></a>. John Wiley &amp; Sons. p.<span>&nbsp;</span>379. ISBN<span>&nbsp;</span><bdi>978-1-119-02694-5</bdi>.</cite></span></li><li id="cite_note-42"> <span id="mw-reference-text-cite_note-42" class="mw-reference-text"><cite id="CITEREFSessaNutt2015" class="citation journal cs1">Sessa B, Nutt D (January 2015). <a href="javascript:if(confirm('https://doi.org/10.1192/bjp.bp.114.152751  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1192/bjp.bp.114.152751'" tppabs="https://doi.org/10.1192/bjp.bp.114.152751" class="external text external">"Making a medicine out of MDMA"</a>. <i>The British Journal of Psychiatry</i>. <b>206</b> (1): 4–6. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1192%2Fbjp.bp.114.152751  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1192%2Fbjp.bp.114.152751'" tppabs="https://doi.org/10.1192%2Fbjp.bp.114.152751" class="external text external">10.1192/bjp.bp.114.152751</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25561485  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25561485'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25561485" class="external text external">25561485</a>.</cite></span></li><li id="cite_note-43"> <span id="mw-reference-text-cite_note-43" class="mw-reference-text"><cite id="CITEREFEbrahimianKarimiKhoshnoudNamavar2017" class="citation journal cs1">Ebrahimian Z, Karimi Z, Khoshnoud MJ, Namavar MR, Daraei B, Haidari MR (1 February 2017). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373794  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373794'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373794" class="external text external">"Behavioral and Stereological Analysis of the Effects of Intermittent Feeding Diet on the Orally Administrated MDMA ("ecstasy") in Mice"</a>. <i>Innovations in Clinical Neuroscience</i>. <b>14</b> (1–2): 40–52. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373794  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373794'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373794" class="external text external">5373794</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28386520  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28386520'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28386520" class="external text external">28386520</a>. <q>MDMA is listed as a Schedule 1 drug by the United States Drug Enforcement Agency, meaning that currently there are no accepted medical uses for MDMA in the United States, there is a lack of accepted safety for use under medical supervision, and there is a high potential for abuse.</q></cite></span></li><li id="cite_note-44"> <span id="mw-reference-text-cite_note-44" class="mw-reference-text"><cite id="CITEREFClimkoRoehrichSweeneyAl-Razi1986" class="citation journal cs1">Climko RP, Roehrich H, Sweeney DR, Al-Razi J (1986). "Ecstacy: a review of MDMA and MDA". <i>International Journal of Psychiatry in Medicine</i>. <b>16</b> (4): 359–72. doi:<a href="javascript:if(confirm('https://doi.org/10.2190%2Fdcrp-u22m-aumd-d84h  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2190%2Fdcrp-u22m-aumd-d84h'" tppabs="https://doi.org/10.2190%2Fdcrp-u22m-aumd-d84h" class="external text external">10.2190/dcrp-u22m-aumd-d84h</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2881902  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2881902'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2881902" class="external text external">2881902</a>.</cite></span></li><li id="cite_note-45"> <span id="mw-reference-text-cite_note-45" class="mw-reference-text"><cite id="CITEREFFreyeLevy2009" class="citation book cs1">Freye E, Levy JV (2009). <i>Pharmacology and abuse of cocaine, amphetamines, ecstasy and related designer drugs a comprehensive review on their mode of action, treatment of abuse and intoxication</i> (Online-Ausg. ed.). Dordrecht: Springer Netherlands. p.<span>&nbsp;</span>152. ISBN<span>&nbsp;</span><bdi>978-90-481-2448-0</bdi>.</cite></span></li><li id="cite_note-Zarembo-46"> <span id="mw-reference-text-cite_note-Zarembo-46" class="mw-reference-text"><cite id="CITEREFZarembo2014" class="citation news cs1">Zarembo A (15 March 2014). <a href="javascript:if(confirm('https://articles.latimes.com/2014/mar/15/local/la-me-mdma-20140316/1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://articles.latimes.com/2014/mar/15/local/la-me-mdma-20140316/1'" tppabs="https://articles.latimes.com/2014/mar/15/local/la-me-mdma-20140316/1" class="external text external">"Exploring therapeutic effects of MDMA on post-traumatic stress"</a>. <i>Los Angeles Times</i>. Los Angeles Times<span class="reference-accessdate">. Retrieved <span class="nowrap">22 February</span> 2015</span>.</cite></span></li><li id="cite_note-MDMA_and_Religion-47"> <span id="mw-reference-text-cite_note-MDMA_and_Religion-47" class="mw-reference-text"><a href="javascript:if(confirm('http://csp.org/practices/entheogens/docs/saunders-ecstasy_rel.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://csp.org/practices/entheogens/docs/saunders-ecstasy_rel.html'" tppabs="http://csp.org/practices/entheogens/docs/saunders-ecstasy_rel.html" class="external text external">MDMA and Religion</a>. CSP. Retrieved on 11 June 2011.</span></li><li id="cite_note-Watson_&amp;_Beck-48"> <span id="mw-reference-text-cite_note-Watson_&amp;_Beck-48" class="mw-reference-text"><cite id="CITEREFWatsonBeck1991" class="citation journal cs1">Watson L, Beck J (1991). "New age seekers: MDMA use as an adjunct to spiritual pursuit". <i>Journal of Psychoactive Drugs</i>. <b>23</b> (3): 261–70. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F02791072.1991.10471587  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F02791072.1991.10471587'" tppabs="https://doi.org/10.1080%2F02791072.1991.10471587" class="external text external">10.1080/02791072.1991.10471587</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1685513  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1685513'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1685513" class="external text external">1685513</a>.</cite></span></li><li id="cite_note-DEA_2015_assessment-49"> <span id="mw-reference-text-cite_note-DEA_2015_assessment-49" class="mw-reference-text"><cite class="citation book cs1"><a href="javascript:if(confirm('http://www.dea.gov/docs/2015%20NDTA%20Report.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.dea.gov/docs/2015%20NDTA%20Report.pdf'" tppabs="http://www.dea.gov/docs/2015%20NDTA%20Report.pdf" class="external text external">"MDMA (3,4-Methylenedioxymethamphetamine)"</a> <span class="cs1-format">(PDF)</span>. <i>2015 National Drug Threat Assessment Summary</i>. <i>Drug Enforcement Administration</i>. United States Department of Justice: Drug Enforcement Administration. October 2015. pp.<span>&nbsp;</span>85–88<span class="reference-accessdate">. Retrieved <span class="nowrap">10 April</span> 2016</span>.</cite></span></li><li id="cite_note-Molly_S05E07-50"> <span id="mw-reference-text-cite_note-Molly_S05E07-50" class="mw-reference-text"><cite class="citation audio-visual cs1"><i>Molly Madness</i>. <i>Drugs, Inc.</i> (TV documentary). National Geographic Channel. 13 August 2014. ASIN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.amazon.com/dp/B00LIC368M  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.amazon.com/dp/B00LIC368M'" tppabs="https://www.amazon.com/dp/B00LIC368M" class="external text external">B00LIC368M</a>.</cite></span></li><li id="cite_note-Molly_S06E05-51"> <span id="mw-reference-text-cite_note-Molly_S06E05-51" class="mw-reference-text"><cite class="citation audio-visual cs1"><i>Manic Molly</i>. <i>Drugs, Inc.</i> (TV documentary). National Geographic Channel. 10 December 2014. ASIN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.amazon.com/dp/B00LIC368M  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.amazon.com/dp/B00LIC368M'" tppabs="https://www.amazon.com/dp/B00LIC368M" class="external text external">B00LIC368M</a>.</cite></span></li><li id="cite_note-Hyponatremia-52"> <span id="mw-reference-text-cite_note-Hyponatremia-52" class="mw-reference-text"><cite id="CITEREFKeane2014" class="citation journal cs1">Keane M (February 2014). "Recognising and managing acute hyponatraemia". <i>Emergency Nurse</i>. <b>21</b> (9): 32–6, quiz 37. doi:<a href="javascript:if(confirm('https://doi.org/10.7748%2Fen2014.02.21.9.32.e1128  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.7748%2Fen2014.02.21.9.32.e1128'" tppabs="https://doi.org/10.7748%2Fen2014.02.21.9.32.e1128" class="external text external">10.7748/en2014.02.21.9.32.e1128</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24494770  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24494770'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24494770" class="external text external">24494770</a>.</cite></span></li><li id="cite_note-hyperpyrexia-53"> <span id="mw-reference-text-cite_note-hyperpyrexia-53" class="mw-reference-text"><cite id="CITEREFWhite2014" class="citation journal cs1">White CM (March 2014). "How MDMA's pharmacology and pharmacokinetics drive desired effects and harms". <i>Journal of Clinical Pharmacology</i>. <b>54</b> (3): 245–52. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fjcph.266  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fjcph.266'" tppabs="https://doi.org/10.1002%2Fjcph.266" class="external text external">10.1002/jcph.266</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24431106  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24431106'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24431106" class="external text external">24431106</a>.</cite></span></li><li id="cite_note-54"> <span id="mw-reference-text-cite_note-54" class="mw-reference-text"><cite id="CITEREFSpauwenNiekampHoebeDukers-Muijrers2015" class="citation journal cs1">Spauwen LW, Niekamp AM, Hoebe CJ, Dukers-Muijrers NH (February 2015). <a href="javascript:if(confirm('https://doi.org/10.1136/sextrans-2014-051626  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1136/sextrans-2014-051626'" tppabs="https://doi.org/10.1136/sextrans-2014-051626" class="external text external">"Drug use, sexual risk behaviour and sexually transmitted infections among swingers: a cross-sectional study in The Netherlands"</a>. <i>Sexually Transmitted Infections</i>. <b>91</b> (1): 31–6. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1136%2Fsextrans-2014-051626  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1136%2Fsextrans-2014-051626'" tppabs="https://doi.org/10.1136%2Fsextrans-2014-051626" class="external text external">10.1136/sextrans-2014-051626</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25342812  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25342812'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25342812" class="external text external">25342812</a>. <q>It is known that some recreational drugs (eg, MDMA or GHB) may hamper the potential to ejaculate or maintain an erection.</q></cite></span></li><li id="cite_note-Toxnet_MDMA_after-effects-55"> <span id="mw-reference-text-cite_note-Toxnet_MDMA_after-effects-55" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+hsdb:@term+@rn+@rel+42542-10-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+hsdb:@term+@rn+@rel+42542-10-9'" tppabs="http://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+hsdb:@term+@rn+@rel+42542-10-9" class="external text external">"3,4-Methylenedioxymethamphetamine"</a>. <i>Hazardous Substances Data Bank</i>. National Library of Medicine. 28 August 2008<span class="reference-accessdate">. Retrieved <span class="nowrap">22 August</span> 2014</span>.</cite></span></li><li id="cite_note-56"> <span id="mw-reference-text-cite_note-56" class="mw-reference-text"><cite id="CITEREFHahn2015" class="citation web cs1">Hahn I (25 March 2015). <a href="javascript:if(confirm('http://emedicine.medscape.com/article/821572-overview  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://emedicine.medscape.com/article/821572-overview#showall'" tppabs="http://emedicine.medscape.com/article/821572-overview#showall" class="external text external">"MDMA Toxicity: Background, Pathophysiology, Epidemiology"</a>. <i>Medscape</i><span class="reference-accessdate">. Retrieved <span class="nowrap">14 May</span> 2016</span>.</cite></span></li><li id="cite_note-57"> <span id="mw-reference-text-cite_note-57" class="mw-reference-text"><cite id="CITEREFParrott2012" class="citation book cs1">Parrott AC (2012). <a href="javascript:if(confirm('https://books.google.com/books?id=yGeBj9U6Za8C  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=yGeBj9U6Za8C'" tppabs="https://books.google.com/books?id=yGeBj9U6Za8C" class="external text external">"13. MDMA and LSD"</a>.  In Verster J, Brady K, Galanter M, Conrod P (eds.). <i>Drug Abuse and Addiction in Medical Illness: Causes, Consequences and Treatment</i>. Springer Science &amp; Business Media. p.<span>&nbsp;</span>179. ISBN<span>&nbsp;</span><bdi>978-1-4614-3375-0</bdi>.</cite></span></li><li id="cite_note-Abstinent_MDMA_fMRI_review-58"> <span id="mw-reference-text-cite_note-Abstinent_MDMA_fMRI_review-58" class="mw-reference-text"><cite id="CITEREFGargKapoorGoelChopra2015" class="citation journal cs1">Garg A, Kapoor S, Goel M, Chopra S, Chopra M, Kapoor A, McCann UD, Behera C (2015). "Functional Magnetic Resonance Imaging in Abstinent MDMA Users: A Review". <i>Current Drug Abuse Reviews</i>. <b>8</b> (1): 15–25. doi:<a href="javascript:if(confirm('https://doi.org/10.2174%2F1874473708666150303115833  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2174%2F1874473708666150303115833'" tppabs="https://doi.org/10.2174%2F1874473708666150303115833" class="external text external">10.2174/1874473708666150303115833</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25731754  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25731754'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25731754" class="external text external">25731754</a>.</cite></span></li><li id="cite_note-mueller2015-59"> <span id="mw-reference-text-cite_note-mueller2015-59" class="mw-reference-text"><cite id="CITEREFMuellerLenzSteinerDolder2016" class="citation journal cs1">Mueller F, Lenz C, Steiner M, Dolder PC, Walter M, Lang UE, Liechti ME, Borgwardt S (March 2016). <a href="javascript:if(confirm('https://doi.org/10.1016/j.neubiorev.2015.12.010  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016/j.neubiorev.2015.12.010'" tppabs="https://doi.org/10.1016/j.neubiorev.2015.12.010" class="external text external">"Neuroimaging in moderate MDMA use: A systematic review"</a>. <i>Neuroscience and Biobehavioral Reviews</i>. <b>62</b>: 21–34. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.neubiorev.2015.12.010  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.neubiorev.2015.12.010'" tppabs="https://doi.org/10.1016%2Fj.neubiorev.2015.12.010" class="external text external">10.1016/j.neubiorev.2015.12.010</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26746590  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26746590'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26746590" class="external text external">26746590</a>.</cite></span></li><li id="cite_note-60"> <span id="mw-reference-text-cite_note-60" class="mw-reference-text"><cite id="CITEREFGouzoulis-MayfrankDaumann2009" class="citation journal cs1">Gouzoulis-Mayfrank E, Daumann J (2009). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181923  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181923'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181923" class="external text external">"Neurotoxicity of drugs of abuse--the case of methylenedioxyamphetamines (MDMA, ecstasy), and amphetamines"</a>. <i>Dialogues in Clinical Neuroscience</i>. <b>11</b> (3): 305–17. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181923  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181923'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181923" class="external text external">3181923</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19877498  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19877498'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19877498" class="external text external">19877498</a>.</cite></span></li><li id="cite_note-Meth_MDMA_NTox-61"> <span id="mw-reference-text-cite_note-Meth_MDMA_NTox-61" class="mw-reference-text"><cite id="CITEREFHalpinCollinsYamamoto2014" class="citation journal cs1">Halpin LE, Collins SA, Yamamoto BK (February 2014). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870191  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870191'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870191" class="external text external">"Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine"</a>. <i>Life Sciences</i>. <b>97</b> (1): 37–44. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.lfs.2013.07.014  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.lfs.2013.07.014'" tppabs="https://doi.org/10.1016%2Fj.lfs.2013.07.014" class="external text external">10.1016/j.lfs.2013.07.014</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870191  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870191'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870191" class="external text external">3870191</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23892199  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23892199'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23892199" class="external text external">23892199</a>. <q>In contrast, MDMA produces damage to serotonergic, but not dopaminergic axon terminals in the striatum, hippocampus, and prefrontal cortex (Battaglia et al., 1987, O'Hearn et al., 1988). The damage associated with Meth and MDMA has been shown to persist for at least 2 years in rodents, non-human primates and humans (Seiden et al., 1988, Woolverton et al., 1989, McCann et al., 1998, Volkow et al., 2001a, McCann et al., 2005)</q></cite></span></li><li id="cite_note-62"> <span id="mw-reference-text-cite_note-62" class="mw-reference-text"><cite id="CITEREFSzigetiWinstockErritzoeMaier2018" class="citation journal cs1">Szigeti B, Winstock AR, Erritzoe D, Maier LJ (July 2018). "Are ecstasy induced serotonergic alterations overestimated for the majority of users?". <i>Journal of Psychopharmacology</i>. <b>32</b> (7): 741–748. doi:<a href="javascript:if(confirm('https://doi.org/10.1177%2F0269881118767646  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1177%2F0269881118767646'" tppabs="https://doi.org/10.1177%2F0269881118767646" class="external text external">10.1177/0269881118767646</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29733742  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29733742'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29733742" class="external text external">29733742</a>. <q>Given the dose-response relationship between MDMA exposure and SERT reductions and the statistically non-significant SERT binding differences for users with use levels similar to the majority of real-life users, it can be speculated that SERT levels may not be significantly affected for most recreational ecstasy users.</q></cite></span></li><li id="cite_note-63"> <span id="mw-reference-text-cite_note-63" class="mw-reference-text"><cite id="CITEREFRobertsJonesMontgomery2016" class="citation journal cs1">Roberts CA, Jones A, Montgomery C (April 2016). <a href="javascript:if(confirm('https://doi.org/10.1016/j.neubiorev.2016.02.003  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016/j.neubiorev.2016.02.003'" tppabs="https://doi.org/10.1016/j.neubiorev.2016.02.003" class="external text external">"Meta-analysis of molecular imaging of serotonin transporters in ecstasy/polydrug users"</a>. <i>Neuroscience and Biobehavioral Reviews</i>. <b>63</b>: 158–67. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.neubiorev.2016.02.003  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.neubiorev.2016.02.003'" tppabs="https://doi.org/10.1016%2Fj.neubiorev.2016.02.003" class="external text external">10.1016/j.neubiorev.2016.02.003</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26855234  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26855234'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26855234" class="external text external">26855234</a>.</cite></span></li><li id="cite_note-Pharm2014-64"> <span id="mw-reference-text-cite_note-Pharm2014-64" class="mw-reference-text"><cite id="CITEREFParrott2014" class="citation journal cs1">Parrott AC (2014). <a href="javascript:if(confirm('https://www.researchgate.net/publication/262381558  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.researchgate.net/publication/262381558'" tppabs="https://www.researchgate.net/publication/262381558" class="external text external">"The potential dangers of using MDMA for psychotherapy"</a>. <i>Journal of Psychoactive Drugs</i>. <b>46</b> (1): 37–43. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F02791072.2014.873690  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F02791072.2014.873690'" tppabs="https://doi.org/10.1080%2F02791072.2014.873690" class="external text external">10.1080/02791072.2014.873690</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24830184  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24830184'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24830184" class="external text external">24830184</a>.</cite></span></li><li id="cite_note-65"> <span id="mw-reference-text-cite_note-65" class="mw-reference-text"><cite id="CITEREFRogersElstonGarsideRoome2009" class="citation journal cs1">Rogers G, Elston J, Garside R, Roome C, Taylor R, Younger P, Zawada A, Somerville M (January 2009). <a href="javascript:if(confirm('http://wrap.warwick.ac.uk/37399/1/WRAP_coversheet_Sutcliffe_Use_classical_novel.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://wrap.warwick.ac.uk/37399/1/WRAP_coversheet_Sutcliffe_Use_classical_novel.pdf'" tppabs="http://wrap.warwick.ac.uk/37399/1/WRAP_coversheet_Sutcliffe_Use_classical_novel.pdf" class="external text external">"The harmful health effects of recreational ecstasy: a systematic review of observational evidence"</a> <span class="cs1-format">(PDF)</span>. <i>Health Technology Assessment</i>. <b>13</b> (6): iii–iv, ix–xii, 1–315. doi:<a href="javascript:if(confirm('https://doi.org/10.3310%2Fhta13050  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3310%2Fhta13050'" tppabs="https://doi.org/10.3310%2Fhta13050" class="external text external">10.3310/hta13050</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19195429  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19195429'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19195429" class="external text external">19195429</a>.</cite></span></li><li id="cite_note-Meta_analysis_-_MDMA_memory_impairment-66"> <span id="mw-reference-text-cite_note-Meta_analysis_-_MDMA_memory_impairment-66" class="mw-reference-text"><cite id="CITEREFKuypersTheunissenvan_Welde_Sousa_Fernandes_Perna2016" class="citation journal cs1">Kuypers KP, Theunissen EL, van Wel JH, de Sousa Fernandes Perna EB, Linssen A, Sambeth A, Schultz BG, Ramaekers JG (2016). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764468  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764468'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764468" class="external text external">"Verbal Memory Impairment in Polydrug Ecstasy Users: A Clinical Perspective"</a>. <i>PLOS ONE</i>. <b>11</b> (2): e0149438. Bibcode:<a href="javascript:if(confirm('https://ui.adsabs.harvard.edu/abs/2016PLoSO..1149438K  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ui.adsabs.harvard.edu/abs/2016PLoSO..1149438K'" tppabs="https://ui.adsabs.harvard.edu/abs/2016PLoSO..1149438K" class="external text external">2016PLoSO..1149438K</a>. doi:<a href="javascript:if(confirm('https://doi.org/10.1371%2Fjournal.pone.0149438  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1371%2Fjournal.pone.0149438'" tppabs="https://doi.org/10.1371%2Fjournal.pone.0149438" class="external text external">10.1371/journal.pone.0149438</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764468  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764468'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764468" class="external text external">4764468</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26907605  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26907605'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26907605" class="external text external">26907605</a>.</cite></span></li><li id="cite_note-67"> <span id="mw-reference-text-cite_note-67" class="mw-reference-text"><cite id="CITEREFLawsKokkalis2007" class="citation journal cs1">Laws KR, Kokkalis J (August 2007). "Ecstasy (MDMA) and memory function: a meta-analytic update". <i>Human Psychopharmacology</i>. <b>22</b> (6): 381–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fhup.857  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fhup.857'" tppabs="https://doi.org/10.1002%2Fhup.857" class="external text external">10.1002/hup.857</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17621368  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17621368'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17621368" class="external text external">17621368</a>.</cite></span></li><li id="cite_note-MDMA_BBB-68"> <span id="mw-reference-text-cite_note-MDMA_BBB-68" class="mw-reference-text"><cite id="CITEREFKousikNapierCarvey2012" class="citation journal cs1">Kousik SM, Napier TC, Carvey PM (2012). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386512  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386512'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386512" class="external text external">"The effects of psychostimulant drugs on blood brain barrier function and neuroinflammation"</a>. <i>Frontiers in Pharmacology</i>. <b>3</b>: 121. doi:<a href="javascript:if(confirm('https://doi.org/10.3389%2Ffphar.2012.00121  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3389%2Ffphar.2012.00121'" tppabs="https://doi.org/10.3389%2Ffphar.2012.00121" class="external text external">10.3389/fphar.2012.00121</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386512  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386512'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386512" class="external text external">3386512</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22754527  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22754527'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22754527" class="external text external">22754527</a>.</cite></span></li><li id="cite_note-69"> <span id="mw-reference-text-cite_note-69" class="mw-reference-text"><cite id="CITEREFMcMillanStarr2014" class="citation book cs1">McMillan B, Starr C (2014). <i>Human biology</i> (10th ed.). Belmont, CA: Brooks/Cole Cengage Learning. ISBN<span>&nbsp;</span><bdi>978-1-133-59916-6</bdi>.</cite></span></li><li id="cite_note-70"> <span id="mw-reference-text-cite_note-70" class="mw-reference-text"><cite id="CITEREFBoyleConnor2010" class="citation journal cs1">Boyle NT, Connor TJ (September 2010). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2962814  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2962814'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2962814" class="external text external">"Methylenedioxymethamphetamine ('Ecstasy')-induced immunosuppression: a cause for concern?"</a>. <i>British Journal of Pharmacology</i>. <b>161</b> (1): 17–32. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2FJ.1476-5381.2010.00899.X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2FJ.1476-5381.2010.00899.X'" tppabs="https://doi.org/10.1111%2FJ.1476-5381.2010.00899.X" class="external text external">10.1111/J.1476-5381.2010.00899.X</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2962814  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2962814'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2962814" class="external text external">2962814</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20718737  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20718737'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20718737" class="external text external">20718737</a>.</cite></span></li><li id="cite_note-pmid17382831-71"> <span id="mw-reference-text-cite_note-pmid17382831-71" class="mw-reference-text"><cite id="CITEREFNuttKingSaulsburyBlakemore2007" class="citation journal cs1">Nutt D, King LA, Saulsbury W, Blakemore C (March 2007). "Development of a rational scale to assess the harm of drugs of potential misuse". <i>Lancet</i>. <b>369</b> (9566): 1047–53. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0140-6736%2807%2960464-4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0140-6736%2807%2960464-4'" tppabs="https://doi.org/10.1016%2FS0140-6736%2807%2960464-4" class="external text external">10.1016/S0140-6736(07)60464-4</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17382831  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17382831'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17382831" class="external text external">17382831</a>. <a href="javascript:if(confirm('http://news.bbc.co.uk/2/hi/health/6474053.stm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://news.bbc.co.uk/2/hi/health/6474053.stm'" tppabs="http://news.bbc.co.uk/2/hi/health/6474053.stm" class="external text external">Lay summary</a> <span>–</span> <i>Scientists want new drug rankings, BBC News</i> (23 March 2007).</cite></span></li><li id="cite_note-vorhees-72"> <span id="mw-reference-text-cite_note-vorhees-72" class="mw-reference-text"><cite id="CITEREFVorhees1997" class="citation journal cs1">Vorhees CV (November 1997). "Methods for detecting long-term CNS dysfunction after prenatal exposure to neurotoxins". <i>Drug and Chemical Toxicology</i>. <b>20</b> (4): 387–99. doi:<a href="javascript:if(confirm('https://doi.org/10.3109%2F01480549709003895  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3109%2F01480549709003895'" tppabs="https://doi.org/10.3109%2F01480549709003895" class="external text external">10.3109/01480549709003895</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9433666  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9433666'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9433666" class="external text external">9433666</a>.</cite></span></li><li id="cite_note-meamar-73"> <span id="mw-reference-text-cite_note-meamar-73" class="mw-reference-text"><cite id="CITEREFMeamarKaramaliSadeghiEtebari2010" class="citation journal cs1">Meamar R, Karamali F, Sadeghi HM, Etebari M, Nasr-Esfahani MH, Baharvand H (June 2010). "Toxicity of ecstasy (MDMA) towards embryonic stem cell-derived cardiac and neural cells". <i>Toxicology in Vitro</i>. <b>24</b> (4): 1133–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.tiv.2010.03.005  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.tiv.2010.03.005'" tppabs="https://doi.org/10.1016%2Fj.tiv.2010.03.005" class="external text external">10.1016/j.tiv.2010.03.005</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20230888  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20230888'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20230888" class="external text external">20230888</a>. <q>In summary, MDMA is a moderate teratogen that could influence cardiac and neuronal differentiation in the ESC model and these results are in concordance with previous in vivo and in vitro models.</q></cite></span></li><li id="cite_note-singer-74"> <span id="mw-reference-text-cite_note-singer-74" class="mw-reference-text"><cite id="CITEREFSingerMooreFultonGoodwin2012" class="citation journal cs1">Singer LT, Moore DG, Fulton S, Goodwin J, Turner JJ, Min MO, Parrott AC (2012). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3367027  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3367027'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3367027" class="external text external">"Neurobehavioral outcomes of infants exposed to MDMA (Ecstasy) and other recreational drugs during pregnancy"</a>. <i>Neurotoxicology and Teratology</i>. <b>34</b> (3): 303–10. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.ntt.2012.02.001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.ntt.2012.02.001'" tppabs="https://doi.org/10.1016%2Fj.ntt.2012.02.001" class="external text external">10.1016/j.ntt.2012.02.001</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3367027  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3367027'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3367027" class="external text external">3367027</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22387807  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22387807'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22387807" class="external text external">22387807</a>.</cite></span></li><li id="cite_note-MDMA_ΔFosB-75"> <span id="mw-reference-text-cite_note-MDMA_ΔFosB-75" class="mw-reference-text"><cite id="CITEREFOlaussonJentschTronsonNeve2006" class="citation journal cs1">Olausson P, Jentsch JD, Tronson N, Neve RL, Nestler EJ, Taylor JR (September 2006). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6674495  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6674495'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6674495" class="external text external">"DeltaFosB in the nucleus accumbens regulates food-reinforced instrumental behavior and motivation"</a>. <i>The Journal of Neuroscience</i>. <b>26</b> (36): 9196–204. doi:<a href="javascript:if(confirm('https://doi.org/10.1523%2FJNEUROSCI.1124-06.2006  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1523%2FJNEUROSCI.1124-06.2006'" tppabs="https://doi.org/10.1523%2FJNEUROSCI.1124-06.2006" class="external text external">10.1523/JNEUROSCI.1124-06.2006</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6674495  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6674495'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6674495" class="external text external">6674495</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16957076  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16957076'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16957076" class="external text external">16957076</a>.</cite></span></li><li id="cite_note-Nestler-76"> <span id="mw-reference-text-cite_note-Nestler-76" class="mw-reference-text"><cite id="CITEREFRobisonNestler2011" class="citation journal cs1">Robison AJ, Nestler EJ (October 2011). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3272277  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3272277'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3272277" class="external text external">"Transcriptional and epigenetic mechanisms of addiction"</a>. <i>Nature Reviews. Neuroscience</i>. <b>12</b> (11): 623–37. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2Fnrn3111  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fnrn3111'" tppabs="https://doi.org/10.1038%2Fnrn3111" class="external text external">10.1038/nrn3111</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3272277  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3272277'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3272277" class="external text external">3272277</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21989194  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21989194'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21989194" class="external text external">21989194</a>.</cite></span></li><li id="cite_note-77"> <span id="mw-reference-text-cite_note-77" class="mw-reference-text"><cite id="CITEREFMackBradyMillerFrances2016" class="citation book cs1">Mack AH, Brady KT, Miller SI, Frances RJ (12 May 2016). <a href="javascript:if(confirm('https://books.google.com/books?id=88W_CwAAQBAJ&pg=PA171  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=88W_CwAAQBAJ&pg=PA171'" tppabs="https://books.google.com/books?id=88W_CwAAQBAJ&pg=PA171" class="external text external"><i>Clinical Textbook of Addictive Disorders</i></a>. Guilford Publications. p.<span>&nbsp;</span>169. ISBN<span>&nbsp;</span><bdi>978-1-4625-2169-2</bdi>. <q>MDMA's addictive liability appears to be lower than that of other drugs of abuse....</q></cite></span></li><li id="cite_note-78"> <span id="mw-reference-text-cite_note-78" class="mw-reference-text"><cite id="CITEREFFavrod-CouneBroers2010" class="citation journal cs1">Favrod-Coune T, Broers B (July 2010). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036656  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036656'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036656" class="external text external">"The Health Effect of Psychostimulants: A Literature Review"</a>. <i>Pharmaceuticals</i>. <b>3</b> (7): 2333–2361. doi:<a href="javascript:if(confirm('https://doi.org/10.3390%2Fph3072333  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3390%2Fph3072333'" tppabs="https://doi.org/10.3390%2Fph3072333" class="external text external">10.3390/ph3072333</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036656  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036656'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036656" class="external text external">4036656</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27713356  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27713356'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27713356" class="external text external">27713356</a>. <q>It seems to present a smaller addiction potential than cocaine or methamphetamine.</q></cite></span></li><li id="cite_note-79"> <span id="mw-reference-text-cite_note-79" class="mw-reference-text"><cite id="CITEREFRiesMillerFiellin2009" class="citation book cs1">Ries R, Miller SC, Fiellin DA (2009). <a href="javascript:if(confirm('https://books.google.com/books?id=j6GGBud8DXcC&pg=PA226  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=j6GGBud8DXcC&pg=PA226'" tppabs="https://books.google.com/books?id=j6GGBud8DXcC&pg=PA226" class="external text external"><i>Principles of addiction medicine</i></a> (4th ed.). Philadelphia: Wolters Kluwer/Lippincott Williams &amp; Wilkins. p.<span>&nbsp;</span>226. ISBN<span>&nbsp;</span><bdi>978-0-7817-7477-2</bdi>. <q>MDA and MDMA are less reinforcing than amphetamine...</q></cite></span></li><li id="cite_note-Steinkellner2011-80"> <span id="mw-reference-text-cite_note-Steinkellner2011-80" class="mw-reference-text"><cite id="CITEREFSteinkellnerFreissmuthSitteMontgomery2011" class="citation journal cs1">Steinkellner T, Freissmuth M, Sitte HH, Montgomery T (January 2011). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4497800  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4497800'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4497800" class="external text external">"The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine"</a>. <i>Biological Chemistry</i>. <b>392</b> (1–2): 103–15. doi:<a href="javascript:if(confirm('https://doi.org/10.1515%2FBC.2011.016  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1515%2FBC.2011.016'" tppabs="https://doi.org/10.1515%2FBC.2011.016" class="external text external">10.1515/BC.2011.016</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4497800  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4497800'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4497800" class="external text external">4497800</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21194370  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21194370'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21194370" class="external text external">21194370</a>. <q>...approximately 15% of routine MDMA users recently fit the diagnostic criteria for MDMA dependence according to the Diagnostic and Statistical Manual, fourth edition/DSMIV.</q></cite></span></li><li id="cite_note-81"> <span id="mw-reference-text-cite_note-81" class="mw-reference-text"><cite class="citation book cs1">Mack AH, Brady KT, Miller SI, Frances RJ (12 May 2016). <a href="javascript:if(confirm('https://books.google.com/books?id=88W_CwAAQBAJ&pg=PA171&dq=mdma+addiction  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=88W_CwAAQBAJ&pg=PA171&dq=mdma+addiction#v=onepage'" tppabs="https://books.google.com/books?id=88W_CwAAQBAJ&pg=PA171&dq=mdma+addiction#v=onepage" class="external text external"><i>Clinical Textbook of Addictive Disorders</i></a>. Guilford Publications. p.<span>&nbsp;</span>171. ISBN<span>&nbsp;</span><bdi>978-1-4625-2169-2</bdi>. <q>There are no known pharmacological treatments for MDMA addiction.</q></cite></span></li><li id="cite_note-82"> <span id="mw-reference-text-cite_note-82" class="mw-reference-text"><cite id="CITEREFVanattou-SaïfoudineMcNamaraHarkin2012" class="citation journal cs1">Vanattou-Saïfoudine N, McNamara R, Harkin A (November 2012). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492978  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492978'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492978" class="external text external">"Caffeine provokes adverse interactions with 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') and related psychostimulants: mechanisms and mediators"</a>. <i>British Journal of Pharmacology</i>. <b>167</b> (5): 946–59. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1476-5381.2012.02065.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1476-5381.2012.02065.x'" tppabs="https://doi.org/10.1111%2Fj.1476-5381.2012.02065.x" class="external text external">10.1111/j.1476-5381.2012.02065.x</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492978  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492978'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492978" class="external text external">3492978</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22671762  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22671762'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22671762" class="external text external">22671762</a>.</cite></span></li><li id="cite_note-83"> <span id="mw-reference-text-cite_note-83" class="mw-reference-text"><cite id="CITEREFHallHenry2006" class="citation journal cs1">Hall AP, Henry JA (June 2006). <a href="javascript:if(confirm('https://academic.oup.com/bja/article/96/6/678/326917/Acute-toxic-effects-of-Ecstasy-MDMA-and-related  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://academic.oup.com/bja/article/96/6/678/326917/Acute-toxic-effects-of-Ecstasy-MDMA-and-related#4457537'" tppabs="https://academic.oup.com/bja/article/96/6/678/326917/Acute-toxic-effects-of-Ecstasy-MDMA-and-related#4457537" class="external text external">"Acute toxic effects of 'Ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management"</a>. <i>British Journal of Anaesthesia</i>. <b>96</b> (6): 678–85. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1093%2Fbja%2Fael078  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fbja%2Fael078'" tppabs="https://doi.org/10.1093%2Fbja%2Fael078" class="external text external">10.1093/bja/ael078</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16595612  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16595612'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16595612" class="external text external">16595612</a>.</cite></span></li><li id="cite_note-pmid15228154-84"> <span id="mw-reference-text-cite_note-pmid15228154-84" class="mw-reference-text"><cite id="CITEREFde_la_TorreFarréRosetPizarro2004" class="citation journal cs1">de la Torre R, Farré M, Roset PN, Pizarro N, Abanades S, Segura M, Segura J, Camí J (April 2004). "Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition". <i>Therapeutic Drug Monitoring</i>. <b>26</b> (2): 137–44. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F00007691-200404000-00009  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F00007691-200404000-00009'" tppabs="https://doi.org/10.1097%2F00007691-200404000-00009" class="external text external">10.1097/00007691-200404000-00009</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15228154  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15228154'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15228154" class="external text external">15228154</a>. <q>It is known that some recreational drugs (e.g., MDMA or GHB) may hamper the potential to ejaculate or maintain an erection.</q></cite></span></li><li id="cite_note-oxford-85"> <span id="mw-reference-text-cite_note-oxford-85" class="mw-reference-text"><cite id="CITEREFKellumGunnSinger2008" class="citation book cs1">Kellum JA, Gunn SR, Singer M (2008). <i>Oxford American Handbook of Critical Care</i>. Oxford University Press. p.<span>&nbsp;</span>464. ISBN<span>&nbsp;</span><bdi>978-0-19-530528-9</bdi>. OCLC<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/oclc/1003197730  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/oclc/1003197730'" tppabs="https://www.worldcat.org/oclc/1003197730" class="external text external">1003197730</a>.</cite></span></li><li id="cite_note-86"> <span id="mw-reference-text-cite_note-86" class="mw-reference-text"><cite class="citation journal cs1">de la Torre R, Farré M, Roset PN, Pizarro N, Abanades S, Segura M, Segura J, Camí J (April 2004). "Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition". <i>Therapeutic Drug Monitoring</i>. <b>26</b> (2): 137–44. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F00007691-200404000-00009  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F00007691-200404000-00009'" tppabs="https://doi.org/10.1097%2F00007691-200404000-00009" class="external text external">10.1097/00007691-200404000-00009</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15228154  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15228154'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15228154" class="external text external">15228154</a>.</cite></span></li><li id="cite_note-87"> <span id="mw-reference-text-cite_note-87" class="mw-reference-text"><cite id="CITEREFChummunTilleyIbe2010" class="citation journal cs1">Chummun H, Tilley V, Ibe J (2010). "3,4-methylenedioxyamfetamine (ecstasy) use reduces cognition". <i>British Journal of Nursing</i>. <b>19</b> (2): 94–100. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20235382  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20235382'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20235382" class="external text external">20235382</a>.</cite></span></li><li id="cite_note-88"> <span id="mw-reference-text-cite_note-88" class="mw-reference-text"><cite id="CITEREFPendergraftHerlitzThornley-BrownRosner2014" class="citation journal cs1">Pendergraft WF, Herlitz LC, Thornley-Brown D, Rosner M, Niles JL (November 2014). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220747  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220747'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220747" class="external text external">"Nephrotoxic effects of common and emerging drugs of abuse"</a>. <i>Clinical Journal of the American Society of Nephrology</i>. <b>9</b> (11): 1996–2005. doi:<a href="javascript:if(confirm('https://doi.org/10.2215%2FCJN.00360114  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2215%2FCJN.00360114'" tppabs="https://doi.org/10.2215%2FCJN.00360114" class="external text external">10.2215/CJN.00360114</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220747  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220747'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220747" class="external text external">4220747</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25035273  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25035273'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25035273" class="external text external">25035273</a>.</cite></span></li><li id="cite_note-89"> <span id="mw-reference-text-cite_note-89" class="mw-reference-text"><cite id="CITEREFSilinsCopelandDillon2007" class="citation journal cs1">Silins E, Copeland J, Dillon P (August 2007). "Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk". <i>The Australian and New Zealand Journal of Psychiatry</i>. <b>41</b> (8): 649–55. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F00048670701449237  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F00048670701449237'" tppabs="https://doi.org/10.1080%2F00048670701449237" class="external text external">10.1080/00048670701449237</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17620161  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17620161'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17620161" class="external text external">17620161</a>.</cite></span></li><li id="cite_note-90"> <span id="mw-reference-text-cite_note-90" class="mw-reference-text"><cite id="CITEREFVuoriHenryOjanperäNieminen2003" class="citation journal cs1">Vuori E, Henry JA, Ojanperä I, Nieminen R, Savolainen T, Wahlsten P, Jäntti M (March 2003). "Death following ingestion of MDMA (ecstasy) and moclobemide". <i>Addiction</i>. <b>98</b> (3): 365–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1046%2Fj.1360-0443.2003.00292.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1046%2Fj.1360-0443.2003.00292.x'" tppabs="https://doi.org/10.1046%2Fj.1360-0443.2003.00292.x" class="external text external">10.1046/j.1360-0443.2003.00292.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12603236  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12603236'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12603236" class="external text external">12603236</a>.</cite></span></li><li id="cite_note-Miller-91"> <span id="mw-reference-text-cite_note-Miller-91" class="mw-reference-text"><cite id="CITEREFMiller2011" class="citation journal cs1">Miller GM (January 2011). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005101  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005101'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005101" class="external text external">"The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity"</a>. <i>Journal of Neurochemistry</i>. <b>116</b> (2): 164–76. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1471-4159.2010.07109.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1471-4159.2010.07109.x'" tppabs="https://doi.org/10.1111%2Fj.1471-4159.2010.07109.x" class="external text external">10.1111/j.1471-4159.2010.07109.x</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005101  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005101'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005101" class="external text external">3005101</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21073468  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21073468'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21073468" class="external text external">21073468</a>.</cite></span></li><li id="cite_note-Drugbank_MDMA-92"> <span id="mw-reference-text-cite_note-Drugbank_MDMA-92" class="mw-reference-text"><cite class="citation encyclopaedia cs1"><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB01454  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB01454'" tppabs="https://www.drugbank.ca/drugs/DB01454" class="external text external">"Midomafetamine"</a>. <i>DrugBank</i>. University of Alberta. 2 May 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">15 May</span> 2018</span>. <q>It enters neurons via carriage by the monoamine transporters. Once inside, MDMA inhibits the vesicular monoamine transporter, which results in increased concentrations of serotonin, norepinephrine, and dopamine into the cytoplasm, and induces their release by reversing their respective transporters through a process known as phosphorylation.</q></cite></span></li><li id="cite_note-Berry_hTAAR_pharmacology_December_2017_review-93"> <span id="mw-reference-text-cite_note-Berry_hTAAR_pharmacology_December_2017_review-93" class="mw-reference-text"><cite id="CITEREFBerryGainetdinovHoenerShahid2017" class="citation journal cs1">Berry MD, Gainetdinov RR, Hoener MC, Shahid M (December 2017). <a href="javascript:if(confirm('https://doi.org/10.1016/j.pharmthera.2017.07.002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016/j.pharmthera.2017.07.002'" tppabs="https://doi.org/10.1016/j.pharmthera.2017.07.002" class="external text external">"Pharmacology of human trace amine-associated receptors: Therapeutic opportunities and challenges"</a>. <i>Pharmacology &amp; Therapeutics</i>. <b>180</b>: 161–180. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.pharmthera.2017.07.002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.pharmthera.2017.07.002'" tppabs="https://doi.org/10.1016%2Fj.pharmthera.2017.07.002" class="external text external">10.1016/j.pharmthera.2017.07.002</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28723415  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28723415'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28723415" class="external text external">28723415</a>. <q>As described above, a number of psychotropic agents including amphetamine, methamphetamine, and MDMA are potent agonists at human TAAR1 (Bunzow et al., 2001; Simmler et al., 2016). The subsequently observed regulatory effect of TAAR1 on dopaminergic systems has further strengthened this interest, given their well-documented involvement in reward circuitry.</q></cite></span></li><li id="cite_note-pmid1982265-94"> <span id="mw-reference-text-cite_note-pmid1982265-94" class="mw-reference-text"><cite id="CITEREFFitzgeraldReid1990" class="citation journal cs1">Fitzgerald JL, Reid JJ (November 1990). "Effects of methylenedioxymethamphetamine on the release of monoamines from rat brain slices". <i>European Journal of Pharmacology</i>. <b>191</b> (2): 217–20. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0014-2999%2890%2994150-V  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0014-2999%2890%2994150-V'" tppabs="https://doi.org/10.1016%2F0014-2999%2890%2994150-V" class="external text external">10.1016/0014-2999(90)94150-V</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1982265  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1982265'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1982265" class="external text external">1982265</a>.</cite></span></li><li id="cite_note-pmid12742084-95"> <span id="mw-reference-text-cite_note-pmid12742084-95" class="mw-reference-text"><cite id="CITEREFBogenHaugMyhreFonnum2003" class="citation journal cs1">Bogen IL, Haug KH, Myhre O, Fonnum F (2003). "Short- and long-term effects of MDMA ("ecstasy") on synaptosomal and vesicular uptake of neurotransmitters in vitro and ex vivo". <i>Neurochemistry International</i>. <b>43</b> (4–5): 393–400. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0197-0186%2803%2900027-5  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0197-0186%2803%2900027-5'" tppabs="https://doi.org/10.1016%2FS0197-0186%2803%2900027-5" class="external text external">10.1016/S0197-0186(03)00027-5</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12742084  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12742084'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12742084" class="external text external">12742084</a>.</cite></span></li><li id="cite_note-96"> <span id="mw-reference-text-cite_note-96" class="mw-reference-text"><cite id="CITEREFKalant2001" class="citation journal cs1">Kalant H (2 October 2001). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC81503  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC81503'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC81503" class="external text external">"The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs"</a>. <i>Canadian Medical Association Journal</i>. <b>165</b> (7): 917–28. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC81503  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC81503'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC81503" class="external text external">81503</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11599334  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11599334'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11599334" class="external text external">11599334</a>.</cite></span></li><li id="cite_note-Goldfrank_2011-97"> <span id="mw-reference-text-cite_note-Goldfrank_2011-97" class="mw-reference-text"><cite id="CITEREFNelsonLewinHowlandHoffman2011" class="citation book cs1">Nelson LS, Lewin NA, Howland MA, Hoffman RS, Goldfrank LR, Flomenbaum NE (2011). <i>Goldfrank's toxicologic emergencies</i> (9th ed.). New York: McGraw-Hill Medical. ISBN<span>&nbsp;</span><bdi>978-0-07-160593-9</bdi>.</cite></span></li><li id="cite_note-pmid2899513-98"> <span id="mw-reference-text-cite_note-pmid2899513-98" class="mw-reference-text"><cite id="CITEREFBattagliaBrooksKulsakdinunDe_Souza1988" class="citation journal cs1">Battaglia G, Brooks BP, Kulsakdinun C, De Souza EB (April 1988). <a href="javascript:if(confirm('https://zenodo.org/record/1253866  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://zenodo.org/record/1253866'" tppabs="https://zenodo.org/record/1253866" class="external text external">"Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites"</a>. <i>European Journal of Pharmacology</i>. <b>149</b> (1–2): 159–63. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0014-2999%2888%2990056-8  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0014-2999%2888%2990056-8'" tppabs="https://doi.org/10.1016%2F0014-2999%2888%2990056-8" class="external text external">10.1016/0014-2999(88)90056-8</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2899513  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2899513'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2899513" class="external text external">2899513</a>.</cite></span></li><li id="cite_note-pmid2871581-99"> <span id="mw-reference-text-cite_note-pmid2871581-99" class="mw-reference-text"><cite id="CITEREFLyonGlennonTiteler1986" class="citation journal cs1">Lyon RA, Glennon RA, Titeler M (1986). "3,4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions at brain 5-HT1 and 5-HT2 receptors". <i>Psychopharmacology</i>. <b>88</b> (4): 525–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2FBF00178519  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2FBF00178519'" tppabs="https://doi.org/10.1007%2FBF00178519" class="external text external">10.1007/BF00178519</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2871581  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2871581'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2871581" class="external text external">2871581</a>.</cite></span></li><li id="cite_note-pmid7824160-100"> <span id="mw-reference-text-cite_note-pmid7824160-100" class="mw-reference-text"><cite id="CITEREFNashRothBrodkinNichols1994" class="citation journal cs1">Nash JF, Roth BL, Brodkin JD, Nichols DE, Gudelsky GA (August 1994). "Effect of the R(-) and S(+) isomers of MDA and MDMA on phosphatidyl inositol turnover in cultured cells expressing 5-HT2A or 5-HT2C receptors". <i>Neuroscience Letters</i>. <b>177</b> (1–2): 111–5. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0304-3940%2894%2990057-4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0304-3940%2894%2990057-4'" tppabs="https://doi.org/10.1016%2F0304-3940%2894%2990057-4" class="external text external">10.1016/0304-3940(94)90057-4</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7824160  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7824160'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7824160" class="external text external">7824160</a>.</cite></span></li><li id="cite_note-pmid12761331-101"> <span id="mw-reference-text-cite_note-pmid12761331-101" class="mw-reference-text"><cite id="CITEREFSetolaHufeisenGrande-AllenVesely2003" class="citation journal cs1">Setola V, Hufeisen SJ, Grande-Allen KJ, Vesely I, Glennon RA, Blough B, Rothman RB, Roth BL (June 2003). <a href="javascript:if(confirm('https://semanticscholar.org/paper/cca65f5f2be82316522d7a1ceb315764b75dd559  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://semanticscholar.org/paper/cca65f5f2be82316522d7a1ceb315764b75dd559'" tppabs="https://semanticscholar.org/paper/cca65f5f2be82316522d7a1ceb315764b75dd559" class="external text external">"3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro"</a>. <i>Molecular Pharmacology</i>. <b>63</b> (6): 1223–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1124%2Fmol.63.6.1223  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1124%2Fmol.63.6.1223'" tppabs="https://doi.org/10.1124%2Fmol.63.6.1223" class="external text external">10.1124/mol.63.6.1223</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12761331  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12761331'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12761331" class="external text external">12761331</a>.</cite></span></li><li id="cite_note-Sigma-102"> <span id="mw-reference-text-cite_note-Sigma-102" class="mw-reference-text"><cite id="CITEREFMatsumoto2009" class="citation journal cs1">Matsumoto RR (July 2009). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662539  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662539'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662539" class="external text external">"Targeting sigma receptors: novel medication development for drug abuse and addiction"</a>. <i>Expert Review of Clinical Pharmacology</i>. <b>2</b> (4): 351–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1586%2Fecp.09.18  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1586%2Fecp.09.18'" tppabs="https://doi.org/10.1586%2Fecp.09.18" class="external text external">10.1586/ecp.09.18</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662539  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662539'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662539" class="external text external">3662539</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22112179  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22112179'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22112179" class="external text external">22112179</a>.</cite></span></li><li id="cite_note-103"> <span id="mw-reference-text-cite_note-103" class="mw-reference-text"><cite id="CITEREFMasFarréde_la_TorreRoset1999" class="citation journal cs1">Mas M, Farré M, de la Torre R, Roset PN, Ortuño J, Segura J, Camí J (July 1999). "Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans". <i>The Journal of Pharmacology and Experimental Therapeutics</i>. <b>290</b> (1): 136–45. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10381769  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10381769'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10381769" class="external text external">10381769</a>.</cite></span></li><li id="cite_note-TORRE1-104"> <span id="mw-reference-text-cite_note-TORRE1-104" class="mw-reference-text"><cite id="CITEREFde_la_TorreFarréOrtuñoMas2000" class="citation journal cs1">de la Torre R, Farré M, Ortuño J, Mas M, Brenneisen R, Roset PN,  et al. (February 2000). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2014905  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2014905'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2014905" class="external text external">"Non-linear pharmacokinetics of MDMA ('ecstasy') in humans"</a>. <i>British Journal of Clinical Pharmacology</i>. <b>49</b> (2): 104–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1046%2Fj.1365-2125.2000.00121.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1046%2Fj.1365-2125.2000.00121.x'" tppabs="https://doi.org/10.1046%2Fj.1365-2125.2000.00121.x" class="external text external">10.1046/j.1365-2125.2000.00121.x</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2014905  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2014905'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2014905" class="external text external">2014905</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10671903  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10671903'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10671903" class="external text external">10671903</a>.</cite></span></li><li id="cite_note-TORRE2-105"> <span id="mw-reference-text-cite_note-TORRE2-105" class="mw-reference-text"><cite id="CITEREFFarréRosetLopezMas2000" class="citation journal cs1">Farré M, Roset PN, Lopez CH, Mas M, Ortuño J, Menoyo E,  et al. (September 2000). "Pharmacology of MDMA in humans". <i>Annals of the New York Academy of Sciences</i>. <b>914</b> (1): 225–37. Bibcode:<a href="javascript:if(confirm('https://ui.adsabs.harvard.edu/abs/2000NYASA.914..225D  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ui.adsabs.harvard.edu/abs/2000NYASA.914..225D'" tppabs="https://ui.adsabs.harvard.edu/abs/2000NYASA.914..225D" class="external text external">2000NYASA.914..225D</a>. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1749-6632.2000.tb05199.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1749-6632.2000.tb05199.x'" tppabs="https://doi.org/10.1111%2Fj.1749-6632.2000.tb05199.x" class="external text external">10.1111/j.1749-6632.2000.tb05199.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11085324  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11085324'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11085324" class="external text external">11085324</a>.</cite></span></li><li id="cite_note-106"> <span id="mw-reference-text-cite_note-106" class="mw-reference-text"><cite id="CITEREFKolbrichGoodwinGorelickHayes2008" class="citation journal cs1">Kolbrich EA, Goodwin RS, Gorelick DA, Hayes RJ, Stein EA, Huestis MA (June 2008). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663855  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663855'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663855" class="external text external">"Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults"</a>. <i>Therapeutic Drug Monitoring</i>. <b>30</b> (3): 320–32. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2FFTD.0b013e3181684fa0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2FFTD.0b013e3181684fa0'" tppabs="https://doi.org/10.1097%2FFTD.0b013e3181684fa0" class="external text external">10.1097/FTD.0b013e3181684fa0</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663855  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663855'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663855" class="external text external">2663855</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18520604  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18520604'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18520604" class="external text external">18520604</a>.</cite></span></li><li id="cite_note-pmid17643356-107"> <span id="mw-reference-text-cite_note-pmid17643356-107" class="mw-reference-text"><cite id="CITEREFShimaKamataKatagiTsuchihashi2007" class="citation journal cs1">Shima N, Kamata H, Katagi M, Tsuchihashi H, Sakuma T, Nemoto N (September 2007). "Direct determination of glucuronide and sulfate of 4-hydroxy-3-methoxymethamphetamine, the main metabolite of MDMA, in human urine". <i>Journal of Chromatography B</i>. <b>857</b> (1): 123–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.jchromb.2007.07.003  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.jchromb.2007.07.003'" tppabs="https://doi.org/10.1016%2Fj.jchromb.2007.07.003" class="external text external">10.1016/j.jchromb.2007.07.003</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17643356  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17643356'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17643356" class="external text external">17643356</a>.</cite></span></li><li id="cite_note-fallon-108"> <span id="mw-reference-text-cite_note-fallon-108" class="mw-reference-text"><cite id="CITEREFFallonKicmanHenryMilligan1999" class="citation journal cs1">Fallon JK, Kicman AT, Henry JA, Milligan PJ, Cowan DA, Hutt AJ (July 1999). <a href="javascript:if(confirm('https://doi.org/10.1093/clinchem/45.7.1058  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093/clinchem/45.7.1058'" tppabs="https://doi.org/10.1093/clinchem/45.7.1058" class="external text external">"Stereospecific analysis and enantiomeric disposition of 3, 4-methylenedioxymethamphetamine (Ecstasy) in humans"</a>. <i>Clinical Chemistry</i>. <b>45</b> (7): 1058–69. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1093%2Fclinchem%2F45.7.1058  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fclinchem%2F45.7.1058'" tppabs="https://doi.org/10.1093%2Fclinchem%2F45.7.1058" class="external text external">10.1093/clinchem/45.7.1058</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10388483  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10388483'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10388483" class="external text external">10388483</a>.</cite></span></li><li id="cite_note-mueller-109"> <span id="mw-reference-text-cite_note-mueller-109" class="mw-reference-text"><cite id="CITEREFMuellerPetersMaurerMcCann2008" class="citation journal cs1">Mueller M, Peters FT, Maurer HH, McCann UD, Ricaurte GA (October 2008). "Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") and its major metabolites in squirrel monkeys at plasma concentrations of MDMA that develop after typical psychoactive doses". <i>The Journal of Pharmacology and Experimental Therapeutics</i>. <b>327</b> (1): 38–44. doi:<a href="javascript:if(confirm('https://doi.org/10.1124%2Fjpet.108.141366  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1124%2Fjpet.108.141366'" tppabs="https://doi.org/10.1124%2Fjpet.108.141366" class="external text external">10.1124/jpet.108.141366</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18591215  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18591215'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18591215" class="external text external">18591215</a>.</cite></span></li><li id="cite_note-110"> <span id="mw-reference-text-cite_note-110" class="mw-reference-text"><cite id="CITEREFMilhazesMartinsUriarteGarrido2007" class="citation journal cs1">Milhazes N, Martins P, Uriarte E, Garrido J, Calheiros R, Marques MP, Borges F (July 2007). "Electrochemical and spectroscopic characterisation of amphetamine-like drugs: application to the screening of 3,4-methylenedioxymethamphetamine (MDMA) and its synthetic precursors". <i>Analytica Chimica Acta</i>. <b>596</b> (2): 231–41. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.aca.2007.06.027  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.aca.2007.06.027'" tppabs="https://doi.org/10.1016%2Fj.aca.2007.06.027" class="external text external">10.1016/j.aca.2007.06.027</a>. hdl:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://hdl.handle.net/10316%2F45124  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://hdl.handle.net/10316%2F45124'" tppabs="https://hdl.handle.net/10316%2F45124" class="external text external">10316/45124</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17631101  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17631101'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17631101" class="external text external">17631101</a>.</cite></span></li><li id="cite_note-111"> <span id="mw-reference-text-cite_note-111" class="mw-reference-text"><cite id="CITEREFMilhazesCunha-OliveiraMartinsGarrido2006" class="citation journal cs1">Milhazes N, Cunha-Oliveira T, Martins P, Garrido J, Oliveira C, Rego AC, Borges F (October 2006). <a href="javascript:if(confirm('https://estudogeral.sib.uc.pt/bitstream/10316/12872/1/Synthesis%20and%20Cytotoxic%20Profile.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://estudogeral.sib.uc.pt/bitstream/10316/12872/1/Synthesis%20and%20Cytotoxic%20Profile.pdf'" tppabs="https://estudogeral.sib.uc.pt/bitstream/10316/12872/1/Synthesis%20and%20Cytotoxic%20Profile.pdf" class="external text external">"Synthesis and cytotoxic profile of 3,4-methylenedioxymethamphetamine ("ecstasy") and its metabolites on undifferentiated PC12 cells: A putative structure-toxicity relationship"</a> <span class="cs1-format">(PDF)</span>. <i>Chemical Research in Toxicology</i>. <b>19</b> (10): 1294–304. doi:<a href="javascript:if(confirm('https://doi.org/10.1021%2Ftx060123i  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1021%2Ftx060123i'" tppabs="https://doi.org/10.1021%2Ftx060123i" class="external text external">10.1021/tx060123i</a>. hdl:<a href="javascript:if(confirm('https://hdl.handle.net/10316%2F12872  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://hdl.handle.net/10316%2F12872'" tppabs="https://hdl.handle.net/10316%2F12872" class="external text external">10316/12872</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17040098  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17040098'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17040098" class="external text external">17040098</a>.</cite></span></li><li id="cite_note-112"> <span id="mw-reference-text-cite_note-112" class="mw-reference-text">Reductive aminations of carbonyl compounds with borohydride and borane reducing agents. Baxter, Ellen W.; Reitz, Allen B. <i>Organic Reactions</i> (Hoboken, New Jersey, United States) (2002), 59.</span></li><li id="cite_note-113"> <span id="mw-reference-text-cite_note-113" class="mw-reference-text"><cite id="CITEREFGimenoBesacierBottexDujourdy2005" class="citation journal cs1">Gimeno P, Besacier F, Bottex M, Dujourdy L, Chaudron-Thozet H (December 2005). "A study of impurities in intermediates and 3,4-methylenedioxymethamphetamine (MDMA) samples produced via reductive amination routes". <i>Forensic Science International</i>. <b>155</b> (2–3): 141–57. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.forsciint.2004.11.013  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.forsciint.2004.11.013'" tppabs="https://doi.org/10.1016%2Fj.forsciint.2004.11.013" class="external text external">10.1016/j.forsciint.2004.11.013</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16226151  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16226151'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16226151" class="external text external">16226151</a>.</cite></span></li><li id="cite_note-114"> <span id="mw-reference-text-cite_note-114" class="mw-reference-text"><cite id="CITEREFPalholBoyerNauletChabrillat2002" class="citation journal cs1">Palhol F, Boyer S, Naulet N, Chabrillat M (September 2002). "Impurity profiling of seized MDMA tablets by capillary gas chromatography". <i>Analytical and Bioanalytical Chemistry</i>. <b>374</b> (2): 274–81. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs00216-002-1477-6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs00216-002-1477-6'" tppabs="https://doi.org/10.1007%2Fs00216-002-1477-6" class="external text external">10.1007/s00216-002-1477-6</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12324849  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12324849'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12324849" class="external text external">12324849</a>.</cite></span></li><li id="cite_note-115"> <span id="mw-reference-text-cite_note-115" class="mw-reference-text"><cite id="CITEREFRentonCowieOon1993" class="citation journal cs1">Renton RJ, Cowie JS, Oon MC (August 1993). "A study of the precursors, intermediates and reaction by-products in the synthesis of 3,4-methylenedioxymethylamphetamine and its application to forensic drug analysis". <i>Forensic Science International</i>. <b>60</b> (3): 189–202. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0379-0738%2893%2990238-6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0379-0738%2893%2990238-6'" tppabs="https://doi.org/10.1016%2F0379-0738%2893%2990238-6" class="external text external">10.1016/0379-0738(93)90238-6</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7901132  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7901132'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7901132" class="external text external">7901132</a>.</cite></span></li><li id="cite_note-World_Drug_Report_2014-116"> <span id="mw-reference-text-cite_note-World_Drug_Report_2014-116" class="mw-reference-text"><cite id="CITEREFMohan2014" class="citation book cs1">Mohan, J, ed. (June 2014). <a href="javascript:if(confirm('http://www.unodc.org/documents/wdr2014/World_Drug_Report_2014_web.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.unodc.org/documents/wdr2014/World_Drug_Report_2014_web.pdf'" tppabs="http://www.unodc.org/documents/wdr2014/World_Drug_Report_2014_web.pdf" class="external text external"><i>World Drug Report 2014</i></a> <span class="cs1-format">(PDF)</span>. Vienna, Austria: United Nations Office on Drugs and Crime. pp.<span>&nbsp;</span>2, 3, 123–152. ISBN<span>&nbsp;</span><bdi>978-92-1-056752-7</bdi><span class="reference-accessdate">. Retrieved <span class="nowrap">1 December</span> 2014</span>.</cite></span></li><li id="cite_note-117"> <span id="mw-reference-text-cite_note-117" class="mw-reference-text"><a href="javascript:if(confirm('http://www.justice.gov/dea/pr/micrograms/2005/mg1105.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.justice.gov/dea/pr/micrograms/2005/mg1105.pdf'" tppabs="http://www.justice.gov/dea/pr/micrograms/2005/mg1105.pdf" class="external text external">Nov 2005 DEA Microgram newsletter, p. 166</a> <a href="javascript:if(confirm('https://web.archive.org/web/20121018052300/http://www.justice.gov/dea/pr/micrograms/2005/mg1105.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20121018052300/http://www.justice.gov/dea/pr/micrograms/2005/mg1105.pdf'" tppabs="https://web.archive.org/web/20121018052300/http://www.justice.gov/dea/pr/micrograms/2005/mg1105.pdf" class="external text external">Archived</a><span> 18 October 2012 at the </span>Wayback Machine. Usdoj.gov (11 November 2005). Retrieved on 12 August 2013.</span></li><li id="cite_note-118"> <span id="mw-reference-text-cite_note-118" class="mw-reference-text">Kolbrich EA, Goodwin RS, Gorelick DA, Hayes RJ, Stein EA, Huestis MA. Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults. Ther. Drug Monit. 30: 320–332, 2008.</span></li><li id="cite_note-119"> <span id="mw-reference-text-cite_note-119" class="mw-reference-text"><cite id="CITEREFBarnesDe_MartinisGorelickGoodwin2009" class="citation journal cs1">Barnes AJ, De Martinis BS, Gorelick DA, Goodwin RS, Kolbrich EA, Huestis MA (March 2009). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669283  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669283'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669283" class="external text external">"Disposition of MDMA and metabolites in human sweat following controlled MDMA administration"</a>. <i>Clinical Chemistry</i>. <b>55</b> (3): 454–62. doi:<a href="javascript:if(confirm('https://doi.org/10.1373%2Fclinchem.2008.117093  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1373%2Fclinchem.2008.117093'" tppabs="https://doi.org/10.1373%2Fclinchem.2008.117093" class="external text external">10.1373/clinchem.2008.117093</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669283  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669283'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669283" class="external text external">2669283</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19168553  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19168553'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19168553" class="external text external">19168553</a>.</cite></span></li><li id="cite_note-120"> <span id="mw-reference-text-cite_note-120" class="mw-reference-text">R. Baselt, <i>Disposition of Toxic Drugs and Chemicals in Man</i>, 9th edition, Biomedical Publications, Seal Beach, California, 2011, pp. 1078–1080.</span></li><li id="cite_note-pmid17152992-121"> <span id="mw-reference-text-cite_note-pmid17152992-121" class="mw-reference-text"><cite id="CITEREFBernschneider-ReifOxlerFreudenmann2006" class="citation journal cs1">Bernschneider-Reif S, Oxler F, Freudenmann RW (November 2006). <a href="javascript:if(confirm('http://www.ingentaconnect.com/content/govi/pharmaz/2006/00000061/00000011/art00015  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ingentaconnect.com/content/govi/pharmaz/2006/00000061/00000011/art00015'" tppabs="http://www.ingentaconnect.com/content/govi/pharmaz/2006/00000061/00000011/art00015" class="external text external">"The origin of MDMA ("ecstasy")--separating the facts from the myth"</a>. <i>Die Pharmazie</i>. <b>61</b> (11): 966–72. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17152992  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17152992'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17152992" class="external text external">17152992</a>.</cite></span></li><li id="cite_note-DE274350-122"> <span id="mw-reference-text-cite_note-DE274350-122" class="mw-reference-text"><cite id="CITEREFFirma_E._Merck_in_Darmstadt1914" class="citation web cs1">Firma E. Merck in Darmstadt (16 May 1914). <a href="javascript:if(confirm('http://v3.espacenet.com/publicationDetails/originalDocument?CC=DE&NR=274350C&FT=D  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://v3.espacenet.com/publicationDetails/originalDocument?CC=DE&NR=274350C&FT=D'" tppabs="http://v3.espacenet.com/publicationDetails/originalDocument?CC=DE&NR=274350C&FT=D" class="external text external">"German Patent 274350: Verfahren zur Darstellung von Alkyloxyaryl-, Dialkyloxyaryl- und Alkylendioxyarylaminopropanen bzw. deren am Stickstoff monoalkylierten Derivaten"</a>. Kaiserliches Patentamt<span class="reference-accessdate">. Retrieved <span class="nowrap">12 April</span> 2009</span>.</cite></span></li><li id="cite_note-DE279194-123"> <span id="mw-reference-text-cite_note-DE279194-123" class="mw-reference-text"><cite class="citation web cs1">Firma E. Merck in Darmstadt (15 October 1914). <a href="javascript:if(confirm('http://v3.espacenet.com/publicationDetails/originalDocument?CC=DE&NR=279194C&FT=D  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://v3.espacenet.com/publicationDetails/originalDocument?CC=DE&NR=279194C&FT=D'" tppabs="http://v3.espacenet.com/publicationDetails/originalDocument?CC=DE&NR=279194C&FT=D" class="external text external">"German Patent 279194: Verfahren zur Darstellung von Hydrastinin Derivaten"</a>. Kaiserliches Patentamt.</cite></span></li><li id="cite_note-124"> <span id="mw-reference-text-cite_note-124" class="mw-reference-text"><cite id="CITEREFShulgin1990" class="citation book cs1">Shulgin AT (1990). "1. History of MDMA".  In Peroutka SJ (ed.). <i>Ecstasy<span>&nbsp;</span>: the clinical, pharmacological, and neurotoxicological effects of the drug MDMA</i>. Boston: Kluwer Academic Publishers. pp.<span>&nbsp;</span>2, 14. ISBN<span>&nbsp;</span><bdi>978-0-7923-0305-3</bdi>.</cite></span></li><li id="cite_note-pmid4197635-125"> <span id="mw-reference-text-cite_note-pmid4197635-125" class="mw-reference-text"><cite id="CITEREFHardmanHaavikSeevers1973" class="citation journal cs1">Hardman HF, Haavik CO, Seevers MH (June 1973). <a href="javascript:if(confirm('http://www.erowid.org/references/refs_view.php?A=ShowDoc1&ID=639  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.erowid.org/references/refs_view.php?A=ShowDoc1&ID=639'" tppabs="http://www.erowid.org/references/refs_view.php?A=ShowDoc1&ID=639" class="external text external">"Relationship of the structure of mescaline and seven analogs to toxicity and behavior in five species of laboratory animals"</a>. <i>Toxicology and Applied Pharmacology</i>. <b>25</b> (2): 299–309. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0041-008X%2873%2980016-X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0041-008X%2873%2980016-X'" tppabs="https://doi.org/10.1016%2FS0041-008X%2873%2980016-X" class="external text external">10.1016/S0041-008X(73)80016-X</a>. hdl:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://hdl.handle.net/2027.42%2F33868  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://hdl.handle.net/2027.42%2F33868'" tppabs="https://hdl.handle.net/2027.42%2F33868" class="external text external">2027.42/33868</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/4197635  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/4197635'" tppabs="https://pubmed.ncbi.nlm.nih.gov/4197635" class="external text external">4197635</a>.</cite></span></li><li id="cite_note-Shulgin-126"> <span id="mw-reference-text-cite_note-Shulgin-126" class="mw-reference-text"><cite id="CITEREFBenzenhöferPassie2010" class="citation journal cs1">Benzenhöfer U, Passie T (August 2010). "Rediscovering MDMA (ecstasy): the role of the American chemist Alexander T. Shulgin". <i>Addiction</i>. <b>105</b> (8): 1355–61. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1360-0443.2010.02948.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1360-0443.2010.02948.x'" tppabs="https://doi.org/10.1111%2Fj.1360-0443.2010.02948.x" class="external text external">10.1111/j.1360-0443.2010.02948.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20653618  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20653618'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20653618" class="external text external">20653618</a>.</cite></span></li><li id="cite_note-127"> <span id="mw-reference-text-cite_note-127" class="mw-reference-text"><cite id="CITEREFBinieckiKrajewski1960" class="citation journal cs1">Biniecki S, Krajewski E (1960). "Production of d,1-N-methyl-beta-(3,4-methylenedioxyphenyl)-isopropylamine and d,1-N-methyl-beta-(3,4-dimthoxyphenyl)-isopropylamine". <i>Acta Polon Pharm</i> (in Polish). <b>17</b>: 421–5.</cite></span></li><li id="cite_note-Siegel_1986-128"> <span id="mw-reference-text-cite_note-Siegel_1986-128" class="mw-reference-text"><cite id="CITEREFSiegel1986" class="citation journal cs1">Siegel RK (October 1986). <a href="javascript:if(confirm('http://www.maps.org/images/pdf/1986_siegel_1.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.maps.org/images/pdf/1986_siegel_1.pdf'" tppabs="http://www.maps.org/images/pdf/1986_siegel_1.pdf" class="external text external">"MDMA. Nonmedical use and intoxication"</a> <span class="cs1-format">(PDF)</span>. <i>Journal of Psychoactive Drugs</i>. <b>18</b> (4): 349–54. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F02791072.1986.10472368  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F02791072.1986.10472368'" tppabs="https://doi.org/10.1080%2F02791072.1986.10472368" class="external text external">10.1080/02791072.1986.10472368</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2880950  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2880950'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2880950" class="external text external">2880950</a>.</cite></span></li><li id="cite_note-129"> <span id="mw-reference-text-cite_note-129" class="mw-reference-text">The first confirmed sample was seized and identified by Chicago Police in 1970, see <cite id="CITEREFSreenivasan_VR1972" class="citation journal cs1">Sreenivasan VR (1972). <a href="javascript:if(confirm('http://www.erowid.org/references/refs_view.php?A=ShowDoc1&ID=1149  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.erowid.org/references/refs_view.php?A=ShowDoc1&ID=1149'" tppabs="http://www.erowid.org/references/refs_view.php?A=ShowDoc1&ID=1149" class="external text external">"Problems in Identification of Methylenedioxy and Methoxy Amphetamines"</a>. <i>Journal of Criminal Law, Criminology, and Police Science</i>. <b>63</b> (2): 304–312. doi:<a href="javascript:if(confirm('https://doi.org/10.2307%2F1142315  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2307%2F1142315'" tppabs="https://doi.org/10.2307%2F1142315" class="external text external">10.2307/1142315</a>. JSTOR<span>&nbsp;</span><a href="javascript:if(confirm('https://www.jstor.org/stable/1142315  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.jstor.org/stable/1142315'" tppabs="https://www.jstor.org/stable/1142315" class="external text external">1142315</a>.</cite></span></li><li id="cite_note-Foderaro_1988-130"> <span id="mw-reference-text-cite_note-Foderaro_1988-130" class="mw-reference-text"><cite id="CITEREFFoderaro1988" class="citation news cs1">Foderaro LW (11 December 1988). <a href="javascript:if(confirm('https://www.nytimes.com/1988/12/11/nyregion/psychedelic-drug-called-ecstasy-gains-popularity-in-manhattan-nightclubs.html?pagewanted=2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nytimes.com/1988/12/11/nyregion/psychedelic-drug-called-ecstasy-gains-popularity-in-manhattan-nightclubs.html?pagewanted=2'" tppabs="https://www.nytimes.com/1988/12/11/nyregion/psychedelic-drug-called-ecstasy-gains-popularity-in-manhattan-nightclubs.html?pagewanted=2" class="external text external">"Psychedelic Drug Called Ecstasy Gains Popularity in Manhattan Nightclubs"</a>. <i>The New York Times</i>. The New York Times Company<span class="reference-accessdate">. Retrieved <span class="nowrap">27 August</span> 2015</span>.</cite></span></li><li id="cite_note-Professor_X-131"> <span id="mw-reference-text-cite_note-Professor_X-131" class="mw-reference-text"><cite id="CITEREFBrown2002" class="citation magazine cs1">Brown E (September 2002). <a href="javascript:if(confirm('http://archive.wired.com/wired/archive/10.09/professorx.html?pg=3&topic=&topic_set=  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://archive.wired.com/wired/archive/10.09/professorx.html?pg=3&topic=&topic_set='" tppabs="http://archive.wired.com/wired/archive/10.09/professorx.html?pg=3&topic=&topic_set=" class="external text external">"Professor X"</a>. <i>Wired</i><span class="reference-accessdate">. Retrieved <span class="nowrap">4 January</span> 2015</span>.</cite></span></li><li id="cite_note-Beck_1987-132"> <span id="mw-reference-text-cite_note-Beck_1987-132" class="mw-reference-text"><cite id="CITEREFBeck1987" class="citation web cs1">Beck JE (April 1987). <a href="javascript:if(confirm('https://erowid.org/chemicals/mdma/mdma_info6.shtml  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://erowid.org/chemicals/mdma/mdma_info6.shtml'" tppabs="https://erowid.org/chemicals/mdma/mdma_info6.shtml" class="external text external">"Drug Abuse Series: MDMA"</a>. <i>Erowid</i>. Drug Abuse Information and Monitoring Project<span class="reference-accessdate">. Retrieved <span class="nowrap">6 August</span> 2015</span>.</cite></span></li><li id="cite_note-exploration-133"> <span id="mw-reference-text-cite_note-exploration-133" class="mw-reference-text"><cite id="CITEREFPentney2001" class="citation journal cs1">Pentney AR (2001). "An exploration of the history and controversies surrounding MDMA and MDA". <i>Journal of Psychoactive Drugs</i>. <b>33</b> (3): 213–21. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F02791072.2001.10400568  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F02791072.2001.10400568'" tppabs="https://doi.org/10.1080%2F02791072.2001.10400568" class="external text external">10.1080/02791072.2001.10400568</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11718314  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11718314'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11718314" class="external text external">11718314</a>.</cite></span></li><li id="cite_note-134"> <span id="mw-reference-text-cite_note-134" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.shulginresearch.org/home/about/alexander-sasha-shulgin/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.shulginresearch.org/home/about/alexander-sasha-shulgin/'" tppabs="http://www.shulginresearch.org/home/about/alexander-sasha-shulgin/" class="external text external">"Alexander 'Sasha' Shulgin"</a>. Alexander Shulgin Research Institute<span class="reference-accessdate">. Retrieved <span class="nowrap">8 January</span> 2015</span>.</cite></span></li><li id="cite_note-PiHKAL-135"> <span id="mw-reference-text-cite_note-PiHKAL-135" class="mw-reference-text"><cite id="CITEREFShulginShulgin1991" class="citation book cs1">Shulgin A, Shulgin A (1991). "Chapters 12, 22". <i>PiHKAL<span>&nbsp;</span>: A Chemical Love Story</i> (7th printing, 1st ed.). Berkeley, CA: Transform Press. ISBN<span>&nbsp;</span><bdi>978-0-9630096-0-9</bdi>.</cite></span></li><li id="cite_note-isbn0-08-021938-1-136"> <span id="mw-reference-text-cite_note-isbn0-08-021938-1-136" class="mw-reference-text"><cite id="CITEREFShulginNichols1978" class="citation book cs1">Shulgin AT, Nichols DE (1978). <a href="javascript:if(confirm('http://www.erowid.org/references/refs_view.php?A=ShowDocPartFrame&ID=961&DocPartID=832  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.erowid.org/references/refs_view.php?A=ShowDocPartFrame&ID=961&DocPartID=832'" tppabs="http://www.erowid.org/references/refs_view.php?A=ShowDocPartFrame&ID=961&DocPartID=832" class="external text external">"Characterization of Three New Psychotomimetics"</a>.  In Willette, Robert E., Stillman, Richard Joseph (eds.). <i>The Psychopharmacology of Hallucinogens</i>. New York: Pergamon Press. pp.<span>&nbsp;</span>74–83. ISBN<span>&nbsp;</span><bdi>978-0-08-021938-7</bdi>.</cite></span></li><li id="cite_note-Dr._Ecstasy-137"> <span id="mw-reference-text-cite_note-Dr._Ecstasy-137" class="mw-reference-text"><cite id="CITEREFBennett2005" class="citation news cs1">Bennett, Drake (30 January 2005). <a href="javascript:if(confirm('https://www.nytimes.com/2005/01/30/magazine/30ECSTASY.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nytimes.com/2005/01/30/magazine/30ECSTASY.html'" tppabs="https://www.nytimes.com/2005/01/30/magazine/30ECSTASY.html" class="external text external">"Dr. Ecstasy"</a>. <i>New York Times Magazine</i>.</cite></span></li><li id="cite_note-rising-138"> <span id="mw-reference-text-cite_note-rising-138" class="mw-reference-text"><cite id="CITEREFJennings2004" class="citation news cs1">Jennings P (1 April 2004). <a href="javascript:if(confirm('https://web.archive.org/web/20150527163756/http://www.thedocumentarygroup.com/PJP/Transcripts%20Files/Script_Ecstasy.doc  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20150527163756/http://www.thedocumentarygroup.com/PJP/Transcripts%20Files/Script_Ecstasy.doc'" tppabs="https://web.archive.org/web/20150527163756/http://www.thedocumentarygroup.com/PJP/Transcripts%20Files/Script_Ecstasy.doc" class="external text external">"Ecstasy Rising"</a>. <i>Primetime Thursday</i> (Special edition). ABC News. Archived from <a href="javascript:if(confirm('http://www.thedocumentarygroup.com/PJP/Transcripts%20Files/Script_Ecstasy.doc  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.thedocumentarygroup.com/PJP/Transcripts%20Files/Script_Ecstasy.doc'" tppabs="http://www.thedocumentarygroup.com/PJP/Transcripts%20Files/Script_Ecstasy.doc" class="external text external">the original</a> on 27 May 2015.</cite></span></li><li id="cite_note-139"> <span id="mw-reference-text-cite_note-139" class="mw-reference-text"><cite id="CITEREFShulgin2004" class="citation book cs1">Shulgin A (2004). <a href="javascript:if(confirm('http://maps.org/images/pdf/books/scr/scr.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://maps.org/images/pdf/books/scr/scr.pdf'" tppabs="http://maps.org/images/pdf/books/scr/scr.pdf" class="external text external">"Tribute to Jacob"</a> <span class="cs1-format">(PDF)</span>.  In Doblin R (ed.). <i>The Secret Chief Revealed</i> (2nd ed.). Sarasota, Fl: Multidisciplinary Association for Psychedelic Studies. pp.<span>&nbsp;</span>17–18. ISBN<span>&nbsp;</span><bdi>978-0-9660019-6-9</bdi><span class="reference-accessdate">. Retrieved <span class="nowrap">7 January</span> 2015</span>.</cite></span></li><li id="cite_note-Nutt-140"> <span id="mw-reference-text-cite_note-Nutt-140" class="mw-reference-text"><a href="javascript:if(confirm('http://open.live.bbc.co.uk/mediaselector/5/redir/version/2.0/mediaset/audio-nondrm-download-low/proto/http/vpid/p0687kzh.mp3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://open.live.bbc.co.uk/mediaselector/5/redir/version/2.0/mediaset/audio-nondrm-download-low/proto/http/vpid/p0687kzh.mp3'" tppabs="http://open.live.bbc.co.uk/mediaselector/5/redir/version/2.0/mediaset/audio-nondrm-download-low/proto/http/vpid/p0687kzh.mp3" class="external text external">Ecstasy on Prescription</a>, BBC Business Daily, May 29, 2018.</span></li><li id="cite_note-Eisner-141"> <span id="mw-reference-text-cite_note-Eisner-141" class="mw-reference-text"><cite id="CITEREFEisner1994" class="citation book cs1">Eisner B (1994). <a href="javascript:if(confirm('https://books.google.com/books?id=8aqUu5M6UpwC  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=8aqUu5M6UpwC'" tppabs="https://books.google.com/books?id=8aqUu5M6UpwC" class="external text external"><i>Ecstasy<span>&nbsp;</span>: The MDMA Story</i></a> (Expanded 2nd ed.). Berkeley, CA: Ronin Publishing. ISBN<span>&nbsp;</span><bdi>978-0-914171-68-3</bdi>.</cite></span></li><li id="cite_note-Beck_&amp;_Rosenbaum-142"> <span id="mw-reference-text-cite_note-Beck_&amp;_Rosenbaum-142" class="mw-reference-text"><cite id="CITEREFBeckRosenbaum1994" class="citation book cs1">Beck J, Rosenbaum M (1994). <a href="javascript:if(confirm('https://books.google.com/books?id=SwdedK36bVMC  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=SwdedK36bVMC'" tppabs="https://books.google.com/books?id=SwdedK36bVMC" class="external text external">"The Distribution of Ecstasy"</a>. <span class="cs1-lock-registration"><a href="javascript:if(confirm('https://archive.org/details/pursuitofecstasy0000beck  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://archive.org/details/pursuitofecstasy0000beck'" tppabs="https://archive.org/details/pursuitofecstasy0000beck" class="external text external"><i>Pursuit of Ecstasy<span>&nbsp;</span>: The MDMA Experience</i></a></span>. Albany: State Univ. of New York Press. ISBN<span>&nbsp;</span><bdi>978-0-7914-1817-8</bdi>.</cite></span></li><li id="cite_note-isbn0803936788-143"> <span id="mw-reference-text-cite_note-isbn0803936788-143" class="mw-reference-text"><cite id="CITEREFDoblinRosenbaum1991" class="citation book cs1">Doblin R, Rosenbaum M (1991). <a href="javascript:if(confirm('http://www.drugtext.org/pdf/Dance/party-drugs-clubbing/why-mdma-should-not-have-been-made-illegal.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.drugtext.org/pdf/Dance/party-drugs-clubbing/why-mdma-should-not-have-been-made-illegal.pdf'" tppabs="http://www.drugtext.org/pdf/Dance/party-drugs-clubbing/why-mdma-should-not-have-been-made-illegal.pdf" class="external text external">"Chapter 6: Why MDMA Should Not Have Been Made Illegal"</a> <span class="cs1-format">(PDF)</span>.  In Inciardi JA (ed.). <a href="javascript:if(confirm('https://archive.org/details/druglegalization00inci  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://archive.org/details/druglegalization00inci'" tppabs="https://archive.org/details/druglegalization00inci" class="external text external"><i>The Drug Legalization Debate</i></a> (2nd ed.). London: Sage Publications, Inc. ISBN<span>&nbsp;</span><bdi>978-0-8039-3678-2</bdi><span class="reference-accessdate">. Retrieved <span class="nowrap">10 August</span> 2015</span>.</cite></span></li><li id="cite_note-isbn9781847656414-144"> <span id="mw-reference-text-cite_note-isbn9781847656414-144" class="mw-reference-text"><cite id="CITEREFCollinGodfrey2010" class="citation book cs1">Collin M, Godfrey J (2010). <a href="javascript:if(confirm('https://books.google.com/books?id=fc8x9qeCekQC  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=fc8x9qeCekQC'" tppabs="https://books.google.com/books?id=fc8x9qeCekQC" class="external text external">"The Technologies of Pleasure"</a>. <i>Altered State: The Story of Ecstasy Culture and Acid House</i> (Updated new ed.). London: Profile Books. ISBN<span>&nbsp;</span><bdi>978-1-84765-641-4</bdi>.</cite></span></li><li id="cite_note-145"> <span id="mw-reference-text-cite_note-145" class="mw-reference-text"><cite id="CITEREFSavlov2000" class="citation news cs1">Savlov M (12 June 2000). <a href="javascript:if(confirm('http://www.weeklywire.com/ww/06-12-00/austin_music_feature.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.weeklywire.com/ww/06-12-00/austin_music_feature.html'" tppabs="http://www.weeklywire.com/ww/06-12-00/austin_music_feature.html" class="external text external">"Countdown to Ecstasy: A New Drug for a New Millennium"</a>. <i>The Austin Chronicle</i>. Weekly Wire<span class="reference-accessdate">. Retrieved <span class="nowrap">6 August</span> 2015</span>.</cite></span></li><li id="cite_note-146"> <span id="mw-reference-text-cite_note-146" class="mw-reference-text"><cite id="CITEREFOwenGavin2013" class="citation magazine cs1">Owen F, Gavin L (20 October 2013). <a href="javascript:if(confirm('http://www.playboy.com/articles/molly-party-drug-ecstasy  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.playboy.com/articles/molly-party-drug-ecstasy'" tppabs="http://www.playboy.com/articles/molly-party-drug-ecstasy" class="external text external">"Molly Isn't Who You Think She Is: A Deeper Look at MDMA"</a>. <i>Playboy</i><span class="reference-accessdate">. Retrieved <span class="nowrap">6 August</span> 2015</span>.</cite></span></li><li id="cite_note-147"> <span id="mw-reference-text-cite_note-147" class="mw-reference-text"><cite id="CITEREFSylvan2005" class="citation book cs1">Sylvan R (2005). "A Brief History of the Rave Scene". <i>Trance Formation: The Spiritual and Religious Dimensions of Global Rave Culture</i>. New York, NY: Routledge. pp.<span>&nbsp;</span>21–22. ISBN<span>&nbsp;</span><bdi>978-0-415-97090-7</bdi>.</cite></span></li><li id="cite_note-148"> <span id="mw-reference-text-cite_note-148" class="mw-reference-text"><cite id="CITEREFParrott2004" class="citation journal cs1">Parrott AC (May 2004). <a href="javascript:if(confirm('http://psy.swansea.ac.uk/staff/parrott/p-IsEcstasyMDMA-Psychopharm-2004.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://psy.swansea.ac.uk/staff/parrott/p-IsEcstasyMDMA-Psychopharm-2004.pdf'" tppabs="http://psy.swansea.ac.uk/staff/parrott/p-IsEcstasyMDMA-Psychopharm-2004.pdf" class="external text external">"Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity"</a> <span class="cs1-format">(PDF)</span>. <i>Psychopharmacology</i>. <b>173</b> (3–4): 234–41. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs00213-003-1712-7  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs00213-003-1712-7'" tppabs="https://doi.org/10.1007%2Fs00213-003-1712-7" class="external text external">10.1007/s00213-003-1712-7</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15007594  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15007594'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15007594" class="external text external">15007594</a>.</cite></span></li><li id="cite_note-149"> <span id="mw-reference-text-cite_note-149" class="mw-reference-text"><cite id="CITEREFRenfroe1986" class="citation journal cs1">Renfroe CL (October 1986). "MDMA on the street: Analysis Anonymous". <i>Journal of Psychoactive Drugs</i>. <b>18</b> (4): 363–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F02791072.1986.10472371  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F02791072.1986.10472371'" tppabs="https://doi.org/10.1080%2F02791072.1986.10472371" class="external text external">10.1080/02791072.1986.10472371</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2880953  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2880953'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2880953" class="external text external">2880953</a>.</cite></span></li><li id="cite_note-150"> <span id="mw-reference-text-cite_note-150" class="mw-reference-text"><cite class="citation journal cs1"><a href="javascript:if(confirm('http://maps.org/research-archive/dea-mdma/pdf/0194.PDF  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://maps.org/research-archive/dea-mdma/pdf/0194.PDF'" tppabs="http://maps.org/research-archive/dea-mdma/pdf/0194.PDF" class="external text external">"Schedules of Controlled Substances Proposed Placement of 3,4-Methylenedioxymethamphetamine in Schedule I"</a> <span class="cs1-format">(PDF)</span>. <i>Federal Register</i>. <b>49</b> (146): 30210. 27 July 1984<span class="reference-accessdate">. Retrieved <span class="nowrap">15 January</span> 2015</span>.</cite></span></li><li id="cite_note-151"> <span id="mw-reference-text-cite_note-151" class="mw-reference-text"><cite id="CITEREFAdlerAbramsonKatzHager1985" class="citation news cs1">Adler J, Abramson P, Katz S, Hager M (15 April 1985). <a href="javascript:if(confirm('http://www.maps.org/research-archive/hmma/Newsweek4.85.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.maps.org/research-archive/hmma/Newsweek4.85.pdf'" tppabs="http://www.maps.org/research-archive/hmma/Newsweek4.85.pdf" class="external text external">"Getting High on 'Ecstasy<span class="cs1-kern-right">'</span>"</a> <span class="cs1-format">(PDF)</span>. <i>Newsweek Magazine</i>. Life/Style. p.<span>&nbsp;</span>96<span class="reference-accessdate">. Retrieved <span class="nowrap">1 February</span> 2015</span>.</cite></span></li><li id="cite_note-comprehensive-152"> <span id="mw-reference-text-cite_note-comprehensive-152" class="mw-reference-text"><cite id="CITEREFHolland2001" class="citation book cs1">Holland J (2001). "The History of MDMA".  In Holland J (ed.). <i>Ecstasy: the complete guide; a comprehensive look at the risks and benefits of MDMA</i>. Rochester, VT: Park Street Press. ISBN<span>&nbsp;</span><bdi>978-0-89281-857-0</bdi>.</cite></span></li><li id="cite_note-New_York_Times-153"> <span id="mw-reference-text-cite_note-New_York_Times-153" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('https://www.nytimes.com/1985/06/01/us/us-will-ban-ecstasy-a-hallucinogenic-drug.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nytimes.com/1985/06/01/us/us-will-ban-ecstasy-a-hallucinogenic-drug.html'" tppabs="https://www.nytimes.com/1985/06/01/us/us-will-ban-ecstasy-a-hallucinogenic-drug.html" class="external text external">"U.S. will ban 'ecstasy,' a hallucinogenic drug"</a>. <i>The New York Times</i>. The Associated Press. 1 June 1985<span class="reference-accessdate">. Retrieved <span class="nowrap">29 April</span> 2015</span>.</cite></span></li><li id="cite_note-154"> <span id="mw-reference-text-cite_note-154" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.erowid.org/chemicals/mdma/mdma_law3.shtml  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.erowid.org/chemicals/mdma/mdma_law3.shtml'" tppabs="https://www.erowid.org/chemicals/mdma/mdma_law3.shtml" class="external text external">"MDMA – FDA REPORT, 1985"</a>. <i>Erowid</i>. Food and Drug Administration. 1985<span class="reference-accessdate">. Retrieved <span class="nowrap">11 August</span> 2015</span>.</cite></span></li><li id="cite_note-155"> <span id="mw-reference-text-cite_note-155" class="mw-reference-text"><cite id="CITEREFBaker1985" class="citation news cs1">Baker K (30 May 1985). <a href="javascript:if(confirm('http://www.apnewsarchive.com/1985/DEA-To-Ban-Ecstasy-The-Drug-MDMA/id-26214cd32a8b4c05e361158df14715b0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.apnewsarchive.com/1985/DEA-To-Ban-Ecstasy-The-Drug-MDMA/id-26214cd32a8b4c05e361158df14715b0'" tppabs="http://www.apnewsarchive.com/1985/DEA-To-Ban-Ecstasy-The-Drug-MDMA/id-26214cd32a8b4c05e361158df14715b0" class="external text external">"DEA To Ban "Ecstasy" – The Drug MDMA"</a>. The Associated Press<span class="reference-accessdate">. Retrieved <span class="nowrap">7 August</span> 2015</span>.</cite></span></li><li id="cite_note-156"> <span id="mw-reference-text-cite_note-156" class="mw-reference-text"><cite id="CITEREFCorwin1985" class="citation news cs1">Corwin M (31 May 1985). <a href="javascript:if(confirm('https://articles.latimes.com/1985-05-31/news/mn-14566_1_street-drugs  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://articles.latimes.com/1985-05-31/news/mn-14566_1_street-drugs'" tppabs="https://articles.latimes.com/1985-05-31/news/mn-14566_1_street-drugs" class="external text external">"U.S. to Ban Use of Drug MDMA<span>&nbsp;</span>: Street Abuse Cited; Used by Psychiatrists"</a>. <i>Los Angeles Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">11 August</span> 2015</span>.</cite></span></li><li id="cite_note-157"> <span id="mw-reference-text-cite_note-157" class="mw-reference-text"><cite id="CITEREFWeber2014" class="citation news cs1">Weber B (7 June 2014). <a href="javascript:if(confirm('https://www.nytimes.com/2014/06/08/us/alexander-shulgin-psychedelia-researcher-dies-at-88.html?_r=0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nytimes.com/2014/06/08/us/alexander-shulgin-psychedelia-researcher-dies-at-88.html?_r=0'" tppabs="https://www.nytimes.com/2014/06/08/us/alexander-shulgin-psychedelia-researcher-dies-at-88.html?_r=0" class="external text external">"Alexander Shulgin, Psychedelia Researcher, Dies at 88"</a>. <i>The New York Times</i>. The New York Times Company<span class="reference-accessdate">. Retrieved <span class="nowrap">28 August</span> 2015</span>.</cite></span></li><li id="cite_note-158"> <span id="mw-reference-text-cite_note-158" class="mw-reference-text"><cite id="CITEREFVastag2014" class="citation news cs1">Vastag B (3 June 2014). <a href="javascript:if(confirm('https://www.washingtonpost.com/national/health-science/chemist-alexander-shulgin-popularizer-of-the-drug-ecstasy-dies-at-88/2014/06/03/19fd9580-eb34-11e3-b98c-72cef4a00499_story.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.washingtonpost.com/national/health-science/chemist-alexander-shulgin-popularizer-of-the-drug-ecstasy-dies-at-88/2014/06/03/19fd9580-eb34-11e3-b98c-72cef4a00499_story.html'" tppabs="https://www.washingtonpost.com/national/health-science/chemist-alexander-shulgin-popularizer-of-the-drug-ecstasy-dies-at-88/2014/06/03/19fd9580-eb34-11e3-b98c-72cef4a00499_story.html" class="external text external">"Chemist Alexander Shulgin, popularizer of the drug Ecstasy, dies at 88"</a>. <i>The Washington Post</i>. WP Company LLC<span class="reference-accessdate">. Retrieved <span class="nowrap">28 August</span> 2015</span>.</cite></span></li><li id="cite_note-Harpers-159"> <span id="mw-reference-text-cite_note-Harpers-159" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('https://newspaperarchive.com/profile/Robert_Thomas/clipnumber/34618/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://newspaperarchive.com/profile/Robert_Thomas/clipnumber/34618/'" tppabs="https://newspaperarchive.com/profile/Robert_Thomas/clipnumber/34618/" class="external text external">"Ecstasy has its pros and cons"</a>. <i>Kokomo Tribune</i>. Kokomo, Indiana. Harper's Bazaar. 23 November 1985. p.<span>&nbsp;</span>6 <span>–</span> via newspaperarchive.com.</cite> <span style="position:relative; top: -2px;"><figure-inline><img src="../I/m/Lock-green.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Lock-green.svg.png" data-file-width="512" data-file-height="813" data-file-type="drawing" height="14" width="9"></figure-inline></span></span></li><li id="cite_note-160"> <span id="mw-reference-text-cite_note-160" class="mw-reference-text"><cite class="citation book cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20141019192225/http://whqlibdoc.who.int/trs/WHO_TRS_729.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20141019192225/http://whqlibdoc.who.int/trs/WHO_TRS_729.pdf'" tppabs="https://web.archive.org/web/20141019192225/http://whqlibdoc.who.int/trs/WHO_TRS_729.pdf" class="external text external"><i>WHO Expert Committee on Drug Dependence: Twenty-second Report</i></a> <span class="cs1-format">(PDF)</span>. Geneva: World Health Organization. 1985. pp.<span>&nbsp;</span>24–25. ISBN<span>&nbsp;</span><bdi>978-9241207294</bdi>. Archived from <a href="javascript:if(confirm('http://whqlibdoc.who.int/trs/WHO_TRS_729.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://whqlibdoc.who.int/trs/WHO_TRS_729.pdf'" tppabs="http://whqlibdoc.who.int/trs/WHO_TRS_729.pdf" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on 19 October 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">29 August</span> 2012</span>.</cite></span></li><li id="cite_note-161"> <span id="mw-reference-text-cite_note-161" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.unodc.org/documents/commissions/CND/Drug_Resolutions/1980-1989/1986/CND_Decision-1986-07_S-IX.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.unodc.org/documents/commissions/CND/Drug_Resolutions/1980-1989/1986/CND_Decision-1986-07_S-IX.pdf'" tppabs="http://www.unodc.org/documents/commissions/CND/Drug_Resolutions/1980-1989/1986/CND_Decision-1986-07_S-IX.pdf" class="external text external">"Decision to place MDMA into Schedule I"</a> <span class="cs1-format">(PDF)</span>. <i>UNODC</i>. Commission on Narcotic Drugs. 11 February 1986<span class="reference-accessdate">. Retrieved <span class="nowrap">9 May</span> 2015</span>.</cite></span></li><li id="cite_note-162"> <span id="mw-reference-text-cite_note-162" class="mw-reference-text"><cite id="CITEREFMcKinley2013" class="citation news cs1">McKinley JC (12 September 2013). <a href="javascript:if(confirm('http://artsbeat.blogs.nytimes.com/2013/09/12/overdoses-of-molly-led-to-electric-zoo-deaths/?_r=0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://artsbeat.blogs.nytimes.com/2013/09/12/overdoses-of-molly-led-to-electric-zoo-deaths/?_r=0'" tppabs="http://artsbeat.blogs.nytimes.com/2013/09/12/overdoses-of-molly-led-to-electric-zoo-deaths/?_r=0" class="external text external">"Overdoses of 'Molly' Led to Electric Zoo Deaths"</a>. <i>The New York Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">9 December</span> 2013</span>.</cite></span></li><li id="cite_note-163"> <span id="mw-reference-text-cite_note-163" class="mw-reference-text"><a href="javascript:if(confirm('http://www.maps.org/research/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.maps.org/research/'" tppabs="http://www.maps.org/research/" class="external text external">Bibliography of Psychedelic Research Studies.</a> collected by the Multidisciplinary Association for Psychedelic Studies  <a href="javascript:if(confirm('https://web.archive.org/web/20131203011733/http://www.maps.org/research/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20131203011733/http://www.maps.org/research/'" tppabs="https://web.archive.org/web/20131203011733/http://www.maps.org/research/" class="external text external">Archived</a><span> 3 December 2013 at the </span>Wayback Machine</span></li><li id="cite_note-164"> <span id="mw-reference-text-cite_note-164" class="mw-reference-text"><cite id="CITEREFJames2015" class="citation web cs1">James SD (23 February 2015). <a href="javascript:if(confirm('https://www.nbcnews.com/health/health-news/what-molly-why-it-dangerous-n311291  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nbcnews.com/health/health-news/what-molly-why-it-dangerous-n311291'" tppabs="https://www.nbcnews.com/health/health-news/what-molly-why-it-dangerous-n311291" class="external text external">"What Is Molly and Why Is It Dangerous?"</a>. NBCNews.com<span class="reference-accessdate">. Retrieved <span class="nowrap">23 February</span> 2015</span>. <q>Why is it called Molly?  That's short for "molecule."  "You can put a ribbon and bow on it and call it a cute name like 'Molly' and people are all in," said Paul Doering, professor emeritus of pharmacology at the University of Florida.</q></cite></span></li><li id="cite_note-165"> <span id="mw-reference-text-cite_note-165" class="mw-reference-text"><cite id="CITEREFAleksander2013" class="citation news cs1">Aleksander I (21 June 2013). <a href="javascript:if(confirm('https://www.nytimes.com/2013/06/23/fashion/molly-pure-but-not-so-simple.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nytimes.com/2013/06/23/fashion/molly-pure-but-not-so-simple.html'" tppabs="https://www.nytimes.com/2013/06/23/fashion/molly-pure-but-not-so-simple.html" class="external text external">"Molly: Pure, but Not So Simple"</a>. <i>The New York Times</i>. The New York Times Company<span class="reference-accessdate">. Retrieved <span class="nowrap">24 February</span> 2015</span>.</cite></span></li><li id="cite_note-166"> <span id="mw-reference-text-cite_note-166" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('http://scientopia.org/blogs/drugmonkey/2010/09/19/mephedrone-4-methylmethcathinone-appearing-in-ecstasy-in-the-netherlands/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://scientopia.org/blogs/drugmonkey/2010/09/19/mephedrone-4-methylmethcathinone-appearing-in-ecstasy-in-the-netherlands/'" tppabs="http://scientopia.org/blogs/drugmonkey/2010/09/19/mephedrone-4-methylmethcathinone-appearing-in-ecstasy-in-the-netherlands/" class="external text external">"Mephedrone (4-Methylmethcathinone) appearing in "Ecstasy" in the Netherlands"</a>. 19 September 2010<span class="reference-accessdate">. Retrieved <span class="nowrap">31 December</span> 2012</span>.</cite></span></li><li id="cite_note-167"> <span id="mw-reference-text-cite_note-167" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('http://news.bbc.co.uk/1/hi/england/london/8468372.stm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://news.bbc.co.uk/1/hi/england/london/8468372.stm'" tppabs="http://news.bbc.co.uk/1/hi/england/london/8468372.stm" class="external text external">"Why ecstasy is 'vanishing' from UK nightclubs"</a>. <i>BBC News</i>. 19 January 2010<span class="reference-accessdate">. Retrieved <span class="nowrap">14 February</span> 2010</span>.</cite></span></li><li id="cite_note-168"> <span id="mw-reference-text-cite_note-168" class="mw-reference-text"><cite id="CITEREFBish2017" class="citation journal cs1">Bish J (4 August 2017). <a href="javascript:if(confirm('https://www.vice.com/en_uk/article/pagjxg/watch-out-for-pentylone-the-horrible-new-mdma-additive  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.vice.com/en_uk/article/pagjxg/watch-out-for-pentylone-the-horrible-new-mdma-additive'" tppabs="https://www.vice.com/en_uk/article/pagjxg/watch-out-for-pentylone-the-horrible-new-mdma-additive" class="external text external">"Watch Out for Pentylone, the Horrible New MDMA Additive"</a>. <i>Vice</i>.</cite></span></li><li id="cite_note-169"> <span id="mw-reference-text-cite_note-169" class="mw-reference-text"><cite class="citation book cs1"><a href="javascript:if(confirm('https://dataunodc.un.org/drugs/prevalence_regional  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dataunodc.un.org/drugs/prevalence_regional'" tppabs="https://dataunodc.un.org/drugs/prevalence_regional" class="external text external">"Annual prevalence of use of drugs, by region and globally, 2016"</a>. <a href="javascript:if(confirm('https://www.unodc.org/wdr2018/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.unodc.org/wdr2018/'" tppabs="https://www.unodc.org/wdr2018/" class="external text external"><i>World Drug Report 2018</i></a>. United Nations Office on Drugs and Crime. 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">7 July</span> 2018</span>.</cite></span></li><li id="cite_note-170"> <span id="mw-reference-text-cite_note-170" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.slp.wa.gov.au/legislation/statutes.nsf/main_mrtitle_4607_homepage.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.slp.wa.gov.au/legislation/statutes.nsf/main_mrtitle_4607_homepage.html'" tppabs="https://www.slp.wa.gov.au/legislation/statutes.nsf/main_mrtitle_4607_homepage.html" class="external text external">"Misuse of Drugs Act 1981"</a>. The Government of Western Australia. Department of the Premier and Cabinet. 23 October 1981.</cite></span></li><li id="cite_note-Drugs_2.0-171"> <span id="mw-reference-text-cite_note-Drugs_2.0-171" class="mw-reference-text"><cite id="CITEREFPower2013" class="citation book cs1">Power M (2013). <a href="javascript:if(confirm('https://books.google.com/books?id=gj6zMQEACAAJ&dq=Drugs+2.0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=gj6zMQEACAAJ&dq=Drugs+2.0'" tppabs="https://books.google.com/books?id=gj6zMQEACAAJ&dq=Drugs+2.0" class="external text external"><i>Drugs 2.0<span>&nbsp;</span>: the web revolution that's changing how the world gets high</i></a> <span class="cs1-format">(epub file)</span>. London: Portobello. ISBN<span>&nbsp;</span><bdi>978-1-84627-459-6</bdi>.</cite></span></li><li id="cite_note-UK_legality-172"> <span id="mw-reference-text-cite_note-UK_legality-172" class="mw-reference-text"><a href="javascript:if(confirm('http://www.statutelaw.gov.uk/content.aspx?LegType=All+Primary&PageNumber=57&NavFrom=2&parentActiveTextDocId=1367412&ActiveTextDocId=1367472&filesize=411  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.statutelaw.gov.uk/content.aspx?LegType=All+Primary&PageNumber=57&NavFrom=2&parentActiveTextDocId=1367412&ActiveTextDocId=1367472&filesize=411'" tppabs="http://www.statutelaw.gov.uk/content.aspx?LegType=All+Primary&PageNumber=57&NavFrom=2&parentActiveTextDocId=1367412&ActiveTextDocId=1367472&filesize=411" class="external text external">Misuse of Drugs Act 1971</a>. Statutelaw.gov.uk (5 January 1998). Retrieved on 11 June 2011.</span></li><li id="cite_note-173"> <span id="mw-reference-text-cite_note-173" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('https://www.telegraph.co.uk/news/uknews/law-and-order/4537874/Ecstasy-no-more-dangerous-than-horse-riding.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.telegraph.co.uk/news/uknews/law-and-order/4537874/Ecstasy-no-more-dangerous-than-horse-riding.html'" tppabs="https://www.telegraph.co.uk/news/uknews/law-and-order/4537874/Ecstasy-no-more-dangerous-than-horse-riding.html" class="external text external">"Ecstasy 'no more dangerous than horse riding<span class="cs1-kern-right">'</span>"</a>. <i>Telegraph.co.uk</i>. 7 February 2009<span class="reference-accessdate">. Retrieved <span class="nowrap">4 December</span> 2015</span>.</cite></span></li><li id="cite_note-174"> <span id="mw-reference-text-cite_note-174" class="mw-reference-text"><cite id="CITEREFNutt2009" class="citation journal cs1">Nutt DJ (January 2009). "Equasy-- an overlooked addiction with implications for the current debate on drug harms". <i>Journal of Psychopharmacology</i>. <b>23</b> (1): 3–5. doi:<a href="javascript:if(confirm('https://doi.org/10.1177%2F0269881108099672  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1177%2F0269881108099672'" tppabs="https://doi.org/10.1177%2F0269881108099672" class="external text external">10.1177/0269881108099672</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19158127  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19158127'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19158127" class="external text external">19158127</a>.</cite></span></li><li id="cite_note-johnson-175"> <span id="mw-reference-text-cite_note-johnson-175" class="mw-reference-text"><cite id="CITEREFJohnson2009" class="citation news cs1">Johnson A (2 November 2009). <a href="javascript:if(confirm('https://www.theguardian.com/politics/2009/nov/02/drug-policy-alan-johnson-nutt  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.theguardian.com/politics/2009/nov/02/drug-policy-alan-johnson-nutt'" tppabs="https://www.theguardian.com/politics/2009/nov/02/drug-policy-alan-johnson-nutt" class="external text external">"Why Professor David Nutt was shown the door"</a>. <i>The Guardian</i>. London<span class="reference-accessdate">. Retrieved <span class="nowrap">3 November</span> 2009</span>.</cite></span></li><li id="cite_note-176"> <span id="mw-reference-text-cite_note-176" class="mw-reference-text"><i>Schedules of Controlled Substances; Scheduling of 3,4-Methylenedioxymethamphetamine (MDMA) Into Schedule I of the Controlled Substances Act; Remand</i>, 53 Fed. Reg. 5,156 (DEA 22 February 1988).</span></li><li id="cite_note-177"> <span id="mw-reference-text-cite_note-177" class="mw-reference-text"><a href="javascript:if(confirm('https://www.aclu.org/criminal-law-reform/court-rejects-harsh-federal-drug-sentencing-guideline-scientifically-unjustified  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.aclu.org/criminal-law-reform/court-rejects-harsh-federal-drug-sentencing-guideline-scientifically-unjustified'" tppabs="https://www.aclu.org/criminal-law-reform/court-rejects-harsh-federal-drug-sentencing-guideline-scientifically-unjustified" class="external text external">Court Rejects Harsh Federal Drug Sentencing Guideline as Scientifically Unjustified | American Civil Liberties Union</a>. Aclu.org (15 July 2011). Retrieved on 29 August 2012.</span></li><li id="cite_note-papers.ssrn.com-178"> <span id="mw-reference-text-cite_note-papers.ssrn.com-178" class="mw-reference-text"><cite id="CITEREFHennig2014" class="citation journal cs1">Hennig AC (2014). "An Examination of Federal Sentencing Guidelines' Treatment of MDMA ('Ecstasy')". <i>Belmont Law Review</i>. <b>1</b>: 267. SSRN<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://ssrn.com/abstract=2481227  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ssrn.com/abstract=2481227'" tppabs="https://ssrn.com/abstract=2481227" class="external text external">2481227</a></span>.</cite></span></li><li id="cite_note-179"> <span id="mw-reference-text-cite_note-179" class="mw-reference-text"><a href="javascript:if(confirm('http://www.rijksoverheid.nl/documenten-en-publicaties/rapporten/2011/06/27/rapport-drugs-in-lijsten.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.rijksoverheid.nl/documenten-en-publicaties/rapporten/2011/06/27/rapport-drugs-in-lijsten.html'" tppabs="http://www.rijksoverheid.nl/documenten-en-publicaties/rapporten/2011/06/27/rapport-drugs-in-lijsten.html" class="external text external">Rapport Drugs in Lijsten | Rapport</a> <a href="javascript:if(confirm('https://web.archive.org/web/20120306112130/http://www.rijksoverheid.nl/documenten-en-publicaties/rapporten/2011/06/27/rapport-drugs-in-lijsten.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20120306112130/http://www.rijksoverheid.nl/documenten-en-publicaties/rapporten/2011/06/27/rapport-drugs-in-lijsten.html'" tppabs="https://web.archive.org/web/20120306112130/http://www.rijksoverheid.nl/documenten-en-publicaties/rapporten/2011/06/27/rapport-drugs-in-lijsten.html" class="external text external">Archived</a><span> 6 March 2012 at the </span>Wayback Machine. Rijksoverheid.nl (27 June 2011). Retrieved on 29 August 2012.</span></li><li id="cite_note-180"> <span id="mw-reference-text-cite_note-180" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.government.nl/documents-and-publications/press-releases/2011/06/24/committee-the-current-system-of-the-opium-act-does-not-have-to-be-changed.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.government.nl/documents-and-publications/press-releases/2011/06/24/committee-the-current-system-of-the-opium-act-does-not-have-to-be-changed.html'" tppabs="http://www.government.nl/documents-and-publications/press-releases/2011/06/24/committee-the-current-system-of-the-opium-act-does-not-have-to-be-changed.html" class="external text external">"Committee: the current system of the Opium Act does not have to be changed"</a>. <i>government.nl</i>. 24 June 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">29 August</span> 2012</span>.</cite></span></li><li id="cite_note-CDSA_Schedule_I:_Amphetamines-181"> <span id="mw-reference-text-cite_note-CDSA_Schedule_I:_Amphetamines-181" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://isomerdesign.com/Cdsa/schedule.php?schedule=1&section=18.5&structure=C  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://isomerdesign.com/Cdsa/schedule.php?schedule=1&section=18.5&structure=C'" tppabs="http://isomerdesign.com/Cdsa/schedule.php?schedule=1&section=18.5&structure=C" class="external text external">"Schedule I"</a>. <i>Controlled Drugs and Substances Act</i>. Isomer Design<span class="reference-accessdate">. Retrieved <span class="nowrap">9 December</span> 2013</span>.</cite></span></li><li id="cite_note-Definitions_and_Interpretations-182"> <span id="mw-reference-text-cite_note-Definitions_and_Interpretations-182" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://isomerdesign.com/Cdsa/definitions.php?structure=C  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://isomerdesign.com/Cdsa/definitions.php?structure=C'" tppabs="http://isomerdesign.com/Cdsa/definitions.php?structure=C" class="external text external">"Definitions and interpretations"</a>. <i>Controlled Drugs and Substances Act</i>. Isomer Design<span class="reference-accessdate">. Retrieved <span class="nowrap">9 December</span> 2013</span>.</cite></span></li><li id="cite_note-:0-183"> <span id="mw-reference-text-cite_note-:0-183" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.emcdda.europa.eu/data/stats2018/gps_en  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.emcdda.europa.eu/data/stats2018/gps_en'" tppabs="http://www.emcdda.europa.eu/data/stats2018/gps_en" class="external text external">"Statistical Bulletin 2018 —<span>&nbsp;</span>prevalence of drug use | www.emcdda.europa.eu"</a>. <i>www.emcdda.europa.eu</i><span class="reference-accessdate">. Retrieved <span class="nowrap">5 February</span> 2019</span>.</cite></span></li><li id="cite_note-184"> <span id="mw-reference-text-cite_note-184" class="mw-reference-text"><cite id="CITEREFWuLiuPhamJin2010" class="citation journal cs1">Wu P, Liu X, Pham TH, Jin J, Fan B, Jin Z (November 2010). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967577  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967577'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967577" class="external text external">"Ecstasy use among US adolescents from 1999 to 2008"</a>. <i>Drug and Alcohol Dependence</i>. <b>112</b> (1–2): 33–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.drugalcdep.2010.05.006  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.drugalcdep.2010.05.006'" tppabs="https://doi.org/10.1016%2Fj.drugalcdep.2010.05.006" class="external text external">10.1016/j.drugalcdep.2010.05.006</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967577  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967577'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967577" class="external text external">2967577</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20570447  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20570447'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20570447" class="external text external">20570447</a>.</cite></span></li><li id="cite_note-185"> <span id="mw-reference-text-cite_note-185" class="mw-reference-text"><cite id="CITEREFEuropean_Monitoring_Centre_for_Drugs_and_Drug_Addiction2008" class="citation book cs1">European Monitoring Centre for Drugs and Drug Addiction (2008). <a href="javascript:if(confirm('http://www.emcdda.europa.eu/attachements.cfm/att_64227_EN_EMCDDA_AR08_en.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.emcdda.europa.eu/attachements.cfm/att_64227_EN_EMCDDA_AR08_en.pdf'" tppabs="http://www.emcdda.europa.eu/attachements.cfm/att_64227_EN_EMCDDA_AR08_en.pdf" class="external text external"><i>Annual report: the state of the drugs problem in Europe</i></a> <span class="cs1-format">(PDF)</span>. Luxembourg: Office for Official Publications of the European Communities. p.<span>&nbsp;</span>49. ISBN<span>&nbsp;</span><bdi>978-92-9168-324-6</bdi>.</cite></span></li><li id="cite_note-186"> <span id="mw-reference-text-cite_note-186" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.emcdda.europa.eu/attachements.cfm/att_228272_EN_TDAT14001ENN.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.emcdda.europa.eu/attachements.cfm/att_228272_EN_TDAT14001ENN.pdf'" tppabs="http://www.emcdda.europa.eu/attachements.cfm/att_228272_EN_TDAT14001ENN.pdf" class="external text external">"European Drug Report 2014, page 26"</a> <span class="cs1-format">(PDF)</span>.</cite></span></li><li id="cite_note-187"> <span id="mw-reference-text-cite_note-187" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20151208142205/http://www.unodc.org/documents/wdr2014/Statistics/Prices_ATS.xls  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20151208142205/http://www.unodc.org/documents/wdr2014/Statistics/Prices_ATS.xls'" tppabs="https://web.archive.org/web/20151208142205/http://www.unodc.org/documents/wdr2014/Statistics/Prices_ATS.xls" class="external text external">"Ecstasy-type substances Retail and wholesale prices* and purity levels, by drug, region and country or territory"</a>. United Nations Office on Drugs and Crime. Archived from <a href="javascript:if(confirm('http://www.unodc.org/documents/wdr2014/Statistics/Prices_ATS.xls  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.unodc.org/documents/wdr2014/Statistics/Prices_ATS.xls'" tppabs="http://www.unodc.org/documents/wdr2014/Statistics/Prices_ATS.xls" class="external text external">the original</a> on 8 December 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">2 January</span> 2015</span>.</cite></span></li><li id="cite_note-188"> <span id="mw-reference-text-cite_note-188" class="mw-reference-text"><cite id="CITEREFCamargoEsseivaGonzálezWist2012" class="citation journal cs1">Camargo J, Esseiva P, González F, Wist J, Patiny L (November 2012). <a href="javascript:if(confirm('http://www.fsijournal.org/article/S0379-0738(12)00458-6/abstract  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.fsijournal.org/article/S0379-0738(12)00458-6/abstract'" tppabs="http://www.fsijournal.org/article/S0379-0738(12)00458-6/abstract" class="external text external">"Monitoring of illicit pill distribution networks using an image collection exploration framework"</a>. <i>Forensic Science International</i>. <b>223</b> (1–3): 298–305. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.forsciint.2012.10.004  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.forsciint.2012.10.004'" tppabs="https://doi.org/10.1016%2Fj.forsciint.2012.10.004" class="external text external">10.1016/j.forsciint.2012.10.004</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23107059  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23107059'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23107059" class="external text external">23107059</a>.</cite></span></li><li id="cite_note-189"> <span id="mw-reference-text-cite_note-189" class="mw-reference-text"><a href="javascript:if(confirm('http://www.drugtext.org/library/articles/dillon.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.drugtext.org/library/articles/dillon.htm'" tppabs="http://www.drugtext.org/library/articles/dillon.htm" class="external text external">Drugtext – 10 years of ecstasy and other party drug use in Australia: What have we done and what is there left to do?</a>. Drugtext.org. Retrieved on 11 June 2011.  <a href="javascript:if(confirm('https://web.archive.org/web/20120209142314/http://www.drugtext.org/library/articles/dillon.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20120209142314/http://www.drugtext.org/library/articles/dillon.htm'" tppabs="https://web.archive.org/web/20120209142314/http://www.drugtext.org/library/articles/dillon.htm" class="external text external">Archived</a><span> 9 February 2012 at the </span>Wayback Machine</span></li><li id="cite_note-190"> <span id="mw-reference-text-cite_note-190" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.erowid.org/chemicals/mdma/mdma_images.shtml  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.erowid.org/chemicals/mdma/mdma_images.shtml'" tppabs="https://www.erowid.org/chemicals/mdma/mdma_images.shtml" class="external text external">"Erowid MDMA Vault<span>&nbsp;</span>: Images"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">3 March</span> 2016</span>.</cite></span></li><li id="cite_note-191"> <span id="mw-reference-text-cite_note-191" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20150812022920/http://www.westerndailypress.co.uk/sick-dealers-peddle-Shaun-Sheep-Ecstasy-tablets/story-27521142-detail/story.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20150812022920/http://www.westerndailypress.co.uk/sick-dealers-peddle-Shaun-Sheep-Ecstasy-tablets/story-27521142-detail/story.html'" tppabs="https://web.archive.org/web/20150812022920/http://www.westerndailypress.co.uk/sick-dealers-peddle-Shaun-Sheep-Ecstasy-tablets/story-27521142-detail/story.html" class="external text external">"Now sick dealers peddle Shaun the Sheep Ecstasy tablets"</a>. <i>Western Daily Press</i>. Archived from <a href="javascript:if(confirm('http://www.westerndailypress.co.uk/sick-dealers-peddle-Shaun-Sheep-Ecstasy-tablets/story-27521142-detail/story.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.westerndailypress.co.uk/sick-dealers-peddle-Shaun-Sheep-Ecstasy-tablets/story-27521142-detail/story.html'" tppabs="http://www.westerndailypress.co.uk/sick-dealers-peddle-Shaun-Sheep-Ecstasy-tablets/story-27521142-detail/story.html" class="external text external">the original</a> on 12 August 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">3 March</span> 2016</span>.</cite></span></li><li id="cite_note-192"> <span id="mw-reference-text-cite_note-192" class="mw-reference-text"><cite id="CITEREFDanforthStrubleYazar-KlosinskiGrob2016" class="citation journal cs1">Danforth AL, Struble CM, Yazar-Klosinski B, Grob CS (January 2016). <a href="javascript:if(confirm('https://doi.org/10.1016/j.pnpbp.2015.03.011  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016/j.pnpbp.2015.03.011'" tppabs="https://doi.org/10.1016/j.pnpbp.2015.03.011" class="external text external">"MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults"</a>. <i>Progress in Neuro-Psychopharmacology &amp; Biological Psychiatry</i>. <b>64</b>: 237–49. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.pnpbp.2015.03.011  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.pnpbp.2015.03.011'" tppabs="https://doi.org/10.1016%2Fj.pnpbp.2015.03.011" class="external text external">10.1016/j.pnpbp.2015.03.011</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25818246  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25818246'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25818246" class="external text external">25818246</a>.</cite></span></li><li id="cite_note-193"> <span id="mw-reference-text-cite_note-193" class="mw-reference-text"><cite id="CITEREFMaxmen" class="citation magazine cs1">Maxmen A. <a href="javascript:if(confirm('https://www.scientificamerican.com/article/psychedelic-compound-in-ecstasy-moves-closer-to-approval-to-treat-ptsd/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.scientificamerican.com/article/psychedelic-compound-in-ecstasy-moves-closer-to-approval-to-treat-ptsd/'" tppabs="https://www.scientificamerican.com/article/psychedelic-compound-in-ecstasy-moves-closer-to-approval-to-treat-ptsd/" class="external text external">"Psychedelic Compound in Ecstasy Moves Closer to Approval to Treat PTSD"</a>. <i>Scientific American</i><span class="reference-accessdate">. Retrieved <span class="nowrap">18 May</span> 2017</span>.</cite></span></li><li id="cite_note-194"> <span id="mw-reference-text-cite_note-194" class="mw-reference-text"><cite id="CITEREFMaxmen2017" class="citation journal cs1">Maxmen A (2017). <a href="javascript:if(confirm('https://www.nature.com/news/psychedelic-compound-in-ecstasy-moves-closer-to-approval-to-treat-ptsd-1.21917  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nature.com/news/psychedelic-compound-in-ecstasy-moves-closer-to-approval-to-treat-ptsd-1.21917'" tppabs="https://www.nature.com/news/psychedelic-compound-in-ecstasy-moves-closer-to-approval-to-treat-ptsd-1.21917" class="external text external">"Psychedelic compound in ecstasy moves closer to approval to treat PTSD"</a>. <i>Nature</i>. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2Fnature.2017.21917  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fnature.2017.21917'" tppabs="https://doi.org/10.1038%2Fnature.2017.21917" class="external text external">10.1038/nature.2017.21917</a><span class="reference-accessdate">. Retrieved <span class="nowrap">18 May</span> 2017</span>.</cite></span></li><li id="cite_note-195"> <span id="mw-reference-text-cite_note-195" class="mw-reference-text"><cite id="CITEREFWaldman2017" class="citation book cs1">Waldman A (10 January 2017). <a href="javascript:if(confirm('https://books.google.com/books?id=5fIqDAAAQBAJ&pg=PA157  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=5fIqDAAAQBAJ&pg=PA157'" tppabs="https://books.google.com/books?id=5fIqDAAAQBAJ&pg=PA157" class="external text external"><i>A Really Good Day: How Microdosing Made a Mega Difference in My Mood, My Marriage, and My Life</i></a>. Knopf Doubleday Publishing Group. ISBN<span>&nbsp;</span><bdi>978-0-451-49410-8</bdi><span class="reference-accessdate">. Retrieved <span class="nowrap">18 May</span> 2017</span>.</cite></span></li><li id="cite_note-196"> <span id="mw-reference-text-cite_note-196" class="mw-reference-text"><cite id="CITEREFLattin2015" class="citation web cs1">Lattin D (19 March 2015). <a href="javascript:if(confirm('https://web.archive.org/web/20160424202622/http://www.sfchronicle.com/health/article/Patients-in-ecstasy-clinical-trial-find-drug-6924152.php  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20160424202622/http://www.sfchronicle.com/health/article/Patients-in-ecstasy-clinical-trial-find-drug-6924152.php'" tppabs="https://web.archive.org/web/20160424202622/http://www.sfchronicle.com/health/article/Patients-in-ecstasy-clinical-trial-find-drug-6924152.php" class="external text external">"Patients in ecstasy clinical trial find drug beneficial"</a>. <i>San Francisco Chronicle</i>. Hearst Corporation. Archived from <a href="javascript:if(confirm('http://www.sfchronicle.com/health/article/Patients-in-ecstasy-clinical-trial-find-drug-6924152.php  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.sfchronicle.com/health/article/Patients-in-ecstasy-clinical-trial-find-drug-6924152.php'" tppabs="http://www.sfchronicle.com/health/article/Patients-in-ecstasy-clinical-trial-find-drug-6924152.php" class="external text external">the original</a> on 24 April 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">28 April</span> 2016</span>.</cite></span></li><li id="cite_note-Mithoefer_2016-197"> <span id="mw-reference-text-cite_note-Mithoefer_2016-197" class="mw-reference-text"><cite id="CITEREFMithoeferGrobBrewerton2016" class="citation journal cs1">Mithoefer MC, Grob CS, Brewerton TD (May 2016). "Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA". <i>The Lancet. Psychiatry</i>. <b>3</b> (5): 481–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS2215-0366%2815%2900576-3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS2215-0366%2815%2900576-3'" tppabs="https://doi.org/10.1016%2FS2215-0366%2815%2900576-3" class="external text external">10.1016/S2215-0366(15)00576-3</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27067625  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27067625'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27067625" class="external text external">27067625</a>.</cite></span></li><li id="cite_note-The_New_York_Times_Company-198"> <span id="mw-reference-text-cite_note-The_New_York_Times_Company-198" class="mw-reference-text"><cite id="CITEREFPhilipps2016" class="citation news cs1">Philipps D (29 November 2016). <a href="javascript:if(confirm('https://www.nytimes.com/2016/11/29/us/ptsd-mdma-ecstasy.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nytimes.com/2016/11/29/us/ptsd-mdma-ecstasy.html'" tppabs="https://www.nytimes.com/2016/11/29/us/ptsd-mdma-ecstasy.html" class="external text external">"F.D.A. Agrees to New Trials for Ecstasy as Relief for PTSD Patients"</a>. The New York Times Company. The New York Times. <a href="javascript:if(confirm('https://web.archive.org/web/20170106084750/http://www.nytimes.com/2016/11/29/us/ptsd-mdma-ecstasy.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170106084750/http://www.nytimes.com/2016/11/29/us/ptsd-mdma-ecstasy.html'" tppabs="https://web.archive.org/web/20170106084750/http://www.nytimes.com/2016/11/29/us/ptsd-mdma-ecstasy.html" class="external text external">Archived</a> from the original on 6 January 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">1 December</span> 2016</span>.</cite></span></li><li id="cite_note-199"> <span id="mw-reference-text-cite_note-199" class="mw-reference-text"><cite id="CITEREFDevlin2017" class="citation news cs1">Devlin H (30 June 2017). <a href="javascript:if(confirm('https://www.theguardian.com/science/2017/jun/30/world-first-trials-mdma-treat-alcohol-addiction-set-begin?CMP=fb_gu  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.theguardian.com/science/2017/jun/30/world-first-trials-mdma-treat-alcohol-addiction-set-begin?CMP=fb_gu'" tppabs="https://www.theguardian.com/science/2017/jun/30/world-first-trials-mdma-treat-alcohol-addiction-set-begin?CMP=fb_gu" class="external text external">"World's first trials of MDMA to treat alcohol addiction set to begin"</a>. <i>The Guardian</i>.</cite></span></li><li id="cite_note-200"> <span id="mw-reference-text-cite_note-200" class="mw-reference-text"><cite id="CITEREFPatelTitheradge2015" class="citation journal cs1">Patel R, Titheradge D (June 2015). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4502590  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4502590'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4502590" class="external text external">"MDMA for the treatment of mood disorder: all talk no substance?"</a>. <i>Therapeutic Advances in Psychopharmacology</i>. <b>5</b> (3): 179–88. doi:<a href="javascript:if(confirm('https://doi.org/10.1177%2F2045125315583786  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1177%2F2045125315583786'" tppabs="https://doi.org/10.1177%2F2045125315583786" class="external text external">10.1177/2045125315583786</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4502590  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4502590'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4502590" class="external text external">4502590</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26199721  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26199721'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26199721" class="external text external">26199721</a>.</cite></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    

<ul><li><a href="javascript:if(confirm('https://www.drugabuse.gov/publications/drugfacts/mdma-ecstasymolly  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugabuse.gov/publications/drugfacts/mdma-ecstasymolly'" tppabs="https://www.drugabuse.gov/publications/drugfacts/mdma-ecstasymolly" class="external text external">MDMA Facts and Statistics</a> National Institute on Drug Abuse</li>
<li><a href="javascript:if(confirm('http://www.emcdda.europa.eu/publications/drug-profiles/mdma  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.emcdda.europa.eu/publications/drug-profiles/mdma'" tppabs="http://www.emcdda.europa.eu/publications/drug-profiles/mdma" class="external text external">Methylenedioxymethamphetamine (MDMA or 'Ecstasy') drug profile</a> European Monitoring Centre for Drugs and Drug Addiction</li>
<li><a href="javascript:if(confirm('http://www.maps.org/research/mdma  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.maps.org/research/mdma'" tppabs="http://www.maps.org/research/mdma" class="external text external">MDMA-Assisted Psychotherapy</a> Multidisciplinary Association for Psychedelic Studies</li></ul>

<div role="navigation" class="navbox" aria-labelledby="Recreational_uses" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2" style="background:#e8e8ff;background:#ccccff"><div id="Recreational_uses" style="font-size:114%;margin:0 4em">Recreational uses</div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;font-size:114%"><div style="padding:0px">
<div role="navigation" class="navbox" aria-labelledby="Recreational_drug_use" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2" style="text-align:center;"><div id="Recreational_drug_use" style="font-size:114%;margin:0 4em">Recreational drug use</div></th></tr><tr><th scope="row" class="navbox-group" style="text-align:center;;width:1%">Major<br> recreational<br> drugs</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Depressants</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Barbiturate.htm" tppabs="https://ptable.com/wiki/compounds/A/Barbiturate" title="Barbiturate">Barbiturates</a></li>
<li>Benzodiazepines</li>
<li>Carbamates</li>
<li>Ethanol (alcohol)
<ul><li>Alcoholic drinks</li>
<li>Beer</li>
<li>Wine</li></ul></li>
<li>Gabapentinoids</li>
<li><a href="Gamma-Hydroxybutyric_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Gamma-Hydroxybutyric_acid" title="Gamma-Hydroxybutyric acid">GHB</a></li>
<li>Inhalants
<ul><li>Medical
<ul><li><a href="Nitrous_oxide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nitrous_oxide" title="Nitrous oxide">Nitrous oxide</a></li></ul></li>
<li>Hazardous solvents
<ul><li>contact adhesives</li>
<li>Gasoline</li>
<li>nail polish remover</li>
<li>Paint thinner</li></ul></li>
<li>Other
<ul><li>Freon</li></ul></li></ul></li>
<li><a href="Kava.htm" tppabs="https://ptable.com/wiki/compounds/A/Kava" title="Kava">Kava</a></li>
<li>Nonbenzodiazepines</li>
<li>Quinazolinones</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Opioids</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Buprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Buprenorphine" title="Buprenorphine">Buprenorphine</a>
<ul><li>Suboxone</li>
<li>Subutex</li></ul></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Codeine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Codeine'" tppabs="https://ptable.com/wiki/compounds/A/Codeine" title="Codeine">Codeine</a></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Desomorphine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Desomorphine'" tppabs="https://ptable.com/wiki/compounds/A/Desomorphine" title="Desomorphine">Desomorphine</a>
<ul><li>Krokodil</li></ul></li>
<li><a href="Dextropropoxyphene.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextropropoxyphene" title="Dextropropoxyphene">Dextropropoxyphene</a>
<ul><li>Darvocet</li>
<li>Darvon</li></ul></li>
<li><a href="Fentanyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Fentanyl" title="Fentanyl">Fentanyl</a></li>
<li><a href="Heroin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heroin" title="Heroin">Diamorphine</a>
<ul><li>Heroin</li></ul></li>
<li><a href="Hydrocodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydrocodone" title="Hydrocodone">Hydrocodone</a></li>
<li><a href="Hydromorphone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydromorphone" title="Hydromorphone">Hydromorphone</a>
<ul><li>Dilaudid</li></ul></li>
<li><a href="Methadone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methadone" title="Methadone">Methadone</a></li>
<li>Mitragyna speciosa
<ul><li>Kratom</li></ul></li>
<li><a href="Morphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Morphine" title="Morphine">Morphine</a>
<ul><li>Opium</li></ul></li>
<li><a href="Oxycodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxycodone" title="Oxycodone">Oxycodone</a>
<ul><li>/paracetamol</li></ul></li>
<li><a href="Tramadol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tramadol" title="Tramadol">Tramadol</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Stimulants</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Amphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphetamine" title="Amphetamine">Amphetamine</a></li>
<li><a href="Arecoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Arecoline" title="Arecoline">Arecoline</a>
<ul><li>Areca</li></ul></li>
<li>Betel</li>
<li><a href="Caffeine.htm" tppabs="https://ptable.com/wiki/compounds/A/Caffeine" title="Caffeine">Caffeine</a>
<ul><li>Coffee</li>
<li>Energy drinks</li>
<li>Tea</li></ul></li>
<li><a href="Cathinone.htm" tppabs="https://ptable.com/wiki/compounds/A/Cathinone" title="Cathinone">Cathinone</a>
<ul><li>Khat</li></ul></li>
<li><a href="Cocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaine" title="Cocaine">Cocaine</a>
<ul><li>Coca</li>
<li>Crack</li></ul></li>
<li><a href="Ephedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ephedrine" title="Ephedrine">Ephedrine</a>
<ul><li><a href="Ephedra.htm" tppabs="https://ptable.com/wiki/compounds/A/Ephedra" title="Ephedra">Ephedra</a></li></ul></li>
<li>MDPV</li>
<li>Mephedrone</li>
<li><a href="Methamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamphetamine" title="Methamphetamine">Methamphetamine</a></li>
<li>Methylone</li>
<li><a href="Methylphenidate.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylphenidate" title="Methylphenidate">Methylphenidate</a></li>
<li><a href="Modafinil.htm" tppabs="https://ptable.com/wiki/compounds/A/Modafinil" title="Modafinil">Modafinil</a></li>
<li><a href="Nicotine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicotine" title="Nicotine">Nicotine</a>
<ul><li>Tobacco</li></ul></li>
<li><a href="Theobromine.htm" tppabs="https://ptable.com/wiki/compounds/A/Theobromine" title="Theobromine">Theobromine</a>
<ul><li>Cocoa</li>
<li>Chocolate</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Entactogens</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>2C series</li>
<li>6-APB
<ul><li>Benzofury</li></ul></li>
<li><a href="Alpha-Methyltryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Alpha-Methyltryptamine" title="Alpha-Methyltryptamine">AMT</a></li>
<li><a href="3,4-Methylenedioxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/3%2C4-Methylenedioxyamphetamine" title="3,4-Methylenedioxyamphetamine">MDA</a></li>
<li><a href="MDMA.htm" tppabs="https://ptable.com/wiki/compounds/A/MDMA" title="MDMA">MDMA</a>
<ul><li>Ecstasy</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Hallucinogens</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Psychedelics</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Bufotenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Bufotenin" title="Bufotenin">Bufotenin</a>
<ul><li>Psychoactive toads</li>
<li>Vilca</li>
<li>Yopo</li></ul></li>
<li>DMT
<ul><li>Ayahuasca</li></ul></li>
<li>LSA</li>
<li><a href="Lysergic_acid_diethylamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Lysergic_acid_diethylamide" title="Lysergic acid diethylamide">LSD-25</a></li>
<li>Mescaline
<ul><li>Peruvian torch</li>
<li>Peyote</li>
<li>San Pedro</li></ul></li>
<li>Psilocybin / <a href="Psilocin.htm" tppabs="https://ptable.com/wiki/compounds/A/Psilocin" title="Psilocin">Psilocin</a>
<ul><li>Psilocybin mushrooms</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Dissociatives</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Dextromethorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextromethorphan" title="Dextromethorphan">DXM</a></li>
<li>Glaucine</li>
<li>Inhalants
<ul><li><a href="Nitrous_oxide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nitrous_oxide" title="Nitrous oxide">Nitrous oxide</a></li>
<li>alkyl nitrites</li>
<li>poppers</li>
<li><a href="Amyl_nitrite.htm" tppabs="https://ptable.com/wiki/compounds/A/Amyl_nitrite" title="Amyl nitrite">amyl nitrite</a></li></ul></li>
<li><a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">Ketamine</a></li>
<li>MXE</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Muscimol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Muscimol'" tppabs="https://ptable.com/wiki/compounds/A/Muscimol" title="Muscimol">Muscimol</a>
<ul><li>Amanita muscaria</li></ul></li>
<li><a href="Phencyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phencyclidine" title="Phencyclidine">PCP</a></li>
<li><a href="Salvinorin_A.htm" tppabs="https://ptable.com/wiki/compounds/A/Salvinorin_A" title="Salvinorin A">Salvinorin A</a>
<ul><li><a href="Salvia_divinorum.htm" tppabs="https://ptable.com/wiki/compounds/A/Salvia_divinorum" title="Salvia divinorum">Salvia divinorum</a></li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Deliriants</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Atropine.htm" tppabs="https://ptable.com/wiki/compounds/A/Atropine" title="Atropine">Atropine</a> and <a href="Scopolamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Scopolamine" title="Scopolamine" class="mw-redirect">Scopolamine</a>
<ul><li>Atropa belladonna</li>
<li>Datura</li>
<li>Hyoscyamus niger</li>
<li>Mandragora officinarum</li></ul></li>
<li><a href="Dimenhydrinate.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimenhydrinate" title="Dimenhydrinate">Dimenhydrinate</a></li>
<li><a href="Diphenhydramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Diphenhydramine" title="Diphenhydramine">Diphenhydramine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Cannabinoids</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>JWH-018</li>
<li><a href="Tetrahydrocannabinol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetrahydrocannabinol" title="Tetrahydrocannabinol">THC</a>
<ul><li>Cannabis</li>
<li>Hashish</li>
<li>Hash oil</li>
<li>Marijuana</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Oneirogens</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Calea zacatechichi</li>
<li>Silene capensis</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Club drugs</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Cocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaine" title="Cocaine">Cocaine</a></li>
<li>Quaaludes</li>
<li><a href="MDMA.htm" tppabs="https://ptable.com/wiki/compounds/A/MDMA" title="MDMA">MDMA</a> (Ecstasy)</li>
<li><a href="Nitrous_oxide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nitrous_oxide" title="Nitrous oxide">Nitrous oxide</a></li>
<li>Poppers</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="text-align:center;;width:1%">Drug culture</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Cannabis culture</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>420</li>
<li>Cannabis cultivation</li>
<li>Cannabis smoking</li>
<li>Head shop</li>
<li>Legal history of cannabis in the United States</li>
<li>Legality of cannabis</li>
<li>Marijuana Policy Project</li>
<li>Medical cannabis</li>
<li>NORML</li>
<li>Cannabis and religion</li>
<li>Stoner film</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Coffee culture</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Coffee break</li>
<li>Coffeehouse</li>
<li>Latte art</li>
<li>Tea house</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Drinking culture</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Bartending</li>
<li>Beer culture</li>
<li>Beer festival</li>
<li>Binge drinking</li>
<li><a href="Diethyl_ether.htm#Recreational_use" tppabs="https://ptable.com/wiki/compounds/A/Diethyl_ether#Recreational_use" title="Diethyl ether">Diethyl ether</a></li>
<li>Drinking games</li>
<li>Drinking song</li>
<li>Happy hour</li>
<li>Hip flask</li>
<li>Nightclub</li>
<li>Pub</li>
<li>Pub crawl</li>
<li>Sommelier</li>
<li>Sports bar</li>
<li>Tailgate party</li>
<li>Wine bar</li>
<li>Wine tasting</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Psychedelia</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Psychonautics</li>
<li>Art</li>
<li>Drug</li>
<li>Era</li>
<li>Experience</li>
<li>Literature</li>
<li>Music</li>
<li>Microdosing</li>
<li>Therapy</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Smoking culture</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Cigarette card</li>
<li>Fashion cigarettes</li>
<li>Cloud-chasing</li>
<li>Loosie</li>
<li>Smokeasy</li>
<li>Smoking fetishism</li>
<li>Tobacco smoking</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Other</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Club drug</li>
<li>Counterculture of the 1960s</li>
<li>Dance party</li>
<li>Drug paraphernalia</li>
<li>Drug tourism</li>
<li>Entheogen</li>
<li>Hippie</li>
<li>Needle sharing</li>
<li>Nootropic</li>
<li>Party and play</li>
<li>Poly drug use</li>
<li>Rave</li>
<li>Religion and drugs</li>
<li>Self-medication</li>
<li>Sex and drugs</li>
<li>Whoonga</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="text-align:center;;width:1%">Drug<br> production<br> and trade</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Drug<br> production</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Coca production in Colombia</li>
<li>Drug precursors</li>
<li>Opium production in Afghanistan</li>
<li>Rolling meth lab</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Drug trade</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Illegal drug trade
<ul><li>Colombia</li></ul></li>
<li>Darknet market</li>
<li>Drug distribution
<ul><li>Beer shop</li>
<li>Cannabis shop</li>
<li>Liquor store</li>
<li>Liquor license</li></ul></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="text-align:center;;width:1%">Issues with<br> drug use</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Abuse</li>
<li>Date rape drug</li>
<li>Impaired driving</li>
<li>Drug harmfulness
<ul><li>Effects of cannabis</li></ul></li>
<li>Addiction</li>
<li>Dependence
<ul><li>Prevention</li>
<li>Opioid replacement therapy</li>
<li>Rehabilitation</li>
<li>Responsible use</li></ul></li>
<li>Drug-related crime</li>
<li>Fetal alcohol spectrum disorder</li>
<li>Long-term effects of cannabis</li>
<li>Neurotoxicity</li>
<li>Overdose</li>
<li>Passive smoking
<ul><li>of tobacco or other substances</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="text-align:center;;width:1%">Legality of<br> drug use</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">International</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>1961 Narcotic Drugs</li>
<li>1971 Psychotropic Substances</li>
<li>1988 Drug Trafficking</li>
<li>Council of the European Union decisions on designer drugs</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">State level</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Drug policy
<ul><li>Decriminalization</li>
<li>Prohibition</li>
<li>Supply reduction</li></ul></li>
<li>Policy reform
<ul><li>Demand reduction</li>
<li>Drug Policy Alliance</li>
<li>Harm reduction</li>
<li>Law Enforcement Action Partnership</li>
<li>Liberalization
<ul><li>Latin America</li></ul></li>
<li>Students for Sensible Drug Policy</li>
<li>Transform Drug Policy Foundation</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Drug policy<br>by country</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Australia</li>
<li>Canada</li>
<li>Germany</li>
<li>India</li>
<li>Netherlands</li>
<li>Portugal</li>
<li>Slovakia</li>
<li>Soviet Union</li>
<li>Sweden</li>
<li>Switzerland</li>
<li>United States
<ul><li>Just Say No</li>
<li>Office of National Drug Control Policy</li>
<li>School district drug policies</li>
<li>California</li>
<li>Colorado</li>
<li>Maryland</li>
<li>Virginia</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Other</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Arguments for and against drug prohibition</li>
<li>Capital punishment for drug trafficking</li>
<li>Cognitive liberty</li>
<li>Designer drug</li>
<li>Drug court</li>
<li>Drug possession</li>
<li>Drug test</li>
<li>Narc</li>
<li>Politics of drug abuse</li>
<li>War on Drugs
<ul><li>Mexican Drug War</li>
<li>Plan Colombia</li>
<li>Philippine Drug War</li></ul></li>
<li>Zero tolerance</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="text-align:center;;width:1%">Lists of<br> countries by...</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Alcohol legality
<ul><li>Alcohol consumption</li></ul></li>
<li>Anabolic steroid legality</li>
<li>Cannabis legality
<ul><li>Annual use</li>
<li>Lifetime use</li></ul></li>
<li>Cigarette consumption</li>
<li>Cocaine legality
<ul><li>Cocaine use</li></ul></li>
<li>Methamphetamine legality</li>
<li>Opiates use</li>
<li>Psilocybin mushrooms legality</li>
<li>Salvia legality</li></ul>
</div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Empathogens/entactogens" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Empathogens/entactogens" style="font-size:114%;margin:0 4em">Empathogens/entactogens</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Phenylalkyl-<br>amines<br>(other than<br>cathinones)</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Unfused benzene ring:</i> 3-CMA</li>
<li>4-CAB</li>
<li>4-FA</li>
<li>4-MA</li>
<li>4-MMA</li>
<li>4-FMA</li>
<li>4-MTA</li>
<li>4,4'-DMAR</li>
<li>Ariadne</li>
<li>Metaescaline</li>
<li>MMA</li>
<li><a href="Para-Methoxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Para-Methoxyamphetamine" title="Para-Methoxyamphetamine">PMA</a></li>
<li>PMEA</li>
<li>PMMA</li>
<li>mMMA<br><i>Benzodioxine:</i> EDMA<br><i>Benzodioxoles:</i> Phenethylamine: {<span>&nbsp;</span>Lophophine<span>&nbsp;</span>}</li>
<li>Amphetamines: {<span>&nbsp;</span>2-Methyl-MDA</li>
<li>2,3-MDA</li>
<li><a href="3,4-Methylenedioxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/3%2C4-Methylenedioxyamphetamine" title="3,4-Methylenedioxyamphetamine">3,4-MDA (tenamfetamine)</a></li>
<li>5-Methyl-MDA</li>
<li>6-Methyl-MDA</li>
<li>DiFMDA</li>
<li>DMMDA</li>
<li>DMMDA-2</li>
<li>EIDA</li>
<li>MDEA</li>
<li><a href="MDMA.htm" tppabs="https://ptable.com/wiki/compounds/A/MDMA" title="MDMA">MDMA (midomafetamine)</a></li>
<li>MDMOH</li>
<li>MDOH</li>
<li>MMDA</li>
<li>MMDA-2</li>
<li>MMDMA<span>&nbsp;</span>}</li>
<li>1-Phenylbutan-2-amines: {<span>&nbsp;</span>BDB</li>
<li>EBDB</li>
<li>MBDB<span>&nbsp;</span>}</li>
<li>Phentermines: {<span>&nbsp;</span>MDMP</li>
<li>MDPH<span>&nbsp;</span>}<br><i>Benzofurans and dihydrobenzofurans:</i> 5-APB</li>
<li>5-APDB</li>
<li>5-EAPB</li>
<li>5-MAPB</li>
<li>5-MAPDB</li>
<li>5-MBPB</li>
<li>6-APB</li>
<li>6-APDB</li>
<li>6-EAPB</li>
<li>6-MAPB</li>
<li>6-MAPDB</li>
<li>IBF5MAP<br><i>Indanes:</i> 5-APDI</li>
<li>5-MAPDI<br><i>Indoles:</i> 5-IT</li>
<li>6-API<br><i>Naphthalenes:</i> Methamnetamine</li>
<li>Naphthylaminopropane<br><i>Tetralin:</i> 6-APT</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Cyclized phenyl-<br>alkylamines</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Aminoindanes:</i> 5-IAI</li>
<li>AMMI</li>
<li>ETAI</li>
<li>MDAI</li>
<li>MDMAI</li>
<li>MMAI</li>
<li>MEAI</li>
<li>NM-2-AI</li>
<li>TAI<br><i>Aminotetralins:</i> 6-CAT</li>
<li>MDAT</li>
<li>MDMAT</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Cathinones</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>3-MMC</li>
<li>4-EMC</li>
<li>Brephedrone</li>
<li>Butylone</li>
<li>Ethylone</li>
<li>Eutylone</li>
<li>Flephedrone</li>
<li>Mephedrone</li>
<li>Methedrone</li>
<li>Methylone</li>
<li>TH-PVP</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Tryptamines</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>4-Methyl-αET</li>
<li><a href="Alpha-Ethyltryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Alpha-Ethyltryptamine" title="Alpha-Ethyltryptamine">αET</a></li>
<li><a href="Alpha-Methyltryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Alpha-Methyltryptamine" title="Alpha-Methyltryptamine">αMT</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Chemical classes</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Substituted amphetamine</li>
<li>Sub. benzofuran</li>
<li>Sub. cathinone</li>
<li>Sub. MDPEA</li>
<li>Sub. PEA</li>
<li>Sub. tryptamine</li></ul>
</div></td></tr></tbody></table></div>

<div role="navigation" class="navbox" aria-labelledby="Drugs_which_induce_euphoria" style="padding:3px"><table class="nowraplinks hlist mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Drugs_which_induce_euphoria" style="font-size:114%;margin:0 4em">Drugs which induce euphoria</div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>μ-Opioid receptor agonists (opioids) (e.g., <a href="Morphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Morphine" title="Morphine">morphine</a>, <a href="Heroin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heroin" title="Heroin">heroin</a>, <a href="Hydrocodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydrocodone" title="Hydrocodone">hydrocodone</a>, <a href="Oxycodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxycodone" title="Oxycodone">oxycodone</a>, opium, kratom)</li>
<li>α<sub>2</sub>δ subunit-containing voltage-dependent calcium channels blockers (gabapentinoids) (e.g., <a href="Gabapentin.htm" tppabs="https://ptable.com/wiki/compounds/A/Gabapentin" title="Gabapentin">gabapentin</a>, <a href="Pregabalin.htm" tppabs="https://ptable.com/wiki/compounds/A/Pregabalin" title="Pregabalin">pregabalin</a>, phenibut)</li>
<li>AMPA receptor antagonists (e.g., perampanel)</li>
<li>CB<sub>1</sub> receptor agonists (cannabinoids) (e.g., <a href="Tetrahydrocannabinol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetrahydrocannabinol" title="Tetrahydrocannabinol">THC</a>, cannabis)</li>
<li>Dopamine receptor agonists (e.g., levodopa)</li>
<li>Dopamine releasing agents (e.g., <a href="Amphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphetamine" title="Amphetamine">amphetamine</a>, <a href="Methamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamphetamine" title="Methamphetamine">methamphetamine</a>, <a href="MDMA.htm" tppabs="https://ptable.com/wiki/compounds/A/MDMA" title="MDMA">MDMA</a>, mephedrone)</li>
<li>Dopamine reuptake inhibitors (e.g., <a href="Cocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaine" title="Cocaine">cocaine</a>, <a href="Methylphenidate.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylphenidate" title="Methylphenidate">methylphenidate</a>)</li>
<li>GABA<sub>A</sub> receptor positive allosteric modulators (e.g., <a href="Barbiturate.htm" tppabs="https://ptable.com/wiki/compounds/A/Barbiturate" title="Barbiturate">barbiturates</a>, benzodiazepines, carbamates, ethanol (alcohol) (alcoholic drink), inhalants, nonbenzodiazepines, quinazolinones)</li>
<li><a href="Gamma-Hydroxybutyric_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Gamma-Hydroxybutyric_acid" title="Gamma-Hydroxybutyric acid">GHB</a> (sodium oxybate) and analogues</li>
<li>Glucocorticoids (corticosteroids) (e.g., <a href="Dexamethasone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dexamethasone" title="Dexamethasone">dexamethasone</a>, <a href="Prednisone.htm" tppabs="https://ptable.com/wiki/compounds/A/Prednisone" title="Prednisone">prednisone</a>)</li>
<li>nACh receptor agonists (e.g., <a href="Nicotine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicotine" title="Nicotine">nicotine</a>, tobacco, <a href="Arecoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Arecoline" title="Arecoline">arecoline</a>, areca nut)</li>
<li>Nitric oxide prodrugs (e.g., alkyl nitrites (poppers))</li>
<li>NMDA receptor antagonists (e.g., <a href="Dextromethorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextromethorphan" title="Dextromethorphan">DXM</a>, <a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">ketamine</a>, methoxetamine, <a href="Nitrous_oxide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nitrous_oxide" title="Nitrous oxide">nitrous oxide</a>, <a href="Phencyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phencyclidine" title="Phencyclidine">phencyclidine</a>, inhalants)</li>
<li>Orexin receptor antagonists (e.g., suvorexant)</li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div><i><b>See also:</b> Recreational drug use</i></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Hallucinogens" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Hallucinogens" style="font-size:114%;margin:0 4em">Hallucinogens</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Psychedelics<br><small>(5-HT<sub>2A</sub><br>agonists)</small></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Benzofurans</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>2C-B-FLY</li>
<li>2CBFly-NBOMe</li>
<li>5-MeO-BFE</li>
<li>5-MeO-DiBF</li>
<li>Bromo-DragonFLY</li>
<li>F-2</li>
<li>F-22</li>
<li>TFMFly</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Lyserg‐<br>amides</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>1B-LSD</li>
<li>1CP-LSD</li>
<li>1P-ETH-LAD</li>
<li>1P-LSD</li>
<li>2-Butyllysergamide</li>
<li>3-Pentyllysergamide</li>
<li>AL-LAD</li>
<li>ALD-52</li>
<li>BU-LAD</li>
<li>Diallyllysergamide</li>
<li>Dimethyllysergamide</li>
<li>ECPLA</li>
<li><a href="Ergometrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ergometrine" title="Ergometrine">Ergometrine</a></li>
<li>ETH-LAD</li>
<li>IP-LAD</li>
<li>LAE-32</li>
<li><span class="new">LAMPA</span></li>
<li>LPD-824</li>
<li>LSA</li>
<li><a href="Lysergic_acid_diethylamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Lysergic_acid_diethylamide" title="Lysergic acid diethylamide">LSD</a></li>
<li>LSD-Pip</li>
<li>LSH</li>
<li>LSM-775</li>
<li>LSZ</li>
<li><a href="Methylergometrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylergometrine" title="Methylergometrine">Methylergometrine</a></li>
<li>MIPLA</li>
<li><a href="Methysergide.htm" tppabs="https://ptable.com/wiki/compounds/A/Methysergide" title="Methysergide">Methysergide</a></li>
<li>MLD-41</li>
<li>PARGY-LAD</li>
<li>PRO-LAD</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Phenethyl‐<br>amines</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="2C-x" scope="row" class="navbox-group" style="width:1%">2C-<i>x</i></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="2C-B.htm" tppabs="https://ptable.com/wiki/compounds/A/2C-B" title="2C-B">2C-B</a></li>
<li><span class="new">2C-B-AN</span></li>
<li><span class="new">2C-Bn</span></li>
<li><span class="new">2C-Bu</span></li>
<li>2C-C</li>
<li><span class="new">2C-CN</span></li>
<li><span class="new">2C-CP</span></li>
<li>2C-D</li>
<li>2C-E</li>
<li><span class="new">2C-EF</span></li>
<li>2C-F</li>
<li>2C-G</li>
<li>2C-G-1</li>
<li>2C-G-2</li>
<li>2C-G-3</li>
<li>2C-G-4</li>
<li>2C-G-5</li>
<li>2C-G-6</li>
<li>2C-G-N</li>
<li><a href="2C-H.htm" tppabs="https://ptable.com/wiki/compounds/A/2C-H" title="2C-H">2C-H</a></li>
<li>2C-I</li>
<li>2C-iP</li>
<li>2C-N</li>
<li><span class="new">2C-NH2</span></li>
<li>2C-O</li>
<li>2C-O-4</li>
<li>2C-P</li>
<li><span class="new">2C-Ph</span></li>
<li>2C-SE</li>
<li>2C-T</li>
<li>2C-T-2</li>
<li><span class="new">2C-T-3</span></li>
<li>2C-T-4</li>
<li><span class="new">2C-T-5</span></li>
<li><span class="new">2C-T-6</span></li>
<li>2C-T-7</li>
<li>2C-T-8</li>
<li>2C-T-9</li>
<li><span class="new">2C-T-10</span></li>
<li><span class="new">2C-T-11</span></li>
<li><span class="new">2C-T-12</span></li>
<li>2C-T-13</li>
<li><span class="new">2C-T-14</span></li>
<li>2C-T-15</li>
<li>2C-T-16</li>
<li>2C-T-17</li>
<li><span class="new">2C-T-18</span></li>
<li>2C-T-19</li>
<li><span class="new">2C-T-20</span></li>
<li>2C-T-21</li>
<li><span class="new">2C-T-22</span></li>
<li><span class="new">2C-T-22.5</span></li>
<li><span class="new">2C-T-23</span></li>
<li><span class="new">2C-T-24</span></li>
<li><span class="new">2C-T-25</span></li>
<li><span class="new">2C-T-27</span></li>
<li><span class="new">2C-T-28</span></li>
<li><span class="new">2C-T-30</span></li>
<li><span class="new">2C-T-31</span></li>
<li><span class="new">2C-T-32</span></li>
<li><span class="new">2C-T-33</span></li>
<li><span class="new">2C-TFE</span></li>
<li>2C-TFM</li>
<li>2C-YN</li>
<li><span class="new">2C-V</span></li></ul>

    </div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="25x-NBx" scope="row" class="navbox-group" style="width:1%">25<i>x</i>-NB<i>x</i></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">25<i>x</i>-<abbr>NB3OMe</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><span class="new">25B-NB3OMe</span></li>
<li>25C-NB3OMe</li>
<li><span class="new">25D-NB3OMe</span></li>
<li><span class="new">25E-NB3OMe</span></li>
<li><span class="new">25H-NB3OMe</span></li>
<li>25I-NB3OMe</li>
<li><span class="new">25N-NB3OMe</span></li>
<li><span class="new">25P-NB3OMe</span></li>
<li><span class="new">25T2-NB3OMe</span></li>
<li><span class="new">25T4-NB3OMe</span></li>
<li><span class="new">25T7-NB3OMe</span></li>
<li><span class="new">25TFM-NB3OMe</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">25<i>x</i>-<abbr>NB4OMe</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><span class="new">25B-NB4OMe</span></li>
<li>25C-NB4OMe</li>
<li><span class="new">25D-NB4OMe</span></li>
<li><span class="new">25E-NB4OMe</span></li>
<li><span class="new">25H-NB4OMe</span></li>
<li>25I-NB4OMe</li>
<li><span class="new">25N-NB4OMe</span></li>
<li><span class="new">25P-NB4OMe</span></li>
<li><span class="new">25T2-NB4OMe</span></li>
<li><span class="new">25T4-NB4OMe</span></li>
<li><span class="new">25T7-NB4OMe</span></li>
<li><span class="new">25TFM-NB4OMe</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">25<i>x</i>-<abbr>NBF</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>25B-NBF</li>
<li>25C-NBF</li>
<li><span class="new">25D-NBF</span></li>
<li><span class="new">25E-NBF</span></li>
<li><span class="new">25H-NBF</span></li>
<li>25I-NBF</li>
<li><span class="new">25P-NBF</span></li>
<li><span class="new">25T2-NBF</span></li>
<li><span class="new">25T7-NBF</span></li>
<li><span class="new">25TFM-NBF</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">25<i>x</i>-<abbr>NBMD</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><span class="new">25B-NBMD</span></li>
<li><span class="new">25C-NBMD</span></li>
<li><span class="new">25D-NBMD</span></li>
<li><span class="new">25E-NBMD</span></li>
<li><span class="new">25F-NBMD</span></li>
<li><span class="new">25H-NBMD</span></li>
<li>25I-NBMD</li>
<li><span class="new">25P-NBMD</span></li>
<li><span class="new">25T2-NBMD</span></li>
<li><span class="new">25T7-NBMD</span></li>
<li><span class="new">25TFM-NBMD</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">25<i>x</i>-<abbr>NBOH</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>25B-NBOH</li>
<li>25C-NBOH</li>
<li>25CN-NBOH</li>
<li><span class="new">25D-NBOH</span></li>
<li><span class="new">25E-NBOH</span></li>
<li><span class="new">25F-NBOH</span></li>
<li><span class="new">25H-NBOH</span></li>
<li>25I-NBOH</li>
<li><span class="new">25P-NBOH</span></li>
<li><span class="new">25T2-NBOH</span></li>
<li><span class="new">25T7-NBOH</span></li>
<li><span class="new">25TFM-NBOH</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">25<i>x</i>-<abbr>NBOMe</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>25B-NBOMe</li>
<li>25C-NBOMe</li>
<li>25CN-NBOMe</li>
<li>25D-NBOMe</li>
<li>25E-NBOMe</li>
<li><span class="new">25F-NBOMe</span></li>
<li>25G-NBOMe</li>
<li>25H-NBOMe</li>
<li>25I-NBOMe</li>
<li>25iP-NBOMe</li>
<li>25N-NBOMe</li>
<li>25P-NBOMe</li>
<li><span class="new">25T2-NBOMe</span></li>
<li><span class="new">25T4-NBOMe</span></li>
<li><span class="new">25T7-NBOMe</span></li>
<li>25TFM-NBOMe</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Atypical structures</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>25I-NB34MD</li>
<li>2CBCB-NBOMe</li>
<li>2CBFly-NBOMe</li>
<li>NBOMe-mescaline</li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">3C-<i>x</i></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><span class="new">3C-AL</span></li>
<li>3C-BZ</li>
<li>3C-DFE</li>
<li>3C-E</li>
<li>3C-P</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">4C-<i>x</i></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><span class="new">4C-B</span></li>
<li>4C-D</li>
<li>4C-T-2</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">DO<i>x</i></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>DOT</li>
<li>DOB</li>
<li>DOC</li>
<li>DOEF</li>
<li><a href="2,5-Dimethoxy-4-ethylamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/2%2C5-Dimethoxy-4-ethylamphetamine" title="2,5-Dimethoxy-4-ethylamphetamine">DOET</a></li>
<li>DOF</li>
<li>DOI</li>
<li>DOiPR</li>
<li><a href="2,5-Dimethoxy-4-methylamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/2%2C5-Dimethoxy-4-methylamphetamine" title="2,5-Dimethoxy-4-methylamphetamine">DOM</a></li>
<li>DON</li>
<li>DOPR</li>
<li>DOTFM</li>
<li>MEM</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">HOT-<i>x</i></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>HOT-2</li>
<li>HOT-7</li>
<li>HOT-17</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">MD<em>xx</em></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>DMMDA</li>
<li>DMMDA-2</li>
<li>Lophophine</li>
<li><a href="3,4-Methylenedioxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/3%2C4-Methylenedioxyamphetamine" title="3,4-Methylenedioxyamphetamine">MDA</a></li>
<li>MMDA</li>
<li>MMDA-2</li>
<li>MMDA-3a</li>
<li>MMDMA</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Mescaline (subst.)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>2-Bromomescaline</li>
<li>3-TE</li>
<li>4-TE</li>
<li>3-TM</li>
<li>4-TM</li>
<li>Allylescaline</li>
<li>Asymbescaline</li>
<li>Buscaline</li>
<li>Cyclopropylmescaline</li>
<li><span class="new">Difluoromescaline</span></li>
<li><span class="new">Difluoroescaline</span></li>
<li>Escaline</li>
<li><span class="new">Fluoroproscaline</span></li>
<li><span class="new">Isobuscaline</span></li>
<li>Isoproscaline</li>
<li>Jimscaline</li>
<li>Mescaline</li>
<li>Metaescaline</li>
<li>Methallylescaline</li>
<li>Proscaline</li>
<li>Thioproscaline</li>
<li><span class="new">Trifluoroescaline</span></li>
<li>Trifluoromescaline</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Trimethoxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Trimethoxyamphetamine" title="Trimethoxyamphetamine">TMAs</a></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>TMA</li>
<li>TMA-2</li>
<li>TMA-3</li>
<li>TMA-4</li>
<li>TMA-5</li>
<li>TMA-6</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>2C-B-BUTTERFLY</li>
<li><span class="new">2C-B-DragonFLY</span></li>
<li><span class="new">2CB-5-hemifly</span></li>
<li>2CB-Ind</li>
<li>2CD-5EtO</li>
<li>2-TOET</li>
<li>5-TOET</li>
<li>2-TOM</li>
<li>5-TOM</li>
<li>BOB</li>
<li>BOD</li>
<li>βk-2C-B</li>
<li><span class="new">βk-2C-I</span></li>
<li>DESOXY</li>
<li>DMCPA</li>
<li>DMBMPP</li>
<li><span class="new">DOB-FLY</span></li>
<li><a href="Fenfluramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenfluramine" title="Fenfluramine">Fenfluramine</a></li>
<li>Ganesha</li>
<li>Macromerine</li>
<li>MMA</li>
<li>TCB-2</li>
<li>TOMSO</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Piperazines</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Benzylpiperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzylpiperazine" title="Benzylpiperazine">BZP</a></li>
<li>pFPP</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Tryptamines</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><i>alpha</i>-alkyltryptamines</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>4,5-DHP-α-MT</li>
<li>5-MeO-α-ET</li>
<li>5-MeO-α-MT</li>
<li><a href="Alpha-Ethyltryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Alpha-Ethyltryptamine" title="Alpha-Ethyltryptamine">α-ET</a></li>
<li><a href="Alpha-Methyltryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Alpha-Methyltryptamine" title="Alpha-Methyltryptamine">α-MT</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><i>x</i>-<abbr>DALT</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><span class="new">(Daltocin) 4-HO-DALT</span></li>
<li>(Daltacetin) 4-AcO-DALT</li>
<li>5-MeO-DALT</li>
<li>DALT</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><i>x</i>-<abbr>DET</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>(Ethacetin) 4-AcO-DET</li>
<li>(Ethocin) 4-HO-DET</li>
<li>5-MeO-DET</li>
<li><a href="Diethyltryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Diethyltryptamine" title="Diethyltryptamine">(T-9) DET</a></li>
<li>(Ethocybin) 4-PO-DET</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><i>x</i>-<abbr>DiPT</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>(Ipracetin) 4-AcO-DiPT</li>
<li>(Iprocin) 4-HO-DiPT</li>
<li>5-MeO-DiPT</li>
<li>DiPT</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><i>x</i>-<abbr>DMT</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>4,5-DHP-DMT</li>
<li>2,N,N-TMT</li>
<li>4-AcO-DMT</li>
<li>4-HO-5-MeO-DMT</li>
<li><span class="new">4,N,N-TMT</span></li>
<li><span class="new">4-Propionyloxy-DMT</span></li>
<li><span class="new">5,6-diBr-DMT</span></li>
<li><span class="new">5-AcO-DMT</span></li>
<li>5-Bromo-DMT</li>
<li><span class="new">5-MeO-2,<i>N</i>,<i>N</i>-TMT</span></li>
<li><span class="new">5-MeO-4,<i>N</i>,<i>N</i>-TMT</span></li>
<li><span class="new">5-MeO-α,N,N-TMT</span></li>
<li><a href="5-MeO-DMT.htm" tppabs="https://ptable.com/wiki/compounds/A/5-MeO-DMT" title="5-MeO-DMT">5-MeO-DMT</a></li>
<li>5-<i>N</i>,<i>N</i>-TMT</li>
<li>7,N,N-TMT</li>
<li>α,N,N-TMT</li>
<li><a href="Bufotenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Bufotenin" title="Bufotenin">(Bufotenin) 5-HO-DMT</a></li>
<li>DMT</li>
<li>Norbaeocystin</li>
<li><a href="Psilocin.htm" tppabs="https://ptable.com/wiki/compounds/A/Psilocin" title="Psilocin">(Psilocin) 4-HO-DMT</a></li>
<li>(Psilocybin) 4-PO-DMT</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><i>x</i>-<abbr>DPT</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><span class="new">(Depracetin) 4-AcO-DPT</span></li>
<li>(Deprocin) 4-HO-DPT</li>
<li>5-MeO-DPT</li>
<li>(The Light) DPT</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Ibogaine-related</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>18-MAC</li>
<li>18-MC</li>
<li>Coronaridine</li>
<li>Ibogaine</li>
<li>Ibogamine</li>
<li>ME-18-MC</li>
<li>Noribogaine</li>
<li>Tabernanthine</li>
<li>Voacangine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><i>x</i>-<abbr>MET</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>(Metocin) 4-HO-MET</li>
<li>(Metocetin) 4-AcO-MET</li>
<li><span class="new">5-MeO-MET</span></li>
<li>MET</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><i>x</i>-<abbr>MiPT</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>(Mipracetin) 4-AcO-MiPT</li>
<li>(Miprocin) 4-HO-MiPT</li>
<li>5-Me-MiPT</li>
<li>(Moxy) 5-MeO-MiPT</li>
<li>MiPT</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>4-HO-DBT</li>
<li>4-HO-EPT</li>
<li>4-HO-McPT</li>
<li>(Lucigenol) 4-HO-MPMI</li>
<li>(Meprocin) 4-HO-MPT</li>
<li>5-MeO-EiPT</li>
<li>5-MeO-MALT</li>
<li>5-MeO-MPMI</li>
<li>Aeruginascin</li>
<li>Baeocystin</li>
<li>DBT</li>
<li><span class="new">DCPT</span></li>
<li>EiPT</li>
<li>EPT</li>
<li>MPT</li>
<li>PiPT</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>AL-38022A</li>
<li>ALPHA</li>
<li>Dimemebfe</li>
<li><a href="Efavirenz.htm" tppabs="https://ptable.com/wiki/compounds/A/Efavirenz" title="Efavirenz">Efavirenz</a></li>
<li>Glaucine</li>
<li>Lorcaserin</li>
<li>M-ALPHA</li>
<li>RH-34<br><small>Also empathogens in general (e. g.: 5-APB, 5-MAPB, 6-APB and other substituted benzofurans, MDAI, <a href="MDMA.htm" tppabs="https://ptable.com/wiki/compounds/A/MDMA" title="MDMA">MDMA</a>).</small></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Dissociatives<br><small>(NMDAR<br>antagonists)</small></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Arylcyclohexylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Arylcyclohexylamine" title="Arylcyclohexylamine">Arylcyclo‐<br>hexylamines</a></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Ketamine-related</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>2-Fluorodeschloroketamine</li>
<li>Arketamine ((R)-ketamine)</li>
<li>Deschloroketamine</li>
<li>Ethketamine (N-Ethylnorketamine)</li>
<li>Esketamine ((S)-ketamine)</li>
<li><a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">Ketamine</a></li>
<li>Methoxetamine</li>
<li>Methoxmetamine</li>
<li>Methoxyketamine</li>
<li>Norketamine</li>
<li>Tiletamine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">PCP-related</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>2'-Oxo-PCE</li>
<li>3-HO-PCP</li>
<li>3-MeO-PCE</li>
<li>3-MeO-PCMo</li>
<li>3-MeO-PCP</li>
<li>4-MeO-PCP</li>
<li>BDPC</li>
<li>Dieticyclidine (PCDE)</li>
<li>Eticyclidine (PCE)</li>
<li>PCPr</li>
<li><a href="Phencyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phencyclidine" title="Phencyclidine">Phencyclidine</a> (PCP)</li>
<li><a href="Rolicyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Rolicyclidine" title="Rolicyclidine">Rolicyclidine</a> (PCPy)</li>
<li><a href="Tenocyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tenocyclidine" title="Tenocyclidine">Tenocyclidine</a> (TCP)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>BTCP</li>
<li>Gacyclidine</li>
<li>PRE-084</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Diarylethylamines</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Diphenidine</li>
<li>Ephenidine</li>
<li>Fluorolintane</li>
<li>Methoxphenidine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Morphinans</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Dextrallorphan</li>
<li><a href="Dextromethorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextromethorphan" title="Dextromethorphan">Dextromethorphan</a></li>
<li>Dextrorphan</li>
<li><a href="Methorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Racemethorphan" title="Racemethorphan" class="mw-redirect">Racemethorphan</a></li>
<li>Racemorphan</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>2-EMSB</li>
<li>2-MDP</li>
<li>8A-PDHQ</li>
<li>Aptiganel</li>
<li>Budipine</li>
<li>Delucemine</li>
<li>Dexoxadrol</li>
<li>Dizocilpine</li>
<li>Etoxadrol</li>
<li>Herkinorin</li>
<li>Ibogaine</li>
<li>Midafotel</li>
<li>NEFA</li>
<li>Neramexane</li>
<li><a href="Nitrous_oxide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nitrous_oxide" title="Nitrous oxide">Nitrous oxide</a></li>
<li>Noribogaine</li>
<li>Perzinfotel</li>
<li>RB-64</li>
<li>Remacemide</li>
<li><a href="Salvinorin_A.htm" tppabs="https://ptable.com/wiki/compounds/A/Salvinorin_A" title="Salvinorin A">Salvinorin A</a></li>
<li>Selfotel</li>
<li><a href="Xenon.htm" tppabs="https://ptable.com/wiki/compounds/A/Xenon" title="Xenon">Xenon</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Deliriants<br><small>(mAChR<br>antagonists)</small></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Atropine.htm" tppabs="https://ptable.com/wiki/compounds/A/Atropine" title="Atropine">Atropine</a></li>
<li><a href="Benactyzine.htm" tppabs="https://ptable.com/wiki/compounds/A/Benactyzine" title="Benactyzine">Benactyzine</a></li>
<li><a href="Benzatropine.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzatropine" title="Benzatropine">Benzatropine</a></li>
<li>Benzydamine</li>
<li><a href="Biperiden.htm" tppabs="https://ptable.com/wiki/compounds/A/Biperiden" title="Biperiden">Biperiden</a></li>
<li><span class="new">BRN-1484501</span></li>
<li><a href="Brompheniramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Brompheniramine" title="Brompheniramine">Brompheniramine</a></li>
<li>BZ</li>
<li>CAR-226,086</li>
<li>CAR-301,060</li>
<li>CAR-302,196</li>
<li><span class="new">CAR-302,282</span></li>
<li><span class="new">CAR-302,368</span></li>
<li><span class="new">CAR-302,537</span></li>
<li><span class="new">CAR-302,668</span></li>
<li>Chloropyramine</li>
<li><a href="Chlorphenamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorphenamine" title="Chlorphenamine">Chlorphenamine</a></li>
<li><a href="Clemastine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clemastine" title="Clemastine">Clemastine</a></li>
<li><span class="new">CS-27349</span></li>
<li><a href="Cyclizine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclizine" title="Cyclizine">Cyclizine</a></li>
<li><a href="Cyproheptadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyproheptadine" title="Cyproheptadine">Cyproheptadine</a></li>
<li><a href="Dicycloverine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dicycloverine" title="Dicycloverine">Dicycloverine</a></li>
<li><a href="Dimenhydrinate.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimenhydrinate" title="Dimenhydrinate">Dimenhydrinate</a></li>
<li><a href="Diphenhydramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Diphenhydramine" title="Diphenhydramine">Diphenhydramine</a></li>
<li>Ditran</li>
<li><a href="Doxylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Doxylamine" title="Doxylamine">Doxylamine</a></li>
<li>EA-3167</li>
<li>EA-3443</li>
<li>EA-3580</li>
<li>EA-3834</li>
<li>Elemicin</li>
<li><a href="Flavoxate.htm" tppabs="https://ptable.com/wiki/compounds/A/Flavoxate" title="Flavoxate">Flavoxate</a></li>
<li><a href="Hyoscyamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Hyoscyamine" title="Hyoscyamine">Hyoscyamine</a></li>
<li>JB-318</li>
<li>JB-336</li>
<li><a href="Meclozine.htm" tppabs="https://ptable.com/wiki/compounds/A/Meclozine" title="Meclozine" class="mw-redirect">Meclozine</a></li>
<li><a href="Mepyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mepyramine" title="Mepyramine">Mepyramine</a></li>
<li><a href="Myristicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Myristicin" title="Myristicin">Myristicin</a></li>
<li><a href="Orphenadrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Orphenadrine" title="Orphenadrine">Orphenadrine</a></li>
<li><a href="Oxybutynin.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxybutynin" title="Oxybutynin">Oxybutynin</a></li>
<li><a href="Pheniramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pheniramine" title="Pheniramine">Pheniramine</a></li>
<li>Phenyltoloxamine</li>
<li><a href="Procyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Procyclidine" title="Procyclidine">Procyclidine</a></li>
<li><a href="Promethazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Promethazine" title="Promethazine">Promethazine</a></li>
<li><a href="Scopolamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Scopolamine" title="Scopolamine" class="mw-redirect">Scopolamine</a></li>
<li><a href="Tolterodine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tolterodine" title="Tolterodine">Tolterodine</a></li>
<li><a href="Trihexyphenidyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Trihexyphenidyl" title="Trihexyphenidyl">Trihexyphenidyl</a></li>
<li><a href="Tripelennamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tripelennamine" title="Tripelennamine">Tripelennamine</a></li>
<li><a href="Triprolidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Triprolidine" title="Triprolidine">Triprolidine</a></li>
<li>WIN-2299</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Cannabinoids<br><small>(CB<sub>1</sub> agonists)</small></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Natural</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Tetrahydrocannabinol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetrahydrocannabinol" title="Tetrahydrocannabinol">THC (Dronabinol)</a></li>
<li>THCV</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Synthetic</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">AM-<i>x</i></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>AM-087</li>
<li>AM-251</li>
<li><span class="new">AM-279</span></li>
<li><span class="new">AM-281</span></li>
<li><span class="new">AM-356</span></li>
<li><span class="new">AM-374</span></li>
<li><span class="new">AM-381</span></li>
<li>AM-404</li>
<li>AM-411</li>
<li>AM-630</li>
<li><span class="new">AM-661</span></li>
<li>AM-678</li>
<li>AM-679</li>
<li>AM-694</li>
<li><span class="new">AM-735</span></li>
<li>AM-855</li>
<li><span class="new">AM-881</span></li>
<li><span class="new">AM-883</span></li>
<li>AM-905</li>
<li>AM-906</li>
<li>AM-919</li>
<li><span class="new">AM-926</span></li>
<li>AM-938</li>
<li><span class="new">AM-1116</span></li>
<li><span class="new">AM-1172</span></li>
<li>AM-1220</li>
<li>AM-1221</li>
<li>AM-1235</li>
<li>AM-1241</li>
<li>AM-1248</li>
<li><span class="new">AM-1710</span></li>
<li>AM-1714</li>
<li><span class="new">AM-1902</span></li>
<li>AM-2201</li>
<li><span class="new">AM-2212</span></li>
<li><span class="new">AM-2213</span></li>
<li>AM-2232</li>
<li>AM-2233</li>
<li>AM-2389</li>
<li><span class="new">AM-3102</span></li>
<li>AM-4030</li>
<li><span class="new">AM-4054</span></li>
<li>AM-4056</li>
<li><span class="new">AM-4113</span></li>
<li>AM-6545</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">CP <i>x</i></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>CP 47,497</li>
<li>CP 55,244</li>
<li>CP 55,940</li>
<li><span class="new">(±)-CP 55,940</span></li>
<li><span class="new">(+)-CP 55,940</span></li>
<li><span class="new">(-)-CP 55,940</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">HU-<i>x</i></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>HU-210</li>
<li>HU-211</li>
<li>HU-239</li>
<li>HU-243</li>
<li>HU-308</li>
<li>HU-320</li>
<li>HU-331</li>
<li>HU-336</li>
<li>HU-345</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">JWH-<i>x</i></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>JWH-007</li>
<li>JWH-015</li>
<li>JWH-018</li>
<li>JWH-019</li>
<li>JWH-030</li>
<li>JWH-047</li>
<li>JWH-048</li>
<li>JWH-051</li>
<li>JWH-057</li>
<li>JWH-073</li>
<li>JWH-081</li>
<li>JWH-098</li>
<li>JWH-116</li>
<li>JWH-120</li>
<li>JWH-122</li>
<li>JWH-133</li>
<li><span class="new">JWH-139</span></li>
<li>JWH-147</li>
<li>JWH-148</li>
<li>JWH-149</li>
<li>JWH-149</li>
<li>JWH-161</li>
<li>JWH-164</li>
<li><span class="new">JWH-166</span></li>
<li>JWH-167</li>
<li>JWH-171</li>
<li>JWH-175</li>
<li>JWH-176</li>
<li><span class="new">JWH-181</span></li>
<li>JWH-182</li>
<li>JWH-184</li>
<li>JWH-185</li>
<li><span class="new">JWH-192</span></li>
<li>JWH-193</li>
<li><span class="new">JWH-194</span></li>
<li><span class="new">JWH-195</span></li>
<li>JWH-196</li>
<li><span class="new">JWH-197</span></li>
<li>JWH-198</li>
<li><span class="new">JWH-199</span></li>
<li>JWH-200</li>
<li>JWH-203</li>
<li><span class="new">JWH-205</span></li>
<li>JWH-210</li>
<li>JWH-210</li>
<li><span class="new">JWH-213</span></li>
<li><span class="new">JWH-220</span></li>
<li><span class="new">JWH-229</span></li>
<li><span class="new">JWH-234</span></li>
<li>JWH-249</li>
<li>JWH-250</li>
<li>JWH-251</li>
<li><span class="new">JWH-253</span></li>
<li><span class="new">JWH-258</span></li>
<li><span class="new">JWH-300</span></li>
<li>JWH-302</li>
<li>JWH-307</li>
<li><span class="new">JWH-336</span></li>
<li><span class="new">JWH-350</span></li>
<li>JWH-359</li>
<li><span class="new">JWH-387</span></li>
<li>JWH-398</li>
<li>JWH-424</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Misc. designer cannabinoids</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>4-HTMPIPO</li>
<li>5F-AB-FUPPYCA</li>
<li>5F-AB-PINACA</li>
<li>5F-ADB</li>
<li>5F-ADB-PINACA</li>
<li>5F-ADBICA</li>
<li>5F-AMB</li>
<li>5F-APINACA</li>
<li>5F-CUMYL-PINACA</li>
<li>5F-NNE1</li>
<li>5F-PB-22</li>
<li>5F-SDB-006</li>
<li>A-796,260</li>
<li>A-836,339</li>
<li>AB-001</li>
<li>AB-005</li>
<li>AB-CHFUPYCA</li>
<li>AB-CHMINACA</li>
<li>AB-FUBINACA</li>
<li>AB-PINACA</li>
<li>ADAMANTYL-THPINACA</li>
<li>ADB-CHMINACA</li>
<li>ADB-FUBINACA</li>
<li>ADB-PINACA</li>
<li>ADBICA</li>
<li>ADSB-FUB-187</li>
<li>AMB-FUBINACA</li>
<li>APICA</li>
<li>APINACA</li>
<li>APP-FUBINACA</li>
<li>CB-13</li>
<li>CUMYL-PICA</li>
<li>CUMYL-PINACA</li>
<li>CUMYL-THPINACA</li>
<li>DMHP</li>
<li>EAM-2201</li>
<li>FAB-144</li>
<li>FDU-PB-22</li>
<li>FUB-144</li>
<li>FUB-APINACA</li>
<li>FUB-JWH-018</li>
<li>FUB-PB-22</li>
<li>FUBIMINA</li>
<li>JTE 7-31</li>
<li>JTE-907</li>
<li>Levonantradol</li>
<li>MDMB-CHMICA</li>
<li>MDMB-CHMINACA</li>
<li>MDMB-FUBINACA</li>
<li>MEPIRAPIM</li>
<li>MAM-2201</li>
<li>MDA-19</li>
<li>MN-18</li>
<li>MN-25</li>
<li>NESS-0327</li>
<li>NESS-040C5</li>
<li><a href="Nabilone.htm" tppabs="https://ptable.com/wiki/compounds/A/Nabilone" title="Nabilone">Nabilone</a></li>
<li>Nabitan</li>
<li>NM-2201</li>
<li>NNE1</li>
<li>Org 28611</li>
<li>Parahexyl</li>
<li>PTI-1</li>
<li>PTI-2</li>
<li>PX-1</li>
<li>PX-2</li>
<li>PX-3</li>
<li>QUCHIC</li>
<li>QUPIC</li>
<li>RCS-4</li>
<li>RCS-8</li>
<li>SDB-005</li>
<li>SDB-006</li>
<li>STS-135</li>
<li>THC-O-acetate</li>
<li>THC-O-phosphate</li>
<li>THJ-018</li>
<li>THJ-2201</li>
<li>UR-144</li>
<li>WIN 55,212-2</li>
<li>XLR-11</li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">D<sub>2</sub> agonists</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Apomorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Apomorphine" title="Apomorphine">Apomorphine</a></li>
<li>Aporphine</li>
<li><a href="Bromocriptine.htm" tppabs="https://ptable.com/wiki/compounds/A/Bromocriptine" title="Bromocriptine">Bromocriptine</a></li>
<li><a href="Cabergoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Cabergoline" title="Cabergoline">Cabergoline</a></li>
<li><a href="Lisuride.htm" tppabs="https://ptable.com/wiki/compounds/A/Lisuride" title="Lisuride">Lisuride</a></li>
<li><a href="Memantine.htm" tppabs="https://ptable.com/wiki/compounds/A/Memantine" title="Memantine">Memantine</a></li>
<li>Nuciferine</li>
<li><a href="Pergolide.htm" tppabs="https://ptable.com/wiki/compounds/A/Pergolide" title="Pergolide">Pergolide</a></li>
<li><a href="Phenethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenethylamine" title="Phenethylamine">Phenethylamine</a></li>
<li>Piribedil</li>
<li>Pramipexole</li>
<li><a href="Ropinirole.htm" tppabs="https://ptable.com/wiki/compounds/A/Ropinirole" title="Ropinirole">Ropinirole</a></li>
<li>Rotigotine</li>
<li><a href="Salvinorin_A.htm" tppabs="https://ptable.com/wiki/compounds/A/Salvinorin_A" title="Salvinorin A">Salvinorin A</a><br><small>Also indirect D<sub>2</sub> agonists, such as dopamine reuptake inhibitors (<a href="Cocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaine" title="Cocaine">cocaine</a>, <a href="Methylphenidate.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylphenidate" title="Methylphenidate">methylphenidate</a>), releasing agents (<a href="Amphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphetamine" title="Amphetamine">amphetamine</a>, <a href="Methamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamphetamine" title="Methamphetamine">methamphetamine</a>), and precursors (<a href="L-DOPA.htm" tppabs="https://ptable.com/wiki/compounds/A/L-DOPA" title="L-DOPA">levodopa</a>).</small></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">GABA<sub>A</sub><br>enhancers</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>CI-966</li>
<li><a href="Eszopiclone.htm" tppabs="https://ptable.com/wiki/compounds/A/Eszopiclone" title="Eszopiclone">Eszopiclone</a></li>
<li><a href="Ibotenic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Ibotenic_acid" title="Ibotenic acid">Ibotenic acid</a></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Muscimol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Muscimol'" tppabs="https://ptable.com/wiki/compounds/A/Muscimol" title="Muscimol">Muscimol</a> (<i>Amanita muscaria</i>)</li>
<li><a href="Zaleplon.htm" tppabs="https://ptable.com/wiki/compounds/A/Zaleplon" title="Zaleplon">Zaleplon</a></li>
<li><a href="Zolpidem.htm" tppabs="https://ptable.com/wiki/compounds/A/Zolpidem" title="Zolpidem">Zolpidem</a></li>
<li><a href="Zopiclone.htm" tppabs="https://ptable.com/wiki/compounds/A/Zopiclone" title="Zopiclone">Zopiclone</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Inhalants<br><small>(Mixed MOA)</small></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Aliphatic hydrocarbons
<ul><li><a href="Butane.htm" tppabs="https://ptable.com/wiki/compounds/A/Butane" title="Butane">Butane</a></li>
<li>Gasoline</li>
<li>Kerosene</li>
<li><a href="Propane.htm" tppabs="https://ptable.com/wiki/compounds/A/Propane" title="Propane">Propane</a></li></ul></li>
<li>Aromatic hydrocarbons
<ul><li><a href="Toluene.htm" tppabs="https://ptable.com/wiki/compounds/A/Toluene" title="Toluene">Toluene</a></li></ul></li>
<li><a href="Ether.htm" tppabs="https://ptable.com/wiki/compounds/A/Ether" title="Ether">Ethers</a>
<ul><li><a href="Diethyl_ether.htm" tppabs="https://ptable.com/wiki/compounds/A/Diethyl_ether" title="Diethyl ether">Diethyl ether</a></li>
<li><a href="Enflurane.htm" tppabs="https://ptable.com/wiki/compounds/A/Enflurane" title="Enflurane">Enflurane</a></li></ul></li>
<li>Haloalkanes
<ul><li>Chlorofluorocarbons</li>
<li><a href="Chloroform.htm" tppabs="https://ptable.com/wiki/compounds/A/Chloroform" title="Chloroform">Chloroform</a></li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">κOR agonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>2-EMSB</li>
<li>Alazocine</li>
<li>Bremazocine</li>
<li><a href="Butorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Butorphan" title="Butorphan" class="mw-redirect">Butorphan</a></li>
<li><a href="Butorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Butorphanol" title="Butorphanol">Butorphanol</a></li>
<li><a href="Cyclazocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclazocine" title="Cyclazocine">Cyclazocine</a></li>
<li>Cyclorphan</li>
<li><a href="Cyprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyprenorphine" title="Cyprenorphine">Cyprenorphine</a></li>
<li><a href="Diprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Diprenorphine" title="Diprenorphine">Diprenorphine</a></li>
<li>Enadoline</li>
<li>Herkinorin</li>
<li><a href="Heroin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heroin" title="Heroin">Heroin</a></li>
<li>HZ-2</li>
<li>Ibogaine</li>
<li>Ketazocine</li>
<li><a href="Levallorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Levallorphan" title="Levallorphan">Levallorphan</a></li>
<li>Levomethorphan</li>
<li><a href="Levorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Levorphanol" title="Levorphanol">Levorphanol</a></li>
<li>LPK-26</li>
<li>Metazocine</li>
<li><a href="Morphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Morphine" title="Morphine">Morphine</a></li>
<li><a href="Nalbuphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalbuphine" title="Nalbuphine">Nalbuphine</a></li>
<li><a href="Nalmefene.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalmefene" title="Nalmefene">Nalmefene</a></li>
<li><a href="Nalorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalorphine" title="Nalorphine">Nalorphine</a></li>
<li>Noribogaine</li>
<li>Oxilorphan</li>
<li><a href="Pentazocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentazocine" title="Pentazocine">Pentazocine</a></li>
<li>Phenazocine</li>
<li>Proxorphan</li>
<li><a href="Methorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Racemethorphan" title="Racemethorphan" class="mw-redirect">Racemethorphan</a></li>
<li>Racemorphan</li>
<li><a href="Salvinorin_A.htm" tppabs="https://ptable.com/wiki/compounds/A/Salvinorin_A" title="Salvinorin A">Salvinorin A</a></li>
<li>Spiradoline</li>
<li>Tifluadom</li>
<li>U-50488</li>
<li>U-69,593</li>
<li>Xorphanol</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Oneirogens</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Calea zacatechichi</li>
<li>Silene capensis</li>
<li><a href="Galantamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Galantamine" title="Galantamine">Galantamine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Glaucine</li>
<li>Isoaminile</li>
<li><a href="Noscapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Noscapine" title="Noscapine">Noscapine</a></li>
<li>Pukateine</li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Stimulants" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Stimulants" style="font-size:114%;margin:0 4em">Stimulants</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Adamantane.htm" tppabs="https://ptable.com/wiki/compounds/A/Adamantane" title="Adamantane">Adamantanes</a></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Adapromine</li>
<li><a href="Amantadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amantadine" title="Amantadine">Amantadine</a></li>
<li>Bromantane</li>
<li><a href="Memantine.htm" tppabs="https://ptable.com/wiki/compounds/A/Memantine" title="Memantine">Memantine</a></li>
<li><a href="Rimantadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Rimantadine" title="Rimantadine">Rimantadine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Adenosine antagonists</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="8-Chlorotheophylline-1.htm" tppabs="https://ptable.com/wiki/compounds/A/8-Chlorotheophylline" title="8-Chlorotheophylline">8-Chlorotheophylline</a></li>
<li>8-Cyclopentyltheophylline</li>
<li>8-Phenyltheophylline</li>
<li><a href="Aminophylline.htm" tppabs="https://ptable.com/wiki/compounds/A/Aminophylline" title="Aminophylline">Aminophylline</a></li>
<li><a href="Caffeine.htm" tppabs="https://ptable.com/wiki/compounds/A/Caffeine" title="Caffeine">Caffeine</a></li>
<li>CGS-15943</li>
<li>Dimethazan</li>
<li><a href="Paraxanthine.htm" tppabs="https://ptable.com/wiki/compounds/A/Paraxanthine" title="Paraxanthine">Paraxanthine</a></li>
<li>SCH-58261</li>
<li><a href="Theobromine.htm" tppabs="https://ptable.com/wiki/compounds/A/Theobromine" title="Theobromine">Theobromine</a></li>
<li><a href="Theophylline.htm" tppabs="https://ptable.com/wiki/compounds/A/Theophylline" title="Theophylline">Theophylline</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Alkylamines</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Cyclopentamine</li>
<li>Cypenamine</li>
<li>Cyprodenate</li>
<li><a href="Heptaminol.htm" tppabs="https://ptable.com/wiki/compounds/A/Heptaminol" title="Heptaminol">Heptaminol</a></li>
<li>Isometheptene</li>
<li>Levopropylhexedrine</li>
<li>Methylhexaneamine</li>
<li><a href="Octodrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Octodrine" title="Octodrine">Octodrine</a></li>
<li>Propylhexedrine</li>
<li><a href="Tuaminoheptane.htm" tppabs="https://ptable.com/wiki/compounds/A/Tuaminoheptane" title="Tuaminoheptane">Tuaminoheptane</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Ampakines</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>CX-516</li>
<li>CX-546</li>
<li>CX-614</li>
<li>CX-691</li>
<li>CX-717</li>
<li>IDRA-21</li>
<li>LY-404,187</li>
<li>LY-503,430</li>
<li>Nooglutyl</li>
<li>Org 26576</li>
<li>PEPA</li>
<li>S-18986</li>
<li>Sunifiram</li>
<li>Unifiram</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Arylcyclohexylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Arylcyclohexylamine" title="Arylcyclohexylamine">Arylcyclohexylamines</a></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Benocyclidine</li>
<li>Dieticyclidine</li>
<li>Esketamine</li>
<li>Eticyclidine</li>
<li>Gacyclidine</li>
<li><a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">Ketamine</a></li>
<li>Phencyclamine</li>
<li><a href="Phencyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phencyclidine" title="Phencyclidine">Phencyclidine</a></li>
<li><a href="Rolicyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Rolicyclidine" title="Rolicyclidine">Rolicyclidine</a></li>
<li><a href="Tenocyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tenocyclidine" title="Tenocyclidine">Tenocyclidine</a></li>
<li>Tiletamine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Benzazepines</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>6-Br-APB</li>
<li>SKF-77434</li>
<li>SKF-81297</li>
<li>SKF-82958</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Cathinones</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>3-Fluoromethcathinone</li>
<li>3,4-DMMC</li>
<li>4-BMC</li>
<li>4-CMC</li>
<li>4-Methylbuphedrone</li>
<li>4-Methylcathinone</li>
<li>4-MEAP</li>
<li>4-Methylpentedrone</li>
<li><a href="Amfepramone.htm" tppabs="https://ptable.com/wiki/compounds/A/Amfepramone" title="Amfepramone">Amfepramone</a></li>
<li>Benzedrone</li>
<li>Buphedrone</li>
<li><a href="Bupropion.htm" tppabs="https://ptable.com/wiki/compounds/A/Bupropion" title="Bupropion">Bupropion</a></li>
<li>Butylone</li>
<li><a href="Cathinone.htm" tppabs="https://ptable.com/wiki/compounds/A/Cathinone" title="Cathinone">Cathinone</a></li>
<li>Dimethylcathinone</li>
<li>Ethcathinone</li>
<li>Ethylone</li>
<li>Flephedrone</li>
<li>Hexedrone</li>
<li>Isoethcathinone</li>
<li>Mephedrone</li>
<li>Methcathinone</li>
<li>Methedrone</li>
<li>Methylenedioxycathinone</li>
<li>Methylone</li>
<li>Mexedrone</li>
<li>N-Ethylbuphedrone</li>
<li>N-Ethylhexedrone</li>
<li>Pentedrone</li>
<li>Pentylone</li>
<li>Phthalimidopropiophenone</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Acetylcholine.htm" tppabs="https://ptable.com/wiki/compounds/A/Acetylcholine" title="Acetylcholine">Cholinergics</a></th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>A-84,543</li>
<li>A-366,833</li>
<li>ABT-202</li>
<li>ABT-418</li>
<li>AR-R17779</li>
<li>Altinicline</li>
<li><a href="Anabasine.htm" tppabs="https://ptable.com/wiki/compounds/A/Anabasine" title="Anabasine">Anabasine</a></li>
<li><a href="Arecoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Arecoline" title="Arecoline">Arecoline</a></li>
<li>Bradanicline</li>
<li><a href="Cotinine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cotinine" title="Cotinine">Cotinine</a></li>
<li><a href="Cytisine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cytisine" title="Cytisine">Cytisine</a></li>
<li>Dianicline</li>
<li>Epibatidine</li>
<li>Epiboxidine</li>
<li>GTS-21</li>
<li>Ispronicline</li>
<li><a href="Nicotine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicotine" title="Nicotine">Nicotine</a></li>
<li>PHA-543,613</li>
<li>PNU-120,596</li>
<li>PNU-282,987</li>
<li>Pozanicline</li>
<li>Rivanicline</li>
<li>Sazetidine A</li>
<li>SIB-1553A</li>
<li>SSR-180,711</li>
<li>TC-1698</li>
<li>TC-1827</li>
<li>TC-2216</li>
<li>Tebanicline</li>
<li>UB-165</li>
<li><a href="Varenicline.htm" tppabs="https://ptable.com/wiki/compounds/A/Varenicline" title="Varenicline">Varenicline</a></li>
<li>WAY-317,538</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Convulsants</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Anatoxin-a.htm" tppabs="https://ptable.com/wiki/compounds/A/Anatoxin-a" title="Anatoxin-a">Anatoxin-a</a></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Bicuculline  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Bicuculline'" tppabs="https://ptable.com/wiki/compounds/A/Bicuculline" title="Bicuculline">Bicuculline</a></li>
<li>DMCM</li>
<li><a href="Flurothyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Flurothyl" title="Flurothyl">Flurothyl</a></li>
<li>Gabazine</li>
<li><a href="Haloperidol.htm" tppabs="https://ptable.com/wiki/compounds/A/Haldol" title="Haldol" class="mw-redirect">Haldol</a></li>
<li><a href="Pentylenetetrazol.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentylenetetrazol" title="Pentylenetetrazol">Pentetrazol</a></li>
<li><a href="Picrotoxin.htm" tppabs="https://ptable.com/wiki/compounds/A/Picrotoxin" title="Picrotoxin">Picrotoxin</a></li>
<li><a href="Strychnine.htm" tppabs="https://ptable.com/wiki/compounds/A/Strychnine" title="Strychnine">Strychnine</a></li>
<li>Thujone</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Eugeroics</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Adrafinil.htm" tppabs="https://ptable.com/wiki/compounds/A/Adrafinil" title="Adrafinil">Adrafinil</a></li>
<li>Armodafinil</li>
<li>CRL-40,940</li>
<li>CRL-40,941</li>
<li>Fluorenol</li>
<li><a href="Modafinil.htm" tppabs="https://ptable.com/wiki/compounds/A/Modafinil" title="Modafinil">Modafinil</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Oxazolines</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="4-Methylaminorex.htm" tppabs="https://ptable.com/wiki/compounds/A/4-Methylaminorex" title="4-Methylaminorex">4-Methylaminorex</a></li>
<li><a href="Aminorex.htm" tppabs="https://ptable.com/wiki/compounds/A/Aminorex" title="Aminorex">Aminorex</a></li>
<li>Clominorex</li>
<li>Cyclazodone</li>
<li>Fenozolone</li>
<li>Fluminorex</li>
<li><a href="Pemoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Pemoline" title="Pemoline">Pemoline</a></li>
<li>Thozalinone</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Phenethylamines</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>1-(4-Methylphenyl)-2-aminobutane</li>
<li>1-Methylamino-1-(3,4-methylenedioxyphenyl)propane</li>
<li>2-Fluoroamphetamine</li>
<li>2-Fluoromethamphetamine</li>
<li><a href="2-Hydroxyphenethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/2-Hydroxyphenethylamine" title="2-Hydroxyphenethylamine" class="mw-redirect">2-OH-PEA</a></li>
<li>2-Phenyl-3-aminobutane</li>
<li>2,3-MDA</li>
<li>3-Fluoroamphetamine</li>
<li>3-Fluoroethamphetamine</li>
<li>3-Methoxyamphetamine</li>
<li>3-Methylamphetamine</li>
<li>4-Fluoroamphetamine</li>
<li>4-Fluoromethamphetamine</li>
<li>4-MA</li>
<li>4-MMA</li>
<li>4-MTA</li>
<li>6-FNE</li>
<li>AL-1095</li>
<li>Alfetamine</li>
<li>a-Ethylphenethylamine</li>
<li>Amfecloral</li>
<li>Amfepentorex</li>
<li>Amidephrine</li>
<li>2-Amino-1,2-dihydronaphthalene</li>
<li>2-Aminoindane</li>
<li>5-(2-Aminopropyl)indole</li>
<li><a href="2-Aminotetralin.htm" tppabs="https://ptable.com/wiki/compounds/A/2-Aminotetralin" title="2-Aminotetralin">2-Aminotetralin</a></li>
<li>Acridorex</li>
<li><a href="Amphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphetamine" title="Amphetamine">Amphetamine</a> (<a href="Dextroamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextroamphetamine" title="Dextroamphetamine">Dextroamphetamine</a>, <a href="Levoamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Levoamphetamine" title="Levoamphetamine">Levoamphetamine</a>)</li>
<li>Amphetaminil</li>
<li><a href="Arbutamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Arbutamine" title="Arbutamine">Arbutamine</a></li>
<li><a href="Β-Methylphenethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/%CE%92-Methylphenethylamine" title="Β-Methylphenethylamine">β-Methylphenethylamine</a></li>
<li>β-Phenylmethamphetamine</li>
<li>Benfluorex</li>
<li><a href="Benzphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzphetamine" title="Benzphetamine">Benzphetamine</a></li>
<li>BDB</li>
<li>BOH</li>
<li>3-Benzhydrylmorpholine</li>
<li>BPAP</li>
<li>Camfetamine</li>
<li><a href="Cathine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cathine" title="Cathine">Cathine</a></li>
<li><a href="Chlorphentermine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorphentermine" title="Chlorphentermine">Chlorphentermine</a></li>
<li>Cilobamine</li>
<li>Cinnamedrine</li>
<li><a href="Clenbuterol.htm" tppabs="https://ptable.com/wiki/compounds/A/Clenbuterol" title="Clenbuterol">Clenbuterol</a></li>
<li>Clobenzorex</li>
<li>Cloforex</li>
<li><a href="Clortermine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clortermine" title="Clortermine">Clortermine</a></li>
<li>Cypenamine</li>
<li><small>D</small>-Deprenyl</li>
<li>Denopamine</li>
<li><a href="Dimethoxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimethoxyamphetamine" title="Dimethoxyamphetamine">Dimethoxyamphetamine</a></li>
<li>Dimethylamphetamine</li>
<li><a href="Dobutamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dobutamine" title="Dobutamine">Dobutamine</a></li>
<li><a href="L-DOPA.htm" tppabs="https://ptable.com/wiki/compounds/A/L-DOPA" title="L-DOPA">DOPA</a> (Dextrodopa, <a href="L-DOPA.htm" tppabs="https://ptable.com/wiki/compounds/A/L-DOPA" title="L-DOPA">Levodopa</a>)</li>
<li><a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">Dopamine</a></li>
<li>Dopexamine</li>
<li><a href="L-DOPS.htm" tppabs="https://ptable.com/wiki/compounds/A/L-DOPS" title="L-DOPS" class="mw-redirect">Droxidopa</a></li>
<li>EBDB</li>
<li><a href="Ephedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ephedrine" title="Ephedrine">Ephedrine</a></li>
<li><a href="Epinephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Epinephrine" title="Epinephrine" class="mw-redirect">Epinephrine</a></li>
<li>Epinine</li>
<li>Etafedrine</li>
<li>Ethylnorepinephrine</li>
<li>Etilamfetamine</li>
<li>Etilefrine</li>
<li>Famprofazone</li>
<li>Fencamfamin</li>
<li>Fencamine</li>
<li><a href="Fenethylline.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenethylline" title="Fenethylline">Fenethylline</a></li>
<li><a href="Fenfluramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenfluramine" title="Fenfluramine">Fenfluramine</a> (<a href="Dexfenfluramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dexfenfluramine" title="Dexfenfluramine">Dexfenfluramine</a>, Levofenfluramine)</li>
<li><a href="Fenproporex.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenproporex" title="Fenproporex">Fenproporex</a></li>
<li>Feprosidnine</li>
<li>Fludorex</li>
<li>Formetorex</li>
<li>Furfenorex</li>
<li>Gepefrine</li>
<li>Hexapradol</li>
<li>HMMA</li>
<li>Hordenine</li>
<li>4-Hydroxyamphetamine</li>
<li>5-Iodo-2-aminoindane</li>
<li>Ibopamine</li>
<li>Indanylamphetamine</li>
<li>Iofetamine</li>
<li><a href="Isoetarine.htm" tppabs="https://ptable.com/wiki/compounds/A/Isoetarine" title="Isoetarine">Isoetarine</a></li>
<li><a href="Isoprenaline.htm" tppabs="https://ptable.com/wiki/compounds/A/Isoprenaline" title="Isoprenaline">Isoprenaline</a></li>
<li><a href="Selegiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Selegiline" title="Selegiline"><small>L</small>-Deprenyl</a> (Selegiline)</li>
<li>Lefetamine</li>
<li><a href="Lisdexamfetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lisdexamfetamine" title="Lisdexamfetamine">Lisdexamfetamine</a></li>
<li>Lophophine</li>
<li>MBDB</li>
<li><a href="3,4-Methylenedioxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/3%2C4-Methylenedioxyamphetamine" title="3,4-Methylenedioxyamphetamine">MDA (tenamfetamine)</a></li>
<li>MDBU</li>
<li>MDEA</li>
<li><a href="MDMA.htm" tppabs="https://ptable.com/wiki/compounds/A/MDMA" title="MDMA">MDMA (midomafetamine)</a></li>
<li>MDMPEA</li>
<li>MDOH</li>
<li>MDPR</li>
<li>MDPEA</li>
<li>Mefenorex</li>
<li><a href="Mephentermine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mephentermine" title="Mephentermine">Mephentermine</a></li>
<li>Metanephrine</li>
<li><a href="Metaraminol.htm" tppabs="https://ptable.com/wiki/compounds/A/Metaraminol" title="Metaraminol">Metaraminol</a></li>
<li>Mesocarb</li>
<li><a href="Methamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamphetamine" title="Methamphetamine">Methamphetamine</a> (<a href="Methamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamphetamine" title="Methamphetamine">Dextromethamphetamine</a>, Levomethamphetamine)</li>
<li><a href="Methoxamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methoxamine" title="Methoxamine">Methoxamine</a></li>
<li>Methoxyphenamine</li>
<li>MMA</li>
<li>Methoxyphenamine</li>
<li>MMDA</li>
<li>MMDMA</li>
<li>MMMA</li>
<li>Morforex</li>
<li>N,alpha-Diethylphenylethylamine</li>
<li>N,N-Dimethylphenethylamine</li>
<li>Naphthylamphetamine</li>
<li>Nisoxetine</li>
<li>Norepinephrine</li>
<li><a href="Norfenefrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Norfenefrine" title="Norfenefrine">Norfenefrine</a></li>
<li>Norfenfluramine</li>
<li>Normetanephrine</li>
<li><a href="L-Norpseudoephedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/L-Norpseudoephedrine" title="L-Norpseudoephedrine"><small>L</small>-Norpseudoephedrine</a></li>
<li>Octopamine</li>
<li><a href="Orciprenaline.htm" tppabs="https://ptable.com/wiki/compounds/A/Orciprenaline" title="Orciprenaline">Orciprenaline</a></li>
<li>Ortetamine</li>
<li>Oxifentorex</li>
<li>Oxilofrine</li>
<li>PBA</li>
<li>PCA</li>
<li>PCMA</li>
<li>PHA</li>
<li>Pentorex</li>
<li><span class="new">Phenatine</span></li>
<li>Phenpromethamine</li>
<li><a href="Phentermine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phentermine" title="Phentermine">Phentermine</a></li>
<li><a href="Phenylalanine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenylalanine" title="Phenylalanine">Phenylalanine</a></li>
<li><a href="Phenylephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenylephrine" title="Phenylephrine">Phenylephrine</a></li>
<li><a href="Phenylpropanolamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenylpropanolamine" title="Phenylpropanolamine">Phenylpropanolamine</a></li>
<li><a href="Pholedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pholedrine" title="Pholedrine">Pholedrine</a></li>
<li>PIA</li>
<li><a href="Para-Methoxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Para-Methoxyamphetamine" title="Para-Methoxyamphetamine">PMA</a></li>
<li>PMEA</li>
<li>PMMA</li>
<li>PPAP</li>
<li><a href="Prenylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Prenylamine" title="Prenylamine">Prenylamine</a></li>
<li>Propylamphetamine</li>
<li><a href="Pseudoephedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pseudoephedrine" title="Pseudoephedrine">Pseudoephedrine</a></li>
<li><a href="Ropinirole.htm" tppabs="https://ptable.com/wiki/compounds/A/Ropinirole" title="Ropinirole">Ropinirole</a></li>
<li><a href="Salbutamol.htm" tppabs="https://ptable.com/wiki/compounds/A/Salbutamol" title="Salbutamol">Salbutamol</a> (Levosalbutamol)</li>
<li><a href="Sibutramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Sibutramine" title="Sibutramine">Sibutramine</a></li>
<li>Solriamfetol</li>
<li><a href="Synephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Synephrine" title="Synephrine">Synephrine</a></li>
<li>Theodrenaline</li>
<li>Tiflorex</li>
<li><a href="Tranylcypromine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tranylcypromine" title="Tranylcypromine">Tranylcypromine</a></li>
<li><a href="Tyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyramine" title="Tyramine">Tyramine</a></li>
<li><a href="Tyrosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyrosine" title="Tyrosine">Tyrosine</a></li>
<li>Xylopropamine</li>
<li>Zylofuramine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Phenylmorpholines</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>3-Fluorophenmetrazine</li>
<li>Fenbutrazate</li>
<li>Fenmetramide</li>
<li>G-130</li>
<li>Manifaxine</li>
<li>Morazone</li>
<li>Morforex</li>
<li>Oxaflozane</li>
<li>PD-128,907</li>
<li><a href="Phendimetrazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phendimetrazine" title="Phendimetrazine">Phendimetrazine</a></li>
<li><a href="Phenmetrazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenmetrazine" title="Phenmetrazine">Phenmetrazine</a></li>
<li>2-Phenyl-3,6-dimethylmorpholine</li>
<li>Pseudophenmetrazine</li>
<li>Radafaxine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Piperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Piperazine" title="Piperazine">Piperazines</a></th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>2C-B-BZP</li>
<li>3C-PEP</li>
<li><a href="Benzylpiperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzylpiperazine" title="Benzylpiperazine">BZP</a></li>
<li>CM156</li>
<li>DBL-583</li>
<li>GBR-12783</li>
<li>GBR-12935</li>
<li>GBR-13069</li>
<li>GBR-13098</li>
<li>GBR-13119</li>
<li>MeOPP</li>
<li>MBZP</li>
<li>oMPP</li>
<li><a href="Vanoxerine.htm" tppabs="https://ptable.com/wiki/compounds/A/Vanoxerine" title="Vanoxerine">Vanoxerine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Piperidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Piperidine" title="Piperidine">Piperidines</a></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>1-Benzyl-4-(2-(diphenylmethoxy)ethyl)piperidine</li>
<li>2-Benzylpiperidine</li>
<li>2-Methyl-3-phenylpiperidine</li>
<li>3,4-Dichloromethylphenidate</li>
<li><a href="4-Benzylpiperidine.htm" tppabs="https://ptable.com/wiki/compounds/A/4-Benzylpiperidine" title="4-Benzylpiperidine">4-Benzylpiperidine</a></li>
<li>4-Fluoromethylphenidate</li>
<li>4-Methylmethylphenidate</li>
<li>Desoxypipradrol</li>
<li>Difemetorex</li>
<li>Diphenylpyraline</li>
<li>Ethylnaphthidate</li>
<li>Ethylphenidate</li>
<li>Methylnaphthidate</li>
<li>Isopropylphenidate</li>
<li>JZ-IV-10</li>
<li><a href="Methylphenidate.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylphenidate" title="Methylphenidate">Methylphenidate</a> (Dexmethylphenidate)</li>
<li>Nocaine</li>
<li>Phacetoperane</li>
<li>Pipradrol</li>
<li>Propylphenidate</li>
<li>SCH-5472</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Pyrrolidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pyrrolidine" title="Pyrrolidine">Pyrrolidines</a></th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>2-Diphenylmethylpyrrolidine</li>
<li>4-Cl-PVP</li>
<li>5-DBFPV</li>
<li>α-PPP</li>
<li>α-PBP</li>
<li>α-PCYP</li>
<li>α-PHiP</li>
<li>α-PHP</li>
<li>α-PHPP</li>
<li>α-PVP</li>
<li>α-PVT</li>
<li>Diphenylprolinol</li>
<li>DMPVP</li>
<li>FPOP</li>
<li>FPVP</li>
<li>MDPPP</li>
<li>MDPBP</li>
<li>MPBP</li>
<li>MPHP</li>
<li>MPPP</li>
<li>MOPVP</li>
<li>MOPPP</li>
<li>Indapyrophenidone</li>
<li>MDPV</li>
<li>Naphyrone</li>
<li>PEP</li>
<li>Picilorex</li>
<li>Prolintane</li>
<li>Pyrovalerone</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Racetams</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Oxiracetam.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxiracetam" title="Oxiracetam">Oxiracetam</a></li>
<li>Phenylpiracetam</li>
<li>Phenylpiracetam hydrazide</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Tropane.htm" tppabs="https://ptable.com/wiki/compounds/A/Tropane" title="Tropane">Tropanes</a></th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>4-fluorotropacocaine</li>
<li>4'-Fluorococaine</li>
<li>Altropane (IACFT)</li>
<li>Brasofensine</li>
<li>CFT (WIN 35,428)</li>
<li>β-CIT (RTI-55)</li>
<li><a href="Cocaethylene.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaethylene" title="Cocaethylene">Cocaethylene</a></li>
<li><a href="Cocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaine" title="Cocaine">Cocaine</a></li>
<li>Dichloropane (RTI-111)</li>
<li>Difluoropine</li>
<li>FE-β-CPPIT</li>
<li>FP-β-CPPIT</li>
<li>Ioflupane (<sup>123</sup>I)</li>
<li>Norcocaine</li>
<li>PIT</li>
<li>PTT</li>
<li>RTI-31</li>
<li>RTI-32</li>
<li>RTI-51</li>
<li>RTI-112</li>
<li>RTI-113</li>
<li>RTI-120</li>
<li>RTI-121 (IPCIT)</li>
<li>RTI-126</li>
<li>RTI-150</li>
<li>RTI-177</li>
<li>RTI-229</li>
<li>RTI-336</li>
<li>RTI-354</li>
<li>RTI-371</li>
<li>RTI-386</li>
<li>Salicylmethylecgonine</li>
<li>Tesofensine</li>
<li>Troparil (β-CPT, WIN 35,065-2)</li>
<li>Tropoxane</li>
<li>WF-23</li>
<li>WF-33</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Tryptamines</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>4-HO-αMT</li>
<li>4-Methyl-αET</li>
<li>4-Methyl-αMT</li>
<li>5-Chloro-αMT</li>
<li>5-Fluoro-αMT</li>
<li>5-MeO-αET</li>
<li>5-MeO-αMT</li>
<li>5-MeO-DIPT</li>
<li>6-Fluoro-αMT</li>
<li>7-Methyl-αET</li>
<li>αET</li>
<li>αMT</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>2-MDP</li>
<li>3,3-Diphenylcyclobutanamine</li>
<li>Amfonelic acid</li>
<li><a href="Amineptine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amineptine" title="Amineptine">Amineptine</a></li>
<li><a href="Amiphenazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Amiphenazole" title="Amiphenazole">Amiphenazole</a></li>
<li>Atipamezole</li>
<li><a href="Atomoxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Atomoxetine" title="Atomoxetine">Atomoxetine</a></li>
<li><a href="Bemegride.htm" tppabs="https://ptable.com/wiki/compounds/A/Bemegride" title="Bemegride">Bemegride</a></li>
<li>Benzydamine</li>
<li>BTQ</li>
<li>BTS 74,398</li>
<li>Centanafadine</li>
<li>Ciclazindol</li>
<li>Clofenciclan</li>
<li>Cropropamide</li>
<li>Crotetamide</li>
<li>D-161</li>
<li>Desipramine</li>
<li>Diclofensine</li>
<li>Dimethocaine</li>
<li>Efaroxan</li>
<li><a href="Etamivan.htm" tppabs="https://ptable.com/wiki/compounds/A/Etamivan" title="Etamivan">Etamivan</a></li>
<li>Fenisorex</li>
<li>Fenpentadiol</li>
<li>Gamfexine</li>
<li>Gilutensin</li>
<li>GSK1360707F</li>
<li>GYKI-52895</li>
<li>Hexacyclonate</li>
<li>Idazoxan</li>
<li>Indanorex</li>
<li>Indatraline</li>
<li>JNJ-7925476</li>
<li>Lazabemide</li>
<li>Leptacline</li>
<li>Lomevactone</li>
<li>LR-5182</li>
<li><a href="Mazindol.htm" tppabs="https://ptable.com/wiki/compounds/A/Mazindol" title="Mazindol">Mazindol</a></li>
<li>Meclofenoxate</li>
<li>Medifoxamine</li>
<li>Mefexamide</li>
<li>Methamnetamine</li>
<li>Methastyridone</li>
<li>Methiopropamine</li>
<li>Naphthylaminopropane</li>
<li>Nefopam</li>
<li><a href="Nikethamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nikethamide" title="Nikethamide">Nikethamide</a></li>
<li><a href="Nomifensine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nomifensine" title="Nomifensine">Nomifensine</a></li>
<li>O-2172</li>
<li>Oxaprotiline</li>
<li>PNU-99,194</li>
<li>PRC200-SS</li>
<li><a href="Rasagiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Rasagiline" title="Rasagiline">Rasagiline</a></li>
<li>Rauwolscine</li>
<li><a href="Rubidium_chloride.htm" tppabs="https://ptable.com/wiki/compounds/A/Rubidium_chloride" title="Rubidium chloride">Rubidium chloride</a></li>
<li>Setazindol</li>
<li>Tametraline</li>
<li>Tandamine</li>
<li>Thiopropamine</li>
<li>Thiothinone</li>
<li>Trazium</li>
<li>UH-232</li>
<li><a href="Yohimbine.htm" tppabs="https://ptable.com/wiki/compounds/A/Yohimbine" title="Yohimbine">Yohimbine</a></li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2" style="font-style:italic"><div>ATC code: N06B</div></td></tr></tbody></table></div></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Pharmacodynamics" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2" style="background:#e8e8ff;background:#ccccff"><div id="Pharmacodynamics" style="font-size:114%;margin:0 4em">Pharmacodynamics</div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;font-size:114%"><div style="padding:0px">
<div role="navigation" class="navbox" aria-labelledby="Monoamine_neurotoxins" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Monoamine_neurotoxins" style="font-size:114%;margin:0 4em">Monoamine neurotoxins</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Adrenergic</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>DSP-4</li>
<li><a href="Oxidopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxidopamine" title="Oxidopamine">Oxidopamine (6-OHDA)</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Dopaminergic</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Fenpropathrin</li>
<li><a href="Methamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamphetamine" title="Methamphetamine">Methamphetamine</a></li>
<li>MPP<sup>+</sup></li>
<li><a href="MPTP.htm" tppabs="https://ptable.com/wiki/compounds/A/MPTP" title="MPTP">MPTP</a></li>
<li>Norsalsolinol</li>
<li><a href="Oxidopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxidopamine" title="Oxidopamine">Oxidopamine (6-OHDA)</a></li>
<li><a href="Rotenone.htm" tppabs="https://ptable.com/wiki/compounds/A/Rotenone" title="Rotenone">Rotenone</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Serotonergic</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><span class="new">3-CA</span></li>
<li>4-CAB</li>
<li>5,7-DHT</li>
<li><a href="Alpha-Methyldopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Alpha-Methyldopamine" title="Alpha-Methyldopamine">α-Me-DA (3,4-DHA)</a></li>
<li><a href="Alpha-Ethyltryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Alpha-Ethyltryptamine" title="Alpha-Ethyltryptamine">αET</a></li>
<li><a href="Alpha-Methyltryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Alpha-Methyltryptamine" title="Alpha-Methyltryptamine">αMT</a></li>
<li>DCA</li>
<li><a href="3,4-Methylenedioxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/3%2C4-Methylenedioxyamphetamine" title="3,4-Methylenedioxyamphetamine">MDA (tenamfetamine)</a></li>
<li><a href="MDMA.htm" tppabs="https://ptable.com/wiki/compounds/A/MDMA" title="MDMA">MDMA (midomafetamine)</a></li>
<li>PBA</li>
<li>PCA</li>
<li>PIA</li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div><small><i><b>See also:</b> Receptor/signaling modulators • Adrenergics • Dopaminergics • Melatonergics • Serotonergics • Monoamine reuptake inhibitors • Monoamine releasing agents • Monoamine metabolism modulators</i></small></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Monoamine_releasing_agents" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Monoamine_releasing_agents" style="font-size:114%;margin:0 4em">Monoamine releasing agents</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>DRAs</abbr></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;text-align: left;"><div style="padding:0em 0.25em">
<ul><li><i>Morpholines:</i> Fenbutrazate</li>
<li>Fenmetramide</li>
<li>Morazone</li>
<li>Morforex</li>
<li><a href="Phendimetrazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phendimetrazine" title="Phendimetrazine">Phendimetrazine</a></li>
<li><a href="Phenmetrazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenmetrazine" title="Phenmetrazine">Phenmetrazine</a></li>
<li>Pseudophenmetrazine</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px;text-align: left;"><div style="padding:0em 0.25em">
<ul><li><i>Oxazolines:</i> <a href="4-Methylaminorex.htm" tppabs="https://ptable.com/wiki/compounds/A/4-Methylaminorex" title="4-Methylaminorex">4-MAR</a></li>
<li><a href="Aminorex.htm" tppabs="https://ptable.com/wiki/compounds/A/Aminorex" title="Aminorex">Aminorex</a></li>
<li>Clominorex</li>
<li>Cyclazodone</li>
<li>Fenozolone</li>
<li>Fluminorex</li>
<li><a href="Pemoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Pemoline" title="Pemoline">Pemoline</a></li>
<li>Thozalinone</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;text-align: left;"><div style="padding:0em 0.25em">
<ul><li><i>Phenethylamines:</i> 2-OH-PEA</li>
<li>4-CAB</li>
<li>4-FA</li>
<li>4-FMA</li>
<li>4-MA</li>
<li>4-MMA</li>
<li>Alfetamine</li>
<li>Amfecloral</li>
<li>Amfepentorex</li>
<li><a href="Amfepramone.htm" tppabs="https://ptable.com/wiki/compounds/A/Amfepramone" title="Amfepramone">Amfepramone</a></li>
<li><a href="Amphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphetamine" title="Amphetamine">Amphetamine</a> (<a href="Dextroamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextroamphetamine" title="Dextroamphetamine">Dextroamphetamine</a></li>
<li><a href="Levoamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Levoamphetamine" title="Levoamphetamine">Levoamphetamine</a>)</li>
<li>Amphetaminil</li>
<li><a href="Β-Methylphenethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/%CE%92-Methylphenethylamine" title="Β-Methylphenethylamine">β-Me-PEA</a></li>
<li>BDB</li>
<li>BOH</li>
<li><a href="Benzphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzphetamine" title="Benzphetamine">Benzphetamine</a></li>
<li>Buphedrone</li>
<li>Butylone</li>
<li><a href="Cathine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cathine" title="Cathine">Cathine</a></li>
<li><a href="Cathinone.htm" tppabs="https://ptable.com/wiki/compounds/A/Cathinone" title="Cathinone">Cathinone</a></li>
<li>Clobenzorex</li>
<li><a href="Clortermine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clortermine" title="Clortermine">Clortermine</a></li>
<li>D-Deprenyl</li>
<li><a href="Dimethoxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimethoxyamphetamine" title="Dimethoxyamphetamine">DMA</a></li>
<li>DMMA</li>
<li>Dimethylamphetamine</li>
<li><a href="Ephedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ephedrine" title="Ephedrine">Ephedrine</a></li>
<li>Ethcathinone</li>
<li>EBDB</li>
<li>Ethylone</li>
<li>Etilamfetamine</li>
<li>Famprofazone</li>
<li><a href="Fenethylline.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenethylline" title="Fenethylline">Fenethylline</a></li>
<li><a href="Fenproporex.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenproporex" title="Fenproporex">Fenproporex</a></li>
<li>Flephedrone</li>
<li>Fludorex</li>
<li>Furfenorex</li>
<li>Hordenine</li>
<li>4-Hydroxyamphetamine</li>
<li>Iofetamine (123I)</li>
<li>Lophophine</li>
<li>Mefenorex</li>
<li>Mephedrone</li>
<li>Metamfepramone</li>
<li><a href="Methamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamphetamine" title="Methamphetamine">Methamphetamine</a>
<ul><li>Dextromethamphetamine</li>
<li>Levomethamphetamine</li></ul></li>
<li>Methcathinone</li>
<li>Methedrone</li>
<li>MMDA</li>
<li>MMDMA</li>
<li>MBDB</li>
<li><a href="3,4-Methylenedioxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/3%2C4-Methylenedioxyamphetamine" title="3,4-Methylenedioxyamphetamine">MDA (tenamfetamine)</a></li>
<li>MDEA</li>
<li><a href="MDMA.htm" tppabs="https://ptable.com/wiki/compounds/A/MDMA" title="MDMA">MDMA (midomafetamine)</a></li>
<li>MDMPEA</li>
<li>MDOH</li>
<li>MDPEA</li>
<li>Methylone</li>
<li>Morforex</li>
<li>Ortetamine</li>
<li><i>p</i>BA</li>
<li><i>p</i>CA</li>
<li><i>p</i>IA</li>
<li><a href="Pholedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pholedrine" title="Pholedrine">Pholedrine</a></li>
<li><a href="Phenethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenethylamine" title="Phenethylamine">Phenethylamine</a></li>
<li><a href="Pholedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pholedrine" title="Pholedrine">Pholedrine</a></li>
<li>Phenpromethamine</li>
<li><a href="Prenylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Prenylamine" title="Prenylamine">Prenylamine</a></li>
<li>Propylamphetamine</li>
<li><a href="Pseudoephedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pseudoephedrine" title="Pseudoephedrine">Pseudoephedrine</a></li>
<li>Tiflorex</li>
<li><a href="Tyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyramine" title="Tyramine">Tyramine</a></li>
<li>Xylopropamine</li>
<li>Zylofuramine</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px;text-align: left;"><div style="padding:0em 0.25em">
<ul><li><i>Piperazines:</i> 2C-B-BZP</li>
<li><a href="Benzylpiperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzylpiperazine" title="Benzylpiperazine">BZP</a></li>
<li>MBZP</li>
<li>MDBZP</li>
<li>MeOPP</li>
<li>oMPP</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;text-align: left;"><div style="padding:0em 0.25em">
<ul><li><i>Others:</i> 2-ADN</li>
<li>2-AI</li>
<li><a href="2-Aminotetralin.htm" tppabs="https://ptable.com/wiki/compounds/A/2-Aminotetralin" title="2-Aminotetralin">2-AT</a></li>
<li><a href="4-Benzylpiperidine.htm" tppabs="https://ptable.com/wiki/compounds/A/4-Benzylpiperidine" title="4-Benzylpiperidine">4-BP</a></li>
<li>5-APDI</li>
<li>5-IAI</li>
<li><a href="Amineptine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amineptine" title="Amineptine">Amineptine</a></li>
<li>Clofenciclan</li>
<li>Cyclopentamine</li>
<li>Cypenamine</li>
<li>Cyprodenate</li>
<li>Feprosidnine</li>
<li>Gilutensin</li>
<li><a href="Heptaminol.htm" tppabs="https://ptable.com/wiki/compounds/A/Heptaminol" title="Heptaminol">Heptaminol</a></li>
<li>Hexacyclonate</li>
<li>Indanorex</li>
<li>Isometheptene</li>
<li>Methylhexanamine</li>
<li>Naphthylaminopropane</li>
<li><a href="Octodrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Octodrine" title="Octodrine">Octodrine</a></li>
<li>Phthalimidopropiophenone</li>
<li>Phenylbiguanide</li>
<li>Propylhexedrine
<ul><li>Levopropylhexedrine</li></ul></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>NRAs</abbr></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px;text-align: left;"><div style="padding:0em 0.25em">
<ul><li><i>Morpholines:</i> Fenbutrazate</li>
<li>Fenmetramide</li>
<li>Morazone</li>
<li>Morforex</li>
<li><a href="Phendimetrazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phendimetrazine" title="Phendimetrazine">Phendimetrazine</a></li>
<li><a href="Phenmetrazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenmetrazine" title="Phenmetrazine">Phenmetrazine</a></li>
<li>Pseudophenmetrazine</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;text-align: left;"><div style="padding:0em 0.25em">
<ul><li><i>Oxazolines:</i> <a href="4-Methylaminorex.htm" tppabs="https://ptable.com/wiki/compounds/A/4-Methylaminorex" title="4-Methylaminorex">4-MAR</a></li>
<li><a href="Aminorex.htm" tppabs="https://ptable.com/wiki/compounds/A/Aminorex" title="Aminorex">Aminorex</a></li>
<li>Clominorex</li>
<li>Cyclazodone</li>
<li>Fenozolone</li>
<li>Fluminorex</li>
<li><a href="Pemoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Pemoline" title="Pemoline">Pemoline</a></li>
<li>Thozalinone</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px;text-align: left;"><div style="padding:0em 0.25em">
<ul><li><i>Phenethylamines:</i> 2-OH-PEA</li>
<li>4-CAB</li>
<li>4-FA</li>
<li>4-FMA</li>
<li>4-MA</li>
<li>4-MMA</li>
<li>Alfetamine</li>
<li>Amfecloral</li>
<li>Amfepentorex</li>
<li><a href="Amfepramone.htm" tppabs="https://ptable.com/wiki/compounds/A/Amfepramone" title="Amfepramone">Amfepramone</a></li>
<li><a href="Amphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphetamine" title="Amphetamine">Amphetamine</a>
<ul><li><a href="Dextroamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextroamphetamine" title="Dextroamphetamine">Dextroamphetamine</a></li>
<li><a href="Levoamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Levoamphetamine" title="Levoamphetamine">Levoamphetamine</a></li></ul></li>
<li>Amphetaminil</li>
<li><a href="Β-Methylphenethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/%CE%92-Methylphenethylamine" title="Β-Methylphenethylamine">β-Me-PEA</a></li>
<li>BDB</li>
<li><a href="Benzphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzphetamine" title="Benzphetamine">Benzphetamine</a></li>
<li>BOH</li>
<li>Buphedrone</li>
<li>Butylone</li>
<li><a href="Cathine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cathine" title="Cathine">Cathine</a></li>
<li><a href="Cathinone.htm" tppabs="https://ptable.com/wiki/compounds/A/Cathinone" title="Cathinone">Cathinone</a></li>
<li>Clobenzorex</li>
<li><a href="Clortermine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clortermine" title="Clortermine">Clortermine</a></li>
<li>Dimethylamphetamine</li>
<li><a href="Dimethoxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimethoxyamphetamine" title="Dimethoxyamphetamine">DMA</a></li>
<li>DMMA</li>
<li>EBDB</li>
<li><a href="Ephedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ephedrine" title="Ephedrine">Ephedrine</a></li>
<li>Ethcathinone</li>
<li>Ethylone</li>
<li>Etilamfetamine</li>
<li>Famprofazone</li>
<li><a href="Fenethylline.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenethylline" title="Fenethylline">Fenethylline</a></li>
<li><a href="Fenproporex.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenproporex" title="Fenproporex">Fenproporex</a></li>
<li>Flephedrone</li>
<li>Fludorex</li>
<li>Furfenorex</li>
<li>Hordenine</li>
<li>4-Hydroxyamphetamine</li>
<li>5-APDI (IAP)</li>
<li>Iofetamine (123I)</li>
<li><a href="Lisdexamfetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lisdexamfetamine" title="Lisdexamfetamine">Lisdexamfetamine</a></li>
<li>Lophophine</li>
<li>MBDB</li>
<li><a href="3,4-Methylenedioxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/3%2C4-Methylenedioxyamphetamine" title="3,4-Methylenedioxyamphetamine">MDA (tenamfetamine)</a></li>
<li>MDEA</li>
<li><a href="MDMA.htm" tppabs="https://ptable.com/wiki/compounds/A/MDMA" title="MDMA">MDMA (midomafetamine)</a></li>
<li>Metamfepramone</li>
<li>MDMPEA</li>
<li>MDOH</li>
<li>MDPEA</li>
<li>Mefenorex</li>
<li>Mephedrone</li>
<li><a href="Mephentermine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mephentermine" title="Mephentermine">Mephentermine</a></li>
<li><a href="Methamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamphetamine" title="Methamphetamine">Methamphetamine</a>
<ul><li>Dextromethamphetamine</li>
<li>Levomethamphetamine</li></ul></li>
<li>Methcathinone</li>
<li>Methedrone</li>
<li>Methylone</li>
<li>Morforex</li>
<li>Naphthylaminopropane</li>
<li>Ortetamine</li>
<li><i>p</i>BA</li>
<li><i>p</i>CA</li>
<li>Pentorex</li>
<li><a href="Phenethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenethylamine" title="Phenethylamine">Phenethylamine</a></li>
<li><a href="Pholedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pholedrine" title="Pholedrine">Pholedrine</a></li>
<li>Phenpromethamine</li>
<li><a href="Phentermine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phentermine" title="Phentermine">Phentermine</a></li>
<li><a href="Phenylpropanolamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenylpropanolamine" title="Phenylpropanolamine">Phenylpropanolamine</a></li>
<li><i>p</i>IA</li>
<li><a href="Prenylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Prenylamine" title="Prenylamine">Prenylamine</a></li>
<li>Propylamphetamine</li>
<li><a href="Pseudoephedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pseudoephedrine" title="Pseudoephedrine">Pseudoephedrine</a></li>
<li><a href="Selegiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Selegiline" title="Selegiline">Selegiline</a> (also <span style="font-size:85%;">D</span>-Deprenyl)</li>
<li>Tiflorex</li>
<li><a href="Tyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyramine" title="Tyramine">Tyramine</a></li>
<li>Xylopropamine</li>
<li>Zylofuramine</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;text-align: left;"><div style="padding:0em 0.25em">
<ul><li><i>Piperazines:</i> 2C-B-BZP</li>
<li><a href="Benzylpiperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzylpiperazine" title="Benzylpiperazine">BZP</a></li>
<li>MBZP</li>
<li><a href="Meta-Chlorophenylpiperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Meta-Chlorophenylpiperazine" title="Meta-Chlorophenylpiperazine">mCPP</a></li>
<li>MDBZP</li>
<li>MeOPP</li>
<li>oMPP</li>
<li>pFPP</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px;text-align: left;"><div style="padding:0em 0.25em">
<ul><li><i>Others:</i> 2-ADN</li>
<li>2-AI</li>
<li><a href="2-Aminotetralin.htm" tppabs="https://ptable.com/wiki/compounds/A/2-Aminotetralin" title="2-Aminotetralin">2-AT</a></li>
<li>2-BP</li>
<li><a href="4-Benzylpiperidine.htm" tppabs="https://ptable.com/wiki/compounds/A/4-Benzylpiperidine" title="4-Benzylpiperidine">4-BP</a></li>
<li>5-IAI</li>
<li>Clofenciclan</li>
<li>Cyclopentamine</li>
<li>Cypenamine</li>
<li>Cyprodenate</li>
<li>Feprosidnine</li>
<li>Gilutensin</li>
<li><a href="Heptaminol.htm" tppabs="https://ptable.com/wiki/compounds/A/Heptaminol" title="Heptaminol">Heptaminol</a></li>
<li>Hexacyclonate</li>
<li>Indanorex</li>
<li>Isometheptene</li>
<li>Methylhexanamine</li>
<li><a href="Octodrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Octodrine" title="Octodrine">Octodrine</a></li>
<li>Phthalimidopropiophenone</li>
<li>Propylhexedrine (Levopropylhexedrine)</li>
<li><a href="Tuaminoheptane.htm" tppabs="https://ptable.com/wiki/compounds/A/Tuaminoheptane" title="Tuaminoheptane">Tuaminoheptane</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>SRAs</abbr></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Aminoindanes:</i> 5-IAI</li>
<li>AMMI</li>
<li>ETAI</li>
<li>MDAI</li>
<li>MDMAI</li>
<li>MMAI</li>
<li>TAI</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Aminotetralins:</i> 6-CAT</li>
<li>8-OH-DPAT</li>
<li>MDAT</li>
<li>MDMAT</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Oxazolines:</i> <a href="4-Methylaminorex.htm" tppabs="https://ptable.com/wiki/compounds/A/4-Methylaminorex" title="4-Methylaminorex">4-Methylaminorex</a></li>
<li><a href="Aminorex.htm" tppabs="https://ptable.com/wiki/compounds/A/Aminorex" title="Aminorex">Aminorex</a></li>
<li>Clominorex</li>
<li>Fluminorex</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Phenethylamines:</i> 2-Methyl-MDA</li>
<li>4-CAB</li>
<li>4-FA</li>
<li>4-FMA</li>
<li>4-HA</li>
<li>4-MTA</li>
<li>5-APDB</li>
<li>5-Methyl-MDA</li>
<li>6-APDB</li>
<li>6-Methyl-MDA</li>
<li>AEMMA</li>
<li>Amiflamine</li>
<li>BDB</li>
<li>BOH</li>
<li>Brephedrone</li>
<li>Butylone</li>
<li><a href="Chlorphentermine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorphentermine" title="Chlorphentermine">Chlorphentermine</a></li>
<li>Cloforex</li>
<li><a href="Amfepramone.htm" tppabs="https://ptable.com/wiki/compounds/A/Amfepramone" title="Amfepramone">Amfepramone</a></li>
<li>Metamfepramone</li>
<li>DCA</li>
<li><a href="Dexfenfluramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dexfenfluramine" title="Dexfenfluramine">Dexfenfluramine</a></li>
<li>DFMDA</li>
<li><a href="Dimethoxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimethoxyamphetamine" title="Dimethoxyamphetamine">DMA</a></li>
<li>DMMA</li>
<li>EBDB</li>
<li>EDMA</li>
<li>Ethylone</li>
<li>Etolorex</li>
<li><a href="Fenfluramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenfluramine" title="Fenfluramine">Fenfluramine</a></li>
<li>Flephedrone</li>
<li>Flucetorex</li>
<li>IAP</li>
<li>Iofetamine</li>
<li>Levofenfluramine</li>
<li>Lophophine</li>
<li>MBDB</li>
<li><a href="3,4-Methylenedioxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/3%2C4-Methylenedioxyamphetamine" title="3,4-Methylenedioxyamphetamine">MDA (tenamfetamine)</a></li>
<li>MDEA</li>
<li>MDHMA</li>
<li><a href="MDMA.htm" tppabs="https://ptable.com/wiki/compounds/A/MDMA" title="MDMA">MDMA (midomafetamine)</a></li>
<li>MDMPEA</li>
<li>MDOH</li>
<li>MDPEA</li>
<li>Mephedrone</li>
<li>Methedrone</li>
<li>Methylone</li>
<li>MMA</li>
<li>MMDA</li>
<li>MMDMA</li>
<li>MMMA</li>
<li>NAP</li>
<li>Norfenfluramine</li>
<li>4-TFMA</li>
<li>pBA</li>
<li>pCA</li>
<li>pIA</li>
<li><a href="Para-Methoxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Para-Methoxyamphetamine" title="Para-Methoxyamphetamine">PMA</a></li>
<li>PMEA</li>
<li>PMMA</li>
<li>TAP</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Piperazines:</i> 2C-B-BZP</li>
<li><span class="new">3-MeOPP</span></li>
<li><a href="Benzylpiperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzylpiperazine" title="Benzylpiperazine">BZP</a></li>
<li><span class="new">DCPP</span></li>
<li>MBZP</li>
<li><a href="Meta-Chlorophenylpiperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Meta-Chlorophenylpiperazine" title="Meta-Chlorophenylpiperazine">mCPP</a></li>
<li>MDBZP</li>
<li>MeOPP</li>
<li>Mepiprazole</li>
<li>oMPP</li>
<li><a href="Para-Chlorophenylpiperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Para-Chlorophenylpiperazine" title="Para-Chlorophenylpiperazine">pCPP</a></li>
<li>pFPP</li>
<li>pTFMPP</li>
<li>TFMPP</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Tryptamines:</i> 4-Methyl-αET</li>
<li>4-Methyl-αMT</li>
<li>5-CT</li>
<li>5-MeO-αET</li>
<li>5-MeO-αMT</li>
<li><a href="5-Methoxytryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/5-Methoxytryptamine" title="5-Methoxytryptamine">5-MT</a></li>
<li><a href="Alpha-Ethyltryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Alpha-Ethyltryptamine" title="Alpha-Ethyltryptamine">αET</a></li>
<li><a href="Alpha-Methyltryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Alpha-Methyltryptamine" title="Alpha-Methyltryptamine">αMT</a></li>
<li><a href="Dimethyltryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimethyltryptamine" title="Dimethyltryptamine" class="mw-redirect">DMT</a></li>
<li><a href="Tryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tryptamine" title="Tryptamine">Tryptamine</a></li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Others:</i> Indeloxazine</li>
<li>Viqualine</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Others</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Monoamine activity enhancers:</i> BPAP</li>
<li>PPAP</li></ul>

<ul><li><i>DAT modulators:</i> <i>Agonist-like:</i> SoRI-9804</li>
<li><span class="new">SoRI-20040</span>; <i>Antagonist-like:</i> SoRI-20041</li></ul>

<ul><li><i>Adrenergic release blockers:</i> <a href="Bethanidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Bethanidine" title="Bethanidine">Bethanidine</a></li>
<li><a href="Bretylium.htm" tppabs="https://ptable.com/wiki/compounds/A/Bretylium" title="Bretylium">Bretylium</a></li>
<li><a href="Guanadrel.htm" tppabs="https://ptable.com/wiki/compounds/A/Guanadrel" title="Guanadrel">Guanadrel</a></li>
<li>Guanazodine</li>
<li><a href="Guanethidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Guanethidine" title="Guanethidine">Guanethidine</a></li>
<li>Guanoxan</li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div><small><i><b>See also:</b> Receptor/signaling modulators • Monoamine reuptake inhibitors • Adrenergics • Dopaminergics • Serotonergics • Monoamine metabolism modulators • Monoamine neurotoxins</i></small></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Serotonin_receptor_modulators" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Serotonin_receptor_modulators" style="font-size:114%;margin:0 4em">Serotonin receptor modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">5-HT<sub>1</sub></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">5-HT<sub>1A</sub></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> 8-OH-DPAT</li>
<li>Adatanserin</li>
<li><a href="Amphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphetamine" title="Amphetamine">Amphetamine</a></li>
<li>Antidepressants (e.g., etoperidone, hydroxynefazodone, <a href="Nefazodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Nefazodone" title="Nefazodone">nefazodone</a>, <a href="Trazodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Trazodone" title="Trazodone">trazodone</a>, triazoledione, vilazodone, vortioxetine)</li>
<li>Atypical antipsychotics (e.g., <a href="Aripiprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Aripiprazole" title="Aripiprazole">aripiprazole</a>, asenapine, brexpiprazole, cariprazine, <a href="Clozapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clozapine" title="Clozapine">clozapine</a>, lurasidone, <a href="Quetiapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Quetiapine" title="Quetiapine">quetiapine</a>, <a href="Ziprasidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Ziprasidone" title="Ziprasidone">ziprasidone</a>)</li>
<li>Azapirones (e.g., <a href="Buspirone.htm" tppabs="https://ptable.com/wiki/compounds/A/Buspirone" title="Buspirone">buspirone</a>, eptapirone, gepirone, perospirone, tandospirone)</li>
<li>Bay R 1531</li>
<li>Befiradol</li>
<li>BMY-14802</li>
<li><a href="Cannabidiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Cannabidiol" title="Cannabidiol">Cannabidiol</a></li>
<li>Dimemebfe</li>
<li><a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">Dopamine</a></li>
<li>Ebalzotan</li>
<li>Eltoprazine</li>
<li>Enciprazine</li>
<li>Ergolines (e.g., <a href="Bromocriptine.htm" tppabs="https://ptable.com/wiki/compounds/A/Bromocriptine" title="Bromocriptine">bromocriptine</a>, <a href="Cabergoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Cabergoline" title="Cabergoline">cabergoline</a>, <a href="Dihydroergotamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydroergotamine" title="Dihydroergotamine">dihydroergotamine</a>, <a href="Ergotamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ergotamine" title="Ergotamine">ergotamine</a>, <a href="Lisuride.htm" tppabs="https://ptable.com/wiki/compounds/A/Lisuride" title="Lisuride">lisuride</a>, <a href="Lysergic_acid_diethylamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Lysergic_acid_diethylamide" title="Lysergic acid diethylamide">LSD</a>, <a href="Methylergometrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylergometrine" title="Methylergometrine">methylergometrine (methylergonovine)</a>, <a href="Methysergide.htm" tppabs="https://ptable.com/wiki/compounds/A/Methysergide" title="Methysergide">methysergide</a>, <a href="Pergolide.htm" tppabs="https://ptable.com/wiki/compounds/A/Pergolide" title="Pergolide">pergolide</a>)</li>
<li><span class="new">F-11461</span></li>
<li><span class="new">F-12826</span></li>
<li><span class="new">F-13714</span></li>
<li><span class="new">F-14679</span></li>
<li>F-15063</li>
<li>F-15,599</li>
<li>Flesinoxan</li>
<li>Flibanserin</li>
<li>Flumexadol</li>
<li>Lesopitron</li>
<li>LY-293284</li>
<li><span class="new">LY-301317</span></li>
<li><a href="Meta-Chlorophenylpiperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Meta-Chlorophenylpiperazine" title="Meta-Chlorophenylpiperazine">mCPP</a></li>
<li>MKC-242</li>
<li>Naluzotan</li>
<li>NBUMP</li>
<li>Osemozotan</li>
<li>Oxaflozane</li>
<li>Pardoprunox</li>
<li>Piclozotan</li>
<li>Rauwolscine</li>
<li>Repinotan</li>
<li>Roxindole</li>
<li>RU-24,969</li>
<li><span class="new">S-14506</span></li>
<li>S-14671</li>
<li>S-15535</li>
<li>Sarizotan</li>
<li><a href="Serotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Serotonin" title="Serotonin">Serotonin (5-HT)</a></li>
<li><span class="new">SSR-181507</span></li>
<li>Sunepitron</li>
<li>Tryptamines (e.g., 5-CT, <a href="5-MeO-DMT.htm" tppabs="https://ptable.com/wiki/compounds/A/5-MeO-DMT" title="5-MeO-DMT">5-MeO-DMT</a>, <a href="5-Methoxytryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/5-Methoxytryptamine" title="5-Methoxytryptamine">5-MT</a>, <a href="Bufotenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Bufotenin" title="Bufotenin">bufotenin</a>, DMT, indorenate, N-Me-5-HT, <a href="Psilocin.htm" tppabs="https://ptable.com/wiki/compounds/A/Psilocin" title="Psilocin">psilocin</a>, psilocybin)</li>
<li>TGBA01AD</li>
<li>U-92,016-A</li>
<li>Urapidil</li>
<li>Vilazodone</li>
<li>Xaliproden</li>
<li><a href="Yohimbine.htm" tppabs="https://ptable.com/wiki/compounds/A/Yohimbine" title="Yohimbine">Yohimbine</a></li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Antagonists:</i> Atypical antipsychotics (e.g., iloperidone, <a href="Risperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Risperidone" title="Risperidone">risperidone</a>, <a href="Sertindole.htm" tppabs="https://ptable.com/wiki/compounds/A/Sertindole" title="Sertindole">sertindole</a>)</li>
<li><span class="new">AV965</span></li>
<li>Beta blockers (e.g., <a href="Alprenolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Alprenolol" title="Alprenolol">alprenolol</a>, <a href="Carteolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Carteolol" title="Carteolol">carteolol</a>, cyanopindolol, iodocyanopindolol, isamoltane, <a href="Oxprenolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxprenolol" title="Oxprenolol">oxprenolol</a>, <a href="Penbutolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Penbutolol" title="Penbutolol">penbutolol</a>, pindobind, <a href="Pindolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Pindolol" title="Pindolol">pindolol</a>, <a href="Propranolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Propranolol" title="Propranolol">propranolol</a>, tertatolol)</li>
<li>BMY-7,378</li>
<li>CSP-2503</li>
<li>Dotarizine</li>
<li>Ergolines (e.g., <a href="Metergoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Metergoline" title="Metergoline">metergoline</a>)</li>
<li><span class="new">FCE-24379</span></li>
<li>Flopropione</li>
<li><span class="new">GR-46611</span></li>
<li>Isamoltane</li>
<li>Lecozotan</li>
<li>Mefway</li>
<li>Metitepine (methiothepin)</li>
<li>MIN-117 (WF-516)</li>
<li>MPPF</li>
<li>NAN-190</li>
<li>Robalzotan</li>
<li>S-15535</li>
<li>SB-649,915</li>
<li><span class="new">SDZ 216-525</span></li>
<li><a href="Spiperone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spiperone" title="Spiperone">Spiperone</a></li>
<li>Spiramide</li>
<li>Spiroxatrine</li>
<li>UH-301</li>
<li>WAY-100135</li>
<li>WAY-100635</li>
<li>Xylamidine</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Unknown/unsorted:</i> Acetryptine</li>
<li>Ergolines (e.g., <a href="Ergometrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ergometrine" title="Ergometrine">ergometrine (ergonovine)</a>)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">5-HT<sub>1B</sub></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> CGS-12066A</li>
<li>CP-93129</li>
<li>CP-94253</li>
<li>CP-122,288</li>
<li>CP-135807</li>
<li>Eltoprazine</li>
<li>Ergolines (e.g., <a href="Bromocriptine.htm" tppabs="https://ptable.com/wiki/compounds/A/Bromocriptine" title="Bromocriptine">bromocriptine</a>, <a href="Dihydroergotamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydroergotamine" title="Dihydroergotamine">dihydroergotamine</a>, <a href="Ergotamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ergotamine" title="Ergotamine">ergotamine</a>, <a href="Methylergometrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylergometrine" title="Methylergometrine">methylergometrine (methylergonovine)</a>, <a href="Methysergide.htm" tppabs="https://ptable.com/wiki/compounds/A/Methysergide" title="Methysergide">methysergide</a>, <a href="Pergolide.htm" tppabs="https://ptable.com/wiki/compounds/A/Pergolide" title="Pergolide">pergolide</a>)</li>
<li><a href="Meta-Chlorophenylpiperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Meta-Chlorophenylpiperazine" title="Meta-Chlorophenylpiperazine">mCPP</a></li>
<li>RU-24,969</li>
<li><a href="Serotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Serotonin" title="Serotonin">Serotonin (5-HT)</a></li>
<li><a href="Triptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Triptan" title="Triptan">Triptans</a> (e.g., avitriptan, donitriptan, <a href="Eletriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Eletriptan" title="Eletriptan">eletriptan</a>, <a href="Sumatriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Sumatriptan" title="Sumatriptan">sumatriptan</a>, <a href="Zolmitriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Zolmitriptan" title="Zolmitriptan">zolmitriptan</a>)</li>
<li>TFMPP</li>
<li>Tryptamines (e.g., 5-BT, 5-CT, <a href="5-Methoxytryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/5-Methoxytryptamine" title="5-Methoxytryptamine">5-MT</a>, DMT)</li>
<li>Vortioxetine</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Antagonists:</i> AR-A000002</li>
<li>Beta blockers (e.g., <a href="Alprenolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Alprenolol" title="Alprenolol">alprenolol</a>, <a href="Carteolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Carteolol" title="Carteolol">carteolol</a>, isamoltane, <a href="Oxprenolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxprenolol" title="Oxprenolol">oxprenolol</a>, <a href="Penbutolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Penbutolol" title="Penbutolol">penbutolol</a>, <a href="Propranolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Propranolol" title="Propranolol">propranolol</a>, tertatolol)</li>
<li>Elzasonan</li>
<li>Ergolines (e.g., <a href="Metergoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Metergoline" title="Metergoline">metergoline</a>)</li>
<li>GR-127935</li>
<li>Isamoltane</li>
<li><span class="new">LY-393558</span></li>
<li>Metitepine (methiothepin)</li>
<li>SB-216641</li>
<li><span class="new">SB-224289</span></li>
<li>SB-236057</li>
<li><a href="Yohimbine.htm" tppabs="https://ptable.com/wiki/compounds/A/Yohimbine" title="Yohimbine">Yohimbine</a></li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Unknown/unsorted:</i> Ergolines (e.g., <a href="Cabergoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Cabergoline" title="Cabergoline">cabergoline</a>, <a href="Ergometrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ergometrine" title="Ergometrine">ergometrine (ergonovine)</a>, <a href="Lisuride.htm" tppabs="https://ptable.com/wiki/compounds/A/Lisuride" title="Lisuride">lisuride</a>)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">5-HT<sub>1D</sub></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> CP-122,288</li>
<li>CP-135807</li>
<li><span class="new">CP-286601</span></li>
<li>Ergolines (e.g., <a href="Bromocriptine.htm" tppabs="https://ptable.com/wiki/compounds/A/Bromocriptine" title="Bromocriptine">bromocriptine</a>, <a href="Cabergoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Cabergoline" title="Cabergoline">cabergoline</a>, <a href="Dihydroergotamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydroergotamine" title="Dihydroergotamine">dihydroergotamine</a>, <a href="Ergotamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ergotamine" title="Ergotamine">ergotamine</a>, <a href="Lysergic_acid_diethylamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Lysergic_acid_diethylamide" title="Lysergic acid diethylamide">LSD</a>, <a href="Methysergide.htm" tppabs="https://ptable.com/wiki/compounds/A/Methysergide" title="Methysergide">methysergide</a>)</li>
<li><span class="new">GR-46611</span></li>
<li>L-694247</li>
<li><span class="new">L-772405</span></li>
<li><a href="Meta-Chlorophenylpiperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Meta-Chlorophenylpiperazine" title="Meta-Chlorophenylpiperazine">mCPP</a></li>
<li><span class="new">PNU-109291</span></li>
<li>PNU-142633</li>
<li><a href="Serotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Serotonin" title="Serotonin">Serotonin (5-HT)</a></li>
<li>TGBA01AD</li>
<li><a href="Triptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Triptan" title="Triptan">Triptans</a> (e.g., <a href="Almotriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Almotriptan" title="Almotriptan">almotriptan</a>, avitriptan, donitriptan, <a href="Eletriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Eletriptan" title="Eletriptan">eletriptan</a>, <a href="Frovatriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Frovatriptan" title="Frovatriptan">frovatriptan</a>, <a href="Naratriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Naratriptan" title="Naratriptan">naratriptan</a>, <a href="Rizatriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Rizatriptan" title="Rizatriptan">rizatriptan</a>, <a href="Sumatriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Sumatriptan" title="Sumatriptan">sumatriptan</a>, <a href="Zolmitriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Zolmitriptan" title="Zolmitriptan">zolmitriptan</a>)</li>
<li>Tryptamines (e.g., 5-BT, 5-CT, 5-Et-DMT, <a href="5-Methoxytryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/5-Methoxytryptamine" title="5-Methoxytryptamine">5-MT</a>, 5-(nonyloxy)tryptamine, DMT)</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Antagonists:</i> Alniditan</li>
<li>BRL-15,572</li>
<li>Elzasonan</li>
<li>Ergolines (e.g., <a href="Metergoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Metergoline" title="Metergoline">metergoline</a>)</li>
<li>GR-127935</li>
<li><a href="Ketanserin.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketanserin" title="Ketanserin">Ketanserin</a></li>
<li>LY-310762</li>
<li><span class="new">LY-367642</span></li>
<li><span class="new">LY-393558</span></li>
<li><span class="new">LY-456219</span></li>
<li><span class="new">LY-456220</span></li>
<li>Metitepine (methiothepin)</li>
<li><a href="Mianserin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mianserin" title="Mianserin">Mianserin</a></li>
<li>Ritanserin</li>
<li><a href="Yohimbine.htm" tppabs="https://ptable.com/wiki/compounds/A/Yohimbine" title="Yohimbine">Yohimbine</a></li>
<li><a href="Ziprasidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Ziprasidone" title="Ziprasidone">Ziprasidone</a></li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Unknown/unsorted:</i> Acetryptine</li>
<li>Ergolines (e.g., <a href="Lisuride.htm" tppabs="https://ptable.com/wiki/compounds/A/Lisuride" title="Lisuride">lisuride</a>, <a href="Lysergol.htm" tppabs="https://ptable.com/wiki/compounds/A/Lysergol" title="Lysergol">lysergol</a>, <a href="Pergolide.htm" tppabs="https://ptable.com/wiki/compounds/A/Pergolide" title="Pergolide">pergolide</a>)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">5-HT<sub>1E</sub></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> BRL-54443</li>
<li>Ergolines (e.g., <a href="Methysergide.htm" tppabs="https://ptable.com/wiki/compounds/A/Methysergide" title="Methysergide">methysergide</a>)</li>
<li><a href="Serotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Serotonin" title="Serotonin">Serotonin (5-HT)</a></li>
<li><a href="Triptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Triptan" title="Triptan">Triptans</a> (e.g., <a href="Eletriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Eletriptan" title="Eletriptan">eletriptan</a>)</li>
<li>Tryptamines (e.g., <a href="Tryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tryptamine" title="Tryptamine">tryptamine</a>)</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Antagonists:</i> Metitepine (methiothepin)</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Unknown/unsorted:</i> Ergolines (e.g., <a href="Ergometrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ergometrine" title="Ergometrine">ergometrine (ergonovine)</a>, <a href="Lysergol.htm" tppabs="https://ptable.com/wiki/compounds/A/Lysergol" title="Lysergol">lysergol</a>, <a href="Methylergometrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylergometrine" title="Methylergometrine">methylergometrine (methylergonovine)</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">5-HT<sub>1F</sub></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> BRL-54443</li>
<li>CP-122,288</li>
<li>Ergolines (e.g., <a href="Bromocriptine.htm" tppabs="https://ptable.com/wiki/compounds/A/Bromocriptine" title="Bromocriptine">bromocriptine</a>, <a href="Lysergol.htm" tppabs="https://ptable.com/wiki/compounds/A/Lysergol" title="Lysergol">lysergol</a>, <a href="Methylergometrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylergometrine" title="Methylergometrine">methylergometrine (methylergonovine)</a> <a href="Methysergide.htm" tppabs="https://ptable.com/wiki/compounds/A/Methysergide" title="Methysergide">methysergide</a>)</li>
<li>Lasmiditan</li>
<li>LY-334370</li>
<li><a href="Serotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Serotonin" title="Serotonin">Serotonin (5-HT)</a></li>
<li><a href="Triptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Triptan" title="Triptan">Triptans</a> (e.g., <a href="Eletriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Eletriptan" title="Eletriptan">eletriptan</a>, <a href="Naratriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Naratriptan" title="Naratriptan">naratriptan</a>, <a href="Sumatriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Sumatriptan" title="Sumatriptan">sumatriptan</a>)</li>
<li>Tryptamines (e.g., <a href="5-Methoxytryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/5-Methoxytryptamine" title="5-Methoxytryptamine">5-MT</a>)</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Antagonists:</i> <a href="Mianserin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mianserin" title="Mianserin">Mianserin</a></li>
<li>Metitepine (methiothepin)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">5-HT<sub>2</sub></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">5-HT<sub>2A</sub></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> 25H/NB series (e.g., 25I-NBF, 25I-NBMD, 25I-NBOH, 25I-NBOMe, 25B-NBOMe, 25C-NBOMe, 25TFM-NBOMe, 2CBCB-NBOMe, 25CN-NBOH, 2CBFly-NBOMe)</li>
<li>2Cs (e.g., <a href="2C-B.htm" tppabs="https://ptable.com/wiki/compounds/A/2C-B" title="2C-B">2C-B</a>, 2C-E, 2C-I, 2C-T-2, 2C-T-7, 2C-T-21)</li>
<li>2C-B-FLY</li>
<li>2CB-Ind</li>
<li><a href="5-Methoxytryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/5-Methoxytryptamine" title="5-Methoxytryptamine">5-Methoxytryptamines</a> (5-MeO-DET, 5-MeO-DiPT, <a href="5-MeO-DMT.htm" tppabs="https://ptable.com/wiki/compounds/A/5-MeO-DMT" title="5-MeO-DMT">5-MeO-DMT</a>, 5-MeO-DPT, <a href="5-Methoxytryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/5-Methoxytryptamine" title="5-Methoxytryptamine">5-MT</a>)</li>
<li>α-Alkyltryptamines (e.g., 5-Cl-αMT, 5-Fl-αMT, 5-MeO-αET, 5-MeO-αMT, α-Me-5-HT, <a href="Alpha-Ethyltryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Alpha-Ethyltryptamine" title="Alpha-Ethyltryptamine">αET</a>, <a href="Alpha-Methyltryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Alpha-Methyltryptamine" title="Alpha-Methyltryptamine">αMT</a>)</li>
<li>AL-34662</li>
<li>AL-37350A</li>
<li>Bromo-DragonFLY</li>
<li>Dimemebfe</li>
<li>DMBMPP</li>
<li>DOx (e.g., DOB, DOC, DOI, <a href="2,5-Dimethoxy-4-methylamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/2%2C5-Dimethoxy-4-methylamphetamine" title="2,5-Dimethoxy-4-methylamphetamine">DOM</a>)</li>
<li><a href="Efavirenz.htm" tppabs="https://ptable.com/wiki/compounds/A/Efavirenz" title="Efavirenz">Efavirenz</a></li>
<li>Ergolines (e.g., 1P-LSD, ALD-52, <a href="Bromocriptine.htm" tppabs="https://ptable.com/wiki/compounds/A/Bromocriptine" title="Bromocriptine">bromocriptine</a>, <a href="Cabergoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Cabergoline" title="Cabergoline">cabergoline</a>, ergine (LSA), <a href="Ergometrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ergometrine" title="Ergometrine">ergometrine (ergonovine)</a>, <a href="Ergotamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ergotamine" title="Ergotamine">ergotamine</a>, <a href="Lisuride.htm" tppabs="https://ptable.com/wiki/compounds/A/Lisuride" title="Lisuride">lisuride</a>, LA-SS-Az, LSB, <a href="Lysergic_acid_diethylamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Lysergic_acid_diethylamide" title="Lysergic acid diethylamide">LSD</a>, LSD-Pip, LSH, LSP, <a href="Methylergometrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylergometrine" title="Methylergometrine">methylergometrine (methylergonovine)</a>, <a href="Pergolide.htm" tppabs="https://ptable.com/wiki/compounds/A/Pergolide" title="Pergolide">pergolide</a>)</li>
<li>Flumexadol</li>
<li>Jimscaline</li>
<li>Lorcaserin</li>
<li>MDxx (e.g., <a href="3,4-Methylenedioxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/3%2C4-Methylenedioxyamphetamine" title="3,4-Methylenedioxyamphetamine">MDA (tenamfetamine)</a>, <a href="MDMA.htm" tppabs="https://ptable.com/wiki/compounds/A/MDMA" title="MDMA">MDMA (midomafetamine)</a>, MDOH, MMDA)</li>
<li>O-4310</li>
<li>Oxaflozane</li>
<li>PHA-57378</li>
<li>PNU-22394</li>
<li>PNU-181731</li>
<li>RH-34</li>
<li>Phenethylamines (e.g., lophophine, mescaline)</li>
<li><a href="Piperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Piperazine" title="Piperazine">Piperazines</a> (e.g., <a href="Benzylpiperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzylpiperazine" title="Benzylpiperazine">BZP</a>, quipazine, TFMPP)</li>
<li><a href="Serotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Serotonin" title="Serotonin">Serotonin (5-HT)</a></li>
<li>TCB-2</li>
<li>TFMFly</li>
<li>Tryptamines (e.g., 5-BT, 5-CT, <a href="Bufotenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Bufotenin" title="Bufotenin">bufotenin</a>, <a href="Diethyltryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Diethyltryptamine" title="Diethyltryptamine">DET</a>, DiPT, DMT, DPT, <a href="Psilocin.htm" tppabs="https://ptable.com/wiki/compounds/A/Psilocin" title="Psilocin">psilocin</a>, psilocybin, <a href="Tryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tryptamine" title="Tryptamine">tryptamine</a>)</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Antagonists:</i> 5-I-R91150</li>
<li>5-MeO-NBpBrT</li>
<li><span class="new">AC-90179</span></li>
<li>Adatanserin</li>
<li>Altanserin</li>
<li>Antihistamines (e.g., <a href="Cyproheptadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyproheptadine" title="Cyproheptadine">cyproheptadine</a>, <a href="Hydroxyzine.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydroxyzine" title="Hydroxyzine">hydroxyzine</a>, <a href="Ketotifen.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketotifen" title="Ketotifen">ketotifen</a>, perlapine)</li>
<li>AMDA</li>
<li>Atypical antipsychotics (e.g., amperozide, <a href="Aripiprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Aripiprazole" title="Aripiprazole">aripiprazole</a>, asenapine, blonanserin, brexpiprazole, carpipramine, clocapramine, clorotepine, <a href="Clozapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clozapine" title="Clozapine">clozapine</a>, fluperlapine, gevotroline, iloperidone, lurasidone, melperone, mosapramine, ocaperidone, <a href="Olanzapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Olanzapine" title="Olanzapine">olanzapine</a>, <a href="Paliperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Paliperidone" title="Paliperidone">paliperidone</a>, <a href="Quetiapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Quetiapine" title="Quetiapine">quetiapine</a>, <a href="Risperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Risperidone" title="Risperidone">risperidone</a>, <a href="Sertindole.htm" tppabs="https://ptable.com/wiki/compounds/A/Sertindole" title="Sertindole">sertindole</a>, zicronapine, <a href="Ziprasidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Ziprasidone" title="Ziprasidone">ziprasidone</a>, zotepine)</li>
<li>Cinanserin</li>
<li>CSP-2503</li>
<li>Deramciclane</li>
<li>Dotarizine</li>
<li>Eplivanserin</li>
<li>Ergolines (e.g., amesergide, <span class="new">LY-53857</span>, LY-215,840, mesulergine, <a href="Metergoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Metergoline" title="Metergoline">metergoline</a>, <a href="Methysergide.htm" tppabs="https://ptable.com/wiki/compounds/A/Methysergide" title="Methysergide">methysergide</a>, sergolexole)</li>
<li>Fananserin</li>
<li>Flibanserin</li>
<li>Glemanserin</li>
<li><span class="new">Irindalone</span></li>
<li><a href="Ketanserin.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketanserin" title="Ketanserin">Ketanserin</a></li>
<li>KML-010</li>
<li><span class="new">Landipirdine</span></li>
<li><span class="new">LY-393558</span></li>
<li><a href="Meta-Chlorophenylpiperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Meta-Chlorophenylpiperazine" title="Meta-Chlorophenylpiperazine">mCPP</a></li>
<li>Medifoxamine</li>
<li>Metitepine (methiothepin)</li>
<li>MIN-117 (WF-516)</li>
<li>Naftidrofuryl</li>
<li>Nantenine</li>
<li>Nelotanserin</li>
<li>Opiranserin (VVZ-149)</li>
<li>Pelanserin</li>
<li><a href="Phenoxybenzamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenoxybenzamine" title="Phenoxybenzamine">Phenoxybenzamine</a></li>
<li>Pimavanserin</li>
<li>Pirenperone</li>
<li>Pizotifen</li>
<li>Pruvanserin</li>
<li>Rauwolscine</li>
<li>Ritanserin</li>
<li>Roluperidone</li>
<li>S-14671</li>
<li>Sarpogrelate</li>
<li>Serotonin antagonists and reuptake inhibitors (e.g., etoperidone, hydroxynefazodone, lubazodone, mepiprazole, <a href="Nefazodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Nefazodone" title="Nefazodone">nefazodone</a>, triazoledione, <a href="Trazodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Trazodone" title="Trazodone">trazodone</a>)</li>
<li><span class="new">SR-46349B</span></li>
<li>TGBA01AD</li>
<li>Teniloxazine</li>
<li><span class="new">Temanogrel</span></li>
<li>Tetracyclic antidepressants (e.g., <a href="Amoxapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amoxapine" title="Amoxapine">amoxapine</a>, aptazapine, esmirtazapine, <a href="Maprotiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Maprotiline" title="Maprotiline">maprotiline</a>, <a href="Mianserin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mianserin" title="Mianserin">mianserin</a>, <a href="Mirtazapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mirtazapine" title="Mirtazapine">mirtazapine</a>)</li>
<li>Tricyclic antidepressants (e.g., <a href="Amitriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Amitriptyline" title="Amitriptyline">amitriptyline</a>)</li>
<li>Typical antipsychotics (e.g., <a href="Chlorpromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpromazine" title="Chlorpromazine">chlorpromazine</a>, <a href="Fluphenazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluphenazine" title="Fluphenazine">fluphenazine</a>, <a href="Haloperidol.htm" tppabs="https://ptable.com/wiki/compounds/A/Haloperidol" title="Haloperidol">haloperidol</a>, <a href="Loxapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Loxapine" title="Loxapine">loxapine</a>, <a href="Perphenazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Perphenazine" title="Perphenazine">perphenazine</a>, <a href="Pimozide.htm" tppabs="https://ptable.com/wiki/compounds/A/Pimozide" title="Pimozide">pimozide</a>, pipamperone, <a href="Prochlorperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Prochlorperazine" title="Prochlorperazine">prochlorperazine</a>, setoperone, <a href="Spiperone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spiperone" title="Spiperone">spiperone</a>, spiramide, <a href="Thioridazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Thioridazine" title="Thioridazine">thioridazine</a>, thiothixene, <a href="Trifluoperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Trifluoperazine" title="Trifluoperazine">trifluoperazine</a>)</li>
<li>Volinanserin</li>
<li>Xylamidine</li>
<li><a href="Yohimbine.htm" tppabs="https://ptable.com/wiki/compounds/A/Yohimbine" title="Yohimbine">Yohimbine</a></li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Unknown/unsorted:</i> Ergolines (e.g., <a href="Dihydroergotamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydroergotamine" title="Dihydroergotamine">dihydroergotamine</a>, <a href="Nicergoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicergoline" title="Nicergoline">nicergoline</a>)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">5-HT<sub>2B</sub></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <a href="4-Methylaminorex.htm" tppabs="https://ptable.com/wiki/compounds/A/4-Methylaminorex" title="4-Methylaminorex">4-Methylaminorex</a></li>
<li><a href="Aminorex.htm" tppabs="https://ptable.com/wiki/compounds/A/Aminorex" title="Aminorex">Aminorex</a></li>
<li>Amphetamines (e.g., <a href="Chlorphentermine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorphentermine" title="Chlorphentermine">chlorphentermine</a>, cloforex, <a href="Dexfenfluramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dexfenfluramine" title="Dexfenfluramine">dexfenfluramine</a>, <a href="Fenfluramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenfluramine" title="Fenfluramine">fenfluramine</a>, levofenfluramine, norfenfluramine)</li>
<li>BW-723C86</li>
<li>DOx (e.g., DOB, DOC, DOI, <a href="2,5-Dimethoxy-4-methylamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/2%2C5-Dimethoxy-4-methylamphetamine" title="2,5-Dimethoxy-4-methylamphetamine">DOM</a>)</li>
<li>Ergolines (e.g., <a href="Cabergoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Cabergoline" title="Cabergoline">cabergoline</a>, dihydroergocryptine, <a href="Dihydroergotamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydroergotamine" title="Dihydroergotamine">dihydroergotamine</a>, <a href="Ergotamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ergotamine" title="Ergotamine">ergotamine</a>, <a href="Methylergometrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylergometrine" title="Methylergometrine">methylergometrine (methylergonovine)</a>, <a href="Methysergide.htm" tppabs="https://ptable.com/wiki/compounds/A/Methysergide" title="Methysergide">methysergide</a>, <a href="Pergolide.htm" tppabs="https://ptable.com/wiki/compounds/A/Pergolide" title="Pergolide">pergolide</a>)</li>
<li>Lorcaserin</li>
<li>MDxx (e.g., <a href="3,4-Methylenedioxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/3%2C4-Methylenedioxyamphetamine" title="3,4-Methylenedioxyamphetamine">MDA (tenamfetamine)</a>, <a href="MDMA.htm" tppabs="https://ptable.com/wiki/compounds/A/MDMA" title="MDMA">MDMA (midomafetamine)</a>, MDOH, [MMDA (drug)</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Antagonists:</i> Agomelatine</li>
<li>Atypical antipsychotics (e.g., <a href="Amisulpride.htm" tppabs="https://ptable.com/wiki/compounds/A/Amisulpride" title="Amisulpride">amisulpride</a>, <a href="Aripiprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Aripiprazole" title="Aripiprazole">aripiprazole</a>, asenapine, brexpiprazole, cariprazine, <a href="Clozapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clozapine" title="Clozapine">clozapine</a>, <span class="new">N-desalkylquetiapine (norquetiapine)</span>, N-desmethylclozapine (norclozapine), <a href="Olanzapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Olanzapine" title="Olanzapine">olanzapine</a>, pipamperone, <a href="Quetiapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Quetiapine" title="Quetiapine">quetiapine</a>, <a href="Risperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Risperidone" title="Risperidone">risperidone</a>, <a href="Ziprasidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Ziprasidone" title="Ziprasidone">ziprasidone</a>)</li>
<li><a href="Cyproheptadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyproheptadine" title="Cyproheptadine">Cyproheptadine</a></li>
<li>EGIS-7625</li>
<li>Ergolines (e.g., amesergide, <a href="Bromocriptine.htm" tppabs="https://ptable.com/wiki/compounds/A/Bromocriptine" title="Bromocriptine">bromocriptine</a>, <a href="Lisuride.htm" tppabs="https://ptable.com/wiki/compounds/A/Lisuride" title="Lisuride">lisuride</a>, <span class="new">LY-53857</span>, LY-272015, mesulergine)</li>
<li><a href="Ketanserin.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketanserin" title="Ketanserin">Ketanserin</a></li>
<li><span class="new">LY-393558</span></li>
<li><a href="Meta-Chlorophenylpiperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Meta-Chlorophenylpiperazine" title="Meta-Chlorophenylpiperazine">mCPP</a></li>
<li>Metadoxine</li>
<li>Metitepine (methiothepin)</li>
<li>Pirenperone</li>
<li>Pizotifen</li>
<li><a href="Propranolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Propranolol" title="Propranolol">Propranolol</a></li>
<li>PRX-08066</li>
<li>Rauwolscine</li>
<li>Ritanserin</li>
<li>RS-127445</li>
<li>Sarpogrelate</li>
<li>SB-200646</li>
<li>SB-204741</li>
<li>SB-206553</li>
<li>SB-215505</li>
<li><span class="new">SB-221284</span></li>
<li><span class="new">SB-228357</span></li>
<li>SDZ SER-082</li>
<li><a href="Tegaserod.htm" tppabs="https://ptable.com/wiki/compounds/A/Tegaserod" title="Tegaserod">Tegaserod</a></li>
<li>Tetracyclic antidepressants (e.g., <a href="Amoxapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amoxapine" title="Amoxapine">amoxapine</a>, <a href="Mianserin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mianserin" title="Mianserin">mianserin</a>, <a href="Mirtazapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mirtazapine" title="Mirtazapine">mirtazapine</a>)</li>
<li><a href="Trazodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Trazodone" title="Trazodone">Trazodone</a></li>
<li>Typical antipsychotics (e.g., <a href="Chlorpromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpromazine" title="Chlorpromazine">chlorpromazine</a>)</li>
<li>TIK-301</li>
<li><a href="Yohimbine.htm" tppabs="https://ptable.com/wiki/compounds/A/Yohimbine" title="Yohimbine">Yohimbine</a></li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Unknown/unsorted:</i> Ergolines (e.g., <a href="Ergometrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ergometrine" title="Ergometrine">ergometrine (ergonovine)</a>)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">5-HT<sub>2C</sub></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> 2Cs (e.g., <a href="2C-B.htm" tppabs="https://ptable.com/wiki/compounds/A/2C-B" title="2C-B">2C-B</a>, 2C-E, 2C-I, 2C-T-2, 2C-T-7, 2C-T-21)</li>
<li><a href="5-Methoxytryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/5-Methoxytryptamine" title="5-Methoxytryptamine">5-Methoxytryptamines</a> (5-MeO-DET, 5-MeO-DiPT, <a href="5-MeO-DMT.htm" tppabs="https://ptable.com/wiki/compounds/A/5-MeO-DMT" title="5-MeO-DMT">5-MeO-DMT</a>, 5-MeO-DPT, <a href="5-Methoxytryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/5-Methoxytryptamine" title="5-Methoxytryptamine">5-MT</a>)</li>
<li>α-Alkyltryptamines (e.g., 5-Cl-αMT, 5-Fl-αMT, 5-MeO-αET, 5-MeO-αMT, α-Me-5-HT, <a href="Alpha-Ethyltryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Alpha-Ethyltryptamine" title="Alpha-Ethyltryptamine">αET</a>, <a href="Alpha-Methyltryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Alpha-Methyltryptamine" title="Alpha-Methyltryptamine">αMT</a>)</li>
<li>A-372159</li>
<li>AL-38022A</li>
<li>Alstonine</li>
<li>CP-809101</li>
<li>Dimemebfe</li>
<li>DOx (e.g., DOB, DOC, DOI, <a href="2,5-Dimethoxy-4-methylamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/2%2C5-Dimethoxy-4-methylamphetamine" title="2,5-Dimethoxy-4-methylamphetamine">DOM</a>)</li>
<li>Ergolines (e.g., ALD-52, <a href="Cabergoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Cabergoline" title="Cabergoline">cabergoline</a>, <a href="Dihydroergotamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydroergotamine" title="Dihydroergotamine">dihydroergotamine</a>, ergine (LSA), <a href="Ergotamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ergotamine" title="Ergotamine">ergotamine</a>, <a href="Lisuride.htm" tppabs="https://ptable.com/wiki/compounds/A/Lisuride" title="Lisuride">lisuride</a>, LA-SS-Az, LSB, <a href="Lysergic_acid_diethylamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Lysergic_acid_diethylamide" title="Lysergic acid diethylamide">LSD</a>, LSD-Pip, LSH, LSP, <a href="Pergolide.htm" tppabs="https://ptable.com/wiki/compounds/A/Pergolide" title="Pergolide">pergolide</a>)</li>
<li>Flumexadol</li>
<li>Lorcaserin</li>
<li>MDxx (e.g., <a href="3,4-Methylenedioxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/3%2C4-Methylenedioxyamphetamine" title="3,4-Methylenedioxyamphetamine">MDA (tenamfetamine)</a>, <a href="MDMA.htm" tppabs="https://ptable.com/wiki/compounds/A/MDMA" title="MDMA">MDMA (midomafetamine)</a>, MDOH, MMDA)</li>
<li>MK-212</li>
<li>ORG-12962</li>
<li>ORG-37684</li>
<li>Oxaflozane</li>
<li>PHA-57378</li>
<li>Phenethylamines (e.g., lophophine, mescaline)</li>
<li><a href="Piperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Piperazine" title="Piperazine">Piperazines</a> (e.g., <a href="Aripiprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Aripiprazole" title="Aripiprazole">aripiprazole</a>, <a href="Benzylpiperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzylpiperazine" title="Benzylpiperazine">BZP</a>, <a href="Meta-Chlorophenylpiperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Meta-Chlorophenylpiperazine" title="Meta-Chlorophenylpiperazine">mCPP</a>, quipazine, TFMPP)</li>
<li>PNU-22394</li>
<li>PNU-181731</li>
<li>Ro60-0175</li>
<li>Ro60-0213</li>
<li><a href="Serotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Serotonin" title="Serotonin">Serotonin (5-HT)</a></li>
<li>Tryptamines (e.g., 5-BT, 5-CT, <a href="Bufotenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Bufotenin" title="Bufotenin">bufotenin</a>, <a href="Diethyltryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Diethyltryptamine" title="Diethyltryptamine">DET</a>, DiPT, DMT, DPT, <a href="Psilocin.htm" tppabs="https://ptable.com/wiki/compounds/A/Psilocin" title="Psilocin">psilocin</a>, psilocybin, <a href="Tryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tryptamine" title="Tryptamine">tryptamine</a>)</li>
<li>Vabicaserin</li>
<li>WAY-629</li>
<li>WAY-161503</li>
<li>YM-348</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Antagonists:</i> Adatanserin</li>
<li>Agomelatine</li>
<li>Atypical antipsychotics (e.g., asenapine, clorotepine, <a href="Clozapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clozapine" title="Clozapine">clozapine</a>, fluperlapine, iloperidone, melperone, <a href="Olanzapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Olanzapine" title="Olanzapine">olanzapine</a>, <a href="Paliperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Paliperidone" title="Paliperidone">paliperidone</a>, <a href="Quetiapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Quetiapine" title="Quetiapine">quetiapine</a>, <a href="Risperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Risperidone" title="Risperidone">risperidone</a>, <a href="Sertindole.htm" tppabs="https://ptable.com/wiki/compounds/A/Sertindole" title="Sertindole">sertindole</a>, <a href="Ziprasidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Ziprasidone" title="Ziprasidone">ziprasidone</a>, zotepine)</li>
<li>Captodiame</li>
<li>CEPC</li>
<li>Cinanserin</li>
<li><a href="Cyproheptadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyproheptadine" title="Cyproheptadine">Cyproheptadine</a></li>
<li>Deramciclane</li>
<li>Desmetramadol</li>
<li>Dotarizine</li>
<li>Eltoprazine</li>
<li>Ergolines (e.g., amesergide, <a href="Bromocriptine.htm" tppabs="https://ptable.com/wiki/compounds/A/Bromocriptine" title="Bromocriptine">bromocriptine</a>, <span class="new">LY-53857</span>, LY-215,840, mesulergine, <a href="Metergoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Metergoline" title="Metergoline">metergoline</a>, <a href="Methysergide.htm" tppabs="https://ptable.com/wiki/compounds/A/Methysergide" title="Methysergide">methysergide</a>, sergolexole)</li>
<li>Etoperidone</li>
<li><a href="Fluoxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluoxetine" title="Fluoxetine">Fluoxetine</a></li>
<li><span class="new">FR-260010</span></li>
<li><span class="new">Irindalone</span></li>
<li><a href="Ketanserin.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketanserin" title="Ketanserin">Ketanserin</a></li>
<li><a href="Ketotifen.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketotifen" title="Ketotifen">Ketotifen</a></li>
<li>Latrepirdine (dimebolin)</li>
<li>Medifoxamine</li>
<li>Metitepine (methiothepin)</li>
<li><a href="Nefazodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Nefazodone" title="Nefazodone">Nefazodone</a></li>
<li>Pirenperone</li>
<li>Pizotifen</li>
<li><a href="Propranolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Propranolol" title="Propranolol">Propranolol</a></li>
<li>Ritanserin</li>
<li>RS-102221</li>
<li>S-14671</li>
<li>SB-200646</li>
<li>SB-206553</li>
<li><span class="new">SB-221284</span></li>
<li><span class="new">SB-228357</span></li>
<li>SB-242084</li>
<li>SB-243213</li>
<li>SDZ SER-082</li>
<li>Tedatioxetine</li>
<li>Tetracyclic antidepressants (e.g., <a href="Amoxapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amoxapine" title="Amoxapine">amoxapine</a>, aptazapine, esmirtazapine, <a href="Maprotiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Maprotiline" title="Maprotiline">maprotiline</a>, <a href="Mianserin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mianserin" title="Mianserin">mianserin</a>, <a href="Mirtazapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mirtazapine" title="Mirtazapine">mirtazapine</a>)</li>
<li>TIK-301</li>
<li><a href="Tramadol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tramadol" title="Tramadol">Tramadol</a></li>
<li><a href="Trazodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Trazodone" title="Trazodone">Trazodone</a></li>
<li>Tricyclic antidepressants (e.g., <a href="Amitriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Amitriptyline" title="Amitriptyline">amitriptyline</a>, <a href="Nortriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Nortriptyline" title="Nortriptyline">nortriptyline</a>)</li>
<li>Typical antipsychotics (e.g., <a href="Chlorpromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpromazine" title="Chlorpromazine">chlorpromazine</a>, <a href="Loxapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Loxapine" title="Loxapine">loxapine</a>, <a href="Pimozide.htm" tppabs="https://ptable.com/wiki/compounds/A/Pimozide" title="Pimozide">pimozide</a>, pipamperone, <a href="Thioridazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Thioridazine" title="Thioridazine">thioridazine</a>)</li>
<li>Xylamidine</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Unknown/unsorted:</i> <a href="Efavirenz.htm" tppabs="https://ptable.com/wiki/compounds/A/Efavirenz" title="Efavirenz">Efavirenz</a></li>
<li>Ergolines (e.g., <a href="Ergometrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ergometrine" title="Ergometrine">ergometrine (ergonovine)</a>, <a href="Methylergometrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylergometrine" title="Methylergometrine">methylergometrine (methylergonovine)</a>)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">5-HT<sub>3</sub><sub>–7</sub></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">5-HT<sub>3</sub></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Alcohols (e.g., <a href="N-Butanol.htm" tppabs="https://ptable.com/wiki/compounds/A/N-Butanol" title="N-Butanol">butanol</a>, ethanol (alcohol), <a href="2,2,2-Trichloroethanol.htm" tppabs="https://ptable.com/wiki/compounds/A/2%2C2%2C2-Trichloroethanol" title="2,2,2-Trichloroethanol">trichloroethanol</a>)</li>
<li>m-CPBG</li>
<li>Phenylbiguanide</li>
<li><a href="Piperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Piperazine" title="Piperazine">Piperazines</a> (e.g., <a href="Benzylpiperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzylpiperazine" title="Benzylpiperazine">BZP</a>, <a href="Meta-Chlorophenylpiperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Meta-Chlorophenylpiperazine" title="Meta-Chlorophenylpiperazine">mCPP</a>, quipazine)</li>
<li>RS-56812</li>
<li><a href="Serotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Serotonin" title="Serotonin">Serotonin (5-HT)</a></li>
<li>SR-57227</li>
<li><span class="new">SR-57227A</span></li>
<li>Tryptamines (e.g., 2-Me-5-HT, 5-CT, bufotenidine (5-HTQ))</li>
<li>Volatiles/gases (e.g., <a href="Halothane.htm" tppabs="https://ptable.com/wiki/compounds/A/Halothane" title="Halothane">halothane</a>, <a href="Isoflurane.htm" tppabs="https://ptable.com/wiki/compounds/A/Isoflurane" title="Isoflurane">isoflurane</a>, <a href="Toluene.htm" tppabs="https://ptable.com/wiki/compounds/A/Toluene" title="Toluene">toluene</a>, <a href="1,1,1-Trichloroethane.htm" tppabs="https://ptable.com/wiki/compounds/A/1%2C1%2C1-Trichloroethane" title="1,1,1-Trichloroethane">trichloroethane</a>)</li>
<li>YM-31636</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Antagonists:</i> <a href="Alosetron.htm" tppabs="https://ptable.com/wiki/compounds/A/Alosetron" title="Alosetron">Alosetron</a></li>
<li><span class="new">Arazasetron</span></li>
<li>AS-8112</li>
<li>Atypical antipsychotics (e.g., <a href="Clozapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clozapine" title="Clozapine">clozapine</a>, <a href="Olanzapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Olanzapine" title="Olanzapine">olanzapine</a>, <a href="Quetiapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Quetiapine" title="Quetiapine">quetiapine</a>)</li>
<li>Azasetron</li>
<li>Batanopride</li>
<li>Bemesetron (MDL-72222)</li>
<li><a href="Bupropion.htm" tppabs="https://ptable.com/wiki/compounds/A/Bupropion" title="Bupropion">Bupropion</a></li>
<li>Cilansetron</li>
<li>CSP-2503</li>
<li>Dazopride</li>
<li><a href="Dolasetron.htm" tppabs="https://ptable.com/wiki/compounds/A/Dolasetron" title="Dolasetron">Dolasetron</a></li>
<li>Galanolactone</li>
<li><a href="Granisetron.htm" tppabs="https://ptable.com/wiki/compounds/A/Granisetron" title="Granisetron">Granisetron</a></li>
<li>Hydroxybupropion</li>
<li><span class="new">ICS-205930</span></li>
<li>Lerisetron</li>
<li><a href="Memantine.htm" tppabs="https://ptable.com/wiki/compounds/A/Memantine" title="Memantine">Memantine</a></li>
<li><a href="Ondansetron.htm" tppabs="https://ptable.com/wiki/compounds/A/Ondansetron" title="Ondansetron">Ondansetron</a></li>
<li>Palonosetron</li>
<li>Ramosetron</li>
<li>Renzapride</li>
<li>Ricasetron</li>
<li>Tedatioxetine</li>
<li>Tetracyclic antidepressants (e.g., <a href="Amoxapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amoxapine" title="Amoxapine">amoxapine</a>, <a href="Mianserin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mianserin" title="Mianserin">mianserin</a>, <a href="Mirtazapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mirtazapine" title="Mirtazapine">mirtazapine</a>)</li>
<li>Thujone</li>
<li>Tropanserin</li>
<li>Tropisetron</li>
<li>Typical antipsychotics (e.g., <a href="Loxapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Loxapine" title="Loxapine">loxapine</a>)</li>
<li>Volatiles/gases (e.g., <a href="Nitrous_oxide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nitrous_oxide" title="Nitrous oxide">nitrous oxide</a>, <a href="Sevoflurane.htm" tppabs="https://ptable.com/wiki/compounds/A/Sevoflurane" title="Sevoflurane">sevoflurane</a>, <a href="Xenon.htm" tppabs="https://ptable.com/wiki/compounds/A/Xenon" title="Xenon">xenon</a>)</li>
<li>Vortioxetine</li>
<li>Zacopride</li>
<li>Zatosetron</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Unknown/unsorted:</i> <span class="new">LY-53857</span></li>
<li><a href="Piperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Piperazine" title="Piperazine">Piperazines</a> (e.g., naphthylpiperazine)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">5-HT<sub>4</sub></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <a href="5-Methoxytryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/5-Methoxytryptamine" title="5-Methoxytryptamine">5-MT</a></li>
<li>BIMU8</li>
<li>Capeserod</li>
<li>Cinitapride</li>
<li><a href="Cisapride.htm" tppabs="https://ptable.com/wiki/compounds/A/Cisapride" title="Cisapride">Cisapride</a></li>
<li>CJ-033466</li>
<li>Dazopride</li>
<li><a href="Metoclopramide.htm" tppabs="https://ptable.com/wiki/compounds/A/Metoclopramide" title="Metoclopramide">Metoclopramide</a></li>
<li><span class="new">Minesapride</span></li>
<li>Mosapride</li>
<li>Prucalopride</li>
<li>PRX-03140</li>
<li>Renzapride</li>
<li>RS-67,333</li>
<li><span class="new">RS-67,506</span></li>
<li><a href="Serotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Serotonin" title="Serotonin">Serotonin (5-HT)</a></li>
<li><a href="Tegaserod.htm" tppabs="https://ptable.com/wiki/compounds/A/Tegaserod" title="Tegaserod">Tegaserod</a></li>
<li>Velusetrag</li>
<li>Zacopride</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Antagonists:</i> GR-113808</li>
<li><span class="new">GR-125487</span></li>
<li><a href="Lysine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lysine" title="Lysine">L-Lysine</a></li>
<li>Piboserod</li>
<li><span class="new">RS-39604</span></li>
<li><span class="new">RS-67532</span></li>
<li><span class="new">SB-203186</span></li>
<li>SB-204070</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">5-HT<sub>5A</sub></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Ergolines (e.g., 2-Br-LSD (BOL-148), <a href="Ergotamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ergotamine" title="Ergotamine">ergotamine</a>, <a href="Lysergic_acid_diethylamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Lysergic_acid_diethylamide" title="Lysergic acid diethylamide">LSD</a>)</li>
<li><a href="Serotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Serotonin" title="Serotonin">Serotonin (5-HT)</a></li>
<li>Tryptamines (e.g., 5-CT)</li>
<li>Valerenic Acid</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Antagonists:</i> Asenapine</li>
<li>Latrepirdine (dimebolin)</li>
<li>Metitepine (methiothepin)</li>
<li>Ritanserin</li>
<li>SB-699551</li></ul>

<ul><li><i>Unknown/unsorted:</i> Ergolines (e.g., <a href="Metergoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Metergoline" title="Metergoline">metergoline</a>, <a href="Methysergide.htm" tppabs="https://ptable.com/wiki/compounds/A/Methysergide" title="Methysergide">methysergide</a>)</li>
<li><a href="Piperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Piperazine" title="Piperazine">Piperazines</a> (e.g., naphthylpiperazine)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">5-HT<sub>6</sub></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Ergolines (e.g., dihydroergocryptine, <a href="Dihydroergotamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydroergotamine" title="Dihydroergotamine">dihydroergotamine</a>, <a href="Ergotamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ergotamine" title="Ergotamine">ergotamine</a>, <a href="Lisuride.htm" tppabs="https://ptable.com/wiki/compounds/A/Lisuride" title="Lisuride">lisuride</a>, <a href="Lysergic_acid_diethylamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Lysergic_acid_diethylamide" title="Lysergic acid diethylamide">LSD</a>, mesulergine, <a href="Metergoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Metergoline" title="Metergoline">metergoline</a>, <a href="Methysergide.htm" tppabs="https://ptable.com/wiki/compounds/A/Methysergide" title="Methysergide">methysergide</a>)</li>
<li><a href="Serotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Serotonin" title="Serotonin">Serotonin (5-HT)</a></li>
<li>Tryptamines (e.g., 2-Me-5-HT, 5-BT, 5-CT, <a href="5-Methoxytryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/5-Methoxytryptamine" title="5-Methoxytryptamine">5-MT</a>, <a href="Bufotenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Bufotenin" title="Bufotenin">Bufotenin</a>, E-6801, E-6837, EMD-386088, EMDT, <span class="new">LY-586713</span>, <span class="new">N-Me-5-HT</span>, <a href="Tryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tryptamine" title="Tryptamine">tryptamine</a>)</li>
<li>WAY-181187</li>
<li>WAY-208466</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Antagonists:</i> <span class="new">ABT-354</span></li>
<li>Atypical antipsychotics (e.g., <a href="Aripiprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Aripiprazole" title="Aripiprazole">aripiprazole</a>, asenapine, clorotepine, <a href="Clozapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clozapine" title="Clozapine">clozapine</a>, fluperlapine, iloperidone, <a href="Olanzapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Olanzapine" title="Olanzapine">olanzapine</a>, tiospirone)</li>
<li>AVN-101</li>
<li>AVN-211</li>
<li><span class="new">AVN-322</span></li>
<li><span class="new">AVN-397</span></li>
<li><span class="new">BGC20-760</span></li>
<li><span class="new">BVT-5182</span></li>
<li><span class="new">BVT-74316</span></li>
<li>Cerlapirdine</li>
<li>EGIS-12,233</li>
<li><span class="new">GW-742457</span></li>
<li>Idalopirdine</li>
<li><a href="Ketanserin.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketanserin" title="Ketanserin">Ketanserin</a></li>
<li><span class="new">Landipirdine</span></li>
<li>Latrepirdine (dimebolin)</li>
<li><span class="new">Masupirdine</span></li>
<li>Metitepine (methiothepin)</li>
<li>MS-245</li>
<li>PRX-07034</li>
<li>Ritanserin</li>
<li>Ro 04-6790</li>
<li><span class="new">Ro 63-0563</span></li>
<li>SB-258585</li>
<li>SB-271046</li>
<li>SB-357134</li>
<li>SB-399885</li>
<li>SB-742457</li>
<li>Tetracyclic antidepressants (e.g., <a href="Amoxapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amoxapine" title="Amoxapine">amoxapine</a>, <a href="Mianserin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mianserin" title="Mianserin">mianserin</a>)</li>
<li>Tricyclic antidepressants (e.g., <a href="Amitriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Amitriptyline" title="Amitriptyline">amitriptyline</a>, <a href="Clomipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clomipramine" title="Clomipramine">clomipramine</a>, <a href="Doxepin.htm" tppabs="https://ptable.com/wiki/compounds/A/Doxepin" title="Doxepin">doxepin</a>, <a href="Nortriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Nortriptyline" title="Nortriptyline">nortriptyline</a>)</li>
<li>Typical antipsychotics (e.g., <a href="Chlorpromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpromazine" title="Chlorpromazine">chlorpromazine</a>, <a href="Loxapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Loxapine" title="Loxapine">loxapine</a>)</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Unknown/unsorted:</i> Ergolines (e.g., 2-Br-LSD (BOL-148), <a href="Bromocriptine.htm" tppabs="https://ptable.com/wiki/compounds/A/Bromocriptine" title="Bromocriptine">bromocriptine</a>, lergotrile, <a href="Pergolide.htm" tppabs="https://ptable.com/wiki/compounds/A/Pergolide" title="Pergolide">pergolide</a>)</li>
<li><a href="Piperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Piperazine" title="Piperazine">Piperazines</a> (e.g., naphthylpiperazine)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">5-HT<sub>7</sub></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> 8-OH-DPAT</li>
<li>AS-19</li>
<li>Bifeprunox</li>
<li>E-55888</li>
<li>Ergolines (e.g., <a href="Lysergic_acid_diethylamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Lysergic_acid_diethylamide" title="Lysergic acid diethylamide">LSD</a>)</li>
<li>LP-12</li>
<li>LP-44</li>
<li>RU-24,969</li>
<li>Sarizotan</li>
<li><a href="Serotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Serotonin" title="Serotonin">Serotonin (5-HT)</a></li>
<li><a href="Triptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Triptan" title="Triptan">Triptans</a> (e.g., <a href="Frovatriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Frovatriptan" title="Frovatriptan">frovatriptan</a>)</li>
<li>Tryptamines (e.g., 5-CT, <a href="5-Methoxytryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/5-Methoxytryptamine" title="5-Methoxytryptamine">5-MT</a>, <a href="Bufotenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Bufotenin" title="Bufotenin">bufotenin</a>, N-Me-5-HT)</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Antagonists:</i> Atypical antipsychotics (e.g., <a href="Amisulpride.htm" tppabs="https://ptable.com/wiki/compounds/A/Amisulpride" title="Amisulpride">amisulpride</a>, <a href="Aripiprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Aripiprazole" title="Aripiprazole">aripiprazole</a>, asenapine, brexpiprazole, clorotepine, <a href="Clozapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clozapine" title="Clozapine">clozapine</a>, fluperlapine, <a href="Olanzapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Olanzapine" title="Olanzapine">olanzapine</a>, <a href="Risperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Risperidone" title="Risperidone">risperidone</a>, <a href="Sertindole.htm" tppabs="https://ptable.com/wiki/compounds/A/Sertindole" title="Sertindole">sertindole</a>, tiospirone, <a href="Ziprasidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Ziprasidone" title="Ziprasidone">ziprasidone</a>, zotepine)</li>
<li>Butaclamol</li>
<li>DR-4485</li>
<li>EGIS-12,233</li>
<li>Ergolines (e.g., 2-Br-LSD (BOL-148), amesergide, <a href="Bromocriptine.htm" tppabs="https://ptable.com/wiki/compounds/A/Bromocriptine" title="Bromocriptine">bromocriptine</a>, <a href="Cabergoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Cabergoline" title="Cabergoline">cabergoline</a>, <a href="Dihydroergotamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydroergotamine" title="Dihydroergotamine">dihydroergotamine</a>, <a href="Ergotamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ergotamine" title="Ergotamine">ergotamine</a>, <span class="new">LY-53857</span>, LY-215,840, mesulergine, <a href="Metergoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Metergoline" title="Metergoline">metergoline</a>, <a href="Methysergide.htm" tppabs="https://ptable.com/wiki/compounds/A/Methysergide" title="Methysergide">methysergide</a>, sergolexole)</li>
<li><span class="new">JNJ-18038683</span></li>
<li><a href="Ketanserin.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketanserin" title="Ketanserin">Ketanserin</a></li>
<li>LY-215,840</li>
<li>Metitepine (methiothepin)</li>
<li>Ritanserin</li>
<li>SB-258719</li>
<li><span class="new">SB-258741</span></li>
<li>SB-269970</li>
<li><span class="new">SB-656104</span></li>
<li><span class="new">SB-656104A</span></li>
<li><span class="new">SB-691673</span></li>
<li><span class="new">SLV-313</span></li>
<li><span class="new">SLV-314</span></li>
<li><a href="Spiperone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spiperone" title="Spiperone">Spiperone</a></li>
<li><span class="new">SSR-181507</span></li>
<li>Tetracyclic antidepressants (e.g., <a href="Amoxapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amoxapine" title="Amoxapine">amoxapine</a>, <a href="Maprotiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Maprotiline" title="Maprotiline">maprotiline</a>, <a href="Mianserin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mianserin" title="Mianserin">mianserin</a>, <a href="Mirtazapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mirtazapine" title="Mirtazapine">mirtazapine</a>)</li>
<li>Tricyclic antidepressants (e.g., <a href="Amitriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Amitriptyline" title="Amitriptyline">amitriptyline</a>, <a href="Clomipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clomipramine" title="Clomipramine">clomipramine</a>, <a href="Imipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Imipramine" title="Imipramine">imipramine</a>)</li>
<li>Typical antipsychotics (e.g., <a href="Acetophenazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Acetophenazine" title="Acetophenazine">acetophenazine</a>, <a href="Chlorpromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpromazine" title="Chlorpromazine">chlorpromazine</a>, <a href="Chlorprothixene.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorprothixene" title="Chlorprothixene">chlorprothixene</a>, <a href="Fluphenazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluphenazine" title="Fluphenazine">fluphenazine</a>, <a href="Loxapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Loxapine" title="Loxapine">loxapine</a>, <a href="Pimozide.htm" tppabs="https://ptable.com/wiki/compounds/A/Pimozide" title="Pimozide">pimozide</a>)</li>
<li>Vortioxetine</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Unknown/unsorted:</i> Ergolines (e.g., <a href="Lisuride.htm" tppabs="https://ptable.com/wiki/compounds/A/Lisuride" title="Lisuride">lisuride</a>, <a href="Pergolide.htm" tppabs="https://ptable.com/wiki/compounds/A/Pergolide" title="Pergolide">pergolide</a>)</li>
<li><a href="Piperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Piperazine" title="Piperazine">Piperazines</a> (e.g., naphthylpiperazine)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div>
<ul><li><small><i><b>See also:</b> Receptor/signaling modulators</i></small></li>
<li><small><i>Adrenergics</i></small></li>
<li><small><i>Dopaminergics</i></small></li>
<li><small><i>Melatonergics</i></small></li>
<li><small><i>Monoamine reuptake inhibitors and releasing agents</i></small></li>
<li><small><i>Monoamine metabolism modulators</i></small></li>
<li><small><i>Monoamine neurotoxins</i></small></li></ul>
</div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Sigma_receptor_modulators" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Sigma_receptor_modulators" style="font-size:114%;margin:0 4em">Sigma receptor modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">σ<sub>1</sub></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Agonists:</b> 3-PPP</li>
<li>4-PPBP</li>
<li><a href="5-MeO-DMT.htm" tppabs="https://ptable.com/wiki/compounds/A/5-MeO-DMT" title="5-MeO-DMT">5-MeO-DMT</a></li>
<li>Alazocine (SKF-10047)</li>
<li><a href="Amantadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amantadine" title="Amantadine">Amantadine</a></li>
<li>ANAVEX2-73</li>
<li>Arketamine</li>
<li><span class="new">BD-737</span></li>
<li>BD-1052</li>
<li>Captodiame</li>
<li><a href="Citalopram.htm" tppabs="https://ptable.com/wiki/compounds/A/Citalopram" title="Citalopram">Citalopram</a></li>
<li><abbr>CGRP</abbr></li>
<li>Cloperastine</li>
<li><a href="Cocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaine" title="Cocaine">Cocaine</a></li>
<li>Cutamesine (SA-4503)</li>
<li><a href="Cyclazocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclazocine" title="Cyclazocine">Cyclazocine</a></li>
<li><a href="Dehydroepiandrosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dehydroepiandrosterone" title="Dehydroepiandrosterone">Dehydroepiandrosterone (DHEA)</a> (prasterone)</li>
<li><a href="Dehydroepiandrosterone_sulfate.htm" tppabs="https://ptable.com/wiki/compounds/A/Dehydroepiandrosterone_sulfate" title="Dehydroepiandrosterone sulfate">Dehydroepiandrosterone sulfate (DHEA-S)</a> (prasterone sulfate)</li>
<li>Dextrallorphan</li>
<li><a href="Dextromethorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextromethorphan" title="Dextromethorphan">Dextromethorphan (DXM)</a></li>
<li>Dextrorphan (DXO)</li>
<li>Dimemorfan</li>
<li><a href="Dimethyltryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimethyltryptamine" title="Dimethyltryptamine" class="mw-redirect">Dimethyltryptamine (DMT)</a></li>
<li>Ditolylguanidine (DTG)</li>
<li><a href="Donepezil.htm" tppabs="https://ptable.com/wiki/compounds/A/Donepezil" title="Donepezil">Donepezil</a></li>
<li>Eliprodil</li>
<li><a href="Escitalopram.htm" tppabs="https://ptable.com/wiki/compounds/A/Escitalopram" title="Escitalopram">Escitalopram</a></li>
<li>Fabomotizole (afobazole)</li>
<li><a href="Fluoxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluoxetine" title="Fluoxetine">Fluoxetine</a></li>
<li><a href="Fluvoxamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluvoxamine" title="Fluvoxamine">Fluvoxamine</a></li>
<li>Ifenprodil</li>
<li>Igmesine (JO-1784)</li>
<li><span class="new">IPAB</span></li>
<li><a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">Ketamine</a></li>
<li>L-687384</li>
<li><a href="MDMA.htm" tppabs="https://ptable.com/wiki/compounds/A/MDMA" title="MDMA"><abbr>MDMA</abbr> (midomafetamine)</a></li>
<li><a href="Memantine.htm" tppabs="https://ptable.com/wiki/compounds/A/Memantine" title="Memantine">Memantine</a></li>
<li><a href="Methamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamphetamine" title="Methamphetamine">Methamphetamine</a></li>
<li>Methoxetamine</li>
<li><a href="Methylphenidate.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylphenidate" title="Methylphenidate">Methylphenidate</a></li>
<li>Nepinalone</li>
<li>Neuropeptide Y</li>
<li><a href="Noscapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Noscapine" title="Noscapine">Noscapine</a></li>
<li><span class="new">OPC-14523</span></li>
<li>Opipramol</li>
<li><a href="Pentazocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentazocine" title="Pentazocine">Pentazocine</a></li>
<li><a href="Pentoxyverine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentoxyverine" title="Pentoxyverine">Pentoxyverine (carbetapentane)</a></li>
<li>PRE-084</li>
<li><a href="Pregnenolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Pregnenolone" title="Pregnenolone">Pregnenolone</a></li>
<li>Pregnenolone sulfate</li>
<li>Pridopidine</li>
<li><a href="Methorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Racemethorphan" title="Racemethorphan" class="mw-redirect">Racemethorphan (methorphan)</a></li>
<li>Racemorphan (morphanol)</li>
<li><span class="new">UMB-23</span></li>
<li><span class="new">UMB-82</span></li></ul>

<ul><li><b>Antagonists:</b> 3-PPP</li>
<li>AC-927</li>
<li>BD-1008</li>
<li>BD-1031</li>
<li>BD-1047</li>
<li>BD-1060</li>
<li>BD-1063</li>
<li>BD-1067</li>
<li>BMY-14802 (BMS-181100)</li>
<li>CM-156</li>
<li><span class="new">Dup-734</span></li>
<li><span class="new">E-5842</span></li>
<li>E-52862 (S1RA)</li>
<li><a href="Haloperidol.htm" tppabs="https://ptable.com/wiki/compounds/A/Haloperidol" title="Haloperidol">Haloperidol</a></li>
<li><span class="new">LR-132</span></li>
<li><span class="new">LR-172</span></li>
<li><span class="new">MS-377</span></li>
<li>NE-100</li>
<li><span class="new">NPC-16377</span></li>
<li>Panamesine (EMD-57455)</li>
<li><span class="new">PD-144418</span></li>
<li><a href="Pentazocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentazocine" title="Pentazocine">Pentazocine</a></li>
<li><a href="Progesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Progesterone" title="Progesterone">Progesterone</a></li>
<li><a href="Rimcazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Rimcazole" title="Rimcazole">Rimcazole (BW-234U)</a></li>
<li><a href="Sertraline.htm" tppabs="https://ptable.com/wiki/compounds/A/Sertraline" title="Sertraline">Sertraline</a></li>
<li><span class="new">SR-31742A</span></li></ul>

<ul><li><b>Allosteric modulators:</b> <a href="Phenytoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenytoin" title="Phenytoin">Phenytoin</a>; <i>Positive:</i> Methylphenylpiracetam</li>
<li><span class="new">SOMCL-668</span></li></ul>

<ul><li><b>Unknown/unsorted:</b> <span class="new">3-Methoxydextrallorphan</span></li>
<li>3-MeO-PCP</li>
<li>4C-T-2</li>
<li><span class="new">4-IBP</span></li>
<li><span class="new">4-IPBS</span></li>
<li>4-MeO-PCP</li>
<li>5-MeO-DALT</li>
<li>5-MeO-DiPT</li>
<li><a href="Amitriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Amitriptyline" title="Amitriptyline">Amitriptyline</a></li>
<li><span class="new">Azidopamil</span></li>
<li><a href="Chlorpromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpromazine" title="Chlorpromazine">Chlorpromazine</a></li>
<li><a href="Clemastine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clemastine" title="Clemastine">Clemastine</a></li>
<li><a href="Clomipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clomipramine" title="Clomipramine">Clomipramine</a></li>
<li><a href="Clorgiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Clorgiline" title="Clorgiline">Clorgiline</a></li>
<li><small>D</small>-Deprenyl</li>
<li><abbr>DiPT</abbr></li>
<li><abbr>DPT</abbr></li>
<li>Ibogaine</li>
<li><a href="Imipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Imipramine" title="Imipramine">Imipramine</a></li>
<li><span class="new">KCR-12-83.1</span></li>
<li>Nemonapride</li>
<li>Noribogaine</li>
<li><span class="new">RHL-033</span></li>
<li>RS-67,333</li>
<li>RTI-55</li>
<li>Saffron</li>
<li>Safinamide</li>
<li><a href="Selegiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Selegiline" title="Selegiline">Selegiline</a></li>
<li><span class="new">Spipethiane</span></li>
<li><a href="Trifluoperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Trifluoperazine" title="Trifluoperazine">Trifluoperazine</a></li>
<li>W-18</li>
<li>YKP10A</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">σ<sub>2</sub></th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Agonists:</b> 3-PPP</li>
<li>Arketamine</li>
<li>BD-1047</li>
<li>BD1063</li>
<li>Ditolylguanidine (DTG)</li>
<li><span class="new">DKR-1005</span></li>
<li><span class="new">DKR-1051</span></li>
<li><a href="Haloperidol.htm" tppabs="https://ptable.com/wiki/compounds/A/Haloperidol" title="Haloperidol">Haloperidol</a></li>
<li>Ifenprodil</li>
<li><a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">Ketamine</a></li>
<li><a href="MDMA.htm" tppabs="https://ptable.com/wiki/compounds/A/MDMA" title="MDMA"><abbr>MDMA</abbr> (midomafetamine)</a></li>
<li><a href="Methamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamphetamine" title="Methamphetamine">Methamphetamine</a></li>
<li><span class="new">OPC-14523</span></li>
<li>Opipramol</li>
<li>PB-28</li>
<li><a href="Phencyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phencyclidine" title="Phencyclidine">Phencyclidine</a></li>
<li>Siramesine (Lu 28-179)</li>
<li><span class="new">UKH-1114</span></li></ul>

<ul><li><b>Antagonists:</b> AC-927</li>
<li>BD-1008</li>
<li>BD-1067</li>
<li>CM-156</li>
<li><span class="new">CT-1812</span></li>
<li><span class="new">LR-172</span></li>
<li>MIN-101</li>
<li>Panamesine (EMD-57455)</li>
<li><span class="new">SAS-0132</span></li></ul>

<ul><li><b>Unknown/unsorted:</b> <span class="new">3-Methoxydextrallorphan</span></li>
<li>3-MeO-PCE</li>
<li>4-MeO-PCP</li>
<li>5-MeO-DALT</li>
<li>5-MeO-DiPT</li>
<li><a href="Clemastine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clemastine" title="Clemastine">Clemastine</a></li>
<li><abbr>DiPT</abbr></li>
<li><abbr>DPT</abbr></li>
<li>Ibogaine</li>
<li>Nemonapride</li>
<li>Nepinalone</li>
<li>Noribogaine</li>
<li><a href="Pentazocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentazocine" title="Pentazocine">Pentazocine</a></li>
<li>RS-67,333</li>
<li>Safinamide</li>
<li><a href="Trimethoxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/3%2C4%2C5-Trimethoxyamphetamine" title="3,4,5-Trimethoxyamphetamine" class="mw-redirect"><abbr>TMA</abbr></a></li>
<li><span class="new">UMB-23</span></li>
<li><span class="new">UMB-82</span></li>
<li>W-18</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Unsorted</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Agonists:</b> <a href="Berberine.htm" tppabs="https://ptable.com/wiki/compounds/A/Berberine" title="Berberine">Berberine</a></li>
<li>Ethylketazocine</li>
<li>Fourphit</li>
<li>Metaphit</li>
<li>Naluzotan</li>
<li>Tapentadol</li>
<li><a href="Tenocyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tenocyclidine" title="Tenocyclidine">Tenocyclidine</a></li></ul>

<ul><li><b>Antagonists:</b> <span class="new">AHD1</span></li>
<li><span class="new">AZ66</span></li>
<li><a href="Lamotrigine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lamotrigine" title="Lamotrigine">Lamotrigine</a></li>
<li><a href="Naloxone.htm" tppabs="https://ptable.com/wiki/compounds/A/Naloxone" title="Naloxone">Naloxone</a></li>
<li><span class="new">SM-21</span></li>
<li><span class="new">UMB-100</span></li>
<li><span class="new">UMB-101</span></li>
<li><span class="new">UMB-103</span></li>
<li><span class="new">UMB-116</span></li>
<li><span class="new">YZ-011</span></li>
<li><span class="new">YZ-069</span></li>
<li><span class="new">YZ-185</span></li></ul>

<ul><li><b>Allosteric modulators:</b> SKF-83959</li></ul>

<ul><li><b>Unknown/unsorted:</b> 18-Methoxycoronaridine</li>
<li><span class="new">BMY-13980</span></li>
<li>Butaclamol</li>
<li>Caramiphen</li>
<li><span class="new">Carvotroline</span></li>
<li><a href="Chlorphenamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorphenamine" title="Chlorphenamine">Chlorphenamine (chlorpheniramine)</a></li>
<li><a href="Chlorpromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpromazine" title="Chlorpromazine">Chlorpromazine</a></li>
<li><a href="Cinnarizine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cinnarizine" title="Cinnarizine">Cinnarizine</a></li>
<li><span class="new">Cinuperone</span></li>
<li>Clocapramine</li>
<li><a href="Dezocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dezocine" title="Dezocine">Dezocine</a></li>
<li><span class="new">EMD-59983</span></li>
<li>Hypericin (St. John's wort)</li>
<li><a href="Fluphenazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluphenazine" title="Fluphenazine">Fluphenazine</a></li>
<li>Gevotroline (WY-47384)</li>
<li><a href="Mepyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mepyramine" title="Mepyramine">Mepyramine (pyrilamine)</a></li>
<li><a href="Molindone.htm" tppabs="https://ptable.com/wiki/compounds/A/Molindone" title="Molindone">Molindone</a></li>
<li><a href="Perphenazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Perphenazine" title="Perphenazine">Perphenazine</a></li>
<li><a href="Pimozide.htm" tppabs="https://ptable.com/wiki/compounds/A/Pimozide" title="Pimozide">Pimozide</a></li>
<li>Proadifen</li>
<li><a href="Promethazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Promethazine" title="Promethazine">Promethazine</a></li>
<li><a href="Propranolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Propranolol" title="Propranolol">Propranolol</a></li>
<li><a href="Quinidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinidine" title="Quinidine">Quinidine</a></li>
<li><a href="Remoxipride.htm" tppabs="https://ptable.com/wiki/compounds/A/Remoxipride" title="Remoxipride">Remoxipride</a></li>
<li><span class="new">SL 82.0715</span></li>
<li><span class="new">SR-31747A</span></li>
<li>Tiospirone (BMY-13859)</li>
<li><a href="Venlafaxine.htm" tppabs="https://ptable.com/wiki/compounds/A/Venlafaxine" title="Venlafaxine">Venlafaxine</a></li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div><i><b>See also:</b> Receptor/signaling modulators</i></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Human_trace_amine-associated_receptor_ligands" style="padding:3px"><table class="nowraplinks hlist mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Human_trace_amine-associated_receptor_ligands" style="font-size:114%;margin:0 4em">Human trace amine-associated receptor ligands</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align: center">TAAR1</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;text-align: center">Agonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;text-align: center">Endogenous<sup><span>†</span></sup></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px;background:white"><div style="padding:0em 0.25em">
<ul><li>Classical monoamine neurotransmitters 
<ul><li><a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">Dopamine</a></li>
<li><a href="Histamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Histamine" title="Histamine">Histamine</a></li>
<li>Norepinephrine</li>
<li><a href="Serotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Serotonin" title="Serotonin">Serotonin</a></li></ul></li>
<li>Trace amines
<ul><li>3-Iodothyronamine</li>
<li><a href="3-Methoxytyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/3-Methoxytyramine" title="3-Methoxytyramine">3-Methoxytyramine</a></li>
<li><a href="N-Methylphenethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/N-Methylphenethylamine" title="N-Methylphenethylamine"><i>N</i>-Methylphenethylamine</a></li>
<li><a href="N-Methyltyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/N-Methyltyramine" title="N-Methyltyramine"><i>N</i>-Methyltyramine</a></li>
<li><i>m</i>-Octopamine</li>
<li><i>p</i>-Octopamine</li>
<li><a href="Phenethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenethylamine" title="Phenethylamine">Phenethylamine</a></li>
<li>Phenylethanolamine</li>
<li><a href="Synephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Synephrine" title="Synephrine">Synephrine</a></li>
<li><a href="Tryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tryptamine" title="Tryptamine">Tryptamine</a></li>
<li><i>m</i>-Tyramine</li>
<li><a href="Tyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Para-Tyramine" title="Para-Tyramine" class="mw-redirect"><i>p</i>-Tyramine</a></li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;text-align: center">Synthetic<sup><span>‡</span></sup></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px;background:white"><div style="padding:0em 0.25em">
<ul><li><a href="Amphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphetamine" title="Amphetamine">Amphetamine</a></li>
<li>DOB</li>
<li><a href="2,5-Dimethoxy-4-ethylamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/2%2C5-Dimethoxy-4-ethylamphetamine" title="2,5-Dimethoxy-4-ethylamphetamine">DOET</a></li>
<li>4-Hydroxyamphetamine</li>
<li><a href="Isoprenaline.htm" tppabs="https://ptable.com/wiki/compounds/A/Isoprenaline" title="Isoprenaline">Isoprenaline</a></li>
<li><a href="3,4-Methylenedioxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/3%2C4-Methylenedioxyamphetamine" title="3,4-Methylenedioxyamphetamine">MDA (tenamfetamine)</a></li>
<li><a href="MDMA.htm" tppabs="https://ptable.com/wiki/compounds/A/MDMA" title="MDMA">MDMA (midomafetamine)</a></li>
<li>2-Methylphenethylamine</li>
<li>3-Methylphenethylamine</li>
<li>4-Methylphenethylamine</li>
<li><a href="Β-Methylphenethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/%CE%92-Methylphenethylamine" title="Β-Methylphenethylamine">β-Methylphenethylamine</a></li>
<li><a href="Methamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamphetamine" title="Methamphetamine">Methamphetamine</a></li>
<li>3-MMA</li>
<li>Norfenfluramine</li>
<li><a href="Phentermine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phentermine" title="Phentermine">Phentermine</a></li>
<li><i>o</i>-PIT</li>
<li>Propylhexedrine</li>
<li>RO5166017</li>
<li><i>N</i>,<i>N</i>-Dimethylphenethylamine</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;text-align: center">Neutral antagonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><span>&nbsp;</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;text-align: center">Inverse agonists</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>EPPTB (RO5212773)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align: center">TAAR2</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;text-align: center">Agonists<sup><span>‡</span></sup></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em"><span>&nbsp;</span></div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;text-align: center">Neutral antagonists</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><span>&nbsp;</span></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align: center">TAAR5</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;text-align: center">Agonists<sup><span>‡</span></sup></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>N</i>,<i>N</i>-Dimethylethylamine</li>
<li><a href="Trimethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Trimethylamine" title="Trimethylamine">Trimethylamine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;text-align: center">Neutral antagonists</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><span>&nbsp;</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;text-align: center">Inverse agonists<sup><span>‡</span></sup></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>3-Iodothyronamine</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div><div style="float: left;"><small><sup><span>†</span></sup> References for all endogenous human TAAR1 ligands are provided at List of trace amines</small></div>
<p><br></p>

<div style="float: left;"><small><sup><span>‡</span></sup> References for synthetic TAAR1 agonists can be found at TAAR1 or in the associated compound articles. For TAAR2 and TAAR5 agonists and inverse agonists, see TAAR for references.</small></div>

<p><br></p>
<small><i><b>See also:</b> Receptor/signaling modulators</i></small></div></td></tr></tbody></table></div></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Phenethylamines" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Phenethylamines" style="font-size:114%;margin:0 4em">Phenethylamines</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Phenethylamines</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Psychedelics:</i> 25B-NBOMe</li>
<li>25C-NBOMe</li>
<li>25D-NBOMe</li>
<li>25I-NBOMe</li>
<li>25N-NBOMe</li></ul>

<ul><li><a href="2C-B.htm" tppabs="https://ptable.com/wiki/compounds/A/2C-B" title="2C-B">2C-B</a></li>
<li><span class="new">2C-B-AN</span></li>
<li><span class="new">2C-Bn</span></li>
<li><span class="new">2C-Bu</span></li>
<li>2C-C</li>
<li><span class="new">2C-CN</span></li>
<li><span class="new">2C-CP</span></li>
<li>2C-D</li>
<li>2C-E</li>
<li><span class="new">2C-EF</span></li>
<li>2C-F</li>
<li>2C-G</li>
<li>2C-G-1</li>
<li>2C-G-2</li>
<li>2C-G-3</li>
<li>2C-G-4</li>
<li>2C-G-5</li>
<li>2C-G-6</li>
<li>2C-G-N</li>
<li><a href="2C-H.htm" tppabs="https://ptable.com/wiki/compounds/A/2C-H" title="2C-H">2C-H</a></li>
<li>2C-I</li>
<li>2C-iP</li>
<li>2C-N</li>
<li><span class="new">2C-NH2</span></li>
<li>2C-O</li>
<li>2C-O-4</li>
<li>2C-P</li>
<li><span class="new">2C-Ph</span></li>
<li>2C-SE</li>
<li>2C-T</li>
<li>2C-T-2</li>
<li><span class="new">2C-T-3</span></li>
<li>2C-T-4</li>
<li><span class="new">2C-T-5</span></li>
<li><span class="new">2C-T-6</span></li>
<li>2C-T-7</li>
<li>2C-T-8</li>
<li>2C-T-9</li>
<li><span class="new">2C-T-10</span></li>
<li><span class="new">2C-T-11</span></li>
<li><span class="new">2C-T-12</span></li>
<li>2C-T-13</li>
<li><span class="new">2C-T-14</span></li>
<li>2C-T-15</li>
<li>2C-T-16</li>
<li>2C-T-17</li>
<li><span class="new">2C-T-18</span></li>
<li>2C-T-19</li>
<li><span class="new">2C-T-20</span></li>
<li>2C-T-21</li>
<li><span class="new">2C-T-22</span></li>
<li><span class="new">2C-T-22.5</span></li>
<li><span class="new">2C-T-23</span></li>
<li><span class="new">2C-T-24</span></li>
<li><span class="new">2C-T-25</span></li>
<li><span class="new">2C-T-27</span></li>
<li><span class="new">2C-T-28</span></li>
<li><span class="new">2C-T-30</span></li>
<li><span class="new">2C-T-31</span></li>
<li><span class="new">2C-T-32</span></li>
<li><span class="new">2C-T-33</span></li>
<li><span class="new">2C-TFE</span></li>
<li>2C-TFM</li>
<li>2C-YN</li>
<li><span class="new">2C-V</span></li></ul>

<ul><li>Allylescaline</li>
<li>DESOXY</li>
<li>Escaline</li>
<li>Isoproscaline</li>
<li>Jimscaline</li>
<li>Macromerine</li>
<li>MEPEA</li>
<li>Mescaline</li>
<li>Metaescaline</li>
<li>Methallylescaline</li>
<li>Proscaline</li>
<li>Psi-2C-T-4</li>
<li>TCB-2</li>
<li><a href="Venlafaxine.htm" tppabs="https://ptable.com/wiki/compounds/A/Venlafaxine" title="Venlafaxine">Venlafaxine</a><br><i>Stimulants:</i> Phenylethanolamine</li>
<li>Hordenine</li>
<li><a href="Phenethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenethylamine" title="Phenethylamine">Phenethylamine</a></li>
<li><a href="Amphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphetamine" title="Amphetamine">α-Methylphenethylamine</a> (amphetamine)</li>
<li><a href="Β-Methylphenethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/%CE%92-Methylphenethylamine" title="Β-Methylphenethylamine">β-Methylphenethylamine</a></li>
<li><i>m</i>-Methylphenethylamine</li>
<li><a href="N-Methylphenethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/N-Methylphenethylamine" title="N-Methylphenethylamine"><i>N</i>-Methylphenethylamine</a></li>
<li><i>o</i>-Methylphenethylamine</li>
<li><i>p</i>-Methylphenethylamine</li>
<li><a href="Methylphenidate.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylphenidate" title="Methylphenidate">Methylphenidate</a></li></ul>

<ul><li><i>Entactogens:</i> Lophophine</li>
<li>MDPEA</li>
<li>MDMPEA<br><i>Others:</i> BOH</li>
<li><a href="3,4-Dimethoxyphenethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/3%2C4-Dimethoxyphenethylamine" title="3,4-Dimethoxyphenethylamine">DMPEA</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Amphetamines</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Psychedelics:</i> 3C-BZ</li>
<li>3C-E</li>
<li>3C-P</li>
<li>Aleph</li>
<li>Beatrice</li>
<li>Bromo-DragonFLY</li>
<li>D-Deprenyl</li>
<li><a href="Dimethoxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimethoxyamphetamine" title="Dimethoxyamphetamine">DMA</a></li>
<li><span class="new">DMCPA</span></li>
<li>DMMDA</li>
<li>DOB</li>
<li>DOC</li>
<li>DOEF</li>
<li><a href="2,5-Dimethoxy-4-ethylamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/2%2C5-Dimethoxy-4-ethylamphetamine" title="2,5-Dimethoxy-4-ethylamphetamine">DOET</a></li>
<li>DOI</li>
<li><a href="2,5-Dimethoxy-4-methylamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/2%2C5-Dimethoxy-4-methylamphetamine" title="2,5-Dimethoxy-4-methylamphetamine">DOM</a></li>
<li>DON</li>
<li>DOPR</li>
<li>DOTFM</li>
<li>Ganesha</li>
<li>MMDA</li>
<li>MMDA-2</li>
<li>Psi-DOM</li>
<li><a href="Trimethoxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Trimethoxyamphetamine" title="Trimethoxyamphetamine">TMA</a></li>
<li>TeMA<br><i>Stimulants:</i> 2-FA</li>
<li>2-FMA</li>
<li>3-FA</li>
<li>3-FMA</li>
<li>Acridorex</li>
<li>Alfetamine</li>
<li>Amfecloral</li>
<li>Amfepentorex</li>
<li><a href="Amphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphetamine" title="Amphetamine">Amphetamine</a> (<a href="Dextroamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextroamphetamine" title="Dextroamphetamine">Dextroamphetamine</a>, <a href="Levoamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Levoamphetamine" title="Levoamphetamine">Levoamphetamine</a>)</li>
<li>Amphetaminil</li>
<li>Benfluorex</li>
<li><a href="Benzphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzphetamine" title="Benzphetamine">Benzphetamine</a></li>
<li><a href="Cathine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cathine" title="Cathine">Cathine</a></li>
<li>Clobenzorex</li>
<li>Dimethylamphetamine</li>
<li><a href="Ephedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ephedrine" title="Ephedrine">Ephedrine</a></li>
<li>Etilamfetamine</li>
<li>Fencamfamin</li>
<li>Fencamine</li>
<li><a href="Fenethylline.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenethylline" title="Fenethylline">Fenethylline</a></li>
<li><a href="Fenfluramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenfluramine" title="Fenfluramine">Fenfluramine</a> (<a href="Dexfenfluramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dexfenfluramine" title="Dexfenfluramine">Dexfenfluramine</a>, Levofenfluramine)</li>
<li><a href="Fenproporex.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenproporex" title="Fenproporex">Fenproporex</a></li>
<li>Flucetorex</li>
<li>Fludorex</li>
<li>Formetorex</li>
<li>Furfenorex</li>
<li>Gepefrine</li>
<li>4-Hydroxyamphetamine</li>
<li>Iofetamine</li>
<li>Isopropylamphetamine</li>
<li>Lefetamine</li>
<li><a href="Lisdexamfetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lisdexamfetamine" title="Lisdexamfetamine">Lisdexamfetamine</a></li>
<li>Mefenorex</li>
<li><a href="Metaraminol.htm" tppabs="https://ptable.com/wiki/compounds/A/Metaraminol" title="Metaraminol">Metaraminol</a></li>
<li><a href="Methamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamphetamine" title="Methamphetamine">Methamphetamine</a> (Dextromethamphetamine, Levomethamphetamine)</li>
<li>Methoxyphenamine</li>
<li>MMA</li>
<li>Morforex</li>
<li>Norfenfluramine</li>
<li><a href="L-Norpseudoephedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/L-Norpseudoephedrine" title="L-Norpseudoephedrine"><span style="font-size:90%;">L </span>-Norpseudoephedrine</a></li>
<li>N,alpha-Diethylphenylethylamine</li>
<li>Oxifentorex</li>
<li>Oxilofrine</li>
<li>Ortetamine</li>
<li>PBA</li>
<li>PCA</li>
<li>Phenpromethamine</li>
<li>PFA</li>
<li>PFMA</li>
<li>PIA</li>
<li><a href="Para-Methoxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Para-Methoxyamphetamine" title="Para-Methoxyamphetamine">PMA</a></li>
<li>PMEA</li>
<li>PMMA</li>
<li><a href="Phenylpropanolamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenylpropanolamine" title="Phenylpropanolamine">Phenylpropanolamine</a></li>
<li><a href="Pholedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pholedrine" title="Pholedrine">Pholedrine</a></li>
<li><a href="Prenylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Prenylamine" title="Prenylamine">Prenylamine</a></li>
<li>Propylamphetamine</li>
<li><a href="Pseudoephedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pseudoephedrine" title="Pseudoephedrine">Pseudoephedrine</a></li>
<li><a href="Sibutramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Sibutramine" title="Sibutramine">Sibutramine</a></li>
<li>Tiflorex</li>
<li><a href="Tranylcypromine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tranylcypromine" title="Tranylcypromine">Tranylcypromine</a></li>
<li>Xylopropamine</li>
<li>Zylofuramine<br><i>Entactogens:</i> 4-FA</li>
<li>4-FMA</li>
<li>4-MA</li>
<li>4-MMA</li>
<li>4-MTA</li>
<li>5-APB</li>
<li>5-APDB</li>
<li>5-EAPB</li>
<li>5-IT</li>
<li>5-MAPB</li>
<li>5-MAPDB</li>
<li>6-APB</li>
<li>6-APDB</li>
<li>6-Chloro-MDMA</li>
<li>6-EAPB</li>
<li>6-IT</li>
<li>6-MAPB</li>
<li>6-MAPDB</li>
<li>EDA</li>
<li>IAP</li>
<li>2,3-MDA</li>
<li><a href="3,4-Methylenedioxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/3%2C4-Methylenedioxyamphetamine" title="3,4-Methylenedioxyamphetamine">3,4-MDA (tenamfetamine)</a></li>
<li>MDEA</li>
<li>MDHMA</li>
<li><a href="MDMA.htm" tppabs="https://ptable.com/wiki/compounds/A/MDMA" title="MDMA">MDMA (midomafetamine)</a></li>
<li>MDOH</li>
<li>Methamnetamine</li>
<li>MMDMA</li>
<li>Naphthylaminopropane</li>
<li>TAP<br><i>Others:</i> 3,4-DCA</li>
<li>Amiflamine</li>
<li>DiFMDA</li>
<li><a href="Selegiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Selegiline" title="Selegiline">Selegiline</a> (also <span style="font-size:90%;">D </span>-Deprenyl)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Phentermine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phentermine" title="Phentermine">Phentermines</a></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Stimulants:</i> <a href="Chlorphentermine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorphentermine" title="Chlorphentermine">Chlorphentermine</a></li>
<li>Cloforex</li>
<li><a href="Clortermine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clortermine" title="Clortermine">Clortermine</a></li>
<li>Etolorex</li>
<li><a href="Mephentermine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mephentermine" title="Mephentermine">Mephentermine</a></li>
<li>Pentorex</li>
<li><a href="Phentermine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phentermine" title="Phentermine">Phentermine</a><br><i>Entactogens:</i> MDPH</li>
<li>MDMPH<br><i>Others:</i> Cericlamine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Cathinones</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Stimulants:</i> 3-FMC</li>
<li>4-MC</li>
<li>4-BMC</li>
<li>4-CMC</li>
<li>4-EMC</li>
<li>4-FMC</li>
<li>4-MEC</li>
<li>4-MeMABP</li>
<li>4-MPD</li>
<li><a href="Amfepramone.htm" tppabs="https://ptable.com/wiki/compounds/A/Amfepramone" title="Amfepramone">Amfepramone</a></li>
<li>Benzedrone</li>
<li>Brephedrone</li>
<li>Buphedrone</li>
<li><a href="Bupropion.htm" tppabs="https://ptable.com/wiki/compounds/A/Bupropion" title="Bupropion">Bupropion</a></li>
<li><a href="Cathinone.htm" tppabs="https://ptable.com/wiki/compounds/A/Cathinone" title="Cathinone">Cathinone</a></li>
<li>Dimethylcathinone</li>
<li>Ethcathinone</li>
<li>Eutylone</li>
<li>Hydroxybupropion</li>
<li>Methcathinone</li>
<li>Methedrone</li>
<li>NEB</li>
<li>N-Ethylhexedrone</li>
<li>N-Ethylpentedrone</li>
<li>Pentedrone</li>
<li>Pentylone</li>
<li>Radafaxine<br><i>Entactogens:</i> 3,4-DMMC</li>
<li>3-MMC</li>
<li>Butylone</li>
<li>Ethylone</li>
<li>Methylone</li>
<li>Methylenedioxycathinone</li>
<li>Mephedrone</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Phenylisobutylamines</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Entactogens:</i> 4-CAB</li>
<li>4-MAB</li>
<li>Ariadne</li>
<li>BDB</li>
<li>Butylone</li>
<li>EBDB</li>
<li>Eutylone</li>
<li>MBDB<br><i>Stimulants:</i> Phenylisobutylamine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Phenylalkylpyrrolidines</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Stimulants:</i> α-PBP</li>
<li>α-PHP</li>
<li>α-PPP</li>
<li>α-PVP</li>
<li>MDPBP</li>
<li>MDPPP</li>
<li>MDPV</li>
<li>4-MePBP</li>
<li>4-MePHP</li>
<li>4-MePPP</li>
<li>MOPPP</li>
<li>MOPVP</li>
<li>MPBP</li>
<li>MPHP</li>
<li>MPPP</li>
<li>Naphyrone</li>
<li>PEP</li>
<li>Prolintane</li>
<li>Pyrovalerone</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Catecholamines<br><span style="font-size:90%;">(and close relatives) </span></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>6-FNE</li>
<li><a href="Oxidopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/6-Hydroxydopamine" title="6-Hydroxydopamine" class="mw-redirect">6-OHDA</a></li>
<li><a href="Alpha-Methyldopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Alpha-Methyldopamine" title="Alpha-Methyldopamine">a-Me-DA</a></li>
<li>a-Me-TRA</li>
<li>Adrenochrome</li>
<li>Ciladopa</li>
<li><span style="font-size:90%;">D </span>-DOPA (Dextrodopa)</li>
<li>Dimetofrine</li>
<li><a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">Dopamine</a></li>
<li>Epinephrine</li>
<li>Epinine</li>
<li>Etilefrine</li>
<li>Ethylnorepinephrine</li>
<li><a href="Fenclonine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenclonine" title="Fenclonine">Fenclonine</a></li>
<li>Ibopamine</li>
<li><a href="Isoprenaline.htm" tppabs="https://ptable.com/wiki/compounds/A/Isoprenaline" title="Isoprenaline">Isoprenaline</a></li>
<li><a href="Isoetarine.htm" tppabs="https://ptable.com/wiki/compounds/A/Isoetarine" title="Isoetarine">Isoetarine</a></li>
<li><a href="L-DOPA.htm" tppabs="https://ptable.com/wiki/compounds/A/L-DOPA" title="L-DOPA"><span style="font-size:90%;">L </span>-DOPA</a> (Levodopa)</li>
<li><a href="L-DOPS.htm" tppabs="https://ptable.com/wiki/compounds/A/L-DOPS" title="L-DOPS" class="mw-redirect"><span style="font-size:90%;">L </span>-DOPS</a> (Droxidopa)</li>
<li><a href="Phenylalanine.htm" tppabs="https://ptable.com/wiki/compounds/A/L-Phenylalanine" title="L-Phenylalanine" class="mw-redirect"><span style="font-size:90%;">L </span>-Phenylalanine</a></li>
<li><span style="font-size:90%;">L </span>-Tyrosine</li>
<li><i>m</i>-Tyramine</li>
<li>Metanephrine</li>
<li><a href="Metaraminol.htm" tppabs="https://ptable.com/wiki/compounds/A/Metaraminol" title="Metaraminol">Metaraminol</a></li>
<li>Metaterol</li>
<li><a href="Metirosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Metirosine" title="Metirosine">Metirosine</a></li>
<li><a href="Methyldopa.htm" tppabs="https://ptable.com/wiki/compounds/A/Methyldopa" title="Methyldopa">Methyldopa</a></li>
<li>N,N-Dimethyldopamine</li>
<li>Nordefrin (Levonordefrin)</li>
<li>Norepinephrine</li>
<li><a href="Norfenefrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Norfenefrine" title="Norfenefrine">Norfenefrine</a> (<i>m</i>-Octopamine)</li>
<li>Normetanephrine</li>
<li><a href="Orciprenaline.htm" tppabs="https://ptable.com/wiki/compounds/A/Orciprenaline" title="Orciprenaline">Orciprenaline</a></li>
<li><i>p</i>-Octopamine</li>
<li><a href="Tyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyramine" title="Tyramine"><i>p</i>-Tyramine</a></li>
<li><a href="Phenylephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenylephrine" title="Phenylephrine">Phenylephrine</a></li>
<li><a href="Synephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Synephrine" title="Synephrine">Synephrine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Miscellaneous</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>AL-LAD</li>
<li>Amidephrine</li>
<li><a href="Arbutamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Arbutamine" title="Arbutamine">Arbutamine</a></li>
<li>Cafedrine</li>
<li>Denopamine</li>
<li>Desvenlafaxine</li>
<li>Diphenidine</li>
<li>Dizocilpine</li>
<li><a href="Dobutamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dobutamine" title="Dobutamine">Dobutamine</a></li>
<li>Dopexamine</li>
<li>Ephenidine</li>
<li>Etafedrine</li>
<li>ETH-LAD</li>
<li>Famprofazone</li>
<li>Fluorolintane</li>
<li>Hexapradol</li>
<li>IP-LAD</li>
<li>Lysergic acid amide</li>
<li>Lysergic acid 2-butyl amide</li>
<li>Lysergic acid 2,4-dimethylazetidide</li>
<li><a href="Lysergic_acid_diethylamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Lysergic_acid_diethylamide" title="Lysergic acid diethylamide">Lysergic acid diethylamide</a></li>
<li><a href="Methoxamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methoxamine" title="Methoxamine">Methoxamine</a></li>
<li>Methoxphenidine</li>
<li>MT-45</li>
<li>PARGY-LAD</li>
<li>Phenibut</li>
<li>PRO-LAD</li>
<li>Pronethalol</li>
<li><a href="Salbutamol.htm" tppabs="https://ptable.com/wiki/compounds/A/Salbutamol" title="Salbutamol">Salbutamol</a> (Levosalbutamol)</li>
<li>Solriamfetol</li>
<li>Theodrenaline</li>
<li><a href="Thiamphenicol.htm" tppabs="https://ptable.com/wiki/compounds/A/Thiamphenicol" title="Thiamphenicol">Thiamphenicol</a></li>
<li>UWA-101</li></ul>
</div></td></tr></tbody></table></div>


















<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-07-30" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=MDMA&oldid=970308198  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=MDMA&oldid=970308198'" tppabs="https://en.wikipedia.org/wiki/?title=MDMA&oldid=970308198">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>
<script src="../-/j/js_modules/mw.MediaWikiPlayer.loader.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mw.MediaWikiPlayer.loader.js" class=""></script>
<script src="../-/j/js_modules/mw.PopUpMediaTransform.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mw.PopUpMediaTransform.js" class=""></script>
<script src="../-/j/js_modules/mw.TMHGalleryHook.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mw.TMHGalleryHook.js" class=""></script>



</body></html>